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ABSTRACT 
Studies were undertaken to clone and characterise a two-component regulatory system from 
a clinical isolate (204) of the human and animal pathogen Burkholderia pseudomallei. A 
number of genomic libraries were constructed in E. coli host-vector systems and screened 
for the presence of a two-component system using oligonucleotide probes based on 
nucleotide sequence homology. Fragments of genomic DNA were cloned and sequenced 
and found to possess two open reading frames (ORFs) that overlap with a single nucleotide 
and are believed to encode a novel two-component regulatory system. A possible promoter 
region was identified upstream of the two ORFs, mrgR and mrgS, which read in the same 
direction and may represent an operon. The deduced translation of mrgR reveals a protein, 
MrgR, which possesses conserved motifs that are consistent with the phosphorylation 
domains and DNA-binding helix-turn-helix structure of a family of response regulatory 
proteins. The deduced translation of mrgS reveals that the MrgS protein possesses all the 
invariant amino acids that characterise other sensor regulatory proteins. Southern 
hybridisation studies showed that the mrgRS locus was present in 19 isolates of B. 
pseudomallei from a wide geographical derivation, but not in any closely related bacterial 
species, including Burkholderia thailandensis. The expression of the two genes was verified 
using antibodies developed to synthetic peptides based on sequences from the C- and N-
terminal regions of MrgR and MrgS, respectively. The specificity of the antibodies was 
confirmed in Western blotting studies in which almost all of mrgR and the proximal quarter 
of mrgS were translationally fused with malE (MBP-MrgR and MBP-MrgS) and expressed 
in E. coli K12. The antibodies were used to probe Western blots ofcellular.and extracellular 
extracts of different isolates of B. pseudomallei and identified multiple bands in whole-cell 
lysates. The sizes of two of these bands were 24 kDa.and 115 kDa, which may represent the 
unprocessed forms of MrgR and MrgS, respectively. It was proposed that the other bands 
represented either isoforms or degradation products of the full-length proteins. The 
recognition of all bands was abolished following pre-incubation of the antibodies with the 
immunising peptide but remained unaffected if an .·irrelevant peptide, was used for this 
purpose. Western blot analysis demonstrated that serum antibodies from a patient with acute 
melioidosis recognised MBP-MrgR but not MBP-MrgS suggesting'a possible role for MrgR 
in the disease process. The expression ofmrgR and mrgS was found to be constitutive in B. 
pseudomallei that had been cultured using different combinations of temperature, pH and 
NaCl suggesting that the genes perform a number of biological functions. There is some 
evidence that at 42°C the processing of MrgR and MrgS may be altered and the possible 
mechanisms for this are discussed. B. pseudomallei grew better at 42°C and pH 5 and less 
well at 25°C and pH 8 and this was influenced by NaCl concentration partly reflecting the 
environmental distribution and intracellular nature of the pathogen. Environmental and 
clinical isolates of B. pseudomallei differed in the pH optimum for growth at 42°C. The 
DNA flanking the mrgRS locus in isolate 204 was cloned, sequenced, and seven ORFs were 
identified including a transcriptional regulatory gene similar to bvgR of Bordetella pertussis. 
Southern blot analysis using three different DNA probes revealed restriction fragment length 
polymorphisms (RFLPs) in the region downstream of mrgRS. Two distinct RFLP patterns 
were identified among 16 different isolates of B. pseudomallei. The potential effects of this 
variation on gene expression and protein function await further investigation. 
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CHAPTER 1 
INTRODUCTION 
Burkholderia pseudomallei is a saprophytic gram-negative bacillus taxonomically 
placed within the family Burkholderiaceae. The bacterium is an opportunistic pathogen that 
is capable of intracellular survival and causes melioidosis, a frequently fatal disease of 
humans and animals, which can be difficult to diagnose. B. pseudomallei is resistant to many 
antibiotics and prolonged multiple antibiotic treatment is often not fully effective and 
relapses are common (Dance, 1990). There is currently no licensed vaccine for melioidosis. 
Although the pathogen is mainly distributed in the soil and water of tropical regions, 
especially south-east Asia and northern Australia, it is able to survive and grow in a wide 
range of environments (Dance, 1991 ). The disease encompasses a broad spectrum of clinical 
symptoms and outcomes, including long periods of latency up to 29 years (Leelarasamee, 
1998). Melioidosis is regarded as an emerging disease and there is some concern that the 
disease may become more widespread with the increasing growth in world trade, tourism 
and travel. Up to 7 million people are at risk in north-east Thailand alone (Currie et al., 
2000b). The attention focused on B. pseudomallei in recent years reflects these concerns. 
Although a number of components have been recently characterised that may 
contribute to the virulence of B. pseudomallei and the pathogenesis of melioidosis, there is 
still a general lack of knowledge about the pathogen (Brown & Beacham, 2000). In 
particular, how the organism is capable of successfully fulfilling its' role as a saprophyte and 
a pathogen. This unique behaviour stimulated our interest in the ways in which B. 
pseudomallei interacts with its' surrounding environment. Bacteria possess highly complex 
systems for controlling their growth and the production of the components that are required 
for survival, in response to their environment. They respond to environmental change by 
altering gene expression via a number of sensory and regulatory pathways that can act either 
individually or in concert with other regulatory networks. Two-component signal 
transduction systems provide the most common means employed by bacteria for regulating 
2 
these adaptive responses to their environment (Stock et al., 2000). In their simplest form, 
two-component signal systems elegantly combine the functions of a sensor, transducer and 
transcriptional regulator within two proteins. Without such sensory pathways bacteria would 
be unable to survive the onset of harsh or deleterious conditions. In order to survive and 
colonise a wide variety of environments, B. pseudomallei must be equipped with 
mechanisms that allow the bacterium to firstly, sense and respond to substantial changes in 
its' environment; secondly, suitably modify its' metabolism and growth potential; and 
thirdly, successfully adapt to these new circumstances. An improved understanding of the 
molecular basis for these adaptive responses will provide valuable information about how 
the bacterium survives and causes disease and assist in the formulation of new approaches 
for interfering with these processes. Therefore, the aims of this thesis were to: 
I) Identify the genes encoding a two-component regulatory system in B. pseudomallei, 
2) Characterise the genes and the flanking regions of the genome, 
3) Examine the possible conditions under which B. pseudomallei modifies the expression of 
these genes. 
The direction of the study was guided by comparative examples drawn from our 
knowledge of other bacterial species, particularly those that share genetic or pathogenic 
similarities. Over the course of this research project a number of experiments were 
performed in order to investigate other aspects of B. pseudomallei, only those that concur 
with the major aims of the work are discussed. The major finding of this study has been the 
identification and molecular characterisation of a two-component signal transduction locus. 
lt is hoped that this locus may be of diagnostic use. 
The aims of the work described in this thesis were facilitated by applying molecular 
techniques for the study of B. pseudomallei according to the strategy outlined in the 
following flow diagram: 
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Construction of B. pseudomallei DNA genomic 
libraries in A. bacteriophage cloning vectors 
Screening of DNA genomic libraries with labelled 
DNA probes 
Selection, identification and characterisation of 
recombinant clones 
DNA sequence analysis of a two-component 
regulatory locus and its' flanking regions 
Southern hybridisation analysis of genomic DNA 
from different B. pseudomallei isolates 
Construction and expression of recombinant fusion 
proteins and production of polyclonal antibodies 
Investigation of gene expression under different 
environmental conditions 
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CHAPTER2 
LITERATURE REVIEW 
5 
2.1 BURKHOLDERJA PSEUDOMALLE/ 
2.1.1 General aspects 
Burkholderia pseudomallei is a small, aerobic, non-acid-fast, non-spore-bearing Gram 
negative bacillus, motile by polar tuft of one to four flagella (Brindle & Cowan, 1951 ), the 
latter being a distinctive feature that distinguishes B. pseudomallei from the closely related 
non-motile species, Burkholderia mallei. The bacterium is oxidase positive, often shows 
bipolar staining, and obtains its energy for growth by respiration and not fermentation 
(Bokman et al., 1957). Other characteristic properties include the accumulation of poly-~­
hydroxybutyrate as intracellular granules; arginine dihydrolase and gelatinase activities; and 
resistance to aminoglycoside and polymyxin antibiotics (Levine & Wolochow, 1960; 
Redfearn et al., 1966). Moreover, B. pseudomallei is known to have a nitrate reductase 
activity that is a requirement for anaerobic respiration and it can grow and survive under 
oxygen-limited conditions by switching from aerobic to anaerobic metabolism 
(Wongwanich et al., 1996). The bacterium is the causative agent of the frequently fatal 
disease of humans, melioidosis (Smith et al., 1987; Dance, 2000a). 
B. pseudomallei is a free-living organism in the natural environment of tropical and 
sub-tropical regions. It is found widely in the soil and surface water of rice paddies, fields 
newly planted with oil palm, monsoon drains, gardens, and playgrounds in endemic areas. It 
is nutritionally versatile and can, for example, utilise an exceptionally wide range of organic 
compounds as the sole source of its carbon and energy needs (Redfeam et al., 1966). 
B. pseudomallei grows readily on most standard culture media, with a tendency to form 
microcolonies and biofilms (Vorachit et al., 1993), but for initial isolations Ashdown's 
selective medium that contains crystal violet and gentamicin (Ashdown, 1979) is favoured. 
The bacterium can grow at temperatures between 18-42oC, and will tolerate 5oC for up to 
190 days (Yabuuchi et al., 1993), but the optimum temperature for growth in vitro is 
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between 37-42oC, reflecting the temperature of the tropical and sub-tropical climate (Dance, 
2000abc). In contrast, Tong et al. (1996) showed that under laboratory conditions, the 
optimum temperature for survival appears to be between 24 and 32oC and B. pseudomallei 
was purportedly isolated at 20oC from drinking water in Bologna, Italy (Zanetti et al., 2000). 
The evidence suggests that B. pseudomallei adapts well to a variety of growth conditions 
(Dejsirilert et al., 1991). For example, it is able to grow in brain heart infusion broth of 
initial pH 4.5 under aerated or non-aerated conditions and survives well for up to 30 days. 
Colonies of B. pseudomallei vary considerably in their morphology depending on the 
culture media and the strain of the organism, ranging from the most common rough type to 
smooth and sometimes even to mucoid appearance (Nicholls, 1930; Dance, 1989). Colonies 
often appear wrinkled, and have a strong musty, earthy odor after incubation for 2 to 3 days 
(Salisbury & Likos, 1970; Dance, 1990; Walsh & Wuthiekanun, 1996). 
Genome analysis of B. pseudomallei has shown that its average gene size is I 031 base 
pairs, and the mol% guanine +cytosine content is 65.7% (range 55.6-74.0%). The genome 
is gene-rich with about 89% of the capacity used as coding sequences. It can therefore be 
estimated that the entire B. pseudomallei genome encodes about 5600 genes (Songsivilai & 
Dharakul, 2000). 
2.1.2 Nomenclature and taxonomy 
Until recently, B. pseudomallei was known as Pseudomonas pseudomallei and over the 
course of the last 80 years has been called Bacillus pseudomallei, Bacillus whitmori, 
Pfeifferella whilmori, Flavobacterium pseudomallei, Actinobacillus pseudomallei, 
Loefferella whitmori and Malleomyces pseudomallei (Howe et al., 1971; Patamasucon et al., 
1982; Sanford, 1985; Brown & Thin, 1986). 
Since the description of Haynes (1957) and until about 1992 this organism was 
classified as a member of the genus Pseudomonas (Migula, 1894) because of many 
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similarities in cultural, morphological and biochemical characteristics. Furthermore, this 
genus included human pathogens such as the opportunistic Pseudomonas aeruginosa, that 
infects wounds, bums and the lungs of cystic fibrosis sufferers and Pseudomonas cepacia, 
an opportunist pathogen in hospital patients, previously known as a phytopathogen and a 
cause of 'soft rot' of onions (Palleroni & Holmes, 1981). Many Pseudomonas species are 
plant pathogens, including P. syringae and P. viridiflavae, the cause of substantial post-
harvest losses of fruits and vegetables, and P. gladioli, the cause of 'flower-rot' in gladioli. 
On the other hand, some strains of P. jluorescens and P. putida display a rather different 
interaction with plants, colonising the roots of several crops and causing significant yield 
increases through production of anti-microbial agents and iron scavenging compounds 
(Schippers et al., 1987). 
Palleroni & Holmes (1981) divided the genus Pseudomonas into five groups of species 
according to the results of rRNA-RNA hybridisation. Subsequently, on the basis of the 16S 
rRNA sequences comparisons, DNA-DNA homology values, cellular lipid and fatty acid 
composition, and phenotypic characteristics, the genus Pseudomonas has been reclassified. 
Yabuuchi et al. ( 1992) transferred seven species of genus Pseudomonas homology group II 
to a new genus Burkho/deria, named after an American bacteriologist W. H. Burkholder, 
with the type species being B. cepacia. Initially, B. cepacia, B. mallei, B. caryophy/li, B. 
gladioli, B. pickettii, B. solanacearum and B. pseudomallei were included in the genus. 
Currently more than 15 species have been placed in the genus Burkho/deria, and these are 
mostly soil saprophytes or plant pathogens; the exceptions are the human pathogens B. 
pseudomallei, B. mallei and B. cepacia. Subsequently, B. pseudomallei and B. mallei were 
found to be genetically indistinguishable, but because of epidemiological dissimilarities, 
they have remained separate species. 
Recently, isolates of B. pseudomallei have been differentiated into two biotypes which 
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distinguish between those that can assimilate L-arabinose (Ara+) and those that can not 
(Ara·) (Smith et al., 1997). Almost all of the clinical isolates of B. pseudomallei are Ara·, 
while both Ara+ and Ara· are found in the soil. The two biotypes exhibit distinct differences 
in their virulence in animal models of infection. Only the Ara- isolates appear to cause 
disease [LD 50 of -10 units ( cfu) in Syrian hamsters (DeShazer et al., 1997a) and 102 cfu in 
mice (Smith et al., 1997)], while the Ara+ isolates are nonvirulent [LD50 of >109 cfu in 
mice]. Differences also exist between the biotypes in the production of proteinase, lipase, 
lecithinase and other enzymes, and in lipopolysaccharide composition. Smith et al. (1997) 
suggested that Ara+ might be different enough from Ara- to warrant its inclusion in a new 
species within the genus Burkholderia. Based on the difference in 16S rRNA gene sequence 
and other supporting evidence, Ara· strains have currently been classified as true B. 
pseudomallei while Ara+ strains are considered to represent a separate species termed B. 
thailandensis (Brett et al., 1998). 
More recently, Songsivilai & Dharakul (2000) analysed the genomes of both B. 
pseudomallei and B. thailandensis by pulsed field gel electrophoresis. They showed that the 
B. pseudomallei genome consisted of two large replicons indicating the presence of two 
chromosomes. B. pseudomallei has chromosomes of approximately 3563 and 2974 
megabase-pairs in size, giving a total genome size of about 6.54 megabase-pairs that places 
it with the largest bacterial genomes. In contrast, the two chromosomes of B. thailandensis 
are about 20% smaller than B. pseudomallei. 
2.1.3 Distribution in the environment 
B. pseudomallei is endemic to south-east Asia and northern Australia, although the 
distribution of the bacterium elsewhere is well documented. Early surveys conducted in 
Malaysia (Strauss et al., 1969), showed that B. pseudomallei was readily isolated from wet 
rice fields and other cleared, cultivated areas. In the urban environment of Singapore, the 
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bacterium was commonly found in soil/water samples from sports fields (Thin et al., 1971 ). 
In Thailand, B. pseudomallei is more frequently found in the south of the country 
(Natchiangmai et al. 1985), from cultivated areas such as rubber plantations and rice fields, 
and in the soil of the north-east (Wuthiekanun et al., 1995). Soil conditions in the north-east 
region of Thailand, the major endemic area of melioidosis, are mostly acidic in a pH ranging 
from 4.38 to 7. 7 (Mitsuchi et al., 1986). Kanai & Kondo (1994) attributed the occurrence of 
B. pseudomallei in such environments to its ability to survive under low pH (4.5). On the 
other hand, Dance (2000abc) considered that the uneven presentation of the bacteria could 
be attributed to technical factors, such as the technique used for the environmental survey, 
the sensitivity of different culture conditions for the isolation of environmental B. 
pseudomallei and the lack of a protocol that considers the so-called viable non-cultivable 
state of the organism, which is thought to be important in the environmental survival of 
other bacteria (Barer et al., 1993). Furthermore, several other factors were found to 
influence the distribution of B. pseudomallei in soil such as temperature, rainfall, sunlight, 
and the physical, chemical and biological characteristics of the soil. 
2.1.4 Survival 
The extended survival of B. pseudomallei in the natural environment, especially its 
resistance to drying, has been demonstrated in field and experimental systems (Stanton & 
Fletcher, 1932; Everett & Nelson, 1975; Soy et al., 1983). The organism was shown to 
remain viable and to retain its virulence even after 27 days of desiccation within garden soil 
at 27oC. It appears that B. pseudomallei can survive in distilled water (Wuthiekanun et al., 
1995) and also in moist clay soil kept in the shade at tropical room temperature, for up to 36 
months (Thomas et al., 1981). However, survival times were much shorter in dry, sandy 
soil. On the other hand, in the dry season B. pseudomallei may survive in a dormant state of 
low metabolic activity in the deeper layers of the soil with poor aeration. In rice paddies, B. 
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pseudomallei has the opportunity to survive not only in the aerobic layer of around 20 mm 
thickness prevailing under the surface water but also in the anaerobic layer located below the 
aerobic layer. Wongwanich et al. (1996) presumed that ammonium sulfate fertiliser will be 
converted to into HN03 by the action of nitrifying bacteria in the aerobic layer and the 
resulting HN03 will move to the anaerobic layer to serve the nitrate respiration of B. 
pseudomallei. Interestingly, Choy et al. (2000) reported that B. pseudomallei demonstrated 
an ability to survive for some time in 'Saffan' (alphaxalone 9 mg/ml and alphadalone 3 
mg/ml solution), an injectable anaesthetic for cats and 'Savlon liquid' (cetrimide 3% and 
chlorhexidine 0.3% solution), an antiseptic/disinfectant solution commonly used for the 
preparation of a surgical site and surgical instrument decontamination. 
Little is known about the behavior of B. pseudomallei in the natural environment. In 
particular, many questions remain unanswered concerning the viable non-cultivable state of 
the organism and its relationship with plants or other protozoans. It is possible that B. 
pseudomallei can survive in soil and water by parasitising other organisms. B. pseudomallei 
is a facultative intracellular bacterial pathogen, and other species in this category, for 
example, L. pneumophila, Mycobacterium avium, and Listeria monocytogenes have been 
shown to survive as endosymbionts in amoebae. Inglis et al. (2000) exposed B. 
pseudomallei to three different amoebic species and showed that the bacterium was able to 
survive within the vacuoles of free-living amoebae. This in vitro demonstration of the 
interaction between B. pseudomallei and free-living Acanthamoebae raises the possibility 
that a similar interaction in vivo might promote environmental survival of B. pseudomallei 
and subsequent human exposure. Since the parasitism of amoebae by bacteria bears a 
striking resemblance to the infection of human phagocytic cells, Inglis et al. (2000) 
postulated the occurrence of similar phenomena in mammalian phagocytic cells. 
Other possible host-parasite relationships have been suggested. Certain strains of B. 
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cepacia can reside in the rhizosphere, the region of the soil modified as a result of the uptake 
and deposition of substances by a growing plant root, and in this case bacteria growing in 
close association with root nodules assist in the fixation of nitrogen and the uptake of 
minerals by the plant (Pitt et al., 2000). Although a specific host for B. pseudomallei has not 
yet been described it is possible that it plays a similar role in the rice paddy field. Moreover, 
Bianciotto et al. (1996) and Ruiz-Lozano & Bonfante (1999) demonstrated the presence of a 
Burkholderia species living in the cytoplasm of Gigaspora margarita, a fungus that is 
known to establish symbiotic associations with the root tissues of more than 80% of land 
plants. Morphological observations show that the obligately intracellular Burkholderia 
multiplies both inside the fungal spore and in the mycelium during differentiation of the 
colonisation structures (Bonfante et al., 1994). If this were the case with B. pseudomallei, it 
may help explain the abundance of the bacteria in certain environments, particularly 
cultivated tropical regions, rather than other areas. 
2.1.5 Opportunistic and intracellular pathogen 
Opportunistic pathogens are organisms that under most circumstances do not cause 
disease. In these cases virulence can be defined only with reference to the host condition. 
Thus, a change or inherent weakness in host resistance initiates the process of infection. 
Opportunistic infections are common nowadays, partly because in circumstances where 
specific microbial pathogens have been effectively eliminated, opportunistic infections are 
relatively more numerous and also because modem medical care keeps alive many people 
who have impaired resistance to microbial infections (Mims et al., 1997). Examples of 
opportunistic pathogens are P. aeruginosa, that is essentially a free-living species sometimes 
present in the intestinal tract, and B. cepacia, an infective agent in hospital patients, but also 
a phytopathogen (Palleroni & Holmes, 1981 ). Although B. pseudomallei infections have 
been documented in otherwise healthy individuals, the organism usually behaves as an 
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opportunist and susceptible individuals have an underlying predisposition such as diabetes 
or renal disease (Chaowagul et al., 1989; Woods et al., 1993). 
Microbial pathogens have evolved several strategies for successfully infecting host 
organisms. One such strategy is the colonisation of niches that allow survival and even 
replication in conditions that are relatively unaffected by host defence mechanisms. 
Intracellular niches seem to be particularly useful for the long-term survival of microbial 
pathogens despite ongoing host immune responses and/or antimicrobial therapy, and many 
diseases caused by intracellular pathogens take a chronic course (Kaufmann & Reddehase, 
1989). 
The clinical manifestation of B. pseudomallei infection and its protracted course have 
led investigators to suspect that the bacterium is a facultative intracellular pathogen which is 
capable of invading eukaryotic cells. B. pseudomallei has been observed to survive and 
multiply within phagocytes (Jones et al., 1996). Wongwanich et al. (1996) demonstrated, by 
electron microscopy, the presence of B. pseudomallei within the phagosomes of 
mononuclear cells and attributed this to the ability of the bacteria to grow in an acidic 
environment such as occurs within phagosomes, pH 4.7 to 5.5 (Sprich, 1956). These 
observations indicated that B. pseudomallei is similar to other facultative intracellular 
bacteria, such as L. monocytogenes and Salmonella typhi. Macrophages and neutrophils kill 
ingested microorganisms by various means including a respiratory burst that leads to the 
production of hydrogen peroxide, superoxide radicals, and other oxygen-derived radicals, 
together with activation of myeloperoxidase. Lysosomes fuse with the pathogen-containing 
phagosome and release their acid hydrolases (glycosidases, proteases, and lipases) (Moulder, 
1985). Therefore, intracellular bacteria have adopted various ways for surviving the 
microbicidal activity of phagocytes, including interference with reactive reactive oxygen 
intermediates, inhibiting phagosome-lysosome fusion (e.g. legionellae, mycobacteria), 
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resistance to bactericidal lysosomal enzymes (e.g. salmonellae), and evading phagosome-
lysosome fusion by escaping into the cytoplasm (e.g. Listeria, shigellae) (Kaufmann, 1993). 
In order to survive inside macrophages, Salmonella have developed a set of at least 40 
proteins that confer resistance to reactive forms of oxygen and defensins, toxic host peptides 
that kill bacteria (Kaufmann & Flesch, 1992). In addition, salmonellae possessing Vi 
capsular polysaccharide are less susceptible to killing by lysosomal contents than rough 
mutants that lack the long polysaccharide chains. B. pseudomallei also possesses a capsular 
polysaccharide that may contribute to serum resistance and intracellular survival. This 
matter is considered in more detail in section 2.4.2.5. 
The mechanism by which B. pseudomallei are able to enter host cells is unknown. 
Studies in vivo (Dannenberg & Scott, 1958) and in vitro (Pruksachartvuthi et al., 1990) 
showed that B. pseudomallei can invade, survive and replicate in 'professional' and 'non-
professional' phagocytes including rat alveolar macrophages, human neutrophils, and 
cultured epithelial cell lines, such as HeLa, CHO, A459, and Vero (Jones et al., 1996). An 
examination of the infected cells by electron microscopy confirmed the presence of 
intracellular bacteria located within membrane-bound vacuoles. B. pseudomallei was able to 
replicate inside human neutrophils after 16 hand in A459 epithelial cells for up to 48 h. In 
addition, the authors demonstrated the degeneration of the membranes of vacuoles 
containing the pathogen in infected cells. Furthermore, Ho et al (1997) observed that a small 
percentage of bacteria could survive the oxidative and nonoxidative bursts following 
phagocytosis by human neutrophils when incubated in the presence of 10% heat-inactivated 
rabbit or human serum. The occurrence of relapsing and late-onset infection has been 
attributed to the ability of B. pseudomallei to survive within macrophages (Sanford et al., 
1971; Praksachartvuthi et al., 1990; Jones et al., 1996). 
In order to establish an infection in a susceptible host, a microbial pathogen must avoid 
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killing by non-specific and specific host defence mechanisms. Intracellular survival and a 
strong resistance to the bactericidal activity of normal human serum (Ismail et al., 1988; 
Egan & Gordon, 1996; Pruksachartvuthi et al., 1990) provides B. pseudomallei with this 
capability. The pathogen is a facultative intracellular parasite that, like mycobacteria, may 
remain dormant in host macrophages for many years. 
2.2 MELIOIDOSIS DISEASE 
2.2.1 General aspects 
Melioidosis is a life-threatening disease that affects humans and animals in tropical and 
subtropical areas where it is known to be a major public health problem. It has been termed 
"the great imitator" of every infectious disease, as virtually any organ can be infected. The 
disease has been qualified as an emerging infection, since it has been recognised more 
frequently during the past two decades, both within established endemic areas and elsewhere 
(Dance, 2000a). The severity of the disease depends on one or more of the following: the 
extent to which host defences are impaired, the strain of the bacterium, and the magnitude 
and route of the inoculum. 
2.2.2 History 
A British pathologist, Captain A. Whitmore, and C. S. Krishnaswami, an assistant 
surgeon, at Rangoon General Hospital, Burma first identified melioidosis in 1911. They 
conducted a post-mortem on a 40-year-old patient suspected of having human glanders who 
had died of pneumonia, and the disease was first known as Whitmore's disease. The post-
mortem examination revealed wide spread lesions not only in the lungs but also in the liver, 
spleen and kidney. It became apparent that the disease was common among the ill-
nourished, neglected Rangoon people with or without morphine addiction and Whitmore 
reported 38 cases of the infection. Since the initial report, cases of melioidosis have been 
regularly reported from South East Asia, although recent interest was generated following 
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reports of the infection in American servicemen serving in Vietnan1. 
In 1921, Stanton and Fletcher coined the term melioidosis, when B. pseudomallei was 
isolated from the blood of a patient in Malaysia. The term is derived from the Greek word 
"melis" meaning "a distemper of donkeys (actually asses)" . The disease resembles glanders, 
which is predominantly a pulmonary disease in asses caused by the bacterium B. mallei 
(formerly known as Pseudomonas mallei) . The same authors in 1932 predicted that 
melioidosis would prove to be far more prevalent than appreciated at that time. They 
concluded that the wild rat was the natural reservoir of an infection that was spread via the 
faeces and urine to the soil and vegetation. They proposed that the infection was 
consequently transmitted to humans through the ingestion of contaminated food or water. 
Several years later, French workers in lndo-China observed that the occurrence of 
melioidosis often followed exposure to mud and water (Dance, 2000b ), and Chambon 
(1955) isolated the bacterium from the mud and water of ponds and rice paddies in South 
Vietnam. It thus became apparent that B. pseudomallei was a saprophyte, and that both man 
and animals were likely to fall victim following exposure to the organism in soil and surface 
water (Dance, 2000b). Although over 300 human cases had been documented by 1957 
(Smith et al. , 1987), melioidosis was a rare event in developed countries until 343 cases of 
the disease were reported among American soldiers serving in the Vietnam war forcing a 
significant reappraisal of the importance of the disease. 
In Thailand, despite the diagnosis of an imported case m 1928 and two cases in 
prisoners of war in 194 7, the first indigenous case was not described until 1955 (Dance, 
1991 ). Punyagupta (1989) reviewed 686 cases of melioidosis. More recently, with 
increasing recognition of the disease, it has been estimated that there are from 2000 to 5000 
cases of melioidosis each year in Thailand (Dharakul & Songsivilai, 1996). 
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2.2.3 Geographical distribution 
The disease is most commonly recognised in south-east Asia and northern Australia 
(Fig 2.1)· In south-east Asian countries serological evidence indicated a widespread 
occurrence of melioidosis in its sub-clinical asymptomatic form (Smith et al., 1987). 
Surveys carried out in Malaysia and Thailand have revealed the presence of circulating 
antibodies to the causative organism in 15-30% of the normal population (Nigg 1963; 
Strauss et al., 1969) and up to 80% of 4 year old children in north-east Thailand (Kanaphun 
et al., 1993) whilst in northern Australia the incidence of seroconversion was reported to be 
5-10% among at risk groups by Ashdown & Guard (1984). 
Sporadic cases of melioidosis have been described in many other regions of the world 
such as the Indian subcontinent, Pacific Islands, Africa, the Caribbean and Central and 
South America, Iran, China, Korea, Philippines, Mexico, Indonesia, Madagascar, Turkey, 
Indonesia, France and UK. Although the disease may be less common elsewhere, many 
thousands of people may die annually from melioidosis world wide, and many millions 
experience minor infections and are at risk of subsequent relapse. It is estimated that about 7 
million people are at risk in north-east Thailand alone (Currie et al., 2000c). 
It is important to note that the frequency of isolation of B. pseudomallei from the 
environment may not be directly related to the incidence of melioidosis in an area 
(Trakulsomboon et al., 1997). Such discrepancies may be partly reflected by phenotypic 
differences between some clinical and environmental isolates (Anuntagool et al., 1998). The 
disease incidence recorded by one hospital in Ubon Ratchathani in north-east Thailand is 
approximately 4.4 per 100 000 population per year (Suputtamongkol et al., 1994). In this 
province melioidosis is the cause of 20% of all community-acquired septicaemias, and 40% 
of deaths that are attributed to septicaemia (Chaowagul et al., 1989). However, it is likely 
that this figure is an underestimate due to problems of diagnosis. The Thai estimate 
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Fig 2.1: Geographical distribution of melioidosis. Shaded areas indicate known endemic 
regions, hatched areas and asterisks indicate sporadic cases. Adapted from Dance (1991). 
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compares with a smaller exposed population in the Northern Territory of Australia of around 
140,000 people, but with an average annual incidence of 18 per I 00,000 (Currie et al., 
2000c). 
A relationship between the geographical distribution of B. pseudomallei and the 
prevalence of human infection has not been clearly established. Melioidosis is not evenly 
distributed within endemic areas, and hot spots for melioidosis were reported during the 
Vietnam War. Dance (2000b) attributed this to the uneven distribution of B. pseudomallei in 
soil (because of climatic, geological or ecological factors), differences in the virulence of 
strains of B. pseudomallei, regional variations in cultural practices leading to exposure (e.g. 
farming techniques), or to differences in the susceptibility of populations to infection. 
Since the B. pseudomallei is nutritionally diverse and is capable of resisting a variety of 
environmental extremes, it is puzzling as to why a more uniform global distribution of the 
bacterium is not more apparent (Smith et al., 1987). It is possible that the disease remains 
greatly under diagnosed in many areas of the tropics where sophisticated laboratory facilities 
are not available. Whatever the reasons it seems likely that the increasing movement of 
humans, animals or infected materials made easier by the huge increase in international 
trade, travel and tourism will provide more opportunities for melioidosis to spread from 
established areas to new pastures (Dance, 2000a). The observation that all recent isolations 
that have been reported from non-endemic areas appear to have been derived from endemic 
areas supports this suggestion. 
2.2.4 Transmission 
Transmission of B. pseudomallei commonly occurs in two ways: 1) by direct contact 
with contaminated soil and/or water through pre-existing skin cuts and abrasions (the 
majority of infections), and 2) inhalation or ingestion of dust particles containing the 
bacteria. 
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Direct contact with the organism through cuts and abrasions is thought to be the most 
frequent means of exposure. In regions where the pathogen is endemic this occurs 
commonly among farmers as a consequence of their occupation and among children whilst 
working and playing (section 2.2.5). However, it has only been proven in from 5-25% of 
cases (Currie et al., 2000c ). 
Although common for some pathogens, e.g. Bordetella pertussis and Mycobacterium 
tuberculosis, inhalation may be a less frequent means for transmission of B. pseudomallei. 
Inhalation has been suggested as a major route of infection during the Vietnam War, where a 
disproportionate number of helicopter crewmen succumbed to B. pseudomallei infections as 
compared to other soldiers stationed in the same region. To explain this phenomenon, it has 
been proposed that the helicopter rotors acted to disturb infectious particles in the dust 
around landing zones, dispersed greater amounts of B. pseudomallei in the air, and thus 
facilitated the pulmonary inoculation of the crewmen (Howe et al., 1971; Sanford, 1990). 
On the other hand, Currie et al. (2000a) postulated haematogenous spread to the lungs 
following presumptive inoculating skin injuries rather than inhalation or spread from the 
upper respiratory tract. 
B. pseudomallei can survive at low pH (Tong et al., 1996), a feature that characterises 
pathogens that follow a faecal-oral route e.g. enteric pathogens such as Salmonella, and the 
possibility of occasional ingestion has been raised (Howe et al., 1971; Dance, 1990). It has 
been shown experimentally that animals can be infected via the oral or nasal mucosa or by 
ingestion (Whitmore, 1913; Stanton & Fletcher, 193 2) although no gastrointestinal lesions 
were found in the infected animals. The possibility that ingestion may be important in some 
circumstances (Cottew, 1952) is supported by autopsy findings of the presence of infected 
gastro-hepatic lymph nodes in pigs (Ketterer et al., 1986), and cases that are thought to be 
associated with contaminated drinking water (lnglis et al., 1998). 
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Horizontal transmission of melioidosis has not yet been proved to be significant and 
there is no evidence for a B. pseudomallei carrier state in humans (Kanaphun et al., 1993). 
Human-to-human transmission of melioidosis has been suspected in only two reports of the 
disease (McCormick et al., 1975; Kunakom et al., 1991). However, there is evidence that 
the bacterium can cross the placenta to infect the foetus or pass perinatally from mother to 
child. In 1997, a goat with melioidosis aborted twins and died soon afterwards. B. 
pseudomallei was isolated from the mother's uterus and from the spleen of one of the 
aborted twins, confirming the transplacental infection. Thomas et al. ( 1988) also supported 
the possibility of this mode of transmission. Transmission from animal to human has been 
reported anecdotally (Galimand & Dodin, 1982; Choy et al., 2000) although infected 
animals may play a role in the dissemination of the organism to new environments (Dance, 
1990; Golledge et al., 1992). Apart from one suspected case (Kan & Kay, 1978), arthropod-
borne infection apparently does not occur naturally (Sanford, 1985), although transmission 
has been accomplished experimentally in guinea pigs both by the bite of the mosquito 
(Aedes aegypti) and of the rat flea (Xenopsylla cheopis) (Sanford, 1995). Moreover, at least 
two incidences of laboratory-acquired melioidosis have been reported (Green & Tuffnell, 
1968). 
In summary, the main route of transmission is probably via percutaneous inoculation 
with contaminated soil or water, although in some circumstance inhalation of aerosols and 
ingestion may be important, while person to person transmission is rare. 
2.2.5 Occupation, age, sex, and season 
In Thailand, the infection is most common m rice-farming communities, an 
environment where individuals are more likely to be exposed to the pathogen. In northern 
Thailand, 81% of all cases of melioidosis occurred in rice farmers or their families 
(Suputtamongkol et al. 1994). Moreover, during an outbreak in Australia, Merianos et al. 
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(1993) found that the risk of melioidosis was approximately I 0-fold higher among 
individuals who were occupationally exposed to soil compared with indoor workers. 
Melioidosis may present at any age (White, 1994). In a study of 423 cases of culture-
positive melioidosis in Ubon Ratchatani, north-east Thailand, Suputtamongkol et al. (1994) 
observed a bimodal age distribution, with the lower peak occuring in the first 9 years of life 
and the highest age-specific incidence occurring at 50-59 years in women and 60-69 years in 
men. Men are more often affected than women or children, and male predominance has been 
cited in many studies (Rode & Webling, I98I; Guard et al., I984; Suputtamongkol et al., 
I994). The male:female ratio in the incidence of melioidosis of 1.5: I in Thailand 
(Suputtamongkol et al., I994) contrasted with that of 5: I in Singapore (Anonymous, 1995), 
and probably reflected work-related differences in exposure to soil and water through rice 
farming (Dance, 2000c). Approximately 20% of cases occur in children under IS years of 
age. Recent reports from Thailand suggest a higher prevalence of the disease in children 
than previously recognised with a unique spectrum of symptoms, notably the presence of 
parotid abscesses (Dance et al., 1989). Infection in the neonatal period has been reported, 
but rarely (Edmond et al., 1998; Halder et al., I998). 
Melioidosis is regarded as a disease which is predominantly associated with the 
tropical monsoon season and the number of cases increase as the rainy season progresses in 
endemic areas and farmers become busy in their fields (Congakpoon et al., I989; 
Sookpranee et al., I989). The risk of exposure to B. pseudomallei, and possible infection, 
are particularly high at the beginning of the wet season in the endemic areas (November-
April) when ploughing and planting of seedlings are performed without protective clothing 
and minor skin trauma is extremely common (Chaowagul et al., 1989; Leelarasamee & 
Bovomkitti, 1989). It is possible that B. pseudomallei organisms lying dormant in the deeper 
layers of the soil will be carried to the surface as the water table rises during the course of 
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the rainy season. In such moistened soil, the organisms will regenerate enhancing their 
potential to infect exposed humans and animals (Kanai & Kondo, 1994). Moreover, the re-
activation of latent disease has been strongly associated with seasonal change and in 
northern Australia 85% of such cases arise during the wet season (Currie et al., 2000c). The 
wet season is therefore an important factor in disease transmission (Golledge et al., 1992). 
2.2.6 Diagnosis 
It seems likely that melioidosis is often under-diagnosed, especially in poor, rural areas 
where appropriate microbiological facilities are not available. The specific diagnosis of 
melioidosis requires awareness on the part of clinicians, and the existence of a laboratory 
capable of isolating and identifying B. pseudomallei (Dance, 2000a). It also demands a high 
degree of clinical suspicion, especially in residents or travelers from endemic areas, and 
particularly if the presenting features are those of fulminant respiratory failure. When overt 
infection occurs it may initially defy diagnosis because of its tendency to resemble other 
more common conditions. Leelarasamee & Bovornkitti (1989) reported that it is difficult to 
estimate the number of cases of melioidosis accurately since many cases are not recognised 
or are misdiagnosed. Among the bacterial infections it rivals syphilis as the great mimicker. 
The high mortality rate (approximately 95%) among acute fulminating melioidosis sufferers 
is mainly due to the failure to recognise the disease in the early stages of an infection (Smith 
et al., 1987). 
Smith et al. ( 1987) elucidated the major limitations that hampered the evaluation and 
recognition of the disease. These included: the wide array of signs and symptoms presented 
by acute melioidosis; the long period of latency associated with chronic melioidosis; and the 
unavailability of suitable diagnostic procedures for melioidosis. Consequently, diagnosis 
depends upon the rapid isolation and identification of the causative organism and/or the 
identification of a specific marker antigen, such as B. pseudomallei exotoxin, in the serum or 
23 
tissues of patients. The diagnostic methods for the identification of clinical and subclinical 
melioidosis are presented in Fig 2.2· 
2.2.6.1 Bacterial culture and identification 
Isolation of the bacterium in culture from clinical specimens is the 'gold standard' for 
laboratory diagnosis of melioidosis, since it is relatively simple and economical to perform 
(Table 2.1). However, because a high percentage of patients with acute septicaemia die 
within 24-48 h of admission, the time required for the isolation and identification of B. 
pseudomallei from blood culture, 3 days-2 weeks, is too lengthy to allow the administration 
of effective therapy in many cases (Dance, 1990; Sirishinha et al., 2000). 
The commercial API 20 NE kit, a substrate-utilisation test panel, was first used by 
Dance et al. (1989) as an easily transportable tool for the biochemical identification of B. 
pseudomallei. The kit identified 390 (97.5%) strains correctly on first testing and all but one 
of the remainder on second testing, although other workers have reported the 
misidentification of B. pseudomallei by this method (lnglis et al., 1998). A serious problem 
in ascertaining the presence of B. pseudomallei in environmental and clinical specimens lies 
in isolating and differentiating the bacterium from the heterogeneous population of 
organisms that may be present (Dance, 1991). Mixed infection with other frequently 
encountered species is possible in endemic areas of melioidosis, where the numbers of B. 
pseudomallei that are present are often relatively low (Werner et al., 1967). Furthermore, B. 
pseudomallei has a generation time of 45 min at 37°C which is lengthy compared with many 
bacterial species (Werner et al., 1967) and the resultant overgrowth by faster growing 
bacteria can mask the pathogen's presence (Kunakorn et al., 2000; Sirisinha et al., 2000). B. 
cepacia is often misidentified as B. pseudomallei and vice versa. Both B. pseudomallei and 
B. cepacia are soil saprophytes, opportunistic pathogens and are similar in their genetic 
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Fig 2.2: Clinical and diagnostic methods for the isolation and identification of B. pseudomallei. 
Adapted from Madigan et al. (1999). 
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Table 2.1: The results of the API 20NE test for identifying B. pseudomallei 
Test Results 
Nitrate reduction + 
Indol (TRP) -
Glucose fermentation -
Arginine dihydrolase + 
Urease -
Aesculin hydrolysis +/-
Gelatinase + 
Galactosidase -
Assimilation of: 
Glucose + 
Arabinose -
Mannose + 
Mannitol + 
Maltose -
N-acetyl-glucosamine + 
Gluconate + 
Caprate + 
Adipate + 
Malate + 
Citrate + 
Phenyl-acetate + 
Oxidase + 
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makeup, colonial morphology, ability to catabolise a wide variety of organic compounds, 
and resistance to the aminoglycoside and polymyxin groups of antibiotics, such as 
gentamicin and colistin (Dance 1990). Another species that sometimes causes confusion is 
Chromobacterium violaceum a soil and water inhabitant that has recently emerged as a 
human pathogen, although the exact reasons for misidentification are not clear in this case 
(Inglis et al., 1998). 
Nevertheless, following isolation in pure culture, the conclusive identification of B. 
pseudomallei can be achieved by a combination of simple tests involving Gram's stain, 
oxidase reaction, typical growth characteristics, and antibiotic resistance (Leelarasamee, 
2000). 
2.2.6.2 Serological tests 
A variety of serological tests for detecting host antibody responses to B. pseudomallei 
have been developed including immunofluorescence (IF A), indirect haemagglutination 
(IHA), complement fixation, and enzyme-linked immunosorbent assay (ELISA). These 
methods have limited value for routine use because of the crude nature of the antigens used 
(Sirisinha, 1991 ), occasional false-positive reactions, and the high background seropositivity 
of many individuals from populations within the endemic areas (Sermswan et al., 1994). It is 
been estimated that more than 80% of children in rice-farming communities in north-east 
Thailand have acquired antibodies against B. pseudomallei, as detected by IHA, by the time 
they are 5 years old (Kanaphun et al., 1993). Nevertheless, the IHA test, remains the most 
widely used serological test for the diagnosis of melioidosis, especially in non-endemic 
areas (Dance, 1990). A crude autoclaved culture filtrate (Ashdown, 1987) or 
lipopolysaccharide extracted from the organism are most commonly used as the antigen for 
the IHA test. 
Serological methods for the detection of the soluble secreted products of B. 
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pseudomallei in blood and urine, and bacterial cells in pus, wound, sputum and throat swabs 
have also been developed. These include a monoclonal antibody-based assay for the 
quantitation of exotoxin (lsmail et al., 1987), and polyclonal antibody-based ELISAs for the 
detection of secreted antigens (Wongratanacheewin et al., 1990) and LPS (Petkanjanapong 
et al., 1992). However, these tests have yet to be evaluated for their clinical usefulness on a 
large-scale (Sirisinha et al., 2000). Recently, Steinmetz et al. (1999) developed a simple 
latex agglutination test for the rapid identification of B. pseudomallei culture isolates, using 
an exopolysaccharide-specific monoclonal antibody (Map 30 15). A variety of B. 
pseudomallei isolates from environmental and clinical sources were tested and showed a 
strong and specific agglutination. In contrast, avirulent B. thailandensis and a variety of 
other bacterial species did not react. 
2.2.6.3 Nucleic acid detection 
There are a variety of diagnostic techniques for the detection and identification of 
bacteria in clinical samples based on characteristic DNA sequences. Nucleic acid-based 
detection systems can allow the identification of bacteria without the need for isolation in 
pure culture (Salyers & Whitt, 1994) or the propagation of living organisms, which 1s 
important for dangerous human pathogens such as B. pseudomallei. The technique 1s 
especially useful for the detection of organisms that can not easily be grown in vitro (leven, 
1998) and nucleic acid-based methods have the potential to provide a rapid, specific and 
highly sensitive means for the detection and identification of pathogenic bacteria (Lew & 
Desmarchelier, 1994). 
(i) Polymerase chain reaction (PCR) 
PCR, a technique for the amplification of DNA sequences in vitro, has been widely 
used to assist in the diagnosis of infectious diseases, for example Streptococcus pneumoniae 
(Zhang et al., 1995), Neisseria gonorrhoeae (Wong et al., 1995). It can be highly specific, 
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provided that the appropriate PCR primers are chosen, thus allowing rapid identification and 
the speed and sensitivity of the technique make it ideal for 'high-throughput' automated 
screening of blood and tissue samples. Furthermore, PCR can detect a single copy of a target 
DNA sequence and therefore requires only small samples for analysis. Although B. 
pseudomallei survives and multiplies intracellularly (Pruksachartvuthi et al., 1990), there 
may be substantial numbers in blood samples, therefore direct analysis of clinical specimens 
with PCR may aid in early diagnosis (Kunakom & Markham, 1995). 
PCR assays using primers based on conserved regions in 168 rRNA gene (Dharakul et 
al., 1996; Brook et al., 1997), 238 rRNA gene (Lew & Desmarchelier, 1994) and 168-238 
rRNA gene spacer (Kunakom & Markham, 1995) have been reported, but this method 
cannot always distinguish B. mallei from B. pseudomallei. Based on the nucleotide sequence 
of a B. pseudomallei-specific DNA probe (8ermswan et al., 1994), Rattanathongkom et al. 
(1997) developed a PCR assay using primers named LP8 I and LP82. The reaction amplified 
a 178-bp sequence from the DNA of I 00 clinical B. pseudomallei isolates, without 
amplification from the DNA of any of the 18 other bacterial species tested, including B. 
cepacia and P. aeruginosa. However, a study comparing these primers with primer sets 
based on 168 rDNA andl68-238 rRNA gene spacer for the PCR diagnosis of melioidosis 
using blood samples taken from septicaemic patients showed that no single set of primers 
could detect all strains of B. pseudomallei (Kunakorn et al., 2000). Hence multiple sets of 
primers are needed for the conclusive diagnosis of B. pseudomallei in order to compensate 
for strain variation. Moreover, none of these PCR assays has been subjected to critical 
evaluation in the field (8irisinha et al., 2000). 
(ii) Nucleic acid hybridisation 
An alternative approach that is currently used for the clinical diagnosis of various 
bacterial diseases such asS. typhi (Rubin et al., 1985), Legionella spp (Edelstein, 1986), and 
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Neisseria gonorrhoeae (Torres et al., 1991), is nucleic acid hybridisation using a specific 
DNA probe. The basic principle of this method is the detection of a specific nucleic acid 
sequence by hybridisation to a complementary sequence of DNA or RNA, a labelled probe, 
followed by detection of the label (Ieven, 1998). Moseley et al. (1980) first applied this 
technology to an infectious disease, for the detection of enterotoxigenic E. coli by DNA-
DNA hybridisation in stool samples. 
A specific DNA probe (pKKU-S23L) was developed and used for the detection of B. 
pseudomallei by dot blot, and was also used to examine 60 clinical B. pseudomallei isolates 
for restriction fragment length polymorphism following Hindlii digestion of total cellular 
DNA (Sermswan et al., 1994). The probe showed no cross-hybridisation with total cellular 
DNA from closely related bacteria such as B. cepacia and P. aeruginosa. Whilst as little as 
1.5 ng of genomic DNA or 4 x I 04 bacterial cells could be detected the hybridisation 
technique was not sufficiently sensitive for routine diagnostic use (Lew & Desmarchelier, 
1994; Sermswan et al., 1994). 
2.2.7 Clinical manifestations and pathology 
The signs and symptoms of melioidosis can mimic various other infections, including 
common bacterial septicemia, malaria, tuberculosis, coccidioidomycosis, and 
histoplasmosis. Furthermore, when the infection manifests itself in an acute form, the 
disease may show gastrointestinal symptoms that can be confused with dysentery or typhoid 
(Stanton & Fletcher, 1932; Khaira et al., 1959). Although the spectrum of clinical symptoms 
is broad, human melioidosis can be divided into three categories: acute, sub-acute and 
chronic disease. 
Localised suppurative infection; acute pneumoma or an overwhelming septicaemia 
characterises acute forms of the disease, which is rapidly fatal. It is a severe illness, with the 
rapid onset (24-48 h) of ill-defined symptoms. Acute forms of the disease may follow either 
30 
a pulmonary or a septicaemic course. Acute pulmonary symptoms appear rapidly and 
usually involve the upper lobes of the lung. They are characterised by high fever and 
pulmonary distress with non-productive or productive cough, followed by the appearance of 
visceral abscesses and death within a few days if left untreated. The septicaemic form is 
characterised by the dissemination of the bacteria via the blood to various organs, and is also 
rapidly fatal. This form occurs predominantly in-patients with underlying diseases (Sanford, 
1995), with clinical indications including malaise, meningitis, cellulitis, as well as cutaneous 
and subcutaneous lesions (Dance, 1990; Sanford, 1990). It is also the most common cause of 
fatality by community-acquired septicaemia in north-eastern Thailand and bacteraemic 
pneumonia in northern Australia. If improperly handled, the mortality rate of the acute 
septicaemic cases can be as high as 70-80% due to shock, respiratory failure, and multiple 
organ failure (Chaowagul et al., 1989; Boonsawat et al., 1990). Even when diagnosis can be 
accomplished quickly and antibiotic therapy is initiated soon after admission, the mortality 
rate is still high (Sirisinha et al., 2000). 
Sub-acute melioidosis is much less severe, with infrequent fatalities. It can arise from a 
primary infection that remains sub-acute or occur as a result of the reactivation of a previous 
infection. It is best described as a prolonged febrile illness characterised by multi-organ 
involvement, systemic abscess formation and bacteraemia. Typically exhibiting pulmonary 
involvement, symptoms are similar to the acute pulmonary form of disease. During the latter 
stages of the disease, the organism can be readily cultured from blood, pus, urine and other 
bodily tissues and secretions (Smith et al., 1987). Most cases of melioidosis seen in non-
endemic areas belong to this group (Ip et al., 1995). Patients may be entirely asymptomatic 
(apart from pulmonary radiograph) or they may present with a disease indistinguishable 
from pulmonary tuberculosis, with a low-grade fever and weight loss that evolves over the 
course of months (Ip et al., 1995; Currie et al., 2000c ). 
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Chronic illness is believed to be the most common form of the disease (Sanford, 1985). 
Described as a 'medical time bomb' because of the ability of asymptomatic chronic infection 
to flare up suddenly into a rapidly fatal form, chronic melioidosis may persist undiagnosed 
for decades. Diagnosis is most often achieved by post-mortem examination of infected 
tissues, or when clinical indications present themselves upon activation of the disease by a 
traumatic event (Brett et al., 1997). In a serologic surveillance study of US army personnel 
who had been stationed in Vietnam, 1-2% had significant antibody titres to B. pseudomallei, 
suggesting acquisition of subclinical melioidosis without developing overt disease (Sanford, 
1971 ). In non-endemic areas, diagnostic clues include a history of travel or residence in an 
endemic area, even in the distant past. Occasionally, patients may present with a fever of 
unknown origin without any obvious localising signs (lp et al., 1995). 
Melioidosis may be commonly localised in the lung and most patients who have the 
disease in a severe form show an infection of the lungs (Smith et al., 1987). However, 
during either acute or chronic infection the organism can be readily isolated from any organ, 
and lesions can form in any tissue including skin and subcutaneous tissues, bones and joints, 
liver, spleen, pancreas, kidney, bladder, prostate gland, genital organs, brain and meninges, 
parotid glands (especially in children), lymph nodes, and pericardium. Moreover, B. 
pseudomallei is similar to K. pneumoniae in its predilection for invading the blood stream, 
causing metastatic abscesses and fulminant pneumonia (Lim, 1997). The histopathology of 
lesions caused by B. pseudomallei vary from acute to chronic granulomatous inflammation, 
a necrotising reaction with varying numbers of neutrophils, macrophages, lymphocytes and 
giant cells (Li & You-wen, 1992; Wong et al., 1995) that resembles the reaction caused 
during tuberculosis (Leelarasamee & Bovornkitti, 1989; Dance, 1990; Sirikulchayanonta & 
Subhadrabandhu, 1994). Likewise, examination of infected tissue reveals either necrotising 
suppuration or granuloma formation (Yabuuchi & Arakawa, 1993) or nodules consisting of 
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polymorphonuclear leukocytes (Liu, 1981 ). Moreover, chest radiographic changes include 
airspace consolidation, lung abscesses, and nodular densities, sometimes with cavitation, 
and, less commonly, pleural effusions (Everett & Nelson, 1975; Chaowagul et al., 1989; Tan 
et al., 1995). 
Further manifestations of melioidosis are regularly described, including the so-called 
'neurological melioidosis'. Although long recognised in both animals (Dannenberg & Scott, 
1958) and humans (Laws & Hall, 1963), the reported occurrence of such neurological 
abnormalities has usually been low. In Australia, studies at Royal Darwin Hospital have 
documented that from 1989 to 1998, there were 232 treated melioidosis cases, 12 of which 
(5%) displayed neurological melioidosis (Currie et al., 2000b). In Thailand, Punyagupta 
(1989) documented that 19/686 (3%) patients with melioidosis had CNS involvement. 
Symptoms comprise cranial nerve palsies, peripheral motor weakness, brain-stem 
encephalitis, aseptic meningitis and respiratory failure (Woods et al., 1992; Lath et al., 
1998). In addition, although bone infection is rare, Subhadrabandhu et al. ( 1995) described 
I 0 cases of melioidotic osteomyelitis. 
In summary, melioidosis encompasses a wide clinical spectrum including acute, sub-
acute and chronic symptoms. Once the individual is infected, the disease may manifest itself 
in many ways including local cutaneous lesions, subacute pneumonia, focal organ abscesses 
and fulminate septicaemia with or without multiple organ abscesses. 
2.2.8 Latency and predisposing factors 
Latency can be defined as the period of persistence of a pathogen in the host without 
concurrent damage, but with the potential for reactivation resulting in active pathogenic 
processes (Penn, 1992). Melioidosis can occur in individuals decades after an initially 
asymptomatic infection, demonstrating the pathogens persistent nature and ability to cause 
severe disease later in life when the host immune system is weakened (Dance, 1991 ). The 
33 
incubation period for acute melioidosis is between I and 21 days, with a mean of 9 days 
(Flamma et al., 1969; Achana et al., 1985; Wang et al., 1993; Suputtamongkol et al., 1994; 
Currie et al., 2000c). It is likely that the inoculating dose, mode of infection, host risk factors 
and differential virulence of B. pseudomallei strains will influence the incubation period 
(Howe et al., 1971; Leelarasamee & Bovomkitti, 1989). The incubation period for chronic 
melioidosis ranges from three weeks up to 29 years following exposure to soil or surface 
water (Chodimella et al., 1997). The activation of latent infection is often associated with 
concurrent disease or injury. Indeed, the long periods of latency and frequent relapses after 
antibiotic treatment are characteristic features of chronic melioidosis (Dance, 1990). 
The majority of patients with clinically apparent melioidosis are recognised as having 
underlying diseases: 76% in Malaysia (Putucheary et al., 1992); 88% in Australia (Currie et 
al., 1993); and 53% in Thailand (Suputtamongkol et al., 1994). Thus it appears that 
melioidosis is often associated with conditions resulting in immune suppression, such as 
diabetes, but the disease may also occur without recognisable risk factors. During a 1 year 
study of patients admitted to a hospital in north-eastern Thailand for treatment of 
septicaemic melioidosis, 32% demonstrated pre-existing diabetes mellitus (Chaowagul et 
al., 1989). In the Australian Northern Territory, a similar figure (36%) was observed (Currie 
et al., 2000a), while the prevalence of diabetes mellitus among patients with melioidosis in 
Singapore was 64% (Lim, 1997). Similarly, it has been shown in a diabetic infant rat model 
of infection that such animals are far more sensitive to challenge with B. pseudomallei 
isolates than are the healthy, non-diabetic rats (Woods et al., 1993). Although it is well 
documented that diabetics have an increased risk of contracting infectious diseases, the 
possible contribution of insulin to the progress of melioidosis has been investigated. Despite 
initial evidence showing that human insulin suppressed the growth of B. pseudomallei 
(Woods et al., 1993), a recent thorough reappraisal of the interaction of insulin with 100 
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clinical isolates found that the growth of B. pseudomallei was unaffected by pure insulin 
(Simpson & Wuthiekanun, 2000). Nevertheless, human insulin has been shown to bind to B. 
pseudomallei cells (Kanai et al., 1996). 
Other specific risk factors that have been identified are alcohol and drug abuse, renal 
disorders, malignancy, HIV infections, connective tissue diseases, heavy occupational 
exposure and ethnicity (Whitmore & Krishnaswami, 1912; Whitmore, 1913; Leelarasamee 
& Bonomkitti, 1989; Tanphaichitra, 1989). 
Human leukocyte antigen (HLA) polymorphism or HLA linked genes may 
substantially influence the type and intensity of the immune response that develops 
following B. pseudomallei infection and determine the course of the disease (Dharakul et al., 
1998). HLA molecules determine the peptide antigens that are presented to T cells and 
therefore selectively activate antigen-specific T lymphocyte subsets. Host genetic factors are 
known to be important in diseases caused by other intracellular pathogens such as 
tuberculosis and leprosy e.g. DR2 (Khomenko et al., 1990; Mehra, 1990; Rani et al., 1993). 
Particular HLA class 11 alleles were common in certain groups of melioidosis patients, 
especially those with severe clinical disease (ORB I* 1602), as well as the relapse cases 
(DRBI*0701). There was no HLA association with localised melioidosis or melioidosis with 
pre-existing diabetes mellitus. 
2.2.9 Outbreaks of melioidosis in animals 
Melioidosis in animals extends the geographic distribution of the disease further into 
Africa (Chad, Egypt, Madagascar, and Niger) (Dance, 1991) and Europe and outbreaks of 
melioidosis have been reported in animals from endemic and non-endemic areas. In non-
endemic areas these outbreaks have been attributed to the importation of animals from 
endemic areas. Foumier (1965) considered that this accounted for the introduction of 
melioidosis into Aruba, and also into Australia after World War 11 (Dance, 2000abc). 
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Melioidosis can develop in a wide spectrum of hosts with varying susceptibility. All species 
of domestic animals may occasionally be affected but the most common are goats, sheep and 
pigs (Choy et al., 2000). However, mortality in animals such as the banded leaf-monkey, 
galah, horse, camel, kangaroo and dolphin have been reported (Thomas, 1981 ; Asche, 1991 ; 
Wernery et al., 1998). Although melioidosis has occurred in dogs, cats and cattle, these 
animals are considered to be fairly resistant to the disease, unless immunocompromised 
(Choy et al., 2000). Moreover, some animals, such as fowl and water buffalo, are regarded 
as immune to the organism (Smith et al., 1987). The latter is frequently used to pull ploughs 
in rice paddies and is, therefore, expected to encounter the microbe on a regular basis (Brett 
& Woods, 2000). 
Among animals, melioidosis was first described from Australia in an outbreak in sheep 
in 1949 in Winton, north Queensland (Cottew, 1950). Since then there have been reports of 
mortalities among sheep, goats, and pigs living on Caribbean islands (1957), dolphin in a 
Hong Kong oceanarium ( 1975), lambs in southern Australia, cattle in south-east Queensland 
(Ketterer et al., 1975), and swine in the Burnett River Valley of Queensland (Ashdown & 
Guard, 1984). The most extensive outbreak of melioidosis in a non-endemic region occurred 
in France in the mid-1970s amongst the animals of a Paris zoo, which had been exposed to 
heavily contaminated soil. The disease subsequently spread to other zoos in Paris and 
throughout France resulting in a number of animal deaths and at least two human fatalities. 
The origin of the outbreak was traced to either infected horses imported from Iran to France, 
or a panda donated to France by Mao Tse Tung in 1973 (Dance, 1991 ). 
In summary, a wide range of animals, terrestrial and aquatic are affected by melioidosis 
with varying severity, and outbreaks often occur following the movement of infected stock. 
2.2.10 Animal models of melioidosis 
Early experimental studies showed that many animal species such as hamster, guinea 
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pig, rabbit, monkey, rat and mouse are sensitive to B. pseudomallei infection (Miller et al., 
1948; Dannenberg & Scott, 1958; Jayanetra et al., 1975). However, the recent availability of 
animal models for melioidosis has boosted research into pathogenesis. These models exhibit 
varying degrees of susceptibility to infection, ranging from diabetic infant rats, which are 
most susceptible, through Syrian hamsters and guinea pigs, to relatively resistant inbred and 
outbred stains of mice. The difference in susceptibility to B. pseudomallei infection has been 
investigated for strains of inbred mice, revealing that BALB/c mice are highly susceptible 
whereas C57BI/6 mice are relatively resistant (Leakey et al., 1998). The course of infection 
in BALB/c mice was similar to acute infections in humans and the mice suffered a rapidly 
progressive bacteraemia, leading to death after 96 hours. In contrast, infection of C57BI/6 
mice appeared to mimic chronic human melioidosis and the mice remained asymptomatic 
for up to 6 weeks. The reasons for these differences may be related to the greater production 
of the proinflammatory cytokines TNF -a, IL-l p and IL-6 in BALB/c mice, as compared 
with C57BL/6 mice, which may contribute to their acute susceptibility (Ulett et al., 2000). 
In addition to enhancing the antimicrobial activity of macrophages, these prointlarnmatory 
cytokines are important mediators of endotoxic shock (Havell & Sehgal, 1991; Takasuka et 
al., 1991). Regulation of their production is therefore critical to the outcome of infection 
especially in the early stages of a non-specific immune response. 
2.2.11 Treatment, relapse and prevention 
The treatment of melioidosis is challenging because B. pseudomallei is resistant in vitro 
to a variety of antimicrobial agents including penicillins, first and second generation 
cephalosporins and many of the aminoglycosides (Dance et al., 1989; Leelarasamee & 
Bovornkitti, 1989; and Godfrey et al., 1991). In addition, because B. pseudomallei can 
survive and multiply intracellularly, antibiotics that penetrate macrophages are thought to be 
a much more effective therapy (Slauch et al., 1995), although it has not been proven 
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clinically. Hence it is important to choose the most appropriate drugs for treatment as 
quickly as possible in order to reduce the risk of mortality (Leelarasamee & Bovornkitti, 
1989). 
Except for kanamycin and ceftazidime, all the usable antibiotics are bacteriostatic and 
may not be effective, especially in the septicaemic form of melioidosis. Until the 1980s, the 
usual treatment for confirmed cases of acute melioidosis was a combination regime 
comprising chloramphenicol, tetracyclines and co-trimoxazole (Dance, 2000c). However, 
for the last decade, ceftazidime is the drug of choice for the treatment of severe melioidosis. 
It was shown to reduce the mortality of patients with septicaemic melioidosis from 74% to 
3 7% when used alone (White et al., 1989) and from 4 7% to 18.5%, when used in 
combination with co-trimoxazole (Sookpranee et al., 1992), compared with conventional 
combination treatment. However, treatment can involve up to 9 months of antibiotic therapy 
for clearance of the infection (Leelarasamee & Bovornkitti 1989), and relapse is common. 
Relapse after an apparently successful primary treatment (Chaowagul et al., 1993 ), 
presumably results from the re-emergence of surviving intracellular bacteria. It has been 
reported to occur in 20-30% of survivors of severe melioidosis in north-east Thailand after 
eight weeks treatment (Dance, 1990; Currie et al., 2000a). The explanation for this is the 
ability of B. pseudomallei to survive within phagocytic cells, production of a glycocalyx, 
and formation of microcolonies in infected tissue (Vorachit et al., 1995). Vorachit et al. 
(2000) suggested that the ideal antimicrobial agents for melioidosis therapy should have a 
bactericidal effect, be able to penetrate phagocytic cells, and eliminate or inhibit the 
production of a glycocalyx. 
In endemic areas, reducing the risk of exposure by wearing protective clothing or by 
attempting to avoid exposure to the organism are not realistic options. Therefore efforts have 
been directed towards prevention by the development of vaccines for effective immunisation 
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(Brett & Woods, 1996; Dance, 2000c). 
2.2.12 Host immune responses 
Host defence against infection with facultative intracellular bacteria such as Salmonella 
and Listeria is predominantly mediated by cellular immune mechanisms. Macrophages can 
kill these pathogens particularly after stimulation with gamma interferon (IFN-y), produced 
by natural killer cells and T lymphocytes, which enhances antimicrobial activity (Kaufmann, 
1993). Although humoral immunity may play a significant role in the resolution of many 
infectious diseases, this is not the case in melioidosis where high levels of circulating 
antibodies against the LPS provide no basis for long-term protection (Razak et al., 1986; 
Bryan et al., 1994). Ulett et al. (1998) demonstrated that enriched peritoneal macrophages 
are unable to effectively kill B. pseudomallei without T lymphocyte interaction and 
attributed the mechanisms responsible for acute and chronic clinical presentations of human 
melioidosis to the balance between Th I /Th2 responses. This is a similar situation for chronic 
infections caused by intracellular pathogens such as mycobacteria (Kaufmann, 2000) and 
Leishmania major (Heinzel et al., 1993). Although B. pseudomallei resists killing by human 
macrophages it appears to be more susceptible to neutrophils (Pruksachartvuthi et al., 1990). 
The two major microbicidal mechanisms for phagocytes are reactive oxygen 
intermediates (ROI), consisting of superoxide anion, hydrogen peroxide, hydroxyl radical, 
and singlet oxygen (Johnston et al., 1975), and reactive nitrogen intermediates (RNI), such 
as nitric oxide (NO) (Hibbs et al., 1987). The killing mechanisms of INFyactivated 
macrophages are mediated by one or more of these oxidants, although the extent of the 
contributions of ROI and RNI may differ from one pathogen to another. It has been 
demonstrated that IFNyactivated macrophages inhibit the intracellular growth of B. 
pseudomallei by RNI- and ROI-dependent killing mechanisms, although RNI was more 
effective (Miyagi et al., 1997). These findings were supported by an in vitro experiment 
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using chemically generated nitrogen- and oxygen-derived oxidants in a macrophage-free 
system. 
Serum levels of neopterin, a stable metabolite produced by IFN-y-stimulated 
macrophages, IFN-y, IL6 and soluble interleukin-2 receptor (siL-2R) are elevated during 
melioidosis, and are directly related to disease severity, with higher levels preceding a fatal 
outcome (Brown et al., 1991; Friedland et al., 1992; Supputtamongkol et al., 1992). 
Although the early production of IFN-y has been correlated with resistance to acute infection 
in a mouse model (Santanirand et al., 1999) the prevailing cytokine millieu is an important 
factor in the outcome of acute melioidosis (Ulett et al., 2000). 
2.2.13 Protective antigens and potential vaccines 
Vaccine$ are usually designed to use immune intervention to tip the balance between 
infection and disease. Surveys conducted in Thailand and south-east Asia have revealed that 
at least 15-30% of the normal population possess antibody against B. pseudomallei 
(Atthasampunna et al., 1969; Strauss et al., 1969). However, the high incidence of clinical 
disease in these areas suggests that circulating antibody is insufficient to protect the infected 
host against the intracellular pathogen (Razak et al., 1986). Hence, there is a need to 
stimulate long-term cellular immunity that would provide the host with a rapid response to 
acute infection and also clear or contain the chronic intracellular bacteria. Preliminary 
research involved the use of simple preparations such as whole heat-killed bacteria (Stanton 
& Fletcher, 1932; Razak et al., 1986), toxic filtrates (Nigg et al., 1955; Razak et al., 1986), 
sonicated cell lysates (Vedros et al., 1983), and protein-polysaccharide mixture (Yedros et 
al., 1988). Despite initially encouraging results there are as yet no licensed vaccines for 
melioidosis (Brett & Woods, 2000). 
Different B. pseudomallei strains express only a single serotype of lipopolysaccharide 
(LPS) that is highly conserved (Pitt et al., 1992), with two distinct 0-polysaccharide (PS) 
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moieties, PS-I and PS-11 (Perry et al., 1995). Interestingly, the nonvirulent B. thailandensis 
(previously known as Ara+) lacks PS-I (Brett et al., 1998). Because the results of IHA 
testing suggest that PS is recognised in natural infections, Bryan et al. (1994) postulated that 
a vaccine that utilised the PS portion of the LPS could be potentially useful. Polyclonal and 
monoclonal antisera raised against tetanus toxoid-conjugated PS provided passive protection 
in a diabetic rat model of B. pseudomallei infections. 
Similarly encouraging results were obtained using highly purified flagellar filaments as 
immunogens. Brett et al. (1994) developed an antibody against purified flagellin protein that 
effectively inhibited the motility of B. pseudomallei, and provided passive protection against 
infection. Extending this work, Brett & Woods (1996) incorporated LPS and flagellar 
antigens to enhance the immunological repertoire of the vaccine recipient and also to afford 
protection against strains that display serotypically distinct antigens of one of the two 
components. The use of a vaccine containing the PS portion but not the toxic lipid A 
component removes the toxic side effects of LPS but retains the protective advantage of the 
PS moiety. Consequently, a candidate vaccine, composed of B. pseudomallei flagellin 
proteins conjugated with the endotoxin derived 0 -polysaccharide (PS) antigens, was tested 
(Brett & Woods, 1996). Passive protection conferred by an immunoglobulin fraction has 
been demonstrated, however, the efficacy of the vaccine in animals has not yet been 
reported. Interestingly, passive immunisation experiments conducted by Steinmetz et al. 
(2000) using a single monoclonal antibody with specificity for the repeating tetrasaccharide 
subunit showed a significant reduction of the bacterial load in various organs in a mouse 
model of melioidosis. From these results they concluded that the tetrasaccharide subunit 
might be a promising candidate for use as a protective antigen in active immunisation 
experiments. 
Other possibilities, including the use of killed B. mallei and killed B. pseudomallei 
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(Russell, personal communication) and a recombinant vaccine based on other bacteria, 
including Francisella tularensis (Kislitchkine, personal communication), are still in the 
experimental stages of development. 
2.2.14 Molecular epidemiological studies 
Information about epidemiology helps us to understand the patterns of transmission of 
the disease between the environment, animals and man, the extreme variation in clinical 
outcomes of the infected patients and the role of different bacterial strains in pathogenesis 
(Sermswan et al., 1994; Choy et al., 2000). Additionally, a typing system would be helpful 
in determining whether relapses are due to reinfection or to the recurrence of the original 
infection (Sermswan et al., 1994). On the other hand, epidemiological investigations are 
highly dependent on the reliability and reproducibility of typing systems to differentiate 
between isolates (Norton et al., 1998). 
Molecular typing of B. pseudomallei has been attempted usmg ribotyping 
(Desmarchelier et al., 1993; Trakulsomboon et al., 1997), randomly amplified polymorphic 
DNA (RAPD) (Haase et al., 1995; Choy et al., 2000), multilocus enzyme electrophoresis 
(MEE) (Norton et al., 1998), restriction fragment length polymorphism (RFLP) (Sermswan 
et al., 1994), pulsed field gel electrophoresis (PFGE) (Trakulsomboon et al., 1994), and 
multiplex PCR (Wongratanacheewin et al., 2000). Generally, these methods have shown 
that enormous diversity exists amongst isolates from endemic and non-endemic areas. 
Early serotyping of B. pseudomallei using the heat-stable 0 antigen, found limited 
diversity among strains and two serotypes were identified (Chambon & Fournier, 1956); one 
was found in Australia and southeast Asia, while the other was unique to Australian isolates 
(Dodin & Fournier, 1970). On the other hand, favouring the inclusion of B. pseudomallei in 
a separate species Trakulsomboon et al. (1997) presented evidence, by RFLP, suggesting 
that B. pseudomallei strains that utilise arabinose (later known as B. thailandensis) 
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constituted a population that was distinct from some other environmental and clinical 
strains. 
Little is known about the strains that cause recurrent or relapsing melioidosis and their 
genetic relatedness with the primary strain infecting the patient. In an attempt to improve our 
understanding of this relationship, Desmarchelier et al. ( 1993) examined BamH1 ribotype 
patterns among 54 isolates and concluded that isolates of similar patterns from a single 
patient represented a single strain. They also found that for most melioidosis patients 
recurrent infection was probably due to the original infecting strain, although reinfection 
with strains of similar types in the environment can not be ruled out. The ribotyping and 
PFGE studies of Vadivelu et al. (1998) supported these findings. Nevertheless, the work 
highlighted the possibility that some patients may be infected by more than one strain of B. 
pseudomallei. 
Ribotyping and RAPD analysis of I 0 isolates from a nontropical focus of animal and 
human disease over a 25 year period indicated the clonality, strain stability, and persistence 
of B. pseudomallei under circumstances where the organism was most likely introduced as a 
single strain (Currie et al., 1994; Haase et al., 1995). However, the clinical outcome of 
melioidosis could not be correlated with RAPD patterns (Haase et al., 1995). On the other 
hand, Norton et al. (1998) compared the genetic inter-relatedness of 18 clinical isolates 
using RAPD and MEE in order to investigate the possible existence of an epidemiological 
link between cases of melioidosis that occurred at about the same time in four different 
locations in North Queensland in Australia. The isolates segregated into two groups that 
correlated with clinical presentation rather than geographical location, one group consisted 
mainly of patients with respiratory disease while the second consisted of isolates from 
patients with abscesses in the viscera rather than the lung or brain. However, these findings 
have not been extended to studies involving a larger group of clinical isolates. 
43 
Interestingly, a comparison of the BamHI ribotypes of 350 isolates of B. pseudomallei 
recovered over 71 years from 23 countries revealed 44 distinct patterns, nineteen of which 
were unique to single isolates and more than three-quarters of the collection fell into just 
nine ribotypes (Pitt et al. 2000). Two ribotypes, 1 and 3, were the most common accounting 
for almost half the collection. Ribotype 3 was prevalent in Asian countries while ribotype 1 
was more widely distributed. In addition, the clinical features of 113 melioidosis patients 
infected with B. pseudomallei strains of different ribotypes were investigated to assess 
whether certain strains or groups were associated with a particular clinical outcome. Disease 
association was suggested for 4 of the ribotypes and strains of ribotype 4 were markedly 
associated with a fatal outcome, while the risk of relapse with isolates of ribotype I was 
more than twice as high as for strains of other ribotypes. In addition, Wongratanacheewin et 
al. (2000) demonstrated, by multiplex PCR, that 21 type patterns were obtained from 37 B. 
pseudomallei environmental and clinical isolates from human and animals. Among human 
and animal isolates, 10 types were described, of which two correlated with the disseminated 
septicaemic melioidosis commonly reported in northeast Thailand. 
2.3 HOST-PATHOGEN INTERACTIONS 
Early views of pathogenicity and virulence were primarily pathogen centred although it 
was recognised that pathogenicity was neither invariant nor absolute (Casadevall & Pirofski, 
1999). In the light of new information on the nature of the complex series of interactions 
between host and pathogen it becomes obvious that the outcome is as dependent on the host 
as it is upon the properties of the pathogen (Falkow, 1997). Any host-pathogen interaction 
can be reduced to two possible outcomes: those that result in damage to the host and those 
that result in no damage. Disease occurs when the host sustains damage that is sufficient to 
impair the normal functioning of cells (including necrosis, apoptosis, and malignant 
transformation), tissues, and organs (including granulomatous inflammation, fibrosis, and 
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tumor) (Sparling, 1983). The consequences of an infection will depend on a combination of 
factors including the virulence of bacterial pathogen, the immune status of the host and the 
innate resistance of the host (Dougan, 1989). However, numerous studies have demonstrated 
the existence of what appear to be 'universal' virulence mechanisms used by diverse 
bacterial species in order to fulfil the following five stages of pathogenicity. Pathogenic 
bacteria must be able to (i) adhere to host tissues, (ii) invade host tissues (usually), (iii) 
multiply in host tissues, (iv) evade host defenses, and (v) cause damage (Mitchell, 1998). 
Each (or all) of these stages should, somehow, involve means for avoiding or subverting the 
host's normal defences. The bacterial products responsible for these five biological 
requirements are the determinants of pathogenicity or virulence factors. 
It is beyond the scope of this thesis to examine each of these aspects in detail and 
excellent reviews are readily available (Falkow, 1997; Finlay & Falkow, 1997; Casavell & 
Pirofski, 1999; Smith, 2000). Recent work has sought to improve our understanding of the 
molecular basis of melioidosis and this work will be considered in the light of these 
'universal' aspects of bacterial pathogenicity. 
2.4 MOLECULAR BASIS OF THE PATHOGENESIS OF MELIOIDOSIS 
Basic understanding of the pathogenic properties of B. pseudomallei is the cornerstone 
for the control, and hence the prevention of melioidosis. A multifactorial mechanism has 
been proposed for the pathogenesis of melioidosis (Wongwanich et al., 1996) and B. 
pseudomallei is capable of expressing an impressive array of both secreted and cell-
associated antigens. However, the role of these products in the pathogenesis of disease has 
to date been relatively ill defined (Brett & Woods, 2000). 
2.4.1 Extracellular products 
Like many other bacteria, B. pseudomallei produces many components that are secreted 
into the extracellular medium, with a variety of biological properties. These extracellular 
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products include a siderophore, haemolysins, proteases, lipase, lecithinase (phospholipase 
C), and toxins. 
2.4.1.1 Siderophores 
Iron is an essential requirement for both in vivo and in vitro growth of nearly all 
microorganisms. Although the mammalian host has an abundance of iron, most is located 
intracellularly. The small amount of iron remaining is withheld by iron-binding or transport 
proteins, transferrin in the serum, and lactoferrin in mucosal secretions and specific granules 
of neutrophils (Spitznagal et al., 1974; Crichton & Wauters, 1987). Many pathogens are able 
to acquire iron from the host by producing specific, water-soluble, low-molecular weight, 
high affinity iron binding compounds termed siderophores. They bind iron with high affinity 
and transport it into the bacterial cells by using specific receptor proteins and appropriate 
transport mechanisms (Neilands, 1993). Production of siderophores is associated with 
virulence in many animal pathogens (Bullen & Griffiths, 1987; Weinberg & Weinberg, 
1995), e.g. Salmonella, Shigella spp., P. aeruginosa and Staphylococcus aureus. Moreover, 
the invasiveness of E. coli strains often correlates with the production of aerobactin, a 
hydroxamate-type siderophore (Jacobson et al., 1988) and B. cepacia express at least 3 
siderophore-mediated iron transport systems including pyochelin, cepabactin and 
azurechelin (Sokol, 1986; Meyer et al., 1989). Morbidity and mortality in infected CF 
patients has been correlated to the production of pyochelin that may assist the dissemination 
of B. cepacia throughout the lungs (Sokol & Wood, 1988). 
A siderophore, malleobactin, has been described by Yang et al. (1991) in 84 B. 
pseudomallei clinical isolates, grown under iron-deficient conditions. Structural and 
chemical analysis of the water-soluble molecule revealed that it belongs to the hydroxamate 
class and has no yellow-green fluorescence, which is different from the siderophores found 
in fluorescent Pseudomonads. Malleobactin, I 000 Da, was shown to promote iron uptake by 
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B. pseudomallei from both transferrin and lactoferrin with a preference for transferrin, and to 
reverse the growth inhibition caused by human transferrin in vitro (Y ang et al., 1993). 
Very recently, Loprasert et al. (2000) cloned and sequenced the ferric uptake regulator 
gene (fur) of B. pseudomallei that encodes a 16 kDa protein that shares antigenic 
determinants with the Fur protein of E. coli. Fur protein represses the transcription of iron-
regulated promoters in response to an increasing intracellular iron concentration. Fur 
mutants of B. pseudomallei that produced an elevated level of siderophore, were defective in 
their ability to repress siderophore biosynthesis, and also showed reduced ferric superoxide 
dismutase (FeSOD) and peroxidase activities. Because these oxidative stress response 
enzymes may have a role in the detoxification of reactive oxygen metabolites during the 
oxidative burst produced by professional phagocytes, they may assist the intracellular 
survival of B. pseudomallei (section 2.1.5). The authors postulated that B. pseudomallei 
might have a strategy to resist the toxic actions of these metabolites following enzymatic 
conversion by SOD, peroxidase and other oxidoreductases, as the case for P. aeruginosa 
(Hassett et al., 1996) and the facultative intracellular bacteria B. pertussis. 
2.4.1.2 Extracellular enzymes 
In an attempt to study the role of excreted products in the pathogenesis of the 
bacterium, one hundred clinical isolates of B. pseudomallei from human were tested for the 
production of extracellular biologically active substances (Ashdown & Koehler, 1990). Over 
90% of the B. pseudomallei isolates tested positive for lecithinase, lipase, protease and 
haemolysin but none was positive for elastase. In addition, four of the isolates had a 
particularly high level of haemolytic activity (alpha haemolysis). The haemolysin was 
shown to be heat labile, most active in an acid environment (pH 5.5), and cytolytic in broth 
culture filtrate for a variety of animal and human erythrocytes. The authors concluded that 
there are at least two haemolysins produced by B. pseudomallei, one is common and weakly 
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cytolytic, while the other occurs infrequently with stronger, heat-labile cytolytic activity. 
It seems likely that the level of haemolytic activity produced by B. pseudomallei is 
dependent on the medium and the culture conditions. Whilst some earlier studies showed 
that the organism was non-haemolytic (Chambon & Fournier, 1956; Wetmore & Gochenour, 
1956), other researchers have reported distinct alpha haemolysis (Crotty et al., 1963; 
Salisbury & Likos, 1970). The haemolysins produced by many bacteria are known to 
contribute to their ability to cause disease, including tissue damage, intracellular survival, 
and virulence e.g. E. coli cytolytic haemolysin (Jonas et al., 1993), phospholipase (Jepson & 
Titball, 2000), but the contribution of haemolysins to the course of B. pseudomallei infection 
remains unclear. 
Sexton et al. (1994) characterised an extracellular protease, termed exoprotease, 
molecular weight 36000, which is a metal-binding enzyme requiring iron for maximal 
activity and belongs to the alkaline protease group of metalloproteases. Antibodies 
developed against an alkaline protease produced by P. aeruginosa cross-reacted with the B. 
pseudomallei exoprotease. The purified exoprotease was capable of digesting a variety of 
eukaryotic proteins including immunoglobulins. The authors detected antibodies to B. 
pseudomallei protease in the sera of melioidosis patients indicating that the protease is 
produced in vivo and that this enzyme may help to inactivate host defence mechanisms and 
facilitate the invasion of host tissues. Furthermore, they reported that studies in animals 
indicated that a B. pseudomallei strain deficient in protease production produced 
significantly less lung damage than its parent strain. Hence, they referred the ability of B. 
pseudomallei to elicit lung damage during infection to the production of the exoprotease in 
vivo. Several studies have demonstrated that purified proteases from B. cepacia (McKevitt et 
al., 1989) and P. aeruginosa (Gray & Kreger, 1979), exert direct histopathological changes 
to rat lungs in vivo and the latter degrade a variety of host proteins and have a direct effect 
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on skin (Holder & Neely, 1989). 
B. pseudomallei also produces another protease of 42000 Da in size (Percheron et al., 
1995). More recently, Gauthier et al. (2000) assessed the production of this protease in 
culture filtrates from 19 different B. pseudomallei strains. No correlation was observed 
between virulence and proteolytic activity of B. pseudomallei. On the contrary, the most 
virulent strain tested produced 17 times less protease than a less virulent strain. Therefore, 
they argued that the secretion products from B. pseudomallei are not a critical factor in the 
pathogenesis of acute melioidosis. This was in agreement with Brett et al. ( 1997) who 
showed that administration of concentrated culture supematant, containing proteases, from 
B. pseudomallei strains of higher and lower virulence were ineffective for eliciting an acute 
illness in a mouse animal model of infection. 
More recently, Lee & Liu, (2000) cloned and sequenced a novel protease gene, mprA 
from B. pseudomallei, a serine metalloprotease containing a signal sequence that could 
cleaved to give 47-kDa mature protein. However, no correlation between virulence and level 
of protease activity was found when B. pseudomallei was intraperitoneally injected in mice. 
By using transposon mutagenesis in B. pseudomallei, the mechanism for the secretion 
of hydrolytic enzymes into the extracellular milieu (including lecithinase, lipase, and 
protease) has recently been elucidated. DeShazer et al. (1999) identified an 11.8kb 
chromosomal locus in the general secretory pathway of twenty-nine unique Tn5-0T182 
mutants that are unable to secrete protease, lipase and lecithinase. The mutants were found 
to be as virulent as the wild type in the Syrian hamster model, suggesting that these secretion 
products have limited role in the virulence of this organism (Dharakul & Songsivilai, 1999). 
Phospholipase C (PLC) is an enzyme that cleaves phosphatidylcholine, a major lung 
surfactant, to yield phosphorylcholine and diacylglycerol, and has been associated with 
cytopathology of lung tissue (Nelson et al., 1994). Previous studies have implicated PLCs as 
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virulence factors involved in infection by pathogenic bacteria such as L. monocylogenes 
where they play a significant role in escape of the pathogen from the phagosome membrane 
and invasion of adjacent cells (Smith et al., 1995). Recently, a nonhaemolytic phospholipase 
C gene (PC-PLC) has been cloned from B. pseudomallei (Korbsrisate et al., 1999). Western 
blot analysis with sera from melioidosis patients indicated that they produced 
immunoglobulin M antibodies against this PC-PLC protein. The authors postulated that PC-
PLC of B. pseudomallei might play a similar role to that of L. monocylogenes. 
In summary, the precise role of proteases, haemolysins, lipases or lecithinases in the 
pathogenesis of B. pseudomallei infections remains to be elucidated. 
2.4.1.3 Exotoxins 
Exotoxins are proteins produced by growing bacteria that are usually secreted into the 
surrounding medium, but are sometimes bound to the bacterial surface and released upon 
lysis. They subvert, alter, or destroy host cell functions, ultimately leading to cellular 
dysfunction or death (Moayeri & Welch, 1998). The mechanism of exotoxin action includes 
assisting bacterial spread in tissues (e.g. hyaluronidase of streptococci breaks down 
hyaluronic acid, the ground substance of connective tissue), lysing cells either by lipase 
action (e.g. lecithinase of clostridia) or insertion in the membrane to form pores (e.g. a-toxin 
of S. aureus; streptolysin 0 of certain streptococci), or by blocking cellular protein synthesis 
(e.g. diphtheria and cholera toxins) (Obrig, 1994; Schaechter, 1998). 
Bacterial exotoxins that inhibit eukaryotic protein synthesis do so by a variety of 
means. For example, ADP ribosylation of elongation factor-2 (EF-2) by diphtheria toxin and 
P. aeruginosa exotoxin A inactivates host protein synthesis (Domenighini et al., 1995) and 
increase epithelial permeability. Shigella spp. shiga toxin and E. coli shiga-like toxin 
inactivate the 60S ribosomal subunits by inhibiting EF-t-dependent amino-acyl tRNA 
binding to the ribosome when they cleave an N-glycosidase bond of the adenine at position 
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4324 in 28S rRNA (Donohue-Rolfe et al., 1988). 
Investigations of B. pseudomallei toxins date from the 1950s. Nigg et al. (1955) raised 
the possibility that the pathogen produces exotoxic material. They observed that the 
inoculation of viable B. pseudomallei into mice or guinea pigs resulted in death within one 
or two days. A crude toxin preparation of bacterial filtrate, which was thermolabile, was not 
only lethal for mice and hamsters but also produced haemorrhagic necrotic lesions following 
the intradermal inoculation of normal guinea pigs. Hence, they associated both lethal 
toxicity and necrotic activity with the heat-labile components of the filtrate. This was 
substantiated by further studies (Heckly & Nigg, 1958). Studies conducted by Liu (1957) 
and Ismail et al. (1987) demonstrated that the lethal exotoxin is separate from the proteolytic 
enzyme. The components that possess necrotic activity are heat-stable, while the lethal 
toxicity of B. pseudomallei filtrate is heat-labile. A thermolabile toxin was purified to 
homogeneity and characterised as a protein of 31000 Da (Ismail et al., 1987). 
In a study to investigate the function of B. pseudomallei exotoxin at the cellular level, 
Mohamed et al. (1989) suggested that exotoxin may play an important role in the early 
stages of infection by exerting a direct and irreversible toxic effect on the host's 
macrophages. They demonstrated that both DNA and protein synthesis were inhibited in 
macrophages which were exposed to the exotoxin, and suggested that it does not belong to 
the membrane-damaging class of bacterial protein toxins such as phospholipases, 
haemolysins, and cytolysins. However, demonstration of the cytolethal effect required a 
relatively high concentration of 20 11g toxin/m!, an amount equivalent to 50-ml bacterial 
culture, suggesting that it is unlikely that this toxin could be the cause of the very rapid onset 
of septicaemic melioidosis. Nevertheless, some workers believe that exotoxins are 
responsible for the rapid onset of the disease and the dramatic course of septicaemic 
melioidosis (Haase et al., 1997). Woods et al. (1992) postulated that 'neurological' 
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melioidosis (Lath et al., 1998) could be attributed to an exotoxin-mediated pathology in the 
absence of direct infections of the central nervous system. However, Currie et al. (2000b) 
suggested that it was more likely to be due to direct invasion. 
Wongwanich et al. (1996) tested the cytotoxic activity in fractions obtained from both 
culture filtrates and cell-free extracts of seven strains of B. pseudomallei by examining the 
morphological effects on cultured cells. All fractions of B. pseudomallei brought about 
complete (100%) and rapid destruction of the cultured-cells. Recently, Haase et al. (1997) 
purified the cytotoxic activity in culture filtrates and identified an exotoxin, that is active in 
very small amounts, had an apparent molecular weight of- 3000 and is most likely to be a 
small peptide. The fast acting nature of the toxin suggested that it may act directly on cell 
membranes rather than interacting with intracellular components and does not therefore · 
represent an ADP ribosylating toxin. The authors proposed that toxin synthesis may be 
upregulated during the course of B. pseudomallei infection. 
A different heat-stable extracellular toxin produced by B. pseudomallei, has been 
purified by Haubler ( 1998). This novel haemolytic glycolipid, with a molecular mass of 762 
Da, was cytotoxic to phagocytic (HL60) and non-phagocytic (HeLa) cell lines. This activity 
was resistant to alkali and acid treatments, but was neutralised by albumin which suggests 
that it is unlikely to be of significance in the pathogenesis of B. pseudomal/ei infections 
(Brett & Woods 2000). 
In conclusion, although a variety of toxins have been reported, the precise role of these 
molecules in the pathogenesis of melioidosis remains obscure. 
2.4.2 Cell-associated factors 
Bacterial pathogens synthesise a variety of cell-associated components that may be 
exposed on the surface of the organism including flagella, pili, acid phosphatase, capsule and 
lipopolysaccharide. These features are often associated with the progression of infection, 
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pathology of the disease, and the immune response of the host (Anuntagool et al., 2000). 
2.4.2.1 Flagella 
For many pathogenic species, the contribution of flagella to virulence has not been 
clearly established. Nonetheless it is generally accepted that flagella make an important 
contribution to motility, and the expression and repression of flagellation and virulence have 
in some cases been shown to be linked (Moens & V anderleyden, 1996). Moreover, the 
presence of flagella on the surface of pathogenic and opportunistic bacteria is thought to 
facilitate colonisation and dissemination from the initial site of attachment (Rozalski et al., 
1997). Currently, flagellar motility has been shown to be implicated in disease caused by 
many pathogens including Helicobacter (Eaton et al., 1992), Campylobacter (Grant et al., 
1993), Salmonella (Carsiotis et al., 1984), Legionella (Pruckler et al., 1995), and Vibrio 
(Milton et al., 1996). 
Bacterial flagella consist of a long helical filament that is driven by a rotary motor 
anchored in the cell surface. The main structural protein of the flagellar filament is flagellin. 
Flagellin proteins from several different strains of B. pseudomallei have been isolated and 
purified to homogeneity (Brett et al., 1994). One single subunit type constitutes the flagellar 
filaments of B. pseudomallei strains. This agrees with evidence suggesting that nonsheathed 
bacterial flagella display only a single flagellin species when disaggregated (Joys, 1988). A 
polyclonal antibody raised against the 43.4 kDa flagellin protein reacted with 64 of 65 B. 
pseudomallei strains that were tested. Winstanley et al. ( 1998) cloned and sequenced the 
tlagellin genes from one environmental and three clinical isolates of B. pseudomallei. They 
compared, by PCR, the genes from four clinical and six environmental isolates and 
demonstrated that while the genes from the clinical isolates were either I 00% identical or 
differed by only one nucleotide, greater genetic variation was detected among some of the 
environmental isolates. 
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It is of note that mutagenesis and animal model experiments have failed to highlight a 
role for the flagellum in the pathogenesis of B. pseudomallei infection. In an attempt to 
identify and characterise potential virulence determinants in B. pseudomallei, DeShazer et 
al. (1997) used the transposon Tn5-0T182 to identify multiple genes involved in motility, 
including the flagellin structural gene,j/iC. Twenty-eight unique motility mutants containing 
Tn5-0T182 integrations in a variety of genes encoding proteins with homology to flagellar 
and chemotaxis proteins in E. coli and S. typhimurium, were identified. There was no 
significant difference in the virulence of the mutant strain I 026b compared to that of the 
wild type, in diabetic rats or Syrian hamster, suggesting that flagella and/or motility are 
probably not virulence determinants in these animal models of B. pseudomallei infection. 
2.4.2.2 Pili 
The first stage in the infection process is colonisation of a host mucosal surface. Many 
pathogenic bacteria adhere to host cells using fimbriae or pili that specifically bind to the 
carbohydrate moiety of glycolipids or glycoproteins. Fimbrial-associated receptor 
recognition permits bacteria to adhere to diverse targets ranging from inorganic substances 
to highly complex biomolecules. A pilus is a rod-shaped structure, which consists primarily 
of an ordered array of helically arranged single protein subunits called pilin. According to 
their morphology and function, pili are classified into conjugative (For sex), which are rigid 
and have a large axial hole, and adhesive pili, which are flexible and may have a small axial 
hole. Adhesive pili bind to receptors on host epithelial cells, allowing pathogens to establish 
a niche within the host. Binding via pili may not only prevent the elimination of bacteria 
from a desirable niche in the host, but may also trigger the expression of a cascade of 
virulence factors that enable the bacterium to thrive in its new environment (Kuehn, 1997). 
The occurrence of fimbriae or pili on B. pseudomallei had not been reported until 
Smith et al. (1987) revealed, by electron micrographs, that B. pseudomallei was heavily 
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fimbriated. They correlated the presence of pili with the haemagglutinating activity of the 
organism. By using experimental techniques to depilate bacterial cells, these authors 
demonstrated that the ability of B. pseudomallei to adhere to human buccal cavity epithelial 
cells is mediated through pili. 
The production and assembly of pili involves a number of genes. Unpublished data 
from D. E. Woods' group in Canada suggests that B. pseudomallei possesses at least two 
types of pili. This group managed to clone and sequence genes (fimA) encoding a 15-kDa 
pilin structural protein that exhibits homology to type I pili, and the accessory genes 
involved in the assembly of type I pili, FimC, a chaperone protein, and FimD, an outer 
membrane usher protein (Reckseidler et al., unpublished). Moreover, the same group cloned 
genes with strong homology to pilE, pi!C, and pi/D of P. aeruginosa. In addition, Kuehn 
( 1997) reported that B. pseudomallei also contain the genes involved in the production of 
type IV pili that are known to mediate attachment to host epithelial cells in an increasing 
number of bacterial pathogens including V. cholerae, P. aeruginosa, and N. gonorrhoeae 
(Hobbs & Mattick, 1993). The pili present in P. aeruginosa and B. cepacia adhere to buccal 
and tracheal epithelial cells in vitro (Kuehn et al., 1992; Wilkinson & Pitt, 1995; Toder, 
1998). Electron microscopy has shown that approximately 60% of B. cepacia strains express 
peritrichous pili (Kuehn et al., 1992) that facilitate attachment to the respiratory mucin from 
CF and non-CF individuals (Sajjan & Forstner, 1992). 
2.4.2.3 Acid phosphatase 
Early studies of bacterial acid phosphatases associated with the cell surface have 
proposed a pathogenic function (Walther et al., 1984). For example, in S. typhimurium a 
regulator gene, phoP, controls the expression of the genes of pag loci including the locus for 
non-specific acid phosphatase (pagN) and other loci needed for survival within macrophages 
(Miller & Mekalanos, 1990). Dejsirilert et al. (1989) described B. pseudomallei acid 
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phosphatase and proposed that the physiological role of the molecule may be to allow the 
organism to obtain orthophosphate from organic phosphate sources to meet nutritional 
demands. Kondo et al. ( 1991 a) reported the presence of heat-stable and heat-labile 
components of acid phosphatase that differed in pH optima, 4.2 and 5.2, respectively. The 
heat-stable molecule was a membrane-associated enzyme and the authors speculated that 
heat-stability would result from the progressive glycosylation of the molecule. Further 
characterisation by Kondo et al. ( 1991 b) revealed the enzyme was concentrated in a 
glycoprotein fraction that was recognised by antibodies in serum from melioidosis patients. 
The B. pseudomallei enzyme had the highest activity among the Pseudomonad species that 
were tested, with a peak at around pH 5.0, similar to the pH of the phagolysosome (Egan & 
Gordon, 1996), and has a preference for phosphotyrosine and phosphoserine substrates 
(Kanai & Kondo, 1991 ). Hence, it was assumed that the enzyme, a glycoprotein, might be a 
cell-surface receptor similar to protein tyrosine phosphatase (PTP). PTP, which is 
considered to be a part of a two-component system involved in signal transduction, accepts 
and transmits messages from the environment to the intracellular millieu (Walton & Dixon, 
1993). Most acid phosphatases are distributed widely in the animal, plant and microbial 
kingdom and are glycoproteins (Vogel & Hinnen, 1990). A similar study by Kondo et al. 
(1994) confirmed the presence of glycoproteins that are synthesised within the cell and 
secreted after translocation to the cell surface. They emphasised that acid phosphatase is a 
cell-surface enzyme and that it is a glycoprotein whose polysaccharide moiety may project 
outside the cell. Moreover, Kondo et al. (1996) established that the acid phosphatase could 
be readily isolated from both whole cell and supematant fractions. Kanai et al. ( 1996) have 
proposed that the cell-associated form of PTP is a high affinity receptor for insulin and that 
this receptor-ligand interaction may be responsible for modulating the enzymatic profiles of 
B. pseudomallei isolates. The authors postulated that the PTP interacts with insulin in a 
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similar manner to protein tyrosine kinase which is thought to work as a regulator of cell 
growth, differentiation, and metabolism (Jin & Inoue, 1993). 
Some bacteria have cell surface proteins that are important for adherence but do not 
assemble themselves into pilin-like structures (Salyers & Whitt, 1994). P. aeruginosa and B. 
cepacia have receptors that specifically bind tissue glycolipids in a receptor-ligand 
relationship (Krivan et al., 1988), which raises the possibility that a similar system may 
operate to mediate adhesion between B. pseudomallei and host tissue in the early stages of 
infection. Kanai et al. (1997) demonstrated that B. pseudomallei binds specifically to tissue 
glycolipids and suggested that cell-surface acid phosphatase, with its strong affinity for 
glycolipids, may be a receptor molecule. 
2.4.2.4 Lipopolysaccharides or endotoxins 
Lipopolysaccharides (LPS) also known as endotoxins are major constituents of the 
outer membrane of Gram-negative bacteria that act as toxins only under special 
circumstances. LPS can be released from the cell surfaces of bacteria during replication, 
lysis, and death and cause a broad spectrum of pathophysiological effects (Rietschel et al., 
1994). At low concentrations, LPS elicits a series of alarm reactions including fever, 
activation of complement, activation of macrophages, and stimulation of B lymphocytes, 
while at high concentrations it produces shock and even death (Schaechter, 1998). Unlike 
exotoxins, endotoxins are not proteins but rather complex molecules with some exotic 
chemical constituents that are much more heat stable. LPS consists of a polysaccharide and a 
lipid A moiety that is embedded in the outer membrane (Fig 1· Appendix II). Lipid A is the 
toxic (active) portion of the molecule and because of its location in the outer membrane, it 
exerts its effects only when bacteria lyse. On the other hand, the polysaccharide moiety 
consists of a core and 0 side chain. Some of the diseases in which endotoxin may play an 
important role include typhoid fever, tularaemia, plague and brucellosis in addition to a 
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variety of hospital-acquired infections caused by opportunistic Gram-negative pathogens 
that include E. coli, Proteus, P. aeruginosa, Enterobacter, Serratia and Klebsiella (Mims et 
al., 1995). For example, the LPS of B. cepacia has endotoxin-like activities including 
lethality and tissue necrosis in CF patients (Straus et al., 1989) whereas the LPS of H 
injluenzae enhances bacterial survival in the nasopharynx and facilitates invasion across 
cellular barriers by disruption of ciliated epithelial cells (Johnson & Inzana, 1986). 
The evaluation of the role of LPS in the virulence and pathogenicity of B. pseudomallei 
has over the years given inconsistent and controversial results (Anuntagool et al., 1998). 
Rapaport et al. (1961) and Redfeam (1964) reported that B. pseudomallei possessed 
endotoxin activities but the chemical and biological characterisation was not completed until 
recently. The importance of LPS in the pathogenesis of melioidosis was highlighted when 
patients with septicaemic melioidosis displayed high levels of anti-LPS antibodies 
(Petkanjanapong et al., 1992) and had significantly elevated levels of proinflammatory 
cytokines, which are known to be activated by LPS (Friedland et al., 1992; Suputtamongkol 
et al., 1992). Pitt et al. ( 1992) demonstrated that the LPS expressed by 12 clinical strains of 
B. pseudomallei which had been isolated over a period of 70 years from southeast Asia and 
Australia exhibited identical patterns. Similarly, Anuntagool et al. (1998) examined 214 
isolates of B. pseudomallei (119 Ara- clinical, 13 Ara- soil, 70 Ara+ soil, and 8 reference 
National Type Culture Collection strains) and identical LPS patterns in 210 of these isolates 
were typical for LPS from other Gram-negative bacteria. Moreover, the same 210 isolates 
exhibited similar immunoblot profiles using either pooled sera from patients with 
melioidosis or hyperimmune mouse sera. 
Because the LPS of the two different B. pseudomallei biotypes (later considered to be 
two different species) appeared antigenically indistinguishable, Anuntagool et al. (1998) 
concluded that it is unlikely that LPS is related to the virulence and pathogenicity of B. 
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pseudomallei. Consistent with these studies, lwasa et al. (1992) and Matsuura et al ( 1996) 
published reports concerning the endotoxin activities of B. pseudomallei. Iwasa et al. (1992) 
studied heat-treated whole cells, culture supematants, and extracted endotoxin preparations 
of B. pseudomallei in comparison with the same preparations from B. cepacia and P. 
aeruginosa. Although the endotoxic effect was detected in all the samples of B. 
pseudomallei, the activity was 30 times less than that present in samples from P. aeruginosa. 
Matsuura et al. (1996) compared the biological properties of B. pseudomallei LPS with 
those of a reference LPS obtained from Salmonella abortus equi. The endotoxic activities of 
B. pseudomallei LPS, such as pyrogenic activity in rabbits, lethal toxicity in mice, and 
macrophage activation, are 10-100 times weaker than Salmonella LPS. 
Moreover, as the shedding of some surface components, particularly the LPS, is known 
to be associated with pathogenicity and virulence in a number of Gram-negative bacteria 
(Rietschel et al., 1996), Anuntagool et al. (2000) compared the shedding of LPS in cultures 
of Ara+ and Ara· isolates, using MAb-based ELISAs. Although the MAb was found to react 
with a 200-kDa surface antigen that was present only in the Ara· isolates (Rugdech et al., 
1995; Sirisinha et al., 1998), the results showed that there was no difference in the LPS 
quantity or shedding profiles of the two biotypes. 
Studies have shown that B. pseudomallei can produce two structurally distinct LPS, 
simultaneously. Knirel et al. (1992) and Perry et al. (1995) revealed by chemical and 
physical methods, that one 0-antigenic polysaccharide is a high-molecular weight 
unbranched 1 ,3-linked homopolymer of 2-0-acetylated 6-deoxy-p-D-manno-heptopyranosyl 
residues, while the other is an unbranched heteropolymer consisting of (-3)-p-D-
glucopyranose-( 1-3)-6-deoxy-a-L-talpopyranosyl-( !-disaccharide repeats (L-6dTalp: -33% 
0-4 acetylated and 0-2 methylated; -66% 0-2 acetylated). 
In conclusion, B. pseudomallei LPS, although chemically unique, is no more potent or 
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unique in its biological properties than the LPS from other organisms. If anything, the LPS 
from B. pseudomallei appears to be less potent than the LPS from E. coli, for example, in 
activating macrophages. 
2.4.2.5 Capsule 
Exopolysaccharides (EPS), also called capsular polysaccharides, were among the first 
known bacterial virulence determinants in both gram-negative and gram-positive bacteria. 
They include structures varying from discrete capsules that are closely associated with the 
cell, to massive slime wall formations that are only loosely associated with the cell surface 
(Steinmetz et al., 1995). 
The presence of a slime layer around the cells of B. pseudomallei has been noted from 
the gross appearance on laboratory media (Jayanetra, 1989) and the bacterium has a biofilm 
producing, mucoid phenotype in vitro and in vivo (Vorachit et al., 2000). The pathogenic 
significance of the B. pseudomallei capsule has been known for more than a decade. Smith 
et al. ( 1987) verified the presence of a capsule using light microscopy on wet and dry Indian 
ink preparations, and by morphological observations with an electron microscope. B. 
pseudomallei was found to be encapsulated when isolated from dead mice that had been 
infected with the organism. The encapsulated form could also be produced in vitro by 
growing the organism in a chemically defined medium supplemented with I% (w/v) lactose 
and 0.1% (w/v) peptone. 
Studies in vitro have determined that both capsulated and non-capsulated B. 
pseudomallei strains are equally susceptible to phagocytosis by neutrophils (PMN), and that 
the presence of exopolysaccharide confers some resistance to the bactericidal effects of the 
phagolysosomal compartment (Smith et al., 1987; Pruksachartvuthi et al., 1990). Ho et al. 
(1997) proposed that the capsular polysaccharide produced by B. pseudomallei was 
important in pathogenesis and may provide protective immunity to immunised hosts. 
60 
Furthermore, Vorachit et al. (1995) attributed chronic infections to the production of 
exopolysaccharide glycocalyces, as demonstrated by scanning electron microscopy of lung 
tissue from infected humans and animals. Using ruthenium red staining of macrophages 
containing ingested B. pseudomallei, Leelarasamee and Bovornkitti (1989) were unable to 
demonstrate the capsule by electron microscopy, although they described the appearance of 
an electron-dense layer surrounding the bacterial cells that may suggest the release during 
growth of one or more soluble slime-like substances. On the other hand, using the same 
technique, Puthucheary et al. ( 1996) revealed the existence of three morphologically distinct 
variants of bacterial cultures: one with a very marked and another with a less distinct 
electron-dense layer, termed glycocalyx, surrounding the cell wall, and a third variety 
devoid of such structures. They suggested that these three morphologic types represent 
either an expression of phase variation due to environmental factors, or different stages in 
the development of the extracellular material. 
While Popov et al. (1994) demonstrated the absence of any well defined structures on 
the bacterial cell surface, they determined, by electron microscopy, that B. pseudomallei 
formed a protective capsule during the first few hours following infection of guinea-pigs. 
Without the capsule, bacterial cells were actively phagocytised by peritoneal macrophages 
and polymorphonuclear leukocytes and then damaged. They observed that encapsulated 
bacteria survived and preserved their normal ultrastructure and concluded that the capsule 
prevented the destruction of the bacteria by the contents of the phagolysosomes. 
Steinmetz et al. (1995) identified and characterised a species-specific 
exopolysaccharide of B. pseudomallei and produced a monoclonal antibody (MAb) with 
specificity for a polysaccharide structure on the bacterial surface by immunising mice with a 
bacterial strain that exhibited mucoid growth characteristics (NCTC 7431 ). Immunoelectron 
microscopy showed that the MAb binds to an exopolysaccharide that had a capsule-like 
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appearance in the mucoid strain used for immunisation. The authors showed that all of the 
12 mucoid and non-mucoid B. pseudomallei strains tested from geographically different 
tropical regions were recognised by the MAb, indicating that the expression of this 
exopolysaccharide is a stable character among this species. Moreover, temperature appeared 
to have little effect on the synthesis of the exopolysaccharide since B. pseudomallei strains 
grown at 15oC and 37oC reacted with the MAb. The exopolysaccharide was classed as group 
I polysaccharide because of its high molecular weight (> 150 kDa) and synthesis below 
20oC. Importantly, specific antibodies present in the sera from a number of melioidosis 
patients recognised the capsular polysaccharide demonstrating that it is expressed in vivo. 
The chemical and structural nature of the polysaccharide, from a virulent clinical isolate, B. 
pseudomallei 304b, was elucidated by Masoud et al. (1997) and shown to have a unique 
structure that is not closely related to any known bacterial polysaccharide. It had a linear 
unbranched polymer of repeating tetrasaccharide units composed of three 0 -galactose units 
and one 3-deoxy-0 -manno-octulosonic acid (KDO), containing an 0-acetyl substituent. 
Similarly, Nimtz et al. (1997) have demonstrated that a structurally identical capsular 
antigen is expressed by B. pseudomallei NCTC 7431. Moreover, B. pseudomallei produces 
two other polysaccharides depending on the growth medium (Kawahara et al., 1998). 
A recent study by Ahmed et al. ( 1999) showed that capsular polysaccharide is important in 
facilitating the attachment of B. pseudomallei to respiratory epithelial cells in vitro, 
apparently without fimbriae (Fig 2.3). Furthermore, Steinmetz et al. (2000) reported that 
unpublished studies revealed the existence of a second exopolysaccharide in virulent B. 
pseudomallei strains. Monosaccharide analysis showed that it does not contain KDO but 
contains galactose and other sugar components. 
The capsular polysaccharide functions in many ways to aid in the survival of bacteria 
in various hostile environments. In addition to a role in mediating direct interaction between 
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Fig 2.3: A transmission electron micrograph of B. pseudomallei (X 3800) attached to a 
pharyngeal epithelial cell, stained with ruthenium red. A thin, granular layer on the 
surface of the bacteria and the cell indicates a polysaccharide layer. Adapted from 
Ahmed et al. (1999). 
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the bacterium and its immediate environment, a number of possible functions have been 
suggested for polysaccharide capsules including adherence, prevention of desiccation, and 
resistance to both specific and non-specific host immunity (Costerton et al., 1987; Roberts, 
1996). In the case of P. aeruginosa, the production of large amount of an alginate-like 
polysaccharide, conferring the mucoid phenotype of most of the strains isolated from the 
lungs of CF patients, is associated with the virulence of this bacterium (Govan & Deretic, 
1996). This event often coincides with a marked deterioration of the pulmonary function in 
CF. Similarly, some B. cepacia strains have been shown to produce capsule that correlates 
well with virulence (Nelson et al., 1994; Wilkinson & Pitt, 1995). During saprophytic 
existence, capsules may protect bacteria from desiccation, concentrate minerals and 
nutrients, reduce contact with hydrophobic or charged molecules, and enhance attachment to 
surfaces. On the other hand, during infection many bacterial pathogens are able to combat 
the bactericidal activity of complement and phagocytes by encapsulation with structurally 
diverse polysaccharides and it may be only in the late phase of the infection that the host 
produces specific anticapsular antibodies. The regulation of capsule synthesis in E. coli and 
several other bacteria is under the control of two-component regulatory systems. 
2.5 TWO-COMPONENT REGULATORY SYSTEMS 
2.5.1 Introduction 
In order to meet the challenges posed by a competitive, changing and often 
unpredictable environment, bacteria have devised sophisticated signalling systems for 
eliciting adaptive responses to environmental variation (Parkinson, 1993). Movement of 
bacteria toward favourable conditions and away from harmful ones is one of these adaptive 
responses, to seek optimal living conditions. Another approach is a regulated response to 
adaptive opportunities. Since bacteria are manifestly capable of such adaptation, they must 
possess the means to gather and analyse environmental information and to transduce this 
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information to the cellular apparatus concerned with mounting the response (Dorman & 
Bhriain, 1992). 
Cells respond to changes in their physical and chemical environment by generating 
intracellular signals that lead to the modification of their structure, metabolism and 
movement (A lex & Simon, 1994 ). Stress conditions of many sorts, such as antibiotics, heavy 
metals, turgor pressure, or starvation, elicit changes in gene expression that lead to effective 
coping responses (Parkinson, 1993). In pathogens, chemical, temperature, or other 
conditions characteristic of the host environment elicit the production of components that 
are essential to ensure survival (Biiska et al., 1993). Bacterial cells must have elaborate 
signalling networks to ensure that they make an appropriate response which, once 
commenced, must be ushered to a successful conclusion (Parkinson, 1993 ). 
2.5.2 Protein phosphorylation and signal transduction 
Protein phosphorylation is one of the most widely used means for regulating biological 
processes in prokaryotes and eukaryotes (Mizuno, 1998). Since the discovery of regulatory 
protein phosphorylation by Krebs, Fischer, and colleagues in the mid-1950s, protein 
phosphorylation-dephosphorylation has been considered to play a key role in cellular 
mechanisms for the detection, transmission, and integration of intra- and extra-cellular 
signals (Fischer & Krebs, 1989). There are two classes of enzymes that regulate signalling 
through the phosphorylation and dephosphorylation of proteins, namely protein kinases and 
protein phosphatases. Protein phosphorylation is ideally suited for signal transduction and 
the shuttle of information from the cell surface to the interior, since protein kinases have an 
in-built mechanism for signal amplification, and protein phosphatases provide a means of 
reversing the signal when the stimulus is removed (Hunter, 1995). 
Proteins can be phosphorylated on acidic (aspartate, glutamate), basic (arginine, 
histidine, lysine), hydroxy (serine, threonine, tyrosine), or cysteine residues (Bourret et al., 
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1990). The enzymes that catalyse protein phosphorylation, protein kinases, can be classified 
according to the amino acid species they phosphorylate: namely, protein serine/threonine 
kinases (PSKs); protein tyrosine kinases (PTKs); protein histidine kinases (PHKs); and also 
a small subfamily of PSKs can phosphorylate both serine/threonine and tyrosine residues. 
Eukaryotes almost exclusively target the hydroxyl amino acids serine, threonine, and 
tyrosine for signal transduction purposes, while bacteria favour the use of histidine and the 
carboxyl amino acids as phosphoacceptors (Kennelly & Potts, 1996). 
In bacteria, it has been well documented that signals are processed via a system that 
involves phosphorylation, which entails the formation of high-energy phosphoamino acids, 
phosphohistidine and phosphoaspartate (Aiex & Simon, 1994). Moreover, both pathogenic 
and non-pathogenic bacteria have evolved signal transduction systems to control the co-
ordinate expression of virulence determinants and to develop adaptive responses to their 
environment. 
2.5.3 Two-component regulatory proteins 
2.5.3.1 Brief history 
All living cells must sense changes in their environment and respond appropriately in 
order to adapt successfully to their environment. To meet this need, bacteria commonly 
employ a sophisticated signal transduction strategy that involves at least two protein 
components of signal transduction. They are therefore referred to as the "two-component 
regulatory system" and their sole purpose is to allow for regulation (Stock et al., 1989, 1990, 
2000; Parkinson, 1993; Hoch & Sailhavy, 1995; Appleby et al., 1996). This family of 
proteins allows bacteria to sense and respond to numerous changes in their environment and 
it was originally defined on the basis of protein sequence similarities between pairs of 
"sensor" and "regulator" proteins. Generally, the genes encoding the sensor and effector pair 
are located near each other, often in the same operon. 
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The first analyses of two-component system pathways were carried out in bacterial 
systems in 1986 when the predicted amino acid sequences of two regulatory proteins in 
Bradyrhizobium sp. were seen to be virtually identical to the NR11 and NR1 proteins of 
Klebsiella pneumoniae (Nixon et al., 1986). In addition, the regulators of nitrogen 
metabolism (NtrB/NtrC), and the chemotactic regulators (CheA/CheY) were identified 
(Ninfa & Magasanik, 1986; Hess et al., 1988; Keener & Kustu, 1988). Soon, the dual 
component nature of these systems was described. Currently, the two-component signal 
transduction systems constitute the most common class of bacterial signal transduction 
proteins and control a broad range of bacterial responses. Apparently, the operation of the 
individual systems vary widely, but their primary activation processes are probably all based 
on the same chemical mechanism of Mg2+-dependant protein phosphorylation (Volz, 1995) 
and a common phosphorylation reaction mechanism exists in most, if not all, two-
component regulatory systems. This is further emphasised by the finding that various protein 
kinases are capable of correctly phosphorylating noncognate regulator proteins in vitro, 
although to a much lesser extent than cognate regulators (Bourret et al., 1991 ). 
In its simplest form, the two-component signal transducing system consists of a 
stimulus-dependent autophosphorylating sensor kinase and its substrate, termed the response 
or effector regulator that mediates an adaptive response by a change in gene expression 
(Mizuno, 1998). 
2.5.3.2 Bacterial sensor histidine kinases 
The histidine protein kinase superfamily, also called sensor kinases, includes molecules 
that monitor certain environmental parameters, and modulate accordingly the functions of 
the response regulator. Most sensor proteins are located in the cytoplasmic membrane with 
the transmitter portion of the molecule projecting into the cell. Many, but not all, have two 
transmembrane domains that anchor the protein to the cell membrane, separated by a loop 
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through the periplasmic space between the inner membrane and cell wall. The periplasmic 
domains of these proteins are structurally unrelated and have diverse receptor functions 
reflecting the variety of chemical and physical stimuli they detect (Stock et al., 2000). 
The N-terminal portion of the histidine protein kinase functions as an input domain, 
detecting environmental stimuli directly or interacting with an upstream receptor, while at 
the C-terminal end of the protein is the transmitter module. In a typical sensory kinase, this 
catalytic domain is generally 240 amino acids long and contains several blocks of residues 
that are conserved among histidine protein kinases. One of these is the H box, typically 
located near the N-terminus of the module, and includes a histidine residue at which the 
proteins autophosphorylate at position N-3 of the imidazole ring through the formation of a 
phosphoamidate, using the y-phosphoryl group of A TP. Mutations in this region frequently 
have a deleterious effect on kinase activity. Four additional blocks of conserved amino acids 
constitute theN (asparagine), Gl, F (phenylalanine) and G2 boxes. The Gl and G2 boxes 
are glycine-rich sequences (DXGXG and GXGXG) that bear a resemblance to the 
nucleotide binding motifs of other proteins. On the other hand, the function of the N and F 
boxes are unknown (Fig 2.4a) (Parkinson, 1993; Alex & Simon, 1994; Appleby et al., 1996; 
Mizuno et al., 1996). However, not all kinases contain all five conserved motifs, for 
example, CheA lacks the conserved H box and is phosphorylated at a histidine in a non-
conserved amino-terminal domain. Once autophosphorylated, the histidine kinase serves as 
a relatively high-energy molecule that acts as a phospho-donor for its cognate response 
regulator (Egger et al., 1997; Mizuno, 1998). 
While histidine kinases were thought to be present only in prokaryotes, they have 
recently been identified in eukaryotic systems including Saccharomyces cerevisiae (yeast), 
Schizosaccharomyces pombe, Arabidopsis thaliana (plant), Neurospora crassa and 
Dictyostelium discoideum (Aiex et al., 1996; Wurgler-Murphy & Saito, 1997). Similar to 
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bacterial hybrid histidine kinases, the majority of the eukaryotic histidine kinases which 
have been characterised to date include both a conserved histidine kinase domain and a 
response regulator type domain in the same protein (Egger et al., 1997). The prevalence of 
histidine kinase/response regulators in organisms from all three kingdoms ( eubacteria, 
archaebacteria, and eukaryota) attests to the early evolution of this signal transduction 
mechanism (Loomis et al., 1997). Moreover, while histidine kinases have not yet been 
isolated from vertebrate tissues, there is evidence in the nucleotide sequence data banks 
indicating that genes encoding members of this family are present in the human genome and 
are likely to play a significant role in signal transduction (Loomis et al., 1997). 
2.5.3.3 Response regulators 
The substrate for the histidine kinase is the response regulator, which is phosphorylated 
at a specific aspartic acid residue. A typical response regulator consists of two domains: a 
conserved N-terminal receiver domain, followed by a variable C-terminal signal output 
domain that has an effector function. The overall organisation of each of the response 
regulators is tailored to a specific effector function, while their receiver domains are highly 
conserved, implying a ubiquitous mechanism of activation by Mg2+-dependent protein 
phosphorylation (Pao & Saier 1995; Mizuno et al., 1996). The lower level of sequence 
conservation within the C-terminal region of response regulators perhaps reflects different 
mechanisms of transcriptional regulation (Bourret et al., 1991 ). 
Response regulators are characterised by, and share, a common receiver domain of 
about 125 amino acids in length in the N-terminal region, which contains the conserved 
motifs that define membership in the response regulator family (Fig 2.4b)· The conserved 
residues include an invariant aspartate (D I) residue which serves as the site of 
phosphorylation and is located around the centre of the receiver domain, a pair of aspartate 
residues (DD) preceding DJ at theN-terminal end, a threonine (T), and a lysine residue (K) 
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Fig 2.4: Structural features of (a) the transmitter, (b) receiver and (c) HPt domains, with 
conserved signature motifs. Conserved residues are as in the text. Adapted from 
Parkinson (1993); Mizuno et al. (1996); Mizuno (1998). 
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at the C-terminal end of the receiver domain, which all contribute to the acidic pocket for the 
phosphorylation site (Stock et al., 1989; Egger et al., 1997). Pao & Saier (1995) analysed 
the sequences of forty-nine response regulators and a multiple alignment of the receiver 
domains of these sequences showed that only one residue is fully conserved in all of these 
domains. This was the aspartyl residue, D I, the site of phosphorylation. 
Receiver-containing proteins can catalyze the transfer of the phosphoryl group from the 
histidine of the sensor kinase to a conserved aspartate residue. Alternatively, they can 
phosphorylate themselves using a variety of small donor molecules (but not A TP) such as 
acetyl phosphate, imidazole phosphate, or phosphoramidate as alternate phosphodonors 
(Feng et al., 1992; Lukat et al., 1992), demonstrating that the response regulator can catalyse 
phosphoryl transfer independently of the histidine kinase. Additionally, receivers can 
catalyse the hydrolytic loss of their phosphoryl groups (Hess et al., 1988), with half-lives 
ranging from a few seconds to many minutes (Fig 2· Appendix Il). 
The phosphorylation state of the receiver domain modulates the activity of a unique C-
terminal output domain, commonly a transcriptional regulator, to elicit an adaptive response 
to the stimulus (Appleby et al., 1996). Accordingly, the response regulator mediates changes 
in gene expression or cell behavior in response to environmental stimuli (Mizuno, 1997). 
The aspartate residue DJ is modified through the formation of an acyl phosphate on 
acquisition of the phosphate from the phospho-histidine of its cognate transmitter. The 
phosphorylated receiver is relatively unstable, and is readily converted to its 
nonphosphorylated form (the in vitro half-lives of phospho-Che Y and phospho-OmpR are a 
few seconds and several hours, respectively) (Bourret et al., 1991 ). Furthermore, the 
structure of receiver modules is well understood and the pattern of conserved residues 
implies that all response regulators will have a similar structure. X-ray crystallography 
studies of the S. typhimurium (Stock et al., 1989) and E. coli (Volz & Matsurnura, 1991) 
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CheY and NarL (Baikalov et al., 1996) proteins proved a barrel-like arrangement of five sets 
of alternating p strands and a helices, in the sequence starting with p1 and ending with aE· 
(Fig 2.5). 
Most response regulators are positive transcriptional regulators, containing DNA 
recognition sequences in their carboxyl-terminal domains and have an effector domain 
linked to theN-terminal domain. It is apparent that the N-terminus in its dephosphorylated 
state inhibits the activity of the effector domain(s) and phosphorylation acts to relieve this 
inhibition. Phosphorylation induces a conformational change by movement of the aE helix 
that swings the attached C-terminal domain into a different orientation with respect to the 
regulatory domain (Stock et al., 1995). The crystal structure of NarL (Fig 2.6) provided the 
first structural determination for the C-terminal domain of the FixJ superfamily (Baikalov et 
al., 1996). It showed that the C-terminal DNA-binding domain, with 62 amino acids, is a 
compact bundle of4 a helices, of which the middle 2 form a helix-turn-helix motif(H-T-H) 
closely related to other H-T-H DNA-binding proteins (Fig 2.7). The 2 domains are 
connected by an a helix of I 0 amino acids. In the nonphosphorylated form of NarL, the C-
terminal domain is turned against the receiver domain in a manner that would preclude DNA 
binding. The NarL structure was considered as a model for other members of the FixJ or 
LuxR family of bacterial transcriptional activators. On the other hand, due to the instability 
of the phosphorylated form of CheY, the crystal structure represented the 
nonphosphorylated state of the protein. Therefore the nature of the precise conformational 
changes which occur upon phosphorylation remain elusive (Egger et al., 1997). 
Based on extensive sequence homology in the less conserved C-terminal domain, 
bacterial response regulators can be separated into five families. These are represented by: 
(i) CheY family (including RegA, SpoOF, and Xccl), with ea. 130 amino acids, has only the 
N-terminal receiver domain, and possesses no output or DNA binding domains; (ii) OmpR 
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Fig 2.5: Tertiary structure of the S. typhimurium Che Y response regulator. The protein is 
composed of a five-stranded parallel ~-sheet (1-5) surrounded by five a-helices (A-E). 
Adapted from Stock et al. ( 1989). 
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Fig 2.6: Secondary structure of the E. coli NarL response regulator. The N-
terminal domain has five a/p motifs, while the C-terminal domain consists of the 
rest ofthe molecule with a8 and a9 forming a Helix-turn-helix motif(H-T-H). 
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Fig 2.7: The orientation of the helix-turn-helix motif (in blue) of the E. coli bacteriophage 
434 repressor in the major groove of the DNA double helix. The 'N' and 'C' indicate the 
Nand C terminals of the motif, respectively. (Adapted from Brown, 1999) 
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family (including AreA, BaeR, BasR, CopR, CreB, CpxR, KdpE, NisR, PetR, PhoB, PhoP, 
ResD, SparR, SphR, TctD, ToxR, and VirG), has a single C-terminal receiver domain and 
ea. 230 amino acids in length; (iii) NtrC family (including AlgB, DctD, HydG, and PilR), 
has 2 effector domains C-terminal to the receiver domain, and ea. 460 amino acids in length; 
(iv) FixJ or LuxR family (including DegU, EvgA, FimZ, NarL, RcsB, and UhpA), has a 
single C-terminal domain and ea. 220 amino acids in all; (v) Unclassified (including BvgS, 
CheB, PleD, RcsC, and VirA), exhibit a wide variation in structure and length (Baikalov et 
al., 1996; Egger et al, 1997). 
2.5.3.4 Hybrid kinases 
While most bacterial histidine-aspartate (His-Asp) phosphorelay systems involve direct 
transfer from the phosphorylated histidine sensor kinase to the conserved aspartyl residue of 
the response regulator, more sophisticated signal transduction proteins of bacteria contain 
domains that resemble both the histidine kinases and the response regulators in one primary 
sequence. This type of signal transducer is referred to as the "hybrid sensory kinase" (Alex 
& Simon, 1994; Mizuno et al., 1996; Egger et al., 1997). E. coli alone has at least 5 hybrid 
kinases (ArcB, BarA, EvgS, RcsC, and TorS) (Mizuno, 1997), while 16 hybrid sensor 
kinases were found in a photosynthetic cyanobacterium, Synechocystis sp. Others have been 
recognised in a wide variety of other bacteria (BvgS, LemA, RpfC, RteA and Vir A). The 
response regulator domain of these proteins is thought to function as a pseudo-substrate 
inhibitor of the kinase domain. Upon detection of the stimulus, the kinase domain undergoes 
autophosphorylation, and then transfers this phosphate to the regulator domain, thus 
relieving inhibition. Phosphorylation of the true substrate can then take place. These ideas 
are largely based on work on ArcB, which controls the anaerobic repression of several 
operons in E. coli by modulating its downstream response regulator, AreA (Alex & Simon, 
1994). 
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2.5.3.5 Histidine-containing phosphotransfer 
The histidine-containing phosphotransfer (HPt) domain was discovered very recently, 
but now is known to play an important role in some, but not all, His-Asp phosphotransfer 
signalling systems (Appleby et al., 1996). In a given sequence of a signal transducer, the 
HPt domain is the most difficult to recognise, because its amino acid sequence is quite 
variable, and does not resemble that of the authentic histidine site of the transmitter (Ishige 
et al., 1994). However, in a typical HPt domain an invariant and phosphorylated histidine 
residue (H2) is followed by a short characteristic stretch of amino acids (Fig 2.4c). Based on 
sequence criterion, a number of bacterial signal transducers were predicted to contain HPt 
domains such as ArcB and BarA of E. coli and BvgS of Bordetella pertussis. Unlike 
authentic transmitters, the HPt domain does not exhibit any catalytic function and as yet 
there is no evidence for intramolecular phosphotransfer within the sensor protein histidine 
kinase. The HPt domain thus appears to serve solely as a passive intermediate molecule, or 
substrate, in His-Asp phosphotransfer by acquiring/transferring a phosphoryl group from/to 
another signalling domain (Mizuno, 1998). 
2.5.3.6 Cross-talk 
Cross-talk is the term given to non-specific interactions between non-partner sensor 
and regulator proteins. It occurs between parallel signal transduction pathways as an 
information-processing network that integrates signals from a wide range of sensory inputs 
to co-ordinate the activities of an equally diverse array of output response strategies (Stock 
et al., 1989). Despite the highly conserved nature of sensor and regulator proteins, cross-talk 
is minimal (Parkinson, 1995) but can occur, although phosphotransfer rates between family 
members are at least two orders of magnitude slower (Egg er et al., 1997). This suggests that 
the regulatory systems possessed by some species have the potential to transduce signals 
from a diverse series of inputs or alternative phosphate donors and to collectively influence 
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several regulatory responses (Gervais & Drapeau, 1992). Biochemical evidence is now 
available for interactions between members of the two-component family, in particular 
EnvZ/OmpR, NtrB/NtrC, CheA/CheY and CheA/CheB (Ninfa et al., 1989; Stock et al., 
1989). One other striking example of integrated signalling pathways in B. subtilis, is 
between the pathways controlling phosphate utilisation (PhoR/PhoP), aerobic and anaerobic 
respiration (ResE/ResD), and sporulation (KinA-B/SpoOA) (Msadek, 1999). Consequently, 
once the cell commits to sporulation, respiration and phosphate utilisation are down-
regulated. Such a networking control system seems to assist the bacteria by increasing the 
flexibility of their environmental responses. 
2.5.3.7 Targets for antimicrobial therapy and vaccines 
The prevalence of two-component systems in a wide variety of bacterial species has 
stimulated interest and some limited success in designing new classes of broad-spectrum 
antimicrobials that can block these signalling pathways (Miller et al., 1989; DiRita & 
Mekalanos 1989; Deretic et al., 1991). The most attractive reason for targeting two-
component systems is that they are used by pathogenic bacteria to control the expression of 
virulence genes required for infectivity such as Salmonella typhimurium PhoP!PhoQ and B. 
pertussis BvgA/BvgS (Stock et al., 2000). General histidine kinase or response regulator 
inhibitors could potentially be candidates for broad-spectrum antibiotics. Bacterial histidine 
kinase inhibitors and inhibitors of aspartyl response regulator DNA-binding have been 
identified (Roychoudhury et al., 1993). Natural inhibitors of two-component systems such 
as unsaturated fatty acids were shown to be noncompetitive inhibitors of the 
autophosphorylation activity of KinA (Strauch et al., 1992), CheA (Roychoudhury et al., 
1993), and NtrB (Barrett & Hoch, 1998). Furthermore, a number of compounds that not only 
inhibit two-component functions but also affect bacterial growth, are currently under 
investigation. These include hydrophobic tyramines (Barrett et al., 1998), salicylanilides 
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(Machielag et al., 1998), and benzoxazines (Barrett & Hoch, 1998). 
The possibility that strains of pathogenic bacteria with mutations in a specific two-
component system may be good candidates for vaccine use has been tested. The rationale for 
this approach is that some two-component systems may regulate gene expression only 
during certain stages of infection. Mutants deficient for such systems might still survive 
within the host long enough to elicit an immune response before becoming growth-limited 
due to the mutation. Mutants of Salmonella typhi were created by deletion of the phoP!phoQ 
two-component system that regulates survival of this organism within the macrophage. 
When tested in human volunteers, the mutants induced greater intestinal and humoral 
immune responses than did four doses of the approved oral typhoid vaccine. This work 
establishes a precedent for studying the use of two-component mutants as vaccines against 
other important pathogens (Miller et al., 1993; DiRita, 1999). 
2.5.4 Circuitry of signalling systems 
The functionally critical step in two-component signal transduction is the interaction 
between the histidine kinase and the response regulator (Stock et al., 1995). Bacterial 
signalling proteins are constructed from modular components: input sensing domains; output 
effector domains; and transmitter and receiver domains for promoting protein-protein 
communication (Fig 2.8). Assembling these elements in various configuration constructs 
signalling circuits (Parkinson & Kofoid, 1992). 
The circuitry of signalling and the phosphorylation events, His-Asp phosphotransfer, 
involved have been demonstrated in several systems. The molecular communication 
between the sensors and their cognate regulators imply phosphotransfer reactions 
(phosphorylation and dephosphorylation) (Mizuno et al., 1996). ln order to trigger a 
reaction, the histidine kinase sensing domain directly bind ligands or detect other physical 
stimuli. Alternatively, more complex schemes involve indirect detection of signals through 
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Fig 2.8: A model for two-component signal transduction proteins, showing the information 
flows through noncovalent controls exerted by one domain upon another (black arrows) and 
by phosphorylation (coloured arrows) involving histidine (H) and aspartate (D) residues. 
(Adapted from Parkinson & Kofoid, 1992) 
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interaction with other protein components (Stock et al., 2000). The general mode of 
phosphorelay involves the following steps: 
1- Autophosphorylation of the sensor histidine kinase at a conserved histidine. 
2- The histidine kinase serves as a phospho-donor for the response regulator, which 
receives the phosphate onto a conserved aspartate within the phospho-accepting domain. 
3- A phosphorylation induced conformational change in the response regulator that 
permits a regulatory target to be engaged, which in turn allows the regulation of downstream 
effectors, commonly by mediating changes in gene expression. 
4- Down-regulation of the pathway by dephosphorylation via phosphatases (Egger et al., 
1997). 
The rate of phosphotransfer depends on both the rate of autophosphorylation and the 
specific protein-protein interactions between the sensor histidine kinase and the response 
regulator (Egger et al., 1997). Following phosphotransfer, the sensor histidine kinase and 
response regulator dissociates, which has been demonstrated in the case of CheA and Che Y 
(Schuster et al., 1993). In the absence of phosphorylation, the C-terminal domain of 
response regulators is not usually active. It has been proposed that the N-terminal domain 
exerts an inhibitory function, and when phosphorylated the conformation of the C-terminal 
domain is altered in a way that permits activation (i.e. DNA binding). 
2.5.5 Signals/ stimuli 
A wide variety of signalling tasks are handled by two-component regulatory systems in 
order to mediate the response to a particular stimulus or set of stimuli. One response to 
changing conditions is to move to a more "favourable" locale. Another possible course of 
action is to adapt the cell to the new environment, either by changing enzyme activity or by 
altering the expression of specific genes or groups of genes, either as a temporary 
adjustment or to establish a new long-term state e.g., the sporulation response to starvation. 
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Signal transduction pathways account for the control of stimulus-response systems including 
host detection and invasion leading to symbiosis or pathogenesis; metabolic adaptation to 
changes in chemical concentrations (carbon, nitrogen, electron acceptor, and phosphate); 
physiological responses to changes in medium osmolarity; chemotaxis; stress-induced 
differentiation, such as sporulation and fruiting-body formation; stress leading to antibiotic 
synthesis, capsule synthesis, gene transfer, heterocyst formation, or sporulation (Parkinson 
& Kofoid, 1992). In addition, nutrient and toxin levels, acidity, temperature, humidity, 
viscosity, or light and many other conditions can change rapidly and unexpectedly. For 
example, the nitrogen system monitors the ratio between two metabolites, glutamine and a-
ketoglutarate, and in this way, determines the availability of nitrogen. The chemotaxis 
system monitors the level of several small-molecule attractants and repellents, the molecular 
identities of which are also clear. By contrast, EnvZ and OmpR mediate the response to 
osmolarity, a property of the environment altered by varying the concentration of several 
small molecules, independent of the identity of these molecules (V an Alphen & Lugtenberg, 
1977). 
The adaptive responses in bacteria range from rapid transit changes in motility to long-
term global reorganisations of gene expression and cell morphology (Stock et al., 1989) and 
the response time varies widely, from milliseconds as in the case of the chemotaxis 
response, to hours which are required for initiating sporulation. Underlying this flexibility is 
a series of protein domains that apparently have been modified and rearranged in evolution 
to accommodate the regulatory requirements of a wide variety of systems (Table I, 
Appendix II). 
2.5.6 E. coli and two-component systems 
The recently completed genome sequence of E. coli has allowed the compilation of a 
complete list of genes encoding the two-component signal transduction proteins (Table 2, 
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Appendix 11). Mizuno (1997) identified at least 62 open reading frames as putative two 
component signal transducers in this single species. Among these there were 32 response 
regulators, 23 orthodox sensory kinases and 5 hybrid sensory kinases, while the rest had 
atypical domains lacking the phosphorylated histidine residue. The hybrid sensory kinases 
are RcsC, TorS, ArcB, EvgS and BarA. RcsC contains both the transmitter and receiver 
domains, while the other four contain HPt as well (Mizuno, 1997). Moreover, fourteen 
ORFs exhibit extensive similarity to members of the OmpR subfamily not only in the 
receiver domains, but also in the output domain. Seven other ORFs appear to be members of 
the NarL subfamily and four are members of the NtrC subfamily. Since OmpR, NarL, and 
NtrC response regulators are known to function as specific DNA-binding transcriptional 
regulators, it can thus be assumed that all these 25 members are DNA-binding 
transcriptional regulators. The response regulators are implicated in gene regulation in 
response to environmental parameters, yet each of them is postulated to regulate (activate or 
repress) a specific subset of genes (Mizuno, 1998). In only 17 cases have the physiological 
consequences of the adaptive responses induced by the sensor/regulators been previously, 
albeit incompletely, documented. The chromosomal positions of the coding sequences 
specifying each of these putative signal transducers are scattered evenly over the E. coli 
genome (Fig 3, Appendix 11). In most instances, a cognate pair of sensor/regulator is located 
next to each other, and most likely, in the same transcriptional unit (or operon). The order of 
these pairs of genes (5 '-sensor/3 '-regulator or 5' -regulator/3 '-sensor) and the transcriptional 
direction relative to the chromosome (direct or complementary) appears to be random 
(Mizuno, 1997). 
2.5.7 Two-component systems in other bacteria 
The homologous of two-component regulatory systems are found in both gram-
negative and gram-positive bacteria, including the genera Agrobacterium, Bradyrhizobium, 
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Bacillus, Bordetella, Enterobacter, Klebsiella, Myxcococcus, Pseudomonas, Rhizobium, 
Staphylococcus, and Salmonella (Stock et al., I 989). However, the number of two-
component proteins differs greatly in different bacteria. Recently, the entire genomic 
sequences have been completed for I 0 prokaryotic microorganisms, including Archaea. A 
brief inspection of these databases revealed that Haemophilus influenzae contains 4 sensors-
5 regulators; Helicobacter pylori, 4 sensors-7 regulators; Synechocystis sp., 32 sensors-38 
regulators; Mycoplasma gentitalium, none; Methanococcus jannashii (archaebacterium), 
none; and Methanobacterium thermoautotrophicum (archaebacterium), I5 sensors-9 
regulators. Bacillus subtilis appears to possess a similar number of sensor-regulator pairs as 
E. coli. Many prokaryotic microorganisms are considered to be exposed to a much greater 
variety of environments than many eukaryotes and this may reflect the greater number of 
His-Asp phosphotransfer signalling systems to be found in these bacteria (Mizuno, I 998). 
The complete genome sequence of P. aeruginosa contains the highest number of putative 
genes encoding two-component regulatory systems of all bacterial genomes sequenced to 
date, 64 response regulators and 63 histidine kinases (Rodriguez et al., 2000). The authors 
attributed this high number of two-component systems to the relatively large size of the P. 
aeruginosa genome (6264 Kb), and to the nature of the organism as an opportunistic 
pathogen that needs to adapt rapidly to a wide variation in environmental conditions. 
Recently, a two-component regulatory system, termed irlRS for invasion related locus, has 
been identified in B. pseudomallei (Jones et al., I 997). The system was detected by using 
Tn5-0T182 mutagenesis to generate mutants deficient in the ability to invade an established 
pulmonary cell line, a human type II pneumocyte cell line. The predicted proteins shared 
considerable homology with other two-component systems involved in the regulation of 
heavy metal (such as Cd2+ and Zn2+) resistance in other organisms. 
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2.5.8 The Res C:egulation of :apsule ~ynthesis) regulatory system 
The res system, found in a number of enteric bacteria, is a typical example of a 
histidine protein kinase/response regulatory system that acts as a mechanism for survival 
under difficult environmental conditions. 
2.5.8.1 The E. coli Res proteins and capsule synthesis 
Although Res proteins are now known to exist in a number of gram-negative bacteria, 
they were first identified in E. coli. Consequently, they are the best characterised of all 
regulators and so Res-like proteins from other organisms are generally identified on the 
basis of homology with the E. coli protein. 
Strains of E. coli as well as other enterobacteria can be provoked to produce a mucoid 
slime in response to external stimuli or mutations in key regulatory loci (Kelley & 
Georgopoulos, 1997). Bacterial capsular polysaccharides are classified into two groups by 
chemical and physical criteria. In general, group I polysaccharides contain uronic acid as the 
acidic component, have high molecular mass and are eo-expressed with specific 0 
polysaccharides. In contrast, group II polysaccharides contain a large variety of acidic 
components and have a relative low molecular mass (Jann & Jann, 1990; Virlogeux et al., 
1996). 
There is considerable information about the regulation of group I polysaccharide 
biosynthesis (Coplin et al., 1990; Stout, 1994), and the regulatory strategies used for colanic 
acid biosynthesis, an extracellular slime produced by E. coli K-12 under appropriate 
conditions, usually serves as the reference model for capsular synthesis (Virlogeux et al., 
1996). E. coli strains produce a variety of cell surface polysaccharides. Some of these 
polysaccharides are serotype specific, such as the lipopolysaccharide (LPS) 0 side chains (0 
antigen) and the capsular (K antigen) polysaccharides (CPS). There are approximately 160 
different 0 antigens in E. coli, and more than 70 biochemically distinct K antigens are 
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recognised (Jann & Jann, 1987). The K antigens are classified into two groups (designated I 
and 11) by chemical, physical, and genetic criteria. Other cell surface polysaccharides, such 
as colanic acid (M antigen) and enterobacterial common antigens, are not serotype specific 
and are found in many different strains of E. coli and in other enteric bacteria. The 0 and K 
antigens are thought to act as virulence determinants in pathogenic E. coli by providing 
resistance to complement-mediated serum killing and phagocytosis (Jann & Jann, 1987). 
In contrast to K antigen, the function(s) of colanic acid is unclear, since this polymer is 
generally produced only at low growth temperatures or on nitrogen-limited, carbon-rich 
media (Houng et al., 1992). Recent experiments suggest that colanic acid capsular 
production may represent an adaptive response that provides cells with the means to survive 
in unfavourable conditions prevailing outside the host such as desiccation and osmotic shock 
(Brill et al., 1988; Stout, 1994 ). 
The general biosynthetic pathway for colanic acid capsular polysaccharide begins with 
the synthesis of the component sugars as nucleotide sugar intermediates, which is followed 
by assembly, transport, and modification of the polymer (Markovitz, 1977). The genes 
thought to be involved in the latter steps of assembly, transport and modification are called 
the cps genes (Stout, 1996). In E. coli K-12 the cps genes are located near the his and the rfb 
(encoding protein 0 antigen LPS synthesis) gene clusters located at 45 min on the 
chromosome (Boulnois & Roberts, 1990). The cps gene cluster is composed of 5 
complementation groups (cpsA-F genes) that encode polymerisation, transport and 
modifications functions. Transcriptional activation of the cps genes depends on a two-
component regulator encoded by rcsC and rcsB ( 4 7 min), which are separated by 196 bp and 
transcribed in opposite directions. They act in concert with the product of the rcsA gene ( 43 
min), an unstable and limiting regulatory protein that is a substrate for the Lon protease, a 
major ATP-dependent protease (Gottesman et al., 1985; Gottesman & Stout, 1991 ). 
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However, studies using gene disruption and complementation revealed an rcsA- independent 
pathway for capsule synthesis and the requirement for RcsA can be partially bypassed by 
overproducing RcsB (Brill et al., 1988). Therefore, RcsA is considered as an auxiliary 
factor, which may interact with RcsB to form a heterodimer required for increased 
transcription of the colanic acid synthesis (cps) genes (Fig 2.9). The RcsAB dimer was 
thought to act as a class I activator (lshihama, 1993) and helps in attracting the RNA 
polymerase or in stabilising the transcriptional complex (Wehland & Bernhard, 2000). RcsC 
has a negative regulatory effect that was described through mutations that increase the level 
of polysaccharide by more than 10-fold (Gottesman et al., 1985). Recessive mutation in 
rcsC, such as rcsC137 a mutant which lacks autophosphorylation activity and, therefore, is 
locked in a conformation that leads to constitutive activation of RcsB, results in 
overexpression of capsular polysaccharide (Stout & Gottesman, 1990). On the other hand, 
RcsB was genetically defined by the isolation of mutations that block the expression of cps 
genes in mutant hosts (Gottesman et al., 1985). Moreover, another positive regulator RcsF, a 
putative membrane protein that has no significant sequence similarity with any known 
sensor proteins, has been proposed to be a kinase that may exerts its action on colanic acid 
synthesis through activation of RcsB (Gervais & Drapeau, 1992). RcsB appears to be 
essential for cps expression (Brill et al., I 988), and RcsA cannot activate cps expression in 
the absence of RcsB (Brill et al., 1988; Torres-Cabassa & Gottesman, 1987). From the 
above, RcsB has three major roles, namely, interaction with RcsC, interaction with RcsA, 
and interaction with the cps promoter (Gupte et al., 1997). 
2.5.8.2 Additional possible roles for RcsB and RcsC proteins 
(i) RcsB 
It is possible that different regulatory networks, using common factors such as RcsB, 
have been adopted for the control of synthesis of different capsules. The environmental 
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Fig 2.9: Model of the RcsB-RcsC two-component signalling system and capsule regulation 
in E. coli. (Adapted from Stout & Gottesman, 1990 and Kelly & Georgopoulos, 1997) 
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circumstances that dictate the need for one type most likely make the production of the other 
unnecessary (Russo & Singh, 1993). The RcsB protein required for the regulation of colanic 
acid capsule is present in the cytoplasm and can be used for regulation of different kinds of 
capsules without the energy waste involved in the synthesis of new and different regulators 
for a different capsule. 
Generally, most two-component systems have single kinase acting on one regulator 
(e.g. NtrB~NtrC or EnvZ~OmpR). However, different numbers of these elements may be 
linked together allowing one kinase to initiate multiple responses (distributive circuit) or 
multiple kinases to initiate a common response (integrative circuit) (Bourret et al., 1991 ). 
The ability to switch or upregulate expression under specific circumstances (e.g. at specific 
phases during infection) would almost certainly provide a selective advantage for pathogens 
(Gottesman et al., 1985). 
In E. coli 04/K54/H5, an extraintestinal pathogenic isolate, its group 11 capsular 
polysaccharide is an important virulence determinant and confers serum resistance. Russo & 
Singh (1993) demonstrated that RcsA is a negative regulator of that capsule, and its action 
appears to be mediated through RcsB, as is the case in E. coli K-12. Likewise, in E. coli and 
Klebsiella pneumoniae, RcsB affects the production of both group I and 11 capsular 
polysaccharides, which is not surprising considering that the function of these capsules 
appears to be divergent, with respect to serum sensitivity (McCallum et al., 1989). The 
environmental circumstances that dictate the need for one type most likely make the 
production of the other unnecessary. Jayaratne et al. (1993) examined the function of the res 
regulatory system in expression of the K30 capsular polysaccharide, which is produced at 
37oC and has been implicated as a virulence factor (Orskov et al., 1971). They indicated that 
the res system is not essential for expression of low levels of the group I capsular 
polysaccharide in Ion+£. coli K30, although it appeared to be more important for achieving 
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high levels of expression. 
On the other hand, rcsB can act as a positive regulator of Klebsiella K2 capsule 
production. Wacharotayankun et al. (1992) demonstrated, by Northern hybridisation, that 
rcsB enhanced a long strand of mRNA from Klebsiella cps genes indicating that rcsB 
regulates the expression of K2 capsular polysaccharide at the transcriptional level. 
Gervais and Drapeau, (1992) and Gervais et al. (1992) suggested that RcsB has a role 
in the regulation of ftsZ, a gene encoding a septurn protein that is critical for cell division, 
and proposed that RcsB increases the transcription offtsZ thus accounting for the restoration 
of colony formation of ftsZ mutant cells. They identified multicopy clones carrying rcsB 
among those that restored the ability of ftsZ mutants to grow on medium without salt; this 
effect is independent of RcsA. Increasing the amount of RcsB led to an increase in the 
expression of anftsAZ-lacZ fusion. Gervais et al. (1992) demonstrated the capacity of rcsB 
to autoregulate its own synthesis, particularly in the presence ofNaCI. 
The 5' untranslated sequence of rcsB contains several regulatory signals. Deleting this 
region or part of it results in a gene that is not sufficiently expressed to promote colanic acid 
synthesis and ftsZ expression. The regulatory signals present are the cr54 promoter which is 
located immediately upstream of the rcsB initiation codon, a consensus LexA-binding site 
sequence containing a presumptive a1o promoter, and another uncharacterised sequence that 
appears to be essential for its expression. 
(ii) RcsC 
RcsC was identified during a search for genes controlling the expression of the to/ 
genes, which encode proteins involved in the maintenance of cell envelope integrity in E. 
coli. Mutations in any of the to/QRA genes render the cell sensitive to drugs and bile salts 
and induce the release of periplasmic enzymes. A rcsC mutant strain, rcsC338, was 
transformed with plasmids containing operon fusions to the to/Q, to/R or to/A genes. The 
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results showed that in the absence of an external signal, RcsC would not phosphorylate its 
transmitter protein. Under such conditions, capsule synthesis is not activated while to!QAR 
genes are expressed to maintain cell-envelop integrity. On the other hand, in the presence of 
a signal indicating some alteration to the cell surface, RcsC switches its control by activating 
capsule synthesis as a stress response to protect the cell (Clavel et al., 1996). 
2.5.8.3 The Res system in other bacterial species 
The res regulatory network has been shown to be widespread among bacterial species, 
and may serve as a common regulatory system for the expression of structurally different 
polysaccharides in bacteria that occupy diverse ecological niches (Jayaratne et al., 1993). 
Homologs of Res proteins have been identified in Erwinia spp, K. pneumoniae, and S. typhi. 
In Erwinia stewartii, a primary determinant of pathogenicity is the production of 
extracellular polysaccharide (EPS). Erwinia spp use RcsA to regulate expression of both the 
species-specific extracellular polysaccharide and a leavan polymer (Toress-Cabassa et al., 
1987; Coleman et al., 1990). The gene promotes the transcription of at least two operons 
(cps) involved in EPS synthesis. Possibly, both RcsB and RcsC, regulate the production of 
group Il capsular polysaccharide. 
There have been few in vivo studies on the possible role, if any, of RcsB and RcsC in 
virulence. Bereswill & Geider ( 1997) showed that overexpression of the rcsB gene in 
Erwinia amylovora from high-copy-number plasmids stimulated the synthesis of the acidic 
exopolysaccharide amylovoran. In addition, inactivation of rcsB by site-directed 
mutagenesis created mutants that were deficient in amylovoran synthesis and avirulent on 
host plants. 
The capsular polysaccharide of S. typhi, a linear homopolymer of a-1,4 2-deoxy-2-N-
acetylgalactosamine uronic acid, is produced by all strains of S. typhi, and Salmonella 
paratyphi as well as from some strains of Salmonella dub/in and Citrobacler freundii. 
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Production of Vi antigen is partially controlled by the two-component regulatory system 
RcsB-RcsC and by the positive regulator TviA, which interacts with RcsB to promote 
optimal transcription of the genes involved in Vi antigen synthesis (Virlogeux et al., 1996). 
However, there are some specific features in the mechanisms controlling Vi antigen 
synthesis in S. typhi that are distinct from those involved in colanic acid synthesis in E. coli: 
(i) RcsA is not involved in Vi antigen synthesis; (ii) TviA is the auxiliary protein interacting 
with RcsB to promote transcription of the viaB locus; and (iii) TviA is not subjected to Lon-
dependent degradation (Virlogeux et al., 1996). 
Furthermore, the production of S. typhi invasion-promoting Sip proteins, secreted 
proteins required for invasion and entry into epithelial cells, and flagellin was reported to be 
modulated by the RcsB-RcsC regulatory system in response to changes in environmental 
osmolarity. This regulation occurs at both the transcriptional and post-translational levels 
(Arricau et al., 1998). The RcsB-RcsC modulation of expression in response to changes in 
the osmolarity of the growth medium was attributed to the adaptive response of S. typhi to 
the changing environments encountered during the different stages of pathogenesis. 
In summary, two-component regulatory systems are widespread amongst bacterial 
species and are essential for regulating responses to changing environments. Therefore, in 
many instances these systems make a vital contribution to the pathogenesis of disease. 
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CHAPTER3 
GENERAL MATERIALS AND METHODS 
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3.1 REAGENTS AND MEDIA 
Details of the formulation ofreagents and composition of media used during this study 
are given in Appendix Ill. When necessary, reagents and media were sterilised by 
autoclaving (121°C, 15 min). Heat-sensitive components, such as antibiotics, were filtered 
using a syringe and membrane filter of 0.2 or 0.45 !liD mesh (Sartorius Ltd). 
Unless stated otherwise, analytical grade chemicals were obtained from Sigma, or BDH, 
while enzymes for the restriction and modification of DNA were obtained from Gibco BRL, 
Boehringer Mannheim, Promega Ltd, Stratagene or New England Biolabs. All PCR 
reactions were performed with reagents obtained from Roche (Lewes, UK). 
3.2 BACTERIOLOGY 
3.2.1 Bacterial strains 
The B. pseudomallei strains that were used in this work are described in Table 3.1, 
while other bacterial species are listed in Table 3.2. The E. coli strains shown in Table 3.3 
were used for general cloning procedures, the propagation of the plasmids that were 
constructed during this study and for the manipulation of cloned genes. 
3.2.2 Laboratory culture and storage of bacteria and phage 
All strains of B. pseudomallei were grown on LB medium at 37°C statically, unless 
otherwise stated, within an authorised Containment Level 3 Laboratory (CL3) either at the 
PHLS, Derriford Hospital, Plymouth by Dr D.A.B Dance, or at 401A Davy Building, 
University of Plymouth by Dr M.L. Gilpin. The identity of B. pseudomallei was confirmed 
by the API 20NE biochemical test. 
E. coli Kl2 strains were routinely incubated aerobically on LB medium at 37°C and 
broth cultures were shaken at 200 strokes/min, overnight. When required, antibiotics were 
added to the autoclaved growth medium after cooling to less than 50°C (Table 1, Appendix 
Ill). 
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Table 3.1: Isolates of B. pseudomallei that were used in this study 
Strain Source Sample Geographical origin Date 
19 Environment Soil Singapore 1991 
22 Environment Soil Burkinafaso 1973 
25 Environment Soil Madagascar 1977 
33 Environment Manure France 1976 
46 Human Blood NE Thailand 1988 
53 Human Urine NE Thailand 1987 
97 Environment Soil Australia -
98 Environment Soil Australia -
102 Environment Soil Australia -
112 Human Multiple NE Thailand 1992 
204 Human Blood Thailand -
212 Environment Soil NE Thailand 1990 
216 Environment Soil NE Thailand 1990 
217 Environment Soil (wet) NE Thailand 1990 
392 Human Pus NE Thailand 1989 
426 Environment Soil Vietnam -
448 Environment Soil Vietnam -
576 Human Blood Thailand 
-
E8 Environment Soil Thailand -
E25 Environment Soil Thailand -
Zhan I Human Blood Malaysia 
Hainan I Human China 
Hainan 2 Human China 
Hainan 3 Human China 
Hainan 4 Human China 
Hainan 55 Human China 
Hainan 106 Human China 
Hainan 706 Human China 
Jie 187 Human China 
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Table 3.2: Bacterial strains that were used for DNA hybridisation studies 
Strain Source 
B. thailandensis E27 T. Pitt 
B. thailandensis E82 T. Pitt 
B. thailandensis E254 T. Pitt 
B. thailandensis E255 T. Pitt 
B. thailandensis E256 T. Pitt 
B. thailandensis E260 T. Pitt 
!B. cepacia I non-epidemic T. Pitt 
B. cepacia II non-epidemic T. Pitt 
!B. cepacia Ilia epidemic T. Pitt 
B. cepacia Ilia non-epidemic T. Pitt 
IB- cepacia Illb non-epidemic T. Pitt 
B. cepacia IIIc epidemic T. Pitt 
B. cepacia IV non-epidemic T. Pitt 
B. cocovenenans LMG 11626 T. Pitt 
B. plantarii LMG l 0908 T. Pitt 
!B. vietnamiensis LMG 6998 T. Pitt 
B. vietnamiensis LMG 6999 T. Pitt 
B. vietnamiensis LMG l 0620 T. Pitt 
B. vandii LMG l 0620 T. Pitt 
P. aeruginosa University of Plymouth culture 
collection 
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Table 3.3: Strains of E. coil K 12 that were used in this study 
Strain Genotype Source 
SY327 A.pir F"araD D(Lac pro) argE (Am) recA56 Rif nalA N. Fairweather 
DHSa F·, endA 1, hsdR 17 (r-k m+k), supE44, thi, recA 1, M. L. Gilpin 
gyrA96, re!Al, MacZMlS 
LE392 F hsdR574 (rK-, mK+) supE44 supF58 !acYl or Promega 
tl(lacZY)6 ga!K2 gaiT22 rnetB 1 trpRSS 
XLl-Biue supE44 hsdR thi-1 thr-1 leuB6 !acYl tonA21 M. L. Gilpin 
Yl088 L1lacUI69 supE supF hsdR. hsdM+ rnetB rtpR Promega 
tonA21 proCDTn5 (pMC9). PMC9=pBR322-/ac0 
XLOLR tl (rncrA) 183 tl (rncrCB-hsdSMR-rnrr) 173 endAl Stratagene 
thi-1 recAl gyrA96 re/A I lac [F' proAB laclq 
ZtlMlS TnlO(Tetr)] su· 
97 
For long term storage of bacterial strains, single colonies were removed using a sterile 
inoculating loop and grown overnight at 37°C in the appropriate broth and 0.5 ml aliquots 
were mixed with 0.5 ml of sterile glycerol, cryoprotectant, and stored at -20°C or at -80°C. 
For short-term storage, cultures on agar plates were sealed with parafilm and stored at 4°C 
for up to eight weeks. To initiate growth after storage at -20°C or -80°C, 50-I 00 Jll of stock 
culture was inoculated into I 0 ml LB broth or streaked onto agar plates, and incubated at 
37°C prior to inoculating media containing the appropriate antibiotics. 
3.2.3 Sterility and viability checks of B. pseudoma/lei culture products 
B. pseudomallei is a Category 3 pathogen, therefore all products that were derived from 
viable cultures that were to be used outside the CL3 facility were rigorously checked to 
confirm sterility. Initially, two independent samples were processed and their entire contents 
were tested for viability by inoculating 0.1 ml aliquots onto LB agar and into LB broth, 
followed by incubation at 37°C for 3 days. If no growth was obtained, then a 10% volume of 
all subsequent preparations were checked by inoculating broth and agar plates with 0.1 ml 
aliquots and incubating at 37°C for 3 days prior to release. 
3.3 PLASMIDS AND PHAGE 
The plasmids and phage shown in Table 3.4 were used for constructing gene libraries 
(A.GEM-11, A.ZAP), subcloning for DNA sequencing (pUC 18, pBSK+) or gene expression 
(pMAL-C2) and for constructing a suicide vector for mutagenesis studies (pCVD442). 
Phage stocks were stored with a few drops of chloroform at 4°C. 
3.4 DNA MANIPULATION 
3.4.1 Preparation of chromosomal DNA 
Prior to the availability of the CL3 facility at the University of Plymouth, B. 
pseudomallei chromosomal DNA was the generous gift ofDr T. Pitt, Central PHLS, London. 
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Table 3.4: Plasmid and phage vectors that were used in cloning studies 
Vector Description Source 
pULl IS LOlt:>l on, facL, Amp•, polyllnKer EcoK1-Hindlll Lab collectiOn 
pB!ueSK+ Co!E I ori, lacZ', Amp' Stratagene 
pCVD442 Amp', pir-dependent R6K replicon, sacB N. Fairweather 
pMAL-c2 lacZ, Amp', /aclq, ma[E New England Biolabs 
Lambda GEM-I! Purified bacteriophage /... left and right arms, 
stuffer fragment removed by BamHl digest 
Promega 
Lambda Zap 
Express ZAP express predigested Gigapack cloning kit- Stratagene 
BamHI/CIAP-treated 
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3.4.1.1 Minipreps 
For B. pseudomallei, I 0 m! of an overnight culture was centrifuged (3,000 x g, 20 min, 
4°C) and the cell pellet was washed in I 0 m! of STE (Appendix Ill). After re-centrifugation, 
as above, the cell pellet was resuspended in 5 m! of solution A (Appendix lll) for 5 min at 
RT, then mixed with I m! of solution 8 (Appendix Ill). After 5 min at room temperature 
(RT), 1.2 m! of solution C (Appendix Ill) was added and mixed then 0.7 m! of solution D 
(Appendix III) was added and the mixture was placed in a water bath at 80°C for 2 h with 
occasional mixing. Finally, the mixture was checked for sterility (section 3.2.3) while the 
remaining lysate was stored at 4°C or at -70°C awaiting the outcome (3 days). For further 
purification of the DNA, the lysate was treated using the Puregene DNA isolation kit as 
detailed in section 3 .4.1.2. 
3.4.1.2 Puregene DNA isolation kit 
For genomic DNA extraction from bacterial species other than B. pseudomallei, the 
Puregene DNA isolation kit was used (Gentra Systems, Minneapolis, USA). The protocol 
used was supplied by the manufacturer for the extraction of genomic DNA from 0.5 ml 
overnight cultures of gram-negative bacteria. Cultures were centrifuged (13,000 x g, 2 min) 
and the supematant removed. The cell pellet was resuspended in 300 f.ll of cell lysis solution 
then incubated at 80°C for 5 min. RNase solution (1.5 f.ll) was mixed with the cell lysate and 
the samples were incubated at 37°C for 30 min before cooling to RT. Protein precipitation 
solution (lOO f.ll) was added then the samples were vortexed (20 s) and centrifuged (13,000 x 
g, 3 min, RT) to pellet the precipitated protein. The supernatant, containing the DNA, was 
poured into a clean tube containing 300 f.ll isopropanol and the samples were gently mixed 
by inverting the tubes 50 times. The tubes were centrifuged (13,000 x g, I min, RT), the 
supernatant was removed and the pelleted DNA was air dried for 15 min. The DNA was 
rehydrated overnight at RT following the addition of 50 f.ll ofTE buffer. 
100 
3.4.2 Preparation of plasmid DNA 
3.4.2.1 Small scale preparation 
The small scale preparation of plasmid DNA from bacterial cultures was performed as 
described by Birnboim & Doly (1979). Aliquots (1.5 ml) of overnight cultures were 
centrifuged (13,000 x g, 30 s, RT). The pelleted cells were resuspended in 100 f..ll of B & D I 
solution (Appendix Ill) and left at RT for 5 min. The bacterial cells were lysed by adding 
200 f..ll of freshly prepared B & D solution 11 (Appendix Ill); the contents were gently mixed 
and incubated on ice for I 0 min. After the addition of ISO f..ll of ice cold B & D solution Ill 
(Appendix Ill), the solution was mixed, placed on ice for 10 min to precipitate cell debris, 
denatured proteins, chromosomal DNA and SDS. The tube was centrifuged (13,000 x g, 5 
min, RT) and the supernatant was transferred to a fresh microfuge tube. The plasmid DNA 
was precipitated by mixing with 1 ml of cold I 00% ethanol, then incubating at -70°C for 15 
min. After centrifugation (13,000 x g, 5 min), the plasmid DNA pellet was resuspended in 
100 f..ll of B & D solution IV (Appendix Ill), reprecipitated by adding 250 f.Ll of 100% cold 
ethanol and centrifuged as above. The pellet was washed with 70% ethanol, centrifuged 
(13,000 x g, 5 min, RT) and the supernatant was discarded. Finally, the precipitated plasmid 
DNA was air dried then resuspended in 10 f..ll of TE buffer. Alternatively, the addition of B 
& D IV was omitted and the plasmid DNA pellet was instead resuspended in 50 f..ll ofRNase 
solution, incubated at 37°C for I h, and the plasmid DNA purified by phenoVchloroform 
extraction (section 3.4.4.2). 
3.4.2.2 Large scale preparation 
The extraction of plasmid DNA on a large scale was performed by a modification of the 
above method. Bacterial cultures (200-500 ml) were harvested by centrifugation (6,000 x g, 
IS min, 4°C) using a MSE, Europa 24M (UK). The pellet was resuspended in 10 m! of B & 
D solution I for 5 min RT, then 1 ml of lysozyme solution (10 mg/ml) was added with 
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mixing and incubated for 5 min. Freshly prepared B & D solution II (20 ml) was added, 
mixed by gently inverting the centrifuge bottle and the suspension was placed on ice for I 0 
min. After the addition of 15 ml of ice-cold B & D solution III, the mixture was placed on 
ice for I 0 m in and centrifuged (9,000 x g, I 0 m in, 4°C). The supematant was carefully 
transferred to a fresh tube, warmed to room temperature and mixed with 0.6 volumes of 
isopropanol for 20 min at RT. Plasmid DNA was pelleted by centrifugation (5,000 x g, 30 
min, 20°C), washed in 70% ethanol, then centrifuged as above, and the pellet was air dried 
and resuspended in 2.5 ml ofTE buffer. 
3.4.2.3 Minipreps 
Rapid extraction of small quantities of pure plasmid DNA from bacterial cultures was 
performed using the Miniprep plasmid DNA extraction kit (Bio-Rad, UK). Aliquots (1.5 ml) 
of overnight cultures were centrifuged (13,000 x g, 30 s, RT) and resuspended in 200 1-11 of 
cell resuspension solution. Cell lysis solution (250 1-11) was added, gently mixed, and 250 1-11 
of neutralization solution was added with mixing. Samples were centrifuged (13,000 x g, 5 
min, RT) and the plasmid DNA contained in the supematant was added to 200 ~I of 
diatomaceous matrix and purified using a spin filter. The matrix was washed twice (13,000 x 
g, 30 s, RT) in wash buffer and the DNA was eluted into a clean tube with 100 ~I of 'Analar' 
H20 or TE prewarmed to 50°C (13,000 x g, I min, RT). 
3.4.2.4 Maxipreps 
Rapid extraction of large quantities of plasmid DNA from bacterial cultures was 
performed using the Maxiprep plasmid DNA isolation kit from Promega, UK. Overnight 
cultures (I 00-500 ml) were centrifuged (6,000 x g, I 0 m in, 4°C) and the pellet was 
resuspended in 15 ml cell resuspension solution. Cell lysis solution (15 ml) was added, the 
solution was mixed gently by inverting the tube several times and then centrifuged ( 11,000 x 
g, 15 min, RT). The supematant was filtered through microcloth, and transferred to a fresh 
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centrifuge tube. To precipitate the plasmid DNA, a 0.5 volume of isopropanol was added, 
mixed gently and the solution was centrifuged (14,000 x g, 15 min, RT). The supematant 
was discarded, the DNA pellet was resuspended in 2 ml TE buffer, and 10 ml of DNA 
purification resin was mixed into the solution. The DNNresin mix was transferred into a 
Maxicolumn, and washed with column wash solution (25 ml) and 80% ethanol (5 ml) using 
a vacuum manifold. After washing, the Maxicolumn was inserted into a 50 ml 
polypropylene tube (Falcon, UK) and centrifuged (1500 x g, 5 min, RT), then placed into a 
fresh 50 ml tube. Preheated (65°C) TE buffer was added (1.5 ml) and left for 1 min before 
the plasmid DNA was eluted by centrifugation (1500 x g, 5 min, RT). Finally, in order to 
remove residual resin the DNA solution was passed through a 0.2 ~-tm membrane filter using 
a syringe and the resulting plasmid DNA was stored at 4°C. 
3.4.3 DNA precipitation 
3.4.3.1 Ethanol precipitation 
To a solution containing DNA, a one tenth volume of 3 M sodium acetate (pH 6.0) was 
added and mixed followed by three volumes of cold ethanol. After thorough mixing the 
solution was stored at -20°C overnight or at -70°C for 20 minutes to precipitate DNA. The 
DNA was pelleted (13,000 x g, 5 minutes, 4°C), the supematant was carefully removed and 
the pellet was rinsed with 70% (v/v) ethanol. After centrifugation, the pellet was dried then 
resuspended in the appropriate amount of TE buffer or 'Analar' water. The concentration 
and purity of the DNA were determined as described in section 3.4.6.1. 
3.4.3.2 Isopropanol precipitation 
DNA was precipitated by adding 0.6 volumes of iso-propanol (2-propanol) to a DNA 
solution, incubated for I h at RT, then centrifuged (10,000 x g, 15 min, RT). The 
supematant was removed and the DNA pellet washed with 70% ethanol and processed as for 
ethanol precipitation (section 3 .4.3.1 ). 
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3.4.4 DNA purification 
3.4.4.1 Caesium chloride density gradient ultracentrifugation 
The method used is described by Sambrook et al. (1989). CsCl (2.5 g) was added to a 
solution of DNA in TE buffer (2.5 m!). A volume (250 J.ll) of ethidium bromide solution ( 10 
mg/ml in TE buffer) was added and after thorough mixing the preparation was left in the 
dark at RT for 18 h. This allowed time for ethidium bromide-protein complexes to form and 
these were removed by centrifugation (13,000 x g, 3 min). The clarified supematant was 
transferred and sealed by heat into 3.3 m! Quick-Seal centrifuge tubes (Beckman, USA) and 
centrifuged at 80,000 rpm for 24 h at 20°C using a fixed angle TLA-1 00.3 rotor in a TLl 00 
benchtop ultracentrifuge (Beckman, USA). DNA molecules are separated from impurities 
according to their densities into two discrete bands. The top band contained chromosomal 
DNA and nicked circular plasmid DNA, whilst the lower band represented the closed 
circular plasmid DNA. The red pellet at the bottom of the tube contained ethidium 
bromide!RNA complex and the proteins lay on the surface of the gradient. After the run, 
DNA bands were visualized with a long-wave UV lamp. A needle was placed in the top of 
the tube to allow air in, and the plasmid band was removed by side puncture ofthe tube with 
a needle and syringe that inserted just below the lower plasmid DNA band, measured and 
transferred to a sterile plastic 5 ml bijoux. Ethidium bromide was removed from purified 
DNA solutions by organic phase extraction. An equal volume of isopropanol saturated with 
water and CsCI was added and the two phases were shaken vigorously. The phases were 
allowed to separate for 3 min and the upper phase consisting of ethidium bromide and 
isopropanol was discarded. Fresh isopropanol mixture was added again and the extraction 
was repeated until all traces of the pink colour of ethidium bromide disappeared. At this 
stage, plasmid DNA contained in the clear aqueous phase was precipitated by ethanol 
(section 3 .4.3 .I) and the CsCI was removed by successive washes in 70% ethanol. The 
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plasmid DNA pellet was air dried then resuspended in either 200 j..Ll TE buffer for high copy 
number plasmids or 100 j..Ll TE buffer for low copy number plasmids. 
3.4.4.2 Phenol chloroform extraction 
Initially, the method for the purification of nucleic acids from cellular extracts involved 
a first step of emulsifying the DNA solution with an equal volume of liquefied phenol 
(equilibrated with 0.1 M Tris-HCl, pH 8.0). This organic solvent precipitates proteins but 
leaves the DNA in aqueous solution. The mixture was then centrifuged (13,000 x g, 2 min, 
RT) to give an upper aqueous phase containing DNA. The aqueous phase was removed 
carefully, leaving the interface behind, and transferred to a new microfuge tube. To this an 
equal volume of phenol/chloroform (Appendix Ill) was added and thoroughly mixed by 
vortexing. The mixture was centrifuged (13,000 x g, 30 s, RT) and the upper aqueous layer, 
containing DNA, was carefully removed and transferred into a clean tube. An equal volume 
of water-saturated chloroform plus IAA (24 parts chloroform: 1 part isoamyl alcohol) was 
added, mixed and centrifuged as above and the upper aqueous layer was removed and 
transferred to a new tube. The chloroform!IAA procedure was repeated. The DNA was then 
precipitated with ethanol, pelleted (13,000 x g, 5 min, RT), washed in 70% ethanol and 
dried. The dried pellet was resuspended in TE buffer and stored at 4°C. 
3.4.4.3 Rapid purification with Prep-A-Gene kit 
The Prep-A-Gene silica-based DNA purification kit (Bio-Rad, UK) provides a fast and 
effective purification and concentration of DNA. Purification was performed us!ng the 
protocol supplied by the manufacturer for the recovery of DNA from solutions (protocol 
3 .2). The amount of Prep-A-Gene matrix that was required was estimated using the capacity 
figure of 0.2 j..Lg supercoiled DNA/j..LI Prep-A-Gene matrix. A quantity of DNA purification 
binding buffer equal to three times the combined volumes of Prep-A-Gene matrix 
suspension and DNA containing solution was added to the sample followed by the addition 
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of the predetermined amount of Prep-A-Gene matrix. The mixture was incubated at RT for 
10 m in with frequent agitation then centrifuged (13,000 x g, 30 s, RT). The supematant was 
removed and the pellet containing DNA was rinsed by resuspension in a volume of binding 
buffer equivalent to 25 X the volume of the added matrix and vortexed. The mixture was 
centrifuged as above and the Prep-A-Gene pellet was washed twice with 25 X matrix 
volume of wash buffer. After the second wash and centrifugation, all traces of wash buffer 
were removed and tubes were left with lids open at either 55°C for 1 minor at RT for 5 min 
to allow residual alcohol to evaporate. Finally, the DNA was eluted by resuspending the 
matrix pellet in at least one pellet volume of elution buffer and incubating at 50°C for 5 min. 
The samples were centifuged as above and the DNA-containing supematant was carefully 
removed to a clean tube and stored at 4°C. 
3.4.5 Restriction endonuclease digestion of DNA 
Class II restriction endonucleases are used extensively in molecular cloning. These 
enzymes recognise and cleave the DNA molecule at a specific sequence. The amount of 
enzyme required for complete digestion depends on the amount of DNA to be cut, the 
number of times the enzyme could be expected to cut the DNA sample, and the specific 
activity of the enzyme. One unit of enzyme is generally defined as the amount that is 
required to completely digest 1 J.lg of bacteriophage A. DNA in 1 hat 37°C. 
3.4.5.1 Single enzyme digestion 
Typically, in a microfuge tube, 0.2-1 J.lg DNA was combined with 1 f.ll (8-20 unit) of 
enzyme, 2 J.ll of recommended restriction endonuclease buffer supplied by the manufacturer 
at 10 x concentration and the reaction volume was made up to 20 f.ll final volume with 
analytical grade H20 (Sigma, Poole, UK). The components were mixed, centrifuged (13,000 
x g, 3 s) and unless otherwise stated, the tubes were incubated at 37°C for 3-18 h. Digests 
were analysed by electrophoresis on a 0.8% (w/v) agarose gel in comparison with DNA 
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molecular size markers. In some cases, enzymes were inactivated by a 10 min incubation at 
68°C. Heat-stable enzymes were removed by phenol/chloroform extraction (section 3.4.4.2) 
or Prep-A-Gene extraction (section 3.4.4.3). Larger amounts of DNA were digested by 
scaling up the reaction mixture, ensuring that the enzyme volume was always kept below 
I 0% of the total volume to prevent non-specific cleavage of DNA due to the high 
concentration of glycerol that is present in stock enzyme solutions. 
3.4.5.2 Double enzyme digestion 
For double enzyme digests where both enzymes reqmre the same buffer, or a 
compatible buffer, the reactions were performed as for single enzyme digestion but using 
half the volume of each enzyme. If the enzymes required different buffers, the DNA was 
digested in two sequential single digests. 
3.4.6 Electrophoresis of nucleic acids 
3.4.6.1 Agarose gel electrophoresis and DNA quantification 
Agarose gel electrophoresis is the standard method for separating DNA molecules 
according to their size, and was carried out using gel electrophoresis apparatus supplied by 
Amersham Pharmacia Biotech (Milton Keynes, UK). Agarose gels were prepared in TBE 
buffer at a concentration that varied between 0.6-1% (w/v) agarose depending on the size of 
fragments to be resolved (Table 2, Appendix Ill). Agarose powder was added to I X TBE 
buffer, heated in a microwave oven until molten, cooled to 60°C before ethidium bromide 
was added to a final concentration of 0.5 J.Lglml and mixed by swirling. Molten agarose was 
then poured into UV -transparent gel cast (Pharmacia) provided with a toothcomb. Once 
solidified, the gel was submerged in 1 X TBE buffer in the electrophoresis tank, and the 
well-forming comb was carefully removed. DNA samples were mixed with 1/6 volume of 6 
X gel loading buffer (Appendix Ill) then loaded into the wells. DNA ladder was run 
alongside in a separate lane to provide molecular size markers. Three molecular markers 
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we're used, namely, the I Kb ladder (Gibco BRL, Paisely, UK), the 100 bp DNA ladder 
(Gibco BRL, UK) and the A-EcoRl ladder (Sigma, Poole, UK). Samples were 
electrophoresed at 120V until resolved. DNA bands were visualised using long wavelength 
ultra violet (UV) illumination and photographed using either a Polaroid CU5 camera system 
(Eastman Kodak, New York, USA) or a gel documentation system (UVI TEC, UK). 
For visual quantification of DNA fragments on agarose gels, a set of standard amounts 
of undigested A phage DNA markers were run in parallel with the samples of unknown 
concentration. Because the amount of fluorescence is proportional to the total mass of DNA, 
the quantity of DNA in the sample can be estimated by comparing the fluorescence yield of 
the sample with that of a series of standards (Sambrook et al., 1989). This approach allows a 
rough estimation of the amount of DNA in a given sample and is capable of detecting as 
little as -5 ng of double-stranded DNA. Usually a set of four known amounts (12, 60, 125 
and 250 ng) of double stranded A phage DNA (Sigma, Poole, UK) were used. 
Alternatively, for pure samples, without substantial amounts of contaminants such as 
proteins or phenol, spectrophotometric measurements for the determination of DNA 
concentration was used. The method is based on the different absorbance spectra of nucleic 
acids and proteins, since DNA and RNA both strongly absorb UV light with a maximum 
absorbance at 260 run. Samples of DNA were appropriately diluted, placed in quartz 
cuvettes and the readings were taken at wavelength 260 run (Pharmacia PU 8720 
spectrophotometer) that allows the calculation of the concentration of nucleic acid. An 
optical density (OD) of I corresponds to approximately 50 J..lg/ml for double stranded DNA, 
40 J..lg/ml for single-stranded DNA and RNA, and 20 J..lg/ml for oligonucleotides (Sambrook 
et al., 1989). When DNA concentrations are low ( <250 ng/ml) spectrophotometric 
measurements may not be accurate. 
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3.4.6.2 Isolation of DNA fragments from agarose gels 
The recovery of DNA molecules from agarose gels was carried out using the Prep-A-
Gene DNA purification system (section 3.4.4.3). Following electrophoresis the agarose gel 
was examined under UV light and the gel slice containing the desired band was excised 
using a sterile razor blade, then transferred to a pre-weighed sterile microfuge tube. The tube 
was weighed again and the weight of the gel slice was calculated. The amount of Prep-A-
Gene matrix that was required was estimated using the capacity figure of 0.2 J.Lg supercoiled 
DNAIJ.Ll Prep-A-Gene matrix. A volume of purification binding buffer equivalent to three 
times the combined volumes of gel and matrix was added and the tube heated in a water bath 
at 55°C for 5 min. The Prep-A-Gene matrix was fully resuspended then added to the 
dissolved gel slice and mixed by inversion. The purification proceeded as described in 
section 3.4.4.3. 
3.5 CLONING INTO PLASMID VECTORS 
Vectors were digested with the appropriate restriction endonuclease (section 3.4.5) and 
phosphatase treated if required (section 3.5.1). Restriction endonuclease activity was 
removed by either phenol/chloroform extraction (section 3.4.4.2) or by rapid purification 
with the Prep-A-Gene kit (section 3.4.4.3). 
3.5.1 Alkaline phosphatase treatment of linearised vector 
Alkaline phosphatase is capable of removing 5' -terminal phosphate groups from nucleic 
acid molecules that are required for DNA ligation. Hence phosphatase treatment of vector 
DNA will prevent self-ligation and simplify cloning because phosphorylated DNA 
molecules can still be ligated into the vector. Linearised vector DNA (I J.Lg) was 
dephosphorylated using 2 units of calf intestinal alkaline phosphatase (ClAP) (Boehringer, 
Mannheim) in the presence of ClAP reaction buffer in a total volume of 30 !J.l at 37°C for I 
109 
h. A further 2 units of enzyme were added after 30 min. Because ClAP can interfere with the 
efficiencies of subsequent ligation and transformation, the alkaline phosphatase was 
inactivated by incubating the reaction for I 0 m in at 68°C and removed completely by 
phenol/chloroform extraction (3.4.4.2) or with the Prep-A-Gene kit (3.4.4.3). 
3.5.2 Ligation of blunt-ended DNA restriction fragments 
All blunt ends are suitable for ligation to one another. Usually a fragment to vector 
ratio of 4: I was used, but often a range of ratios was used to ensure efficient ligation of the 
insert into the vector. The insert and vector were mixed with of I J.d of T4 DNA ligase 
(Gibco BRL IU/J.ll) and ligation buffer (Gibco BRL), and diluted with 'Analar' H20 to a 
final volume of 30 J.ll. The condensing agent hexamine cobalt chloride (Appendix III) was 
added to a concentration of I J.!M, if necessary, to increase molecular crowding and improve 
ligation efficiency. The mixture was incubated at I6°C for 18 h. Once completed, the 
successful ligation was confirmed by agarose electrophoresis in comparison with both the 
digested vector and DNA markers. Ligation mixture was either used directly to transform E. 
coli or frozen at -20°C until required. 
3.5.3 Ligation of cohesive-ended DNA restriction fragments 
Ligation of cohesive DNA molecules was performed as for blunt ended fragments but 
with reduced quantities of DNA and T4 ligase. Generally, the amount of enzyme needed in 
blunt end ligation is found to be I 0 times greater than that needed to achieve sticky-end 
ligation (Perbal, 1988). 
3.5.4 Transformation of recombinant DNA into E. coli K12 
3.5.4.1 Calcium chloride transformation 
The usual method that was used for introducing recombinant plasmids into E. coli was 
by transformation of the host following treatment with calcium chloride (or other cations) to 
induce competency. A single colony of the appropriate host strain of E. coli was cultured in 
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I 0 m! of LB broth (section 3.2.2). A 1.5 m! aliquot of the bacterial culture was centrifuged 
(13,000 x g, 30 s, RT), the cells were resuspended in 200 Jll of ice-cold 75 mM CaCh, briefly 
vortexed, and placed on ice for 30 min. The cells were pelleted (13,000 x g, 30 s, RT) and 
then gently resuspended in 100 1-11 of fresh ice-cold CaCh (75 mM) using a micropipette. 
Between 50-I 00 ng of plasmid DNA in no more than 20 Jll volume was added, mixed gently 
and left on ice for I 0 min. The mixture was then placed at RT for I 0 m in, ice for 30 m in, 
heat shocked for exactly 90 s in a water bath at 42°C, and immediately replaced on ice for a 
further 2 min. A volume of 0.9 m! of LB broth was added and the transformation mixture 
incubated at 37°C for 90 min. After the incubation period, different volumes of the 
transformed cell suspension was spread onto LB agar plates containing the appropriate 
selective antibiotic. If desired, 0.2% glucose was added to the LB agar to repress expression 
of the lac promoter that is present in certain plasmids. For volumes of less than 50 J.ll of 
transformed resuspension, sterile LB broth (I 00 Jll) was added to the plate first, to facilitate 
spreading. Plates were then incubated at 37°C for overnight or up to 36 h. The plasmid DNA 
contained in the resulting transformants was extracted (section 3.4.2) and analysed (sections 
3.4.5; 3.4.6) in order to identify the desired clone. 
3.5.4.2 Transformation using frozen competent cells 
Several colonies were picked from a freshly streaked LB agar plate and inoculated into 5 
ml of LB broth. After vortexing, the suspension was used to inoculate 200 m! of LB broth 
and grown in a water bath at 37°C with shaking (275 rpm) to A600 - 0.6, usually for 2-3 h. 
The culture was then chilled on ice for 20 min, and centrifuged (1000 x g, 15 min, 4°C). The 
supematant was decanted and the tubes were inverted on a paper towel for 5 min to allow the 
last traces of media to drain away. The cell pellet was gently resuspended in 60 ml of 
transformation buffer (RF I medium, Appendix Ill) by vortexing and pi petting, then 
incubated on ice for 20 min. The cells were pelleted as described above, resuspended in 16 
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m! of RF2 medium (Appendix Ill), and then placed on ice for 15 min. Aliquots of 200 1-11 
were distributed into sterile 1.5 m! microfuge tubes, flash frozen in liquid nitrogen, and 
stored at -70°C. 
A tube of frozen competent cells was removed from -70°C and thawed on ice. Plasmid 
DNA (50 ng) was added in a volume <10 Ill, and the tube was mixed gently and immediately 
chilled on ice for 30 min. The transformation mixture was treated as described above (section 
3.5.4.1). 
3.5.5 Blue/white screening for recombinant clones 
Insertional inactivation of the functional lacZ gene that is present in certain plasmid 
vectors including pUC18 and A. bacteriophages (such as A.GT-11) provides a convenient 
means of identifying recombinant clones. Expression of the functional lacZ gene yields a 
blue colour in the presence of the chromogenic substrate X-Gal. 
Transformants were spread onto LB agar with the appropriate selective antibiotic added 
and containing a 4 ml LB agar overlay supplemented with that contained 45 1-11 of X -Gal (20 
mg/ml) and 45 ~-tl ofiPTG (24 mg/ml) solutions. The plates were incubated at 37°C for 24 h, 
then examined for the presence of blue (lac+, non recombinant), and white (lac·, 
recombinant) colonies. 
3.6 CLONING OF A PCR PRODUCT INTO A PLASMID VECTOR 
3.6.1 Blunting and kinasing reaction 
The amplified DNA fragments were purified using the Prep-A-Gene kit (section 
3.4.4.3). A volume of 1-16 ~-tl containing 20-1000 ng DNA was added to a tube containing I 
J.Ll Klenow fragment of DNA polymerase, 2 1-11 of I OX bluntinglkinasing buffer, I 1-11 of 
polynucleotide kinase, and sterile dH20 to a final volume of 20 J-11. The contents were mixed 
gently, centrifuged (13,000 x g, 5 s, RT) and incubated at 3JOC for 30 min. The blunted-
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kinased amplicon was subsequently purified with the Prep-A-Gene kit (section 3.4.4.3). 
3.6.2 Ligation of DNA into pUC18 
The pUCI8 plasmid DNA (Fig 3.1) was purchased as a 'Ready to go' formula 
(Sureclone Kit, Pharmacia). The purified blunted-kinased amplicon (5 J.d) was mixed with I 
J.ll (50 ng) of Smal pre-digested and dephosphorylated pUC 18, 10 J.ll of 2X ligation buffer, I 
J.ll of 0.1 M OTT solution, 1 J.ll of T4 DNA ligase, and sterile dH20 to a final volume of 20 
J.ll. After gentle mixing and centrifuging (13,000 x g, 5 s, RT), the mixture was incubated 
overnight at 16°C for overnight. 
3.6.3 Selection and identification of recombinant clones 
E. coli DHSa was transformed using the ligated DNA (section 3.6.2) and recombinants 
were selected by blue/white screening as described in section (3.5.5). Recombinant plasmid 
DNA was isolated from E. coli using the Miniprep plasmid DNA extraction kit (section 
3.4.2.3), digested with EcoRI and Pstl (section 3.4.5.2) to release inserted DNA fragments, and 
checked by agarose gel electrophoresis (section 3.4.6.1). EcoRI and Pstl restriction sites are 
located either side of the Smal site within the polylinker of pUC 18. 
3.7 RESTRICTION MAPPING 
It is often essential to obtain a restriction map of cloned fragments before additional 
manipulations can be carried out. The cloned DNA is usually cut with a variety of restriction 
enzymes that cleave the vector at specific sites and the sizes and numbers of fragments 
generated by each enzyme are determined. By performing a series of single and multiple 
digests (sections 3.4.5.1 and 3.4.5.2) with a range of enzymes, a complete restriction map of 
the cloned DNA can be deduced (Nicholl, 1998). 
3.8 SEQUENCING OF DNA 
Sequencing grade DNA was prepared from clones using the caesium chloride density 
113 
EC001 09 (2676) 
ORAII ( 267'6) 
AAT11(2622) 
SSPI (2S04) 
XMNI(22S9) 
ASF'700 (2299) 
SCAI (2180) 
amp 
CFR101 (1780) 
OSUI (1769) 
EC0311 (1760) 
pUC18 
2686 bp 
Fig 3.1: Schematic presentation ofthe pUC18 cloning vector. 
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gradient ultracentrifugation (section 3.4.4.1) or using the Maxi prep plasmid DNA isolation 
kit (section 3.4.2.4). Dye terminator or dye primer DNA sequencing was performed by 
MWG-Biotech Ltd (Milton Keynes, UK) using M13 universal and reverse primers or 
custom synthesised primers when needed. 
3.9 COMPUTER SOFTWARE AND SEQUENCE ANALYSIS 
In order to rapidly examine nucleotide sequences for the presence of a variety of 
structural and functional features including restriction endonuclease recognition sites, 
secondary structures in single stranded DNA and RNA molecules, and the presence of open 
reading frames, a variety of computer analysis software packages were used. Only one 
strand of DNA known as the sense strand, contains coded information and directs RNA 
synthesis, and the other complementary strand is known as an antisense strand. Messenger 
RNA is made from 5' to the 3' end and is read in successive groups of three bases, codons, 
each of which codes for an amino acid. A common way of showing that a piece of DNA 
could encode a protein is to demonstrate the presence of an open reading frame, or ORF, in 
the nucleotide sequence. An open reading frame comprises an initiation codon followed by a 
uninterrupted sequence of codons in the same reading frame terminated by a stop codon 
(TAA, TAG, TGA). It is well established that most genes are longer than 50 codons, the 
average length is 317 codons for E. coli (Brown, 1999). To identify possible ORFs, 
translations were carried out in all possible reading frames, i.e. six reading frames, three in 
one direction and three in the reverse direction of the complementary strand. 
Computer analyses of the nucleotide and deduced amino acid sequences were 
performed using DNASIS sequence analysis software package (Hitachi, UK). Gene 
promoter predictions were aided by prokaryotic sequence prediction program (Harley & 
Reynolds, 1987), and only those with a high probability score (>0.8) were selected. Searches 
for nucleotide and amino acid sequence similarities were done using the FAST A and 
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BLAST (Basic Local Alignment Search Tool) programs (Pearson & Lipman, 1988; Altschul 
et al., 1990) in the EMBL, NCBI, GenBank and SWISS-PROT databases, which were 
available through the computing facilities provided by the Department of Biological 
Sciences, University of Plymouth, England. Protein sequences were analysed using the 
PHDTOPOLOGY at PredictProtein Server, EMBL, Germany, while the Prosite program was 
used for motif search. Multiple alignment was performed with NSA and CLUST AL 
alignment programs (Higgins & Sharp, 1988) at IBCP, Lyon France. Hydrophobicity was 
analysed by PEPWINDOW (Kyte & Doolittle, 1982). Helix-turn-helix motifs were predicted 
using HELIXTURNHELIX (Dodd & Egan, 1990). Transmembrane regions were predicted using 
the TopPRED2 (V on Heijne, 1992) and DAS (Cserzo et al., 1997) programs at IBCP, Lyon 
France. 
3.10 SOUTHERN HYBRIDISATION 
Molecular hybridisation is the formation of double-stranded nucleic acid molecules by 
sequence-specific base pairing of complementary single strands. Southern hybridisation 
provides a means for detecting DNA fragments that are complementary to a labelled DNA 
probe (Southern, 1975). The fragmented DNA is firstly separated according to size by 
agarose gel electrophoresis then transferred to a membrane support for ease of handling. 
3.10.1 Capillary transfer of DNA 
Genomic DNA (3 flg) was obtained as described in section 3 .4.1 from the appropriate 
bacterial strains. The DNA was digested to completion with EcoRI (section 3.4.5.1) and 
separated by agarose gel electrophoresis (3.4.6.1) along with bacteriophage A. DNA digested 
with HindiiT and labelled with DIG-dUTP (Roche, Lewes, UK). The gel was 
electrophoresed until the bromophenol blue marker dye reached the bottom of the gel. 
Following electrophoresis, the agarose gel was trimmed to remove any excess, depurinated 
by washing in 0.25 M HCI for I 0 m in, and denaturated by soaking the gel in denaturation 
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solution (Appendix III) for 30 min with gentle agitation on a rotary shaker. The gel was then 
neutralized by immersion in 200 ml of neutralization solution (Appendix Ill) for 30 min at 
RT with constant shaking. 
A Southern blot capillary transfer apparatus was used (Scotlab, UK). The reservoir was 
filled with lOX SSC transfer buffer. The agarose gel was laid on the wick using cling film to 
cover the remaining exposed wick and prevent transfer buffer from "short circuiting" the 
system. Positively charged nylon membrane (Amersham, UK) cut to fit the gel was pre-
wetted in distilled water and positioned carefully over the gel. Three pieces of pre-wetted 
3MM filter paper cut to the same size as the gel were laid on top. Air bubbles were removed 
as each layer was added by gently rolling a glass rod over the surface. A stack of paper 
towels, which serves to draw the transfer buffer through the gel by capillary action, was laid 
on top of the 3MM sheets followed by the blotter lid. Following overnight transfer of the 
DNA the nylon membrane was removed, marked for orientation and washed in 5X SSC for 
5 min at RT. The filter was dried at RT and either stored at 4°C or processed for 
hybridisation. 
3.10.2 Labelling of DNA fragments with digoxigenin-dUTP (DIG) 
A commercial non-radioactive DNA labelling and detection kit (Boehringer-
Mannheium, Germany) was used according to the manufacturer instructions. The method 
relies upon the incorporation of digoxigenin-labelled deoxyuridine triphosphate (DIG-
dUTP) into a DNA probe using Klenow fragment of DNA polymerase and random primers, 
which generates a range of digoxigenin-labelled DNA fragments from the template DNA or 
using Taq polymerase and specific primers in the polymerase chain reaction (PCR). 
3.10.2.1 Randomly primed labelling 
The randomly primed DNA labelling reaction IS fast (1 h) and results in the 
incorporation of one digoxigenin molecule about every 20-25 nucleotides, depending on 
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base content, in the newly synthesized DNA probe. 
DNA template ( 1 1-1g) was denatured in a boiling water bath for 10 mm then 
immediately chilled on ice. A solution containing 10 X hexanucleotide primer (2 Ill), I 0 X 
dNTP labelling mixture (3 1-1l) (dATP, dGTP, dCTP and Digoxigenin-11-dUTP) and 1 1-11 of 
Klenow enzyme (1 U/1-11) was mixed with the denatured DNA template and 'Analar' water 
to a final volume 20 1-1!. The reaction tube was incubated at 37°C for 1 h or preferably 
overnight. The Klenow fragment was inactivated with 2 1-11 0.2 M EDT A pH 8.0 and the 
DNA precipitated with ethanol (3.4.3.1), dried and resuspended in 30 1-11 of HzO. 
Alternatively, the DNA probe was purified using the Prep-A-Gene kit (section 3.4.4.3). 
Finally, the labelled probe was stored at -20°C until required. 
3.10.2.2 PCR labelling 
The PCR-Iabelling reactions were carried out using standard reaction conditions (Table 
3, Appendix Ill) in a 50 1-11 volume containing 5 nmol DIG-dUTP. Reactions mixtures 
contained in thin-walled 0.5 ml tubes were overlaid with 50 1-11 mineral oil (Sigma, Poole, 
UK) and prepared on ice. After denaturation of the template DNA (96°C, 10 m in) the 
amplification procedure was carried out as described in program 1 (section 3.13.2). 
Incorporation of DIG-dUTP into the amplicon was confirmed by agarose gel (1%) 
electrophoresis (3.4.6.1 ). The presence of DIG-dUTP in a PCR amplicon retards the 
migration of the product during electrophoresis when compared with non-labelled amplicon. 
3.10.2.3 Purification of DIG-Labelled DNA 
All DIG-labelled DNA probes were purified using the Prep-A-Gene kit (Bio Rad, UK) 
as described in section 3.4.4.3. 
3.10.3 Hybridisation of DIG-labelled probes to nucleic acids 
Prior to hybridisation, nylon membranes were exposed to UV radiation (254 run) for 2 
min to permanently bind the DNA to the nylon filters. All of the following steps were 
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carried out in sealed glass tubes of 20 cm length and 8 cm diameter using a hybridisation 
oven (Techne, USA). Hybridisation was performed at high stringency (68°C) in order to 
minimise non-specific binding of the probe to the membrane. Filters were prehybridised for 
2 h at 68°C in prehybridisation solution (Appendix Ill). DIG-labelled probe was denatured 
by boiling for 10 min, chilled on ice, and 5 Jll ( 100-500 ng) of denatured probe was added to 
20 m! of hybridisation solution and incubated with the filter overnight at 68°C. Following 
hybridisation, membranes were washed two times in wash buffer 1 (Appendix III) for 5 min 
at RT and two times in wash buffer 2 (Appendix lll) for 15 min at 68°C. The filters were air 
dried at RT. 
3.10.4 Detection of DNA-DNA hybrids 
All the following steps were performed at room temperature. Nylon filters were washed 
briefly in detection buffer 1 (Appendix III) and incubated for 30 m in in I 00 m! blocking 
solution (Appendix Ill) then probed with 10 111 of anti-digoxigenin antibody conjugated to 
alkaline phosphatase in 20 m! of detection buffer 1 for 30 min. Unbound antibody was 
removed by washing 2 x 15 min with I 00 m! of buffer 1. Filters were equilibrated with 20 
m! of buffer 3 (Appendix Ill) for 5 min, then incubated in the dark with 10 m! of substrate 
solution (45 Jll NET-solution and 35 111 X-phosphate-solution in 10 m! of buffer 3). 
Following colour development, the reaction was stopped by washing filters with 50 m! of 
detection buffer 4 (Appendix Ill) for 5 min. 
3.11 CONSTRUCTION OF A B. PSEUDOMALLEI GENOMIC LIBRARY IN 
BACTERIOPHAGE A.GEM-11 
Genes were cloned from the genome of B. pseudomallei, following the construction of 
genomic libraries. The library should represent the entire genome of an organism as a set of 
overlapping cloned fragments, produced in a random manner, and maintained in a stable 
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form with no misrepresentation of sequences. Most genomic libraries are constructed using a 
method called shotgun cloning where genomic DNA digests are ligated to a suitable cloning 
vector that has been cut with the same enzyme or an enzyme that generates compatible ends. 
These recombinant DNA molecules can then be propagated in a suitable host organism. 
The number of clones required depends on the size of the genome and the vector used 
and the size of a library can be calculated on the basis of the probability of a particular 
sequence being represented in the library. The number of clones (N) required for a specific 
genomic library can be estimated using the formula of Clarke & Carbon (1976): N = In (I -
P) I In (1- a/b) where Pis the desired probability of a particular sequence being represented 
(typically 0.95 to 0.99), a is the average size of the DNA fragments to be cloned and b is the 
size of the genome, expressed in the same units as a. 
The size of the B. pseudomallei genome has been recently determined (Songsivilai & 
Dharakul, 2000). B. pseudomallei has two chromosomes of approximately 3.56 and 2.97 Mb 
in size, giving a total genome size of about 6.54 million base-pairs. Replacement 
bacteriophage A. vectors such as 'A.GEM-11 (Fig 3.2) in which about 20 kb of the phage 
genome (stuffer fragment) can be substituted with cloned DNA. A genomic library was 
constructed by ligating the products of a partial Sau3A restriction digest of B. pseudomallei 
chromosomal DNA with purified A. GEM-11 left and right arms (Promega, UK). Assuming 
average of 15 kb inserts, a collection of at least 1400 recombinant molecules must be 
examined to find a particular recombinant. However, since recombinants are created 
randomly and there is a chance that a particular insert will not be included in the putative 
genomic representatives, it is desirable to examine double that number. 
3.11.1 Sau3A partial digestion of chromosomal DNA 
In order to generate B. pseudomallei DNA fragments with a suitable range of sizes for 
constructing a genomic library in 'A.GEM-11 constant amounts of DNA were digested with 
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Fig 3.2: Schematic presentation of the A.GEM-11 cloning vector (Stratagene ). 
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varying amounts of Sau3A enzyme for a fixed incubation period. Genomic DNA (18 !J.g) 
was mixed with 10 X restriction enzyme buffer (15 !J.l) and 'Analar' water to a final volume 
of 150 !J.l. Nine tubes were prepared. Then 30 !J.l of this mixture was dispensed into tube I 
and 15 !J.l into each ofthe remaining tubes. Sau3A enzyme (5 U) was added to tube 1, mixed 
thoroughly, a 15 fll volume transferred to tube 2, mixed well and the twofold serial dilution 
was continued through to tube 8. Tube 9 was the undigested control. All of the tubes were 
incubated at 37°C for 30 min. After incubation, the reactions were stopped by adding 3 !J.l 
0.1 M EDT A pH 7.5 to each tube or by heat inactivation at 65°C for I 0 min. The Sau3A 
digested DNA (2 !J.l) was analysed by agarose gel electrophoresis (section 3.4.6.1) to 
determine which tube contained the desired fragment size distribution. The reaction that had 
a distribution of DNA fragments within the range of approximately 9-23 kb were selected 
for the construction of a AGEM-11 library. The remaining DNA (13 !J.l) was purified using 
phenol/chloroform (section 3.4.4.2). 
3.11.2 Ligation of chromosomal fragments with A arms 
The preferred substrate for in vitro packaging is a concatamer, an end to end chain in 
which recombinant molecules are flanked on both sides by a cos site, and to favour 
concatamer formation, the total DNA concentration should exceed I 00 !J.g/ml. For a ligation 
reaction, a molar ratio of2:1 vector to insert is a good compromise. The concentration ofthe 
Sau3A digested B. pseudomallei DNA was determined by measuring the absorbance at 260 
nm (section 3.4.6.1 ). Approximately I !J.g of this DNA was mixed with 2 !J.g of cleaved, 
dephosphorylated A GEM-11 BamHI vector arms (Promega) in the presence of 2 units of T4 
ligase, I !J.l of I 0 X ligase buffer and 'Analar' H20 to a final volume of 10 !J.l. The ligation 
mixture was incubated for 2 hat RT, then overnight at 4°C. 
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3.11.3 In vitro packaging of ligated DNA 
In vitro packaging of recombinant phage particles was carried out using packaging 
extracts (Promega), that contain all of the structural proteins necessary for the assembly of 
lambda DNA into infective phage particles. 
The packaging extracts (50 ~-tl) were thawed on ice. The ligation mixture (I 0 ~-tl) was 
added to the extract, mixed by gently tapping the bottom of the tube several times, and 
incubated at RT for 3 h. Following incubation, 445 ~-tl of SM phage buffer (Appendix III) 
and 25 ~-tl of chloroform were added to the tube, mixed by inversion, and left to stand for 2 
m in to allow the chloroform to settle to the bottom of the tube; chloroform prevents bacterial 
growth. The phage genomic library was stored at 4°C until used; the phage particles 
normally remain infective for years. 
3.11.4 Titration of packaged phage DNA 
The day before titration of packaged phage DNA, a single colony of E. coli LE392 was 
picked from a freshly streaked NZCYM agar (Appendix Ill) plate, and used to inoculate a 
I 0 m! NZCYM broth (Appendix Ill) supplemented with 0.2% maltose. The presence of 
maltose acts to induce the expression of malB that encodes a phage A. receptor and thereby 
promotes efficient adsorption of the phage to the E. coli host (Sambrook et al., 1989). The 
culture was incubated in a shaking water bath at 37°C, 250 rpm, until OD600 reached 0.6-0.8. 
To investigate the bacteriophage A. titre, i.e. the number of plaque forming units per m!, 
a ten-fold dilution series of the packaging mix from 10-1 to 10-6 was made in SM buffer. In 
duplicate sterile screw cap glass bottles, I 00 ~-tl of each dilution was added to 200 ~-tl of the 
prepared E. coli LE392 culture, mixed gently and incubated at 37°C for 20 min to allow the 
adsorption of the phage. Soft molten NZCYM agarose (Appendix Ill) (3 m!) was added, 
mixed by gentle swirling, and then poured immediately to overlay pre-warmed NZCYM 
agar supplemented with 0.2% maltose by tilting the plates back and forth. Bubbles, if any, 
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were quickly removed by poking with a sharp, sterile needle. When the agarose had set, the 
plates were inverted and incubated at 3 7°C overnight. The titre of the phage particles was 
determined by counting the number of plaques or zones of lysis on the bacterial cell lawn, 
for each dilution. The number of plaque-forming units (pfulml) was then established, 
according to the formula: 
Titre (pfulml) = number of plaques (pfu) x dilution factor x 1000 I volume plated (!J.l) 
3.11.5 Purification of recombinant bacteriophage 
3.11.5.1 Picking bacteriophage A. plaques 
Recombinant phage particles were selected from lysis plates using a sterile Pasteur 
pipette to punch out a plug of agar containing the desired plaque. The plug was then ejected 
into a sterile microfuge tube containing 50 !J.l of SM buffer and 5 !J.l chloroform. This 
suspension was vortexed briefly, left at RT for 1-2 h to allow the bacteriophage particles to 
diffuse out of the agar and was stored at 4°C. In addition, a number of non-recombinant 
phage plaques were picked and processed in this manner to serve as negative controls in 
further experiments. 
3.11.5.2 Preparation of plate lysate stocks from single plaques 
Purified phage was isolated from recombinant and non-recombinant phage by the plate 
lysate method. For maximum yield, the phage titre should be adjusted to give semi-confluent 
lysis after approximately 12 hours of incubation. Using the appropriate phage dilution for 
semi-confluent lysis determined in section (3.11.4), multiple lysis plates were prepared as 
described (section 3.11.4). Following complete (confluent) lysis of the bacterial lawn each 
plate was overlaid with 2 m! of SM buffer and incubated at RT for 2 h with frequent 
agitation to allow the bacteriophage particles to elute. With the help of a sterile bent glass 
rod (spreader), the top agarose was scraped and transferred to sterile 50 m! centrifuge tube. 
The tube was gently shaken at RT for 30 min, then centrifuged {9,000 x g, 10 min, 4°C). The 
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cleared supematant was carefully pooled, transferred to a fresh tube and 0.3% (v/v) 
chloroform was added. The lysate was stored at 4°C for up to 6 months. 
3.11.6 Isolation of phage A, DNA from recombinant clones 
3.11.6.1 Small scale preparation using the Wizard system 
The Wizard /... prep DNA purification kit (Promega, Madison, USA) was used according 
to the protocol supplied by the manufacturer. To a sterile polypropylene tube containing a I 0 
ml volume of bacteriophage lysate (section 3.11.5.2), 40 J.ll ofresuspended nuclease solution 
was added and the mixture was incubated at 37°C for 15 min. Phage precipitant (4 m!) was 
added with mixing and the tube was left at RT for 30 min. After centrifugation (I 0,000 x g, 
I 0 min), the supematant was discarded and the pellet was resuspended in 500 J.ll of phage 
buffer and transferred to a fresh 1.5 ml microfuge tube. Insoluble particles were removed by 
centrifugation (I 0,000 x g, I 0 s) and the supematant transferred to a new microfuge tube. 
Thoroughly mixed purification resin (I ml) was added to the supematant and mixed by 
inverting the tube several times. The phage DNA was then purified using Wizard 
minicolurnns attached to a vacuum manifold. The resin/phage DNA was washed with 2 ml 
of 80% isopropanol and dried briefly. The minicolurnn was then removed, placed into a 
fresh sterile 1.5 ml microfuge tube and centrifuged (I 0,000 x g, 2 min, RT) to remove any 
residual isopropanol. Phage DNA was eluted from the minicolumn by adding I 00 J.ll of pre-
heated (80°C) TE buffer and immediately centrifuging (10,000 x g, 20 s, RT). A second 
elution step was performed, to obtain maximal recovery with 50 J.ll of preheated TE buffer 
and the purified phage DNA was stored at 4°C. 
3.11.6.2 Small scale preparation using the Bio-Rad system 
To 0.8 ml of a bacteriophage plate lysate, prepared as described in section 3.11.5.2, I J.ll 
of freshly prepared DNase (I 0 mg/ml) was added and the mixture was incubated for 30 m in 
at RT. To a sterile polypropylene tube containing 400 J.ll of DNA binding buffer, the lysate 
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was added, mixed by inversion and left at RT for 5 min, to lyse the phage particles. A 
volume of. 30 f.ll of Prep-A-Gene diatomaceous matrix was added, and the tube was 
vortexed, left at RT for 5 min and the phage DNA contained in the mixture was purified 
using a spin filter. The matrix was washed twice in wash buffer, centrifuged (13,000 x g, 30 
s, RT) and the phage DNA was eluted into a clean tube with 100 Ill of 'Analar' H20 or TE 
prewarmed to 50°C (13,000 x g, 1 min). 
3.11.6.3 Large scale preparation of phage A from liquid cultures 
This method affords a high titre stock of A bacteriophage for subsequent use. To ensure 
success it is necessary to strictly control the bacterial cell density and the ratio of phage to 
bacterial cells, also called the multiplicity of exposure (MOE). After infection of a small 
bacterial culture with A bacteriophage at low MOE, a large volume of medium is inoculated 
with the infected culture. Initially the concentration of bacteriophage is low and uninfected 
cells continue to multiply rapidly for several hours until all of the bacterial cells are infected 
by phage. 
A 20 m! volume of NZCYM broth, supplemented with 0.2% maltose, was inoculated 
with a single colony of E coli LE392, and grown at 37°C with shaking (300 rpm) until 
OD6oo- 0.6 (equivalent to- 4.8 X 108 cells/m!). The MOE was calculated based on the 
known bacteriophage titre (section 3.11.4). Different MOEs were chosen; 0.1, I, 10, and 
100, where MOE I represents a 1:1 ratio of phage: bacterial cells. Phage propagation 
medium {Appendix Ill), 500 m! volumes in 2 L flasks, was warmed to 37°C prior to the 
addition of different ratios of bacteriophage: bacterial cells. The flasks were incubated at 
37°C with shaking for about 12 h. By that time successful lysis had occurred in one or more 
of the flasks which could be seen as clear or slightly translucent in appearance, with strings 
of cell debris around the bottom of the flask. By using a range of MOEs, at least one of the 
flasks showed signs of complete lysis and could be processed further. The contents of the 
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flask(s) were harvested and 0.25ml of chloroform per 500 m! culture was added to lyse any 
remaining bacterial cells. The lysate was left for 30 min at 37°C, in a shaking water bath to 
ensure thorough mixing. 
3.11.6.4 Polyethylene glycol precipitation of bacteriophage A. 
The phage lysate prepared in section 3.11.6.3 was cooled toRT and DNase I and RNase 
A were added to a final concentration of I 1-!g/ml each. The lysate was centrifuged (I 0,000 x 
g, I 0 m in) to remove cell debris. The supematant was decanted into a I L sterile measuring 
cylinder and NaCJ added (0.5 M final concentration) and I 0% (w/v) polyethylene glycol 
(PEG 6000). The top of the measuring cylinder was covered with parafilm and the contents 
were shaken gently at RT until the PEG had dissolved. High salt concentration promotes the 
dissociation of the bacteriophage particles from the bacterial debris. The mixture was left to 
stand at 4°C overnight, to allow the bacteriophage particles to precipitate. Precipitated phage 
was recovered by centrifugation (8,000 x g, 30 min, 4°C) and the phage pellet was 
resuspended in 30 m! SM buffer and kept at 4°C. The suspension was transferred into a 40 
m! Beckman Quickseal tube, heat sealed, and centrifuged ( 18,000 x g, 16 h, 20°C). The 
bacteriophage pellet was resuspended in 0.5 m! SM buffer and stored at 4°C. 
3.11.6.5 Extraction of A. DNA from high titre phage stocks 
To a I 00 1-11 volume of a high titre A. stock in a 1.5 m! microfuge tube, I 0 1-11 of 2M Tris-
HCI-0.2M NazEDTA (pH 8.5) solution was added and mixed thoroughly. To this an equal 
volume of formamide (110 1-11) was added, and the mixture was left to stand at RT for I h 
before adding an equal volume of double distilled water (220 1-11). The phage DNA was 
precipitated with ethanol (section 3.4.3 .l ), resuspended in l 00 1-11 of TE buffer and purified 
by phenol/chloroform extraction (section 3 .4.4.2). 
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3.12 CONSTRUCTION OF A B. PSEUDOMALLEI GENOMIC DNA LIBRARY IN A 
ZAP EXPRESS 
The A ZAP express vector (38.9 kb) is a phagemid that contains within it a region 
flanking the multiple cloning site that can be excised in vivo and recovered as a recombinant 
plasmid. A diagramatic representation of the A ZAP Express cloning vector is shown in Fig 
3.3. The number of recombinants required for complete coverage of the B. pseudomallei 
genome in the AZAP Express vector, assuming 10 kb inserts, was estimated (section 3 .I I) to 
be a minimum of 2000 plaques. 
3.12.1 Digestion of B. pseudomallei genomic DNA 
The restriction enzyme Ben was chosen for the digestion of B. pseudomallei DNA. The 
procedure was performed as in section 3.4.5.1, but for optimal enzyme activity the reaction 
was incubated at 50°C overnight. 
3.12.2 Ligation of chromosomal fragments with A ZAP arms 
Lambda ZAP express vector pre-digested with BamHI and ClAP treated was supplied by 
Stratagene (Amsterdam, Netherlands). The vector accommodates inserts ranging in size up 
to 12 kb; insertion into the polylinker inactivates the lacZ gene carried by the vector and 
recombinants give clear rather than blue plaques on IPTG-X-gal agar. A ligation reaction 
between the vector and insert DNA was performed according to the manufacturer's manual. 
A volume of 1 111 of the ZAP express vector ( 1 IJ.g/IJ.I) was mixed with 1 111 of Bell digested 
B. pseudomallei genomic DNA (0.41J.g) in the presence of2111 T4 DNA ligase (2 U) and 0.5 
111 I 0 X ligase buffer. The mixture was centrifuged briefly then incubated at 4°C overnight. 
The sample was heated (68°C, 10 min) to inactivate the ligase. Finally, the ligation mixture 
was purified as described in section 3.4.4.3, and the recombinant DNA was ready for 
packaging into phage particles. 
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Fig 3.3: Physical map of the pBK-CMV cloning vector (Stratagene) 
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3.12.3 Preparation of E. coli XL1-Blue 
E. coli XL!-Blue was cultured in I 0 m! NZCYM broth supplemented with 0.2% 
maltose, at 3 7°C for 6 h (OD600 - 0.8-1 ). The culture was centrifuged (I ,000 x g, I 0 m in) 
and the cell pellet was resuspended and diluted to an OD6oo of 0.5 using I 0 mM MgS04. 
3.12.4 Packaging A. ZAP Express using Gigapack Ill Gold 
Packaging extracts were thawed on ice. Ligated DNA ( 4 1J.l) (section 3 .12.2) was 
immediately added, mixed with a pipette tip and the tube was centrifuged briefly. Following 
incubation at RT for 2 h, 500 1-11 of SM buffer was added and mixed, then 20 IJ.l of 
chloroform was gently mixed in and the tube was centrifuged briefly to sediment the debris. 
The supematant containing the phage was either used immediately or stored at 4°C until 
required. 
3.12.5 Checking recombination efficiency using blue-white colour selection 
Recombinant A.ZAP phage were recovered on NZCYM agar plates as follows. Firstly I 
1-11 of the packaged reaction was mixed with 200 111 of E. coli XL !-Blue culture prepared as 
described in section 3.12.3. The mixture was incubated at 37°C for 15 min, to allow the 
phage to adsorb then 3 m! of soft NZCYM agarose containing 15 111 of 0.5 M IPTG and 50 
1-11 ofX-gal (250 mg/ml) was added, mixed vigorously and overlayed on pre-warmed (37°C) 
NZCYM agar. The agar was allowed to set (I 0 min), then the plates were inverted and 
incubated at 37°C overnight. The plates were examined visually for the presence of 
recombinant phage plaques (clear) and non-recombinant phage plaques (blue colour). The 
recombination efficiency of the method was determined by comparing the relative numbers 
of blue and clear plaques. 
3.12.6 Titration of the A.ZAP Express genomic library 
E. coli XLI-Blue was cultured in a 10 m! volume ofLB broth supplemented with 0.2% 
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maltose and 10 mM MgS04 at 30°C overnight with shaking. A I 00 fll volume of this culture 
was used to inoculate a fresh I 0 ml LB broth, supplemented with 0.2% maltose, that was 
incubated for about 3 hat 37°C with shaking until OD600 ~ 1.0. The culture was then diluted 
to OD600 ~ 0.5 with fresh LB +maltose broth. Ten fold serial dilutions of phage in SM buffer 
were prepared (I o·2 to 10"6) and I fll of each dilution was added to separate tubes containing 
200 fll of the prepared E. coli XLI-Blue culture. The tubes were placed at 37°C for 15 min, 
then 3 ml of soft NZCYM agarose (50°C) was added to each tube, mixed vigorously and 
overlaid immediately on NZCYM agar. The agar was allowed to set, and the plates were 
inverted and incubated at 3 7°C overnight. The number of plaques was counted and the 
phage titre was calculated according to the dilution factor. 
3.12. 7 In vivo excision of tbe pBK-CMV plasmid vector 
The A.ZAP express vector is designed to allow simple and efficient in vivo excision and 
recircularization of a phagemid contained within the A.ZAP vector to form a plasmid, pBK-
CMV containing the cloned insert. The in vivo excision requires the use of a helper phage 
and compatible strain of E. coli, XLOLR. 
Phage plaques were selectively picked from lysis plates and transferred to sterile 
microfuge tubes containing 500 fll of SM buffer and 20 fll of chloroform. The tube was 
vortexed, to release phage particles from the agar plug, and stored at 4°C overnight. To 
excise pBK-CMV, 200 fll of XLI-Blue culture (OD600 1.0- section 3.12.3) were combined 
with 250 1-11 of the A. ZAP phage stock and I J.tl ExAssistant helper phage. After incubation at 
37°C for 15 min, 3 m! ofNZCYM broth were added and the incubation was continued for 3 
h at 37°C with shaking. The tube was heated at 70°C for 20 min to inactivate the parent A. 
phage and kill host bacteria, then centrifuged (2,000 x g, 15 min). The supernatant contained 
the pBK-CMV phagemid packaged as single stranded filamentous phage particles. To 
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recover the excised phagemids, I 0 J.ll of the supernatant was added to 200 J.ll of a fresh 
culture of E. coli XLOLR cells (OD600 -1.0) and incubated at 37°C for I 5 min. To the 
infected cells, 300 J.ll of NZCYM broth was added and the mixture was incubated at 3 7°C 
for 45 min. Finally, 200 J.ll of this culture was spread onto LB agar supplemented with 
kanamycin (50 J.lg/ml) and incubated at 37°C overnight. The resultant colonies, containing 
the pBK-CMV plasmid, were screened for the presence of recombinant insert DNA (section 
3.4.2.3). 
3.13 AMPLIFICATION OF DNA BY POLYMERASE CHAIN REACTION (PCR) 
3.13.1 Primer design 
A variety of PCR Primers were designed using DNASIS sequence analysis software 
(Hitachi, UK) and the most suitable were chosen from among them by using Amplify 
Software (Engels, 1993). In some cases primers were designed to include restriction sites to 
simplify cloning of the PCR products. A number of factors should be considered when 
designing PCR primers in order to improve the chances of a favourable outcome. Ideally, 
primers should be approximately IO to 30 base pairs (bp), with a random base distribution, a 
GC content of 50-60%, minimal self-complementarity, and minimal homology with any 
other region of the DNA template. Oligonucleotide primers were synthesised by Sigma-
Genosys (Cambridgeshire, UK). Once synthesised, primers were resuspended in TE buffer 
(Sigma, Poole, UK) to give an overall concentration of 20 pmoi!J.ll, and stored at -20°C. 
3.13.2 Preparation of PCR reactions 
The use of PCR to amplify a DNA fragment using specific DNA oligonucleotides was 
performed using a Perkin Elmer TCl DNA thermal cycler (Roche, Lewes, UK). Precautions 
include using a set of micropipettes dedicated only to PCR and using filter tips, to avoid 
DNA contamination and cross-contamination. All pipettes, tubes and racks were exposed to 
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UV light for 20 min prior to set up, in a cabinet using filtered air. The reaction components 
were assembled on ice in sterile 0.5 ml thin walled Eppendorftubes and mixed by vortexing. 
Each 50 fll reaction mixture was overlaid with 50 Jll of mineral oil (Sigma, Poole, UK). 
Additionally, each set of reactions incorporated a negative control with the DNA template 
replaced with HPLC water. The reaction mixture is as shown in Table 3, Appendix Ill. 
Program 1 was used for the amplification of fragments less than I kb in size, while program 
2 was used to amplify fragments longer than 1 kb (Table 3.5). Unless otherwise stated, all 
PCR reactions were carried out for 35 cycles of amplification following an initial 2 min 
denaturation at 96°C. 
Table 3.5: General cycling conditions for PCR 
Program 1 Program 2 
Step Temperature Time (s) Time (s) 
Denaturation 96°C 30 60 
Annealing 60-65°C 30 60 
Elongation 72°C 90 120 
After amplification, samples were stored at 4°C until the products were analysed by gel 
electrophoresis as described in section 3.4.6.1. 
3.14 SDS-P AGE AND WESTERN BLOTTING 
3.14.1 Preparation of bacterial cells 
B. pseudomallei cultures were grown at 25°C, 37°C and 42°C for 48 h, then centrifuged 
(4,000 x g, 15 min, RT). The cell pellet was resuspended in 50 J..Ll 2X SDS-PAGE buffer 
without bromophenol-blue (Appendix Ill) and boiled, to destroy proteolytic activity, aid in 
cell breakage, protein solubilization and SDS binding. The suspension containing the soluble 
whole-cell proteins was then stored at -20° C until required. 
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3.14.2 Determination of protein concentration 
A microassay procedure based on the method of Bradford ( 1976) was used to determine 
the concentration of proteins in bacterial cell lysates using the Bio-Rad Protein Assay Kit 
(Bio-Rad, UK). A series of standard protein solutions were made using bovine serum 
albumin (BSA) dissolved in water in the range 0-20 J.lglml. Bacterial cell lysates were 
diluted I 00 times with modified sample buffer (that lacks bromophenol-blue). A volume of 
40 J.ll of each of the diluted bacterial cell lysate and BSA standards was mixed with 160 J.ll 
of dye reagent concentrate in separate wells of a microtitre plate. After a period of 5 m in to 
one hour, the OD of the samples was read at 595 nm. The BSA readings were used to 
construct a standard curve. Unknown protein concentrations of samples were automatically 
determined by OPTI Analyzer microplate reader (Molecular Devices, USA) and the results 
were expressed as J.lg protein/ml. 
3.14.3 SDS-polyacrylamide gel electrophoresis 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is a widely 
used analytical technique for the separation and characterization of complex mixtures of 
proteins and the estimation of the relative molecular size of a protein. SDS-PAGE was 
carried out using the Laemmli discontinuous buffer system (Laemmli, 1970). Two types of 
electrophoretic apparatus used in this study; the Mini-Protean 11 system (Bio-Rad, UK) and 
the SE600 vertical system (Amersham Pharmacia Biotech, UK). The apparatus was 
assembled according to the manufacturer's instructions. The glass plates were cleaned with 
detergent and washed with ethanol prior to use. For routine work, a 12% acrylamide 
resolving gel with a 5% acrylamide stacking gel (Appendix Ill) was prepared. 
Polymerisation of acrylamide gels was achieved using an ammonium persulphate 
(APS)/TEMED catalyst. Following polymerisation the well-forming comb was carefully 
removed and the sample wells were rinsed with dH20 and running buffer (Appendix Ill) 
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before the gel assembly was clamped into the electrophoresis chamber, which was filled 
with running buffer. Protein samples were made up using either 2 X stock sample buffer or 
modified sample buffer (Appendix III). Samples were loaded into each well along with 
either standard molecular weight markers (Sigma, Poole, UK), or pre-stained molecular 
weight markers (Novex, USA) and electrophoresis was carried out at constant voltage. 
Minigels were run for 2-3 hat 120 V, without cooling, while large gels were run for 7-8 hat 
80 V, with cooling. When the marker dye had reached the bottom of the gel, the 
electrophoresis apparatus was switched off, disassembled and the gels were either stained 
for total protein or processed for Western blotting. 
3.14.4 Staining of total proteins 
The most common method for visualising protein bands in SOS-PAGE gels is staining 
with Coomassie blue R-250. Gels were stained for 1 hat RT in Coomassie stain (Appendix 
Ill) in a covered plastic tray, and destained in destaining solution overnight, with gentle 
agitation. The wet gel was photographed under white light. 
3.14.5 Western blotting 
Proteins that had been separated by SOS-PAGE were electrophoretically transferred to 
an immobilizing membrane, consisting of nitrocellulose to facilitate immunological 
detection (Towbin et al., 1979). SOS-PAGE gels were equilibrated in transfer buffer 
(Appendix Ill) for 10 min. A gel sandwich was then assembled, consisting of a sponge, two 
sheets of3MM-Whatrnan paper, the SOS-PAGE gel, nitrocellulose membrane (pore size 0.2 
~-tm Schleicher & Schuell), and a further two sheets of 3MM paper and a sponge. Air 
bubbles were removed by rolling the layers with a glass rod and the whole sandwich was 
placed into the blotting apparatus (Bio-Rad Transblot System, Bio-Rad, UK) with the 
nitrocellulose filter towards the positive electrode. The tank was filled with transfer buffer 
and electrotransfer was carried out using a constant current of 30 mA for 12-16 h. Following 
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transfer, the apparatus was switched off and disassembled. The efficiency of transfer was 
visually determined by the migration of protein molecular weight markers into the 
membrane. The nitrocellulose membrane was washed in PBS for 5 min and placed in I% 
casein blocking solution (Appendix Ill) at RT for 2 h with gentle shaking, to block the free 
protein binding sites on the membrane. The nitrocellulose membrane was probed with 
specific primary antibody diluted in blocking solution and incubated overnight at 4°C. All 
steps were carried out at RT on an orbital shaker. Any unbound antibody was removed by 
rinsing the membrane in blocking solution 3 times, each for I 0 min. The bound antibody 
was detected with a secondary antibody (usually, peroxidase-conjugated swine anti-rabbit 
immunoglobulin, P217, DAKO, UK) at the appropriate concentration for 2 h. The 
membrane was then washed three times in PBS and the bound antibody was visualised by 
immersing the blot in development solution (Appendix Ill). Following development the blot 
was rinsed thoroughly with PBS, dried between sheets of 3MM-Whatman paper and 
photographed. 
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CHAPTER4 
CLONING AND SEQUENCE ANALYSIS OF A TWO-COMPONENT 
REGULATORY SYSTEM 
137 
4.1 INTRODUCTION 
Most, if not all, bacteria possess sophisticated signal transduction systems that involve at 
least two protein components i.e. two-component regulatory systems. This family of proteins 
allows bacteria to sense and respond to numerous changes in their environment and it was 
originally defined on the basis of protein sequence similarities between pairs of "sensor" and 
"regulator" proteins. Generally, the genes encoding the sensor and effector pair are located near 
each other, often in the same operon. The features of two-component systems have been 
thoroughly reviewed in Chapter 2. Currently, over I 00 examples of these protein systems have 
been recognised, and members of the two-component systems have been cloned and 
characterised in more than 50 different bacterial species (Parkinson & Kofoid, 1992). The 
widespread prevalence of two-component systems implies that they provide an essential means 
for mediating a wide variety of adaptive responses by bacterial cells to environmental stimuli 
(Parkinson, 1993), including the establishment and maintenance of infectious states in host 
organisms (Egger et al., 1997). This chapter identifies and characterises, on the basis of 
sequence homology, the genes encoding a two-component regulatory system from B. 
pseudomallei. 
B. pseudomallei is able to survive and grow in a wide range of environmental conditions, 
varying from the rice paddies of tropical regions to temperate regions of Australia and also 
within various mammalian hosts (reviewed in sections 2.1.3-2.1.5). The ability to adapt and 
respond to such varied circumstances implies a requirement for signal transduction systems that 
control the expression of the genes that are needed to meet these challenges. Although two-
component regulatory systems are commonly found in many bacterial pathogens, they have 
only recently been described in B. pseudomallei by Jones et al. (1997) who reported the 
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identification of the irl genes, iriS similar to sensor kinases and ir!R similar to response 
regulators. On the basis of sequence homology it was proposed that the irl genes may be 
involved in the resistance of B. pseudomallei to heavy-metals. 
The primary aim of this work was to identify and characterise the genes encoding an 
additional two-component regulatory system from B. pseudomallei. The first step in this process 
was the development of a strategy for cloning the genes in the absence of a readily selectable 
phenotype. Generally, the lack of an obvious phenotype can be circumvented by screening 
genomic libraries with DNA probes or with specific antibodies. Because specific antibodies 
were unavailable an oligonucleotide probe was developed using PCR and primers based on the 
highly conserved sequences of regulators from other bacteria. Hence, the approach may be 
summarised as follows: 
1- Development of an oligonucleotide probe using PCR. 
2- Construction and screening of a genomic library using A GEM-11 bacteriophage. 
3- Screening of a genomic library using AGT -I I bacteriophage. 
4- Construction and screening of a genomic library using A ZAP, on the basis of the 
information obtained from 1-3 above. 
4.2 MATERIALS AND METHODS 
4.2.1 Construction and screening of a AGEM-11 genomic library 
4.2.1.1 Library construction 
The construction of a B. pseudomallei strain 204 genomic library in AGEM-11 
bacteriophage was performed as outlined in section 3.11. B. pseudomallei DNA was obtained as 
described (section 3.4.1) and a partial Sau3A digest (section 3.11.1) was used in the preparation 
of the library, which enabled insertion into the AGEM-11 BamHI site. A size-selection 
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procedure was followed to isolate DNA fragments sizes suitable for insertion into the vector 
arms, between approximately 9 and 23 kb. The construct was then transduced into E. coli 
LE392 strain (Table 3.3) and plated on NZCYM-agarose (Appendix Ill) containing 0.2% 
maltose. 
4.2.1.2 Development of a DNA probe 
As a part of a broad search for genes in B. pseudomallei that might encode products of 
potential interest for further study, the routine sequencing of a fragment of B. pseudomallei 
DNA revealed a striking similarity with the response regulatory genes from E. coli and S. typhi. 
Oligonucleotide PCR primers were designed on the basis of this sequence data in order to 
amplify a 3 75 bp internal fragment of the response regulatory gene from B. pseudomallei. The 
nucleotide sequences of the forward and reverse primers are written in 5' to 3' orientation in 
Table 4.1 and the primers were designed as described in section 3.13.1. In order to reduce the 
amplification of non-specific PCR products, various concentrations of the components of the 
PCR reactions were tested including primers concentrations (I 0, 20 and I 00 pmol/50 J.ll), DNA 
template (10, 20 and 50 ng/50 J.ll), and primer annealing temperatures (45, 50,60 and 65°C). 
Table 4.1: PCR primers for the amplification of a regulatory gene from B. pseudomallei 
Forward primer (FF) GATTTCACGATGCATCAGGCGAA 
Reverse primer (RR) TTCTGGATCGCCGCGATGTCCGTG 
4.2.1.3 Immobilisation of A. plaques on nitrocellulose filters 
An appropriate number of plaques, 4000, was plated out from B. pseudomallei A.GEM-11 
genomic library. A 100 ,ut of the bacteriophage dilution corresponds to 103 plaques was used to 
infect 100 ,ut of E. coli LE392 as described in section 3.11.4. The plates were cooled at 4°C for 
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I h, to prevent transfer of the soft agarose layer. Gridded positively-charged nitrocellulose 
filters (Schleicher & Schuell) were numbered, marked for the orientation and placed gently onto 
the surface of the top agarose so that it came into direct contact with the plaques without 
trapping any air bubbles. Each filter became a mirror image of the pattern of recombinants on 
the plate. Plates were marked asymmetrically with filter marks. Transfer was allowed to 
proceed for 30 min at 4°C, after which the nitrocellulose filters were peeled away from the 
plate. Filters were then processed to denature the DNA in the samples by immersing, plaques 
side up, in the denaturing solution (Appendix Ill) for 3 min, then into neutralising solution 
(Appendix III) for another 3 min. Filters were rinsed in 2 x SSC solution and placed (plaque) 
DNA side up, on paper towels to dry for 30 min at RT. After complete drying, the filters were 
sandwiched between two sheets of 3MM-Whatman paper and baked for 2 h at 80°C in a 
vacuum oven (Townson & Mercer Ltd, Runcom, England) to fix the DNA to the filters. The 
filters were immediately processed for hybridisation. 
4.2.1.4 Hybridisation of a labelled DNA probe to nitrocellulose filters 
The DNA probe was labelled either by random priming (section 3.10.2.1) or PCR (section 
3.1 0.2.2). Following probe labelling, hybridisation of DIG-labelled probes to nucleic acids was 
performed as described in section 3.1 0.3. 
4.2.1.5 Detection oflabelled DNA hybrids 
All the following steps were performed at room temperature. Nitrocellulose filters were 
washed briefly in detection buffer I (Appendix Ill) and incubated for 30 min in 30 ml blocking 
solution (Appendix III) then probed with I 0 J.Ll of anti-digoxigenin antibody conjugated to 
alkaline phosphatase in 20 ml of detection buffer I for 30 min. Unbound antibody was removed 
by washing 2 x 15 min with I 00 ml of buffer I. Filters were then equilibrated with 20 ml of 
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buffer 3 (Appendix Ill) for 5 min. Each filter was placed in an individual sterile Petri dish (50 
mm) and then incubated in the dark with 10 ml ofsubstrate solution (45 1-11 NBT-solution and 35 
J..ll X-phosphate-solution in I 0 m! of buffer 3). Following colour development, the reaction was 
stopped by washing filters with 50 ml of detection buffer 4 (Appendix Ill) for 5 min. 
4.2.1.6 Selection of positive clones 
The DNA of recombinant plaques to which the labelled probe has hybridised appears as 
intense dark spots on the filters, relative to a weak background. To pick positive plaques, the 
positive spots were circled with a (red) marker and oriented with respect to the original plate. 
Once filter and plate were aligned, positive plaques along with several negative controls were 
picked using a sterile Pasteur pipette and placed into a sterile microfuge tube containing 50 1-11 
of SM phage buffer and two drops of chloroform as described in section 3.11.5.1. 
4.2.1.7 Rescreening of recombinant clones 
In order to purify a single homogeneous A clone, stocks of positive phage plaques were 
diluted and plated as described (section 3.11.4), but at a lower plaque density to enable the 
isolation of a single recombinant. Nitrocellulose filters were prepared and treated as described 
in sections 3.12.1-3 .12.3. For each putative positive, a single, pure plaque was picked. 
4.2.1.8 Isolation of recombinant phage DNA 
A stock of each positive phage was made usmg the plate lysate procedure (section 
3.11.5.2) and the titre was established (section 3.11.4). A phage DNA from recombinant 
(positive) clones was extracted using Wizard Lambda Preps (section 3.11.6.1). 
4.2.2 Screening ofa AGT-11 genomic library 
A.GT-11 (Fig 4.1) is an insertion vector that has a single recognition site for EcoRl, which 
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enables DNA fragment to be inserted into the A genome. This generates left and right arms of 
32.7 and 10.6 kb respectively, which can accept insert DNA fragments up to approximately 7.6 
kb in length. The single EcoRI site for cloning is located at the carboxy-terminal end of the /]-
galactosidase (lacZ) gene present in the vector molecule. Insertion of foreign fragments into this 
site disrupts the function of lacZ and alters the phenotype of the phage. When plated using a 
host strain that is deficient in the expression of lacZ (such as E. coli Y I 088), it is possible to 
check the efficiency of recombination using blue/white screening (section 3.5.5). 
B. pseudomallei strain 204 genomic library was previously constructed in AGT -11 by C. 
Davies, University of Plymouth. B. pseudomallei genomic DNA obtained as outlined in section 
3.4.1 was completely digested with EcoRI (section 3.4.5.1), then ligated to AGT-11 DNA 
(section 3.5.3) that had been pre-cut with EcoRI and pre-treated with alkaline phosphatase 
(Promega, UK). Recombinant DNA was then packaged into phage particles (sections 3.11.3) 
and the titre (3 x 107 pfulml) was determined (section 3.11.4). The library was stored at 4°C. 
The number of clones that represents B. pseudomallei genomic library in AGT-11, assuming 5 
kb inserts, was estimated to be at least 4000 plaques (section 3.11 ). The library was plated out 
as described for AGEM-11 but using E. coli Y I 088 as a bacterial host strain (Table 3.3). 
Aliquots of the packaged phage containing 1-2 x 103 in a volume <50 Ill were mixed with 
200 111 of E. coli strain Yl088 grown to A600 - 0.6 in NZCYM broth supplemented with 0.2% 
lactose at 37°C. The mixture was plated as described in section 3.11.4. An appropriate number 
of plates (8), containing about 8000 plaques that fully represented the library, were overlaid 
with gridded nitrocellulose filters (0.45 11m, Schleicher & Schuell) and screened using a DNA 
probe (section 4.2.1). Positives were rescreened (section 4.2.1.7) and A DNA was isolated using 
standard minipreps (section 3 .11.6.2). 
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4.2.3 Construction and screening of a A.ZAP express genomic library 
A B. pseudomallei strain 204 genomic library was constructed in A.ZAP Express vector as 
described in section 3.12, and plaque hybridisation screening was conducted as outlined in 
section 4.2.1.4 using a DIG-dUTP labelled DNA probe. The number of plaques to be screened 
was estimated (section 3.12) and approximately 5000 plaques were screened in order to ensure 
full coverage of the genome. 
4.3 RESULTS 
4.3.1 Construction of a Sau3A partially digested B. pseudomal/ei genomic library 
A library of B. pseudomallei chromosomal DNA fragments was constructed in A.GEM-11 
as described in section 3 .!I. Genomic DNA from B. pseudomallei strain 204 was partially 
digested with Sau3A (section 3.11.1) to create a series of overlapping fragments for ligation 
into A.GEM-11 arms. The enzyme recognises a tetra-nucleotide DNA sequence (GATC) that 
would be expected to occur on average once every 44 (256) bp in a random DNA sequence and 
the fragments produced can be directly ligated into BamHI-cut vector, after agarose gel size 
fractionation and selection of the appropriate size, 9-23 kb. Test digests were performed with 
serial dilutions of Sau3A incubated with 2 ).lg of B. pseudomallei DNA for 30 min. Following 
agarose gel electrophoresis (Fig 4.2), it was found that 0.078 unit of Sau3A per ).lg of DNA 
(Lane 8) produced the greatest proportion of fragments in the size range of 9-23 kb. After 
ligation (section 3 .11.2), the recombinant phage were packaged (section 3 .11.3) and the titre of 
the library was determined (section 3.11.4). 
A 100 Ill volume of a 10"3 dilution of the A.GEM-11 library yielded approximately 1100 
plaques i.e.- 5.5 x 107 pfulml. Assuming that the average size ofthe Sau3A fragments was 15 
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Fig 4.2: Agarose gel electrophoresis of serial Sau3A digests of B. pseudomallei 204 
genomic DNA. The sizes of DNA fragments were estimated from I kb ladder (Lane 1). 
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kb, then the library stock (I 0 ml) contained a total of 15 x 5.5 x I 08 = 8.25 x I 09 kb of B. 
pseudomallei genomic DNA i.e. approximately 1.3 x I 06 times the size of the B. pseudomallei 
genome providing ample scope for screening. 
4.3.2 Screening with a DNA probe 
4.3.2.1 PCR amplification of a response regulator gene 
PCR primers were developed on the basis of nucleotide sequence homology with the 
response regulatory genes of E. coli and S. typhi (section 4.2.1.2). For PCR reactions, a 
concentration of I 0 pmol of each PCR primer and I 0 ng of B. pseudomallei genomic DNA 
template were used in a 50 Ill reaction volume. The best results were obtained when the 
temperatures that were used for primer annealing were 45°C for the first cycle, 50°C for the 
second and third cycles, and 60°C for the remaining thirty-three cycles. Apart from these 
modifications the PCR reactions were carried out as described in section 3.13.2. The PCR 
products that were obtained were in the range of 300 to 500 bp in size and were isolated from 
agarose gels (section 3.4.6.1), blunt kinased (section 3.6.1) and ligated to Smal blunt-ended-
dephosphorylated plasmid pUCI8 that was available in a 'ready to go' formula (section 3.6.2). 
The ligated molecules were transformed into E. coli DH5a by standard procedures (section 
3.5.4.1 ). A number of recombinants were recovered and found to possess plasmid DNA 
containing inserts of the appropriate size, following EcoRI and Pstl double digestion (sections 
3.4.5.2 & 3.6.3). Seven clones were selected for double stranded sequencing of the inserted 
DNA (section 3.11). One clone, named pRS7, was found to contain a DNA insert of375 bp and 
following translation of the nucleotide sequence a search of the protein databases revealed that 
this portion of the deduced amino acid sequences was highly homologous to a variety of 
prokaryotic response regulator proteins. 
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4.3.2.2 Preparation of a DNA probe 
Plasmid pRS7 was digested with EcoRI and Pstl (section 3.4.5.2) and the 375 bp DNA 
insert was isolated from an agarose gel (section 3.4.6.2), purified (section 3.4.4.3), labelled by 
random priming (3.1 0.2.1) and purified (section 3.1 0.2.3). The probe was designated RS7. 
4.3.3 Isolation of positive clones 
Screening of approximately 4,000 recombinant phage plaques from a A.GEM-11 genomic 
library using the oligonucleotide probe RS7 hybridised at high stringency resulted in the 
identification of five positive clones, designated MRG 1-MRG5, an average of one positive per 
800 plaques screened (Fig 4.3). The five clones were picked from the appropriate plates (section 
3.11.5.1) and rescreened with the RS7 probe. All but one, MRG5, were subsequently shown to 
be true positives (Fig 4.4). 
4.3.4 PCR screening 
PCR was used to confirm the presence of the correct DNA insert in clones MRG1-4. 
Internal PCR primers were designed to amplify a 234 bp fragment of the RS7 sequence (Table 
4.2). The reactions were performed as described in section 3.13.2, using 20 ng of template DNA 
and following agarose gel electrophoresis (section 3.4.6.1) clones MRG 1-4 were each found to 
possess a 234 bp amplicon. 
Table 4.2: Internal primer sequence for RS7 probe 
Forward primer (rs7F1) CCGATCATCGTGTTCACGATGCTG 
Reverse primer ( rs 7R 1 ) TTCCTTCGGCGTCAACGCGTTGAA 
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Fig 4.3: A nitrocellulose filter showing a positive plaque from the Sau3A A.GEM-11 
genomic library. 
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Fig 4.4: A nitrocellulose filter showing the results of rescreening a positive clone. 
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4.3.5 Restriction enzyme digestion of recombinant phage DNA 
Restriction endonuclease Xhol was used to digest phage DNA from clones MRG 1-4 in 
order to determine the size of the DNA inserts. Xhol cuts just outside the BamHI cloning site; 
hence digestion with Xhol should release the cloned fragment and reveal any internal sites. 
Approximately 0.3 Jlg of recombinant A DNA was digested as described in section 3.4.5.1, and 
checked on 0.8% agarose gel (section 3.4.6). Analysis of the restriction digests (Fig 4.5) 
showed that the four positive clones, MRG 1-4 contained inserts of 11.4, 9.3, 8, and 12.1 kb, 
respectively. However, as so little phage DNA was actually isolated after several trials, the 
A DNA was used as template for further PCR as discussed below (section 4.3.11) and it was 
decided to screen another B. pseudomallei gene bank, which had been constructed using the 
'AGT-11 vector. 
4.3.6 Screening of a J...GT -11 genomic library 
A library of B. pseudomallei strain 204 genomic DNA that had been constructed in 'AGT-
11 (section 4.2.3) was screened with the labelled DNA probe, RS7. The library had previously 
been used to successfully screen for a putative B. pseudomallei type IV pilin gene (C. Davies; 
unpublished data). Screening of 8000 plaques with RS7 resulted in the isolation of 2 positive 
clones designated MRG6 and MRG7, which on further investigation were found to be identical. 
One positive clone, MRG6, was selected for further analysis. Approximately 0.3 Jlg of MRG6 
DNA was digested with EcoRI as described in section 3.4.5.1, and found to contain two EcoRI 
inserts with lengths of2.2 and 4.3 kb. 
4.3.7 Subcloning ofMRG6 DNA inserts into pUC18 
In order to determine which of the two EcoRI fragments inserted into MRG6 possessed the 
RS7 sequence, both inserts were subcloned into pUC18. Approximately I Jlg ofMRG6 DNA 
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Fig 4.5: Restriction analysis ofrecombinant A.GEM-11 phage DNA digested withXhol. 
The sizes of fragments were estimated from I kb DNA ladder (Lane 1 & 6). 
Track Phage No. of DNA Approximate size of DNA Total size (kb) 
fragments fragments (kb) 
1 MRGI 4 1.1' 1.6, 2.2, 2.5, 4.0 11.4 
2 MRG2 5 1.4, 2.1 ' 2.3, 3.5 9.3 
3 MRG3 3 1.0, 1.2, 1.5, 2.0, 2.3 8 
4 MRG4 5 1.2, 1.4, 2.5, 3.0, 4.0 12.1 
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was digested with EcoRI (section 3.4.5.1) and purified with the Prep-A-Gene kit (section 
3.4.4.3). Approximately 0.5 J..lg of pUC18 DNA was digested with EcoRI (section 3.4.5.1), 
treated with alkaline phosphatase (section 3.5.1) and then ligated to the purified insert DNA. 
The ligated DNA was transformed into E. coli strain DH5a (section 3.5.4) and recombinant 
clones were recovered and screened as described (section 3.5.5). Plasmid DNA was extracted 
from E. coli clones (section 3.4.2.3) and examined for the presence of the appropriately sized 
DNA inserts using EcoRI digestion (section 3.4.5.1) and agarose gel electrophoresis (section 
3.4.6.1 ). Two subclones were isolated and the plasmids carrying the 2.2 kb and the 4.3 kb 
fragments were designated pMRGI and pMRG2, respectively. 
4.3.8 Southern blot analysis of subclones 
Southern hybridisation was carried out to check pMRG I and pMRG2 for the presence of 
the RS7 sequence and to confirm that the cloned DNA fragment originated from B. 
pseudomallei DNA. Purified plasmid DNA of pMRG 1 and pMRG2 and B. pseudomallei 
genomic DNA were digested to completion with EcoRI (section 3.4.5.1), separated by agarose 
gel electrophoresis (section 4.6.1) and probed with RS7 as described in section 3.10. 
After enzymatic detection, RS7 was shown to hybridise with the 4.3 kb EcoRI insert from 
pMRG2 but not the 2.2 kb insert from pMRG 1 (Fig 4.6). Furthermore, a 4.3 kb band was 
observed in the B. pseudomallei genomic DNA digest confirming the origin of DNA. 
Subsequently, pMRG2 was used as a source of plasmid DNA for nucleotide sequencing and 
other manipulations. Although pMRG 1 did not possess the appropriate DNA insert the plasmid 
was eventually sequenced and found to encode sequences that were closely similar to glutamine 
synthetase (glnA) and the nitrogen regulator (ntrB) from many other bacterial species (Appendix 
IV). 
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Fig 4.6: The detection of RS7 DIG-labelled probe in pMRGl , pMRG2 and B. 
pseudomallei 204 genomic DNA by Southern hybridisation. Lanes 1 & 5: A.-Hindiii 
ladder, Lane 2: EcoRI digested pMRG2, Lane 3: EcoRI digested pMRGl and lane 4: 
EcoRI digested B. pseudoma/lei genomic DNA. 
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4.3.9 Restriction mapping of pMRG2 
Plasmid pMRG2 was cleaved with the following enzymes in a series of single digests 
(section 3.4.5.1): EcoRl, EcoRV, Pvull, Hindlll, Mlul, Ben, and Pstl. Following the digestions, 
the resultant DNA fragments were separated by agarose gel electrophoresis (section 3.4.6.1) and 
the restriction sites were mapped. The restriction analysis of plasmid pMRG2 is summarised in 
Fig 4.7, while the deduced restriction map is presented in Fig 4.8. 
4.3.10 Nucleotide sequencing of pMRG2 
Nucleotide sequencing of pMRG2 showed that it contained an £eaRl fragment consisting 
of 4324 bp of B. pseudoma/lei strain 204 DNA. The sequence was compared with the 
nucleotide sequences of other bacteria stored in the GenBank database. A preliminary check 
suggested that the fragment contained at least one complete gene sequence and another 
incomplete gene sequence downstream. This is explained more fully in section 4.4. On this 
basis it was deemed necessary to identify and clone the DNA encoding the remainder of the 
second gene and also the flanking region. 
4.3.11 Cloning of downstream sequences by PCR amplification 
Based on the sequence data obtained in section 4.3.1 0, two sets of PCR primers (Table 
4.3) were developed to attempt to amplify the downstream sequence from the DNA purified 
from the A.GEM-11 library clones MRG 1-4. The primers were designed to amplify fragments 
between the 3' end of the known sequence obtained above and the 5' sequence of A.GEM-11 
arms in both possible orientations (Fig 4.9). PCR reactions were carried out as described in 
section 3.13.2, and primers GEMF and 4.3 R (1st orientation) amplified a 532 bp DNA fragment 
from MRG4, which was subcloned into pUC18 as described in section 3.6, and sequenced after 
purification (section 3.8) of recombinant plasmid pMRG3. DNA sequence analysis revealed 
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Fig 4.7: Agarose gel electrophoresis of restriction enzyme digests of pMRG2. The sizes of 
fragments were estimated from I kb (Lane I & 9) and I 00 bp (Lane I 0) DNA ladders. 
No. ofDNA No of cleavage Approximate size of DNA Total 
Track Enzyme fragments Sites on fragments (kb) size (kb) 
vector insert 
2 EcoRI 2 I 2 2.68, 4.32 7.00 
3 EcoRV 3 0 3 0.74, 1.66, 4.6 7.00 
4 Pvull 3 2 I 1.8, 2.4, 2.8 7.00 
5 Hindlll I 1 0 7.00 7.00 
6 Mlul 3 3 0 0.5, 1.2, 5.3 7.00 
7 Bell 1 0 1 7.00 7.00 
8 Pstl 3 1 2 0.7, 1.4, 4.9 7.00 
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Fig 4.8: Restriction map of pMRG2 deduced from single enzyme digests. The 4.3 kb 
insert of B. pseudomallei DNA is represented by the blue colour. ampR is the gene 
encoding ampicillin resistance, while numbers represent the number of base pairs of 
DNA between adjacent restriction sites. 
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Fig 4.9: Strategy for cloning the sequence downstream from the 4.3 kb EcoRI fragment 
(cloned from a A.GT-11 library) based on specific primers and A.GEM-11 arms primers. 
Arrows show the direction of amplification. 
158 
that plasmid pMRG3 contains inserted DNA of 532 bp with a 176 bp overlap that exactly 
matched the sequence of the 3' end ofpMRG2 insert DNA. 
Table 4.3: Specific primer sequences for 3' pMRG2 insert and 5' A.GEM-11 arms 
Forward primer (GEMF) TCTGGGTCGACTCTAGGCCTAAAT 
Reverse primer (4.3 R) ATGAAAGGGCGCATCGATCTGGAA 
Forward primer (4.3 F) AAGCAGCCACTGGTAGTCCTTTAG 
Reverse primer (GEMR) GTCTTGCAGACAAACTGCGCAACT 
4.3.12 Construction of a A.ZAP genomic library 
Based on the sequence data obtained from both pMRG2 and pMRG3, another genomic 
DNA library was constructed using the phage vector A.ZAP Express. The sequence was scanned 
for suitable restriction enzyme cleavage sites and Bell was chosen. Chromosomal DNA (3 11g) 
from B. pseudomallei 204 (section 3.4.1) was completely digested with Bell (section 3.4.5.1) 
and the library was constructed by ligating the products of this digest with BamHI and ClAP 
treated A.ZAP Express vector as explained in section 3.12. 
A I 111 volume of the 500 111 packaged library DNA, when mixed with 200 111 of E. coli 
strain XL1-Blue (section 3.12.5), yielded 1380 recombinants and 127 nonrecombinants. This 
represents a total yield of approximately 7 x I 05 recombinant pfu in the library. Assuming that 
the average size of Bell fragment inserted into A.ZAP Express was 4 kb, then the library 
contained a total of 4 x 7 x I 05 = 2.8 x 106 kb of B. pseudomallei genomic DNA, approximately 
4.3 x I 02 times the size of the B. pseudomallei genome. 
!59 
4.3.13 Probe preparation and labelling 
PCR primers that were developed (section 3.13.1) on the basis of sequence data for 
pMRG2 and pMRG3 (Table 4.4) were used to amplify an 829 bp fragment from B. 
pseudomallei genomic DNA. DIG-dUTP was incorporated into the PCR reaction mixture as 
described in section 3.10.2.2, and the labelled probe, RS8, was used to screen the A.ZAP library. 
Table 4.4: Primers developed on the basis of the sequences obtained from pMRG2 and pMRG3 
Forward primer (MR2F) GCTTGATGCAGATCGTCAACGATG 
Reverse primer (MR3R) GCGAGGCTATACATGCTGATTTCC 
4.3.14 Screening of a A.ZAP genomic library 
The screening of the A.ZAP Express library was essentially performed as for the A.GEM-11 
library (section 4.2.1.2). Screening of approximately 5000 plaques, with RS8 (section 4.3.14) 
resulted in the isolation of three putative positive clones. The clones were designated MRG8 to 
MRG I 0. These plaques were picked as described in section 3.11.5.1, and rescreening of the 
three putative positive plaques confirmed that MRG8, MRG9 and MRGIO were all true 
positives. 
4.3.15 In vivo excision of a recombinant pBK-CMV plasmid vector 
A.ZAP Express is designed to allow in vivo excision and recircularisation of any cloned 
insert contained within the lambda vector. The plasmid DNA was excised from the three 
putative positive clones (section 3.12.7) in the form of the kanamycin-resistant pBK-CMV 
phagemid vector containing the inserted DNA. A 200 volume J..ll of XLI-Biue (OD600 - 1.0) 
were infected with 1 J..ll ExAssistant helper phage and 250 J..ll of phage stock for each of the 
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MRG8, MRG9 and MRG10 clones. After the rescue process detailed in section 3.12.7, several 
colonies were picked from LE-kanamycin plates and the plasmid DNA was extracted and 
screened for the presence of recombinant insert DNA (section 3.4.2.3). Following extraction, 
selected plasmids were digested with EcoRl, Pstl and Sacl in a series of single digests as 
described in section 3.4.5.1. The restriction analysis was resolved by agarose gel electrophoresis 
and showed that the plasmid DNA from each of the three positive clones (MRG8-10) were 
indistinguishable, having the same restriction fragment pattern. Subsequently, the plasmid 
pMRG4 from one of the clones was selected for further restriction mapping and DNA 
sequencing. 
Plasmid pMRG4 was cleaved with the following enzymes in a series of single digests: 
Mlul, Sacl, Smal, and Hindlll, which were resolved by agarose gel electrophoresis (3.4.6.1 ). 
Restriction analysis of pMRG4 showed that it contains 8.4 kb of inserted DNA (Fig 4.10). 
Furthermore, DNA sequence information derived from pMRG4 supported the restriction 
analysis and showed that it carries 8404 bp of inserted DNA. This sequence overlaps the full 
length of inserted DNA in pMRG3 and 2706 bp of pMRG2 (Fig 4.11), including the 3' end of 
the second putative gene sequence in addition to a further 4.3 kb of flanking sequence 
information. The physical map ofpMRG4 is shown in Fig 4.12. 
In summary, it was necessary to construct and screen three B. pseudomallei genomic 
libraries in /...GEM-11, /...GT -11 and /...ZAP Express vectors, in order to isolate three overlapping 
genomic clones; pMRG2, pMRG3 and pMRG4 spanning approximately 10 kb of the B. 
pseudomallei chromosome (Fig 4.13). 
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Fig 4.10: Agarose gel electrophoresis of restriction enzyme digests of pMRG4. The sizes of 
fragments were estimated from I kb (Lane 1 & 6) and I 00 bp (Lane 7) DNA ladders. 
No of No of cleavage Approximate size of DNA Total 
Track Enzyme DNA sites on fragments (kb) size (kb) 
fragments vector insert 
2 Mlul 5 I 4 0.163, 0.506, 3.3, 4.049, 4.887 I2.90 
3 Pstl 5 1 4 0.714, 1.079, 2.246, 3.79, 5,093 12.90 
4 Smal 4 I 3 1.296, 1.56I , 2.989, 7,074 12.90 
5 Hindlll 2 1 1 2.46, 10.44 12.90 
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(insert 4324 bp) 
pMRG3 
(insert 532 bp) 
pMRG4 
(insert 8404 bp) 
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Fig 4.11: Schematic presentation of the total sequence overlaps between different 
clones of B. pseudomallei in pMRG2, pMRG3 and pMRG4. Arrows represent open 
reading frames (ORF) and reading direction, while numbers indicate the size of each 
genomic DNA fragments. 
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Fig 4.12: Restriction map of pMRG4 deduced from single enzyme digests. The 8.4 kb 
insert of B. pseudomallei DNA is represented by the grey colour. kanR is the gene 
encoding kanamycin resistance, while numbers represent the number of base pairs of DNA 
between adjacent restriction sites. 
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Fig 4.13: A summary of the results obtained from screening lambda libraries of B. 
pseudomallei genomic DNA with DNA probes. 
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4.4 SEQUENCE ANALYSIS OF A TWO COMPONENT REGULATORY SYSTEM 
4.4.1 Nucleotide sequence analysis 
The raw sequence data obtained from pMRG2, pMRG3 and pMRG4 was scanned for the 
presence of a variety of features including restriction endonuclease cleavage sites, open reading 
frames, initiation codons, -10, -35 and + 1 regions, Shine-Dalgarno sequences (Shine & 
Dalgarno, 1974), transcriptional termination loops and stop codons. 
4.4.1.1 Restriction endonuclease cleavage sites 
A complete restriction map of the sequenced 4.3 kb EcoRl fragment was assembled. The 
predicted restriction sites were found to exactly match the observed endonuclease cleavage 
patterns {Table 1, Appendix IV). 
4.4.1.2 Open reading frames 
The presence of open reading frames (ORFs) was determined according to the methods 
outlined in section 3.9. This chapter will present the results for two major ORFs, while the 
flanking sequences will be considered in the next chapter. 
The first ORF, ORFa, consists of 666 nucleotides (Fig 4.14). The non-coding region 
upstream of ORFa was checked for the presence of characteristic promoter sequences. A 
potential Shine-Dalgarno ribosome binding site (GGAG) was found 5 nucleotides upstream of 
the A TG translation start. Preceding this translational start site, a possible promoter structure 
with an RNA polymerase recognition site (-35 region) and a Pribnow box (-10 region), where 
the RNA polymerase begins to unwind the DNA for eventual transcription, was found. The -35 
region, TTGCAT, shows extensive homology with the E. coli consensus sequence of promoter 
regions, while the -10 region, T ATgca, showed a limited homology with three of the six 
conserved bases (small letters denote nucleotides which are not identical). The distance 
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separating the putative -10 and -35 regwns is 25 bases, which is more than the average 
separation between these two regions (17 bases). This may have some bearing on the relative 
levels of expression of the gene. The start point for transcription of bacterial genes ( + 1) is 
generally located about 10 bp downstream from the centre of the -10 region, and in 90% of 
cases it is a purine (A or G). At 9 bp downstream from the -10 region, a putative transcriptional 
start (A) is located. A second less likely predicted promoter sequence is located downstream 
from the first promoter region. Both promoters have the same -35 sequence (TTGCAT), while 
the second predicted promoter region has a limited similarity in -10 region ( cAtgag) to that of E. 
coli. The distance between the second putative -10 and -35 regions is 8 bases, considerably less 
than the average separation distance. ORFa is apparently terminated by the termination signal 
TGA, however, downstream of the stop codon no putative transcriptional terminators were 
predicted. Analysis of the DNA base composition showed that the individual base content for 
ORFa was A, 17.56%, C, 29.57%, G, 34.38% and T, 18.46% and codons with C or G were 
preferentially used (Table 2, Appendix IV). The sequence was GC rich; mol% G + C = 64%. 
The second putative reading frame, ORFb, consists of 3237 nucleotides (Fig 4.14), and 
seems to be transcribed in the same direction as ORFa. The initiation codon of ORFb overlaps 
by a single nucleotide with the termination codon of ORFa. Eight nucleotides upstream from the 
A TG start codon and in the distal portion of ORFa, there is a purine-rich sequence that possibly 
represents a potential Shine-Dalgamo ribosome binding site (AAGGA) for the high level 
expression of the gene. ORFb is apparently terminated by the presence of a stop codon TGA. 
Downstream of the stop codon in the non-coding region, an inverted repeat capable of forming a 
stem-loop structure, is found, with a stem of 10 bases composed predominantly of G's and C's 
but lacking a T -rich region at its 3 '-end. A free energy (~G) of -26 kcal, was estimated for the 
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Fig 4.14: Nucleotide sequence of two-open reading frames (ORF) overlapping by a single 
nucleotide. The numbering of the sequence starts at the first nucleotide of the ORFa 
initiation codon. The putative -10, -35 regions, transcriptional start site (+I), potential 
ribosomal binding sites (RBS) and initiation codons are highlighted and underlined, while 
putative stop codons are in red bold Italics. The two ORF overlap is marked by an arrow. 
The EcoRl site shown represents the end of genomic insert in pMRG2, the Sau3A site is 
the end of genomic insert pMRG3, while the Ben site is the start of genomic insert in 
pMRG4. Two convergent arrows in the non-coding region downstream from the ORFb 
indicate a putative transcriptional termination region. 
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TTCACGGCCGATTCGCGGCATGGCGAGGCGGGGCGCACGAGCGTCGGCGCCGTTGCATTCGAGC 
-10 +I -3~ 
GAATCGCGCTCGCAAGGCATATGCAGGAACGCAGGCAATCGTTATCGTTTTGCATGGAACGCGC 
-10 +I RRS 
ATGAGCGTGCGCCGGACCTCGTTCGTGCGGCACGGAGGCGCTTTCCGCTTTTTTCGGAGCCGCC 
10 20 30 40 50 60 
ATGTCCAACG TTGCCCTGCA TACAAGAAAA GTCGTCGTGG CCGACGATCA TCCGATCGTC 
70 80 90 100 llO 120 
CTGCGTGCGG TGACGGATTA CGTCAATTCG CTGCCGGGTT TTCACGTCGT GGCGTCGGTT 
130 140 150 160 170 180 
TCGTCGGGGG ACGCGCTGTT GTCCGCGATG CGGGAGCAGG AGGTCAATCT CGTCGTGACC 
190 200 210 220 230 240 
GATTTCACGA TGCATCAGGC GAACGACGAC AAGGACGGCT TGCGCTTGAT CTCGCACCTG 
250 260 270 280 290 300 
ATGAGGGCGT ACGAGCGCAC GCCGATCATC GTGTTCACGA TGCTGACCAA TAGCGGCGTG 
Bel I 310 320 330 340 350 360 
ATCAGCCAGC TGTGCCGCAT GGGCGTGGCG GGGCTCGTCG GCAAGGAGGA GGAGATCGCC 
370 380 390 400 410 420 
GAGCTCGGGC GCGTATGCGT GAGCGTGGCG CGCGGCGTCA GCCAATCGTT GTCGCCCGGC 
430 440 450 460 470 480 
ATGGCTCACC GGCTTGCCGC CGTCGGCAGC ATCAGGCCGG GCGAGGCGGC ATTCAACGCG 
490 500 510 520 530 540 
TTGACGCCGA AGGAACTGGA GGTCGTGCGG CTGTTTACGG GCGGCATGTC GCTCACGGAC 
550 560 570 580 590 600 
ATCGCGCGCA CGCTGAATCG CTCGCTCGGG ACCGTGTCGA CGCAGAAGCG CTCGGCCATG 
610 620 630 640 650 '560 
RRS 
CGCAAGCTGC ACGTGGACAC CAACGTCGAT CTCATCAACT GCGCCCGCGA GCAAGGACTG 
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Fig 4.14 continued 
+ 670 680 690 700 710 720 
CTCTGATG:A AGGACTTCTG CAAGAGCTCG ACGGATCGCC GCTGAGGAAG TTCTATTCGC 
730 740 750 760 770 780 
TCGAGTCGAA TCTGAAGCGC GAGCGGCGGG TCTTCACGAT CGTCATCGTG CTGCTCGTCT 
790 800 810 820 830 840 
GCGCGGCCCT CAGCATCGCG GCCATGACCG TCACCGGCTT GTTCCAGACC GCTTTCCGGC 
850 860 870 880 890 900 
AGGAGGAGCA ATCCGCGCGC ATCCACGAAA AGGAAGTGGT CGACGTGTTC CTGCAGCGCC 
910 920 930 940 950 960 
GCATGATGTT GACGACGGCA AGCCTCGTGC TGCAACTGCG GATGAACGGC GCGCCTTCGG 
970 980 990 1000 1010 1020 
CGCTGAACGT GCCGGCGCCG AACGCGTGCA CGCCGATGGC CCACAATGTG CGCGACGATG 
1030 1040 1050 1060 1070 1080 
CGATCCTGCG CGAGAGCTGC GATTACACGG TGCAGTTGCT GGCCAACTCG GGGCAGACGC 
1090 1100 1110 1120 1130 1140 
CGAGCGTCGA AATGGTGACG GCCGACGGTT CGGTCGGCTA TGGATATCTG TTTCCGACGG 
1150 1160 1170 1180 1190 1200 
GCGACCTGAG CGCGCTACGC TCCAGCACGC CGTCCGAACT CGTGTCGGCC GTGCTCGAGC 
1210 1220 1230 1240 1250 1260 
GCTACGGCAA GCGCGGCCTG GACCCGCTGG AAGCCGCGCG CAAGAAGCGG ATTCTCTGGT 
1270 1280 1290 1300 1310 1320 
TCGCGGTGGG CCGCGGCGGG CGCGGCGAGG AGCTGCATAT GATCGGCGCG TCAGTCGTGT 
1330 1340 1350 1360 1370 1380 
TCAAGGACGA GCGGCTCTAC GCGCTCGTCT TGACGAGCGT GGATCTTCAC AGCCTCGTTT 
1390 1400 1 410 1420 1430 1440 
CGCCGATCGA GCGCGCCGGC CGCGTGCAGC AGCCGGTCGT CGTGGATTCC GAGGGCGTGC 
1450 1460 1470 1480 1490 1500 
CGCTCGTGAA CGCGGACGAC GCGGAAACGG TCCGGAAGGT CGACGGGCGG CTCGCCGGAC 
1510 1520 1530 1540 1550 1560 
AACAGGATGG CCTGTATCAC TGGATTCCCG GCTTCGGGTG GGCCCTACGC CGTCCCGCGC 
1570 1580 1590 1600 1610 1620 
CGTTTTCCGG TTTCGGGCAC ATGACGTATC TGCTTCCGCT CGATCTGCAG TTGCGCTCGA 
1630 1640 1650 1660 1670 1680 
TGCGCTACGA GTTGAGCCTC GTCGGCGGCG CGACGCTCGT GCTGATCGTG TTGCTGTTCG 
1690 1700 1710 1720 1730 1740 
TCGCGTTCCG GTACTGGAAT TACCGGTTCT TGACGCGCAT CTACGAGGAA GCGTCGCGCG 
1750 1760 1770 1780 1790 1800 
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Fig 4.14 continued 
CGCTCGAGAG CGAAATGCTC AACCATCTGC TGGTTCATGC GACGCCGGTC GGGTTGTGCA 
1810 1820 1830 1840 1850 1860 
TCGTGCGGCG GGCGACACTG GAGATCGTCG TCGCCAACCC GATCGCGCGC ACGATGCTCG 
1870 1880 1890 1900 1910 1920 
GCTTGCGGCT GTCGGACCGG CACCTGCCGC AGGAATTGCT GAGCGCGTTC GAATCGTCGC 
1930 1940 1950 1960 1970 1980 
TGGCCGAGCA GGACACCCAG TCCGACGACG CGCGCATTTT CCAGTTCCCG TTCACGCTGT 
1990 2000 2010 2020 2030 2040 
CGCGCGCCGG GCATGCGGCG GTCCATATCG AAATCACGTA CGCGCCCGCG ATGCTGAACG 
2050 2060 2070 2080 2090 2100 
CGCGGGAGGT GTTCTTTTGC GCGATCACGG ACATGACGGC GCACCACCAG GCGGAGATCC 
2110 2120 2130 2140 2150 2160 
TGCTGCGCGA GGCGAAGCTG ACGAGCGACG CGGCGGCCAA GGCGAAGGTG GCGTTCTTCG 
2170 2180 2190 2200 2210 2220 
CATCGATGAG CCATGAAATC CGCACGCCGC TGTCGTCGCT CGTGGGCAAC ATCGAGCTGA 
2230 2240 2250 2260 2270 2280 
TCGCGCGCGG GCCGCTCGCG CCCGAGCAGC AGGCGCGCGT GAAGGCGATG GAGACGTCGG 
2290 2300 2310 2320 2330 2340 
CGCGCGGCTT GATGCAGATC GTCAACGATG TGCTCGATTT CTCGAAGATC GACGTGGGCG 
2350 2360 2370 2380 2390 2400 
AGCTGAGCCT CATGGAGGAG TGGTCGAACA TCGCCGAGCT GCTCGACCGG CTCGCGCTCT 
2410 2420 2430 2440 2450 2460 
CGCACGCGCC GCTCGCGACG CAGCAGGGTT TGAAGTTCTA CATGGTGTTC GATCGCAGCC 
2470 2480 2490 2500 2510 2520 
TGCCCGCGCG GCTCTACTTC GATCCGATCC GGGTCTCGCA GATCGTGAAC AATCTGCTGA 
2530 2540 2550 2560 2570 2580 
GCAACGCGCT GAAGTTCACG CCGTCCGGCA AGATCGTGCT GCGCGCCGGC TGGCGTGCCG 
2590 2600 2610 2620 2630 2640 
GCGCGCTCGA AATCAGCGTG ACGGATTCCG GCATCGGCAT CCCCGATGAC CTGAAGCACC 
2650 2660 2670 2680 2690 2700 
GCCTCTTCCT GCCCTTCACG CAGGGCGACA GCAACCGGCT GCGGCAGGCA CGCGGCACCG 
2710 2720 2730 2740 2750 2760 
GCCTCGGATT GTCGATCTGC GCGCGTCTGT GCGAGCTGAT GAAAGGGCGC ATCGATCTGG 
2770 2780 2790 2800 2810 2820 
AAAGCACCGT CGGCGTGGGA ACCCGGATCG CGGTGACACT GCCGCTCGGC GTGTCGGAGG 
2830 2840 2850 2860 2870 2880 
CCGATTCGAG CGATGCGTAC TGGACGCTTC CGTATCGGCG CGTGGCCGTG CTCGGTCGCG 
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2890 2900 2910 2920 2930 2940 
CACAGGAAAA TCTCGAGTGG CTGGCCAACC TGTTCGACCC GGGCGTCACG GCCGTGACGG 
2950 2960 2970 2980 2990 3000 
CTTTCTCGCG GCCGGCCGAG CCGATCGATG CGCACGCGCA CGATTTCCTG ATGGTCACCG 
ECORI 3010 3020 3030 3040 3050 3060 
ACGAATTCTC GCCGGCCGAG GTGCTGCCGT GGTGGAGGCG GCCGGACTCG ATCGTGTGGG 
3070 3080 3090 3100 3110 3120 
TCGGGCAGGC CGGCCCGCTC GTGCCGAGAC GGCGCGACGA CGGCGGAGTG GAAATCAGCA 
3130 3140 3150 3160 3170 3180 
TGTATAGCCT CGCGGGGCTG AAATCCGCGA CTCACATGCT CGCGGCCGGC CGCACGGCGC 
3190 3200 3210 3220 3230 3240 
TCGCCGAAGC GGGGCACGAG CCGCCGGGAG CCGAGGCGGG AATGACGGTG CTGATCGCCG 
3250 3260 3270 Sau3A 3280 3290 3300 
AGGACAATCT GCTCAACCGC AGCCTGCTGC TCGATCAGCT GACGACGCTG GGCGTGCGGG 
3310 3320 3330 3340 3350 3360 
TCATCGAGGC GAAGAACGGC GAGGAGGCGC TCGCGTTGCT GTTGAAGGAG CCGGTGGACG 
3370 3380 3390 3400 3410 3420 
TCGTGATGAC CGACATCGAC ATGCCGATGA TGGACGGTTT CCAGTTGCTC GCCGAGATGA 
3430 3440 3450 3460 3470 3480 
GGCGGCTCGG CATGACGATG CCGGTGTACG CGGTGAGTGC GAGCGCGCGG CCGGAAGATG 
3490 3500 3510 3520 3530 3540 
TGGCGGAAGG CCGGGCGCGC GGCTTTACCG ACTATCTCGC GAAGCCGGTT TCGCTCGAGC 
3550 3560 3570 3580 3590 3600 
GGCTCGAGAC GGTGGTACGC GCATGTTGCA GCGCGCCGGC GGGCGCGCGC GCCGACGAAG 
3610 3620 3630 3640 3650 3660 
ACGCGCAGGA CGAACTGCCG GGCCTACCCG ACGTGCCGCC CGCCTATGCG AGCGCGTTCG 
3670 3680 3690 3700 3710 3720 
TCGCGCAGGC CGGCAGCGAA ATCGCGGAAT TCGACGCGAT CCTGCGCGAA CGCGCCTGCC 
3730 3740 3750 3760 3770 3780 
GAAACTGCGG CGGTGGCTGC ACGGCGTATC GGGCGGCATC GCGGTCCTCG GGCCTTCCGC 
3790 3800 3810 3820 3830 3840 
ACTGCATGAG CAATGCCAGG AGCTTCGAGC CTACGCGCGC GAATCCGGCG AATGGAATCG 
3850 3860 3870 3880 3890 3900 
CGAAATCGAA CTGCAGGCGC TGGCCATTCG GAACGCGCTG GAGCGAATGG TCGCGGCGC T 
3902 
... ... 
GACGAGCGCGTGATCGGCGCGGGCGCGGCCCTGCCGGAGCGGGCCCGCGCCCGCCATGGAC 
GGCGCGGCGCGGGGGTGTGCGCGGCGTCGCACGTTCCGGCGCGGATTCGAAGATTTGTGATTC 
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stem-loop structure (Fig 4.15). This might act as a strong transcriptional terminator for the 
putative gene. 
The absence of secondary structure around the stop codon of ORFa suggests that 
transcription does not terminate at that point. It is known that secondary structure around the 
termination site greatly influences the efficiency of transcriptional termination. In addition, the 
lack of an obvious promoter region for ORFb suggests that transcription may be under the 
control of the promoter region proposed to precede ORFa. Together these features suggest that 
both ORFs may be transcribed as a polycistronic unit under the control of a single promoter. 
Analysis of the DNA base composition showed that the individual base content was A, 
16.31%, C, 31.32%, G, 35.24% and T, 17.12%. Hence, the overall codon usage (Table 3, 
Appendix IV) was characterised by a strong preference for C or G in the third positions, which 
are the positions most free to drift toward the overall genomic mol% G + C content. The mol% 
G + C was 66.5%. 
4.4.2 Deduced amino acid sequence analysis 
Translation of ORFa revealed that it encodes a protein of 221 amino acids (Fig 4.16) with 
a predicted molecular mass of 23,860 kDa and pi of 7.82. The secondary structure prediction 
indicated that 4 7% of the residues should form a-helices, 12% should be in the p sheet 
configuration and 41% forming loops (Fig 4.17). The amino acid composition as deduced from 
the translated nucleotides is shown in Table 4.5. The translated protein was found to be rich in 
the nonpolar hydrophobic residues valine (12.2%), leucine (11.3%) and alanine (9.1 %). 
The predicted amino acid sequence was used to conduct a BLAST search of the amino 
acid sequences that are deposited in public databases. Protein sequence analysis revealed strong 
homology throughout the protein to the two-component response regulatory proteins of many 
172 
/g~g" 
\ ! 
,-, 
30 ~o--~ 
,-, 
40 ,-, 
~-o"-
/ c 1- 1 
251 - , 
,-, 
,-, 
,-, 
,-, 
,-, 
40 ,-, 
,-, 
17 -c 
Fig 4.15: Predicted secondary structure of transcription termination formed by the 
inverted repeat sequence at the 3' end of the mrg locus; stem-loop structure. Numbers 
indicate position relative to the mrgS stop codon. 
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MSNVALHTRKVVVADDHPIVLRAVTDYVNSLPGFHVVASVSSGDALLSAMREQEVNLVVT 
~FTMHQANDDKDGLRLISHLMRAYERTPIIVFTMLTNSGVISQLCRMGVAGLVGKEEEIA 
ELGRVCVSVARGVSQSLSPGMAHRLAAVGSIRPGEAAFNALTPKELEVVRLFTGGMSLTD 
IARTLNRSLG!VSTQKRSAMR!LHVDTNVDLINCAREQGLL* 
Fig 4.16: The deduced amino acid sequence of ORFa (MrgR protein). Conserved amino 
acids in other response regulator proteins are in bold. Putative Helix-Turn-Helix DNA 
binding motif is in red colour. Conserved residues in response regulatory proteins including 
D, T and K are highlighted and underlined. 
Table 4.5: Amino acid residue composition ofMrgR (%) 
A: 9.1 C: 1.4 D: 5.0 E: 5.0 F: 2.3 
G: 7.2 H: 3.2 1: 4.1 K: 2.7 L: 11.3 
M: 4.1 N: 4.1 P: 2.7 Q: 2.7 R: 7.7 
S: 8.1 T: 6.3 V: 12.2 W:O.O Y: 0.9 
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.. .. , .... 1 ... . , . ... 2 . .. . , . ... 3 .... , . . .. 4 . . .. , .. .. 5 . ... , . ... 6 
aa MSNVALHTRKVVVADDHPIVLRAVTDYVNSLPGFHVVASVSSGDALLSAMREQEVNLVVT 
Pred Str EEEEE HHHHHHHHHHHHH EEEEE HHHHHHHHH EEEE 
.... , . ... 7 .. . . , .. . . 8 .. . . , . ... 9 . . .. , .... 10 .. . , ... . 11 ... , . . .. 12 
aa DFTMHQANDDKDGLRLISHLMRAYERTPIIVFTMLTNSGVISQLCRMGVAGLVGKEEEIA 
Pred str EE HHHHHHHHHH EEEEEEE HHHHHHHHHH EEE HH 
. . . . , .. .. 13 . . . , . ... 14 ... , . ... 15 .. . , ... . 16 ... , .... 17 ... , .... 18 
aa ELGRVCVSVARGVSQSLSPGMAHRLAAVGSIRPGEAAFNALTPKELEVVRLFTGGMSLTD 
Pred str HHHHHHHHHHH HHHHHHHHHH HHHHHHHHHHHH HH 
.... , .... 19 . .. , .... 20 . .. , .... 21 . . . , . . .. 22 
aa IARTLNRSLGTVSTQKRSAMRKLHVDTNVDLINCAREQGLL 
Pred str HHHHH HHHHHHHHHHH HHHHHHHHH 
Fig 4.17: The predicted secondary structure of MrgR. H represents helix, while E is 
extended sheet. 
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different bacterial species. On multiple alignment (Fig 1, Appendix IV), the highest scores 
obtained were with response regulator of capsular synthesis (RcsB) in Erwinia amylovora, E. 
coli, Proteus mirabilis and S. typhi exhibiting 68.9, 68.5, 68.4 and 68.1% homology. The most 
significant similarities are summarised in Table 4.6. On the basis of this similarity the protein 
was designated MrgR (for melioidosis agent !egulatory gene !egulator). The C-terminal domain 
of the protein contained a typical helix-turn-helix motif (position 156 to 177) common to 
response regulators of the FixJ or LuxR family. 
Comparison of the MrgR protein sequence with other response regulatory proteins 
revealed that it possesses the conserved residues characterised to this family of proteins. A 
conserved aspartic acid residue (D) present in all aligned proteins (position 61) is thought to be 
the phosphorylation site in many of the regulatory proteins that is important for regulatory 
activation. In addition, several other conserved motifs were identified in MrgR. These include a 
pair of aspartate residues (DD) at positions 15 and 16 at the N-terminal end, a threonine (T) at 
position 191, and a lysine residue (K) at position 202 at the C-terminal end. All of these 
residues may contribute to the acidic pocket for the phosphorylation site. 
Translation of ORFb shows that it encodes a protein of 1078 amino acids (Fig 4.18) with a 
predicted molecular mass of 118,227 KDa and a theoretical pi of 6.04. The secondary structure 
prediction indicated that 44% of the residues should form a-helices, 14% should be in the ~ 
sheet configuration and 41% forming loops (Fig 4.19). The amino acid composition as deduced 
from the translated nucleotides is shown in Table 4.7. The translated protein was found to be 
rich in hydrophobic nonpolar residues of leucine (12.3%) and alanine (11.6%) as well as the 
hydrophilic positive amino acid arginine but with lesser amounts of cysteine (1.3%), tryptophan 
(1.3%) and histidine {1.9%). 
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Table 4.6: Homology ofMrgRwith the response regulatory proteins from other bacteria 
Bacteria Protein Function 
l£rwinia amylovora RcsB Capsule synthesis 
Escherichia coli RcsB Capsule synthesis 
Proteus mirabilis RcsB Capsule synthesis 
Salmonella typhi RcsB Capsule synthesis 
Erwinia amylovora HrpY Type Ill secretion system 
Ralstonia solanacearum VrsD Virulence genes expression 
Bordetella pertussis BvgA Putative virulence factor 
Rhodococcus erythropolis BpdT ? 
Pseudomonas syringae GacA Global activator 
Pseudomonas syringae FixJ Nitrogen fixation 
Pseudomonas viridiflava RepB Global activator 
Vibrio cholerae GacA Global virulence regulator 
Pseudomonas stutzeri NarL Nitrate reductase 
Pseudomonas aureofaciens GacA Global activator 
Paracoccus denitrificans MoxX Methanol utilization control 
Salmonella typhimurium UhpA Hexose phosphate uptake 
Escherichia coli NarP Nitrate/nitrite regulator 
Similarity% Identity% 
68.9 31.1 
68.5 29.4 
68.4 29.4 
68.1 29.7 
65.8 23.9 
64 23 
63 28 
61.4 26.6 
61.4 23.5 
61.4 23.5 
61.4 23.5 
61 23.5 
60.5 26 
60.4 23.1 
60 25 
59.6 25 
59 24.8 
MQGLLQELDGSPLRKFYSLESNLKRERRVFTIVIVLLVCAALSIAAMTVTGLFQTAFRQE 
EQSARIHEKEVVDVFLQRRMMLTTASLVLQLRMNGAPSALNVPAPNACTPMAHNVRDDAI 
LRESCDYTVQLLANSGQTPSVEMVTADGSVGYGYLFPTGDLSALRSSTPSELVSAVLERY 
GKRGLDPLEAARKKRILWFAVGRGGRGEELHMIGASVVFKDERLYALVLTSVDLHSLVSP 
IERAGRVQQPVVVDSEGVPLVNADDAETVRKVDGRLAGQQDGLYHWIPGFGWALRRPAPF 
SGFGHMTYLLPLDLQLRSMRYELSLVGGATLVLIVLLFVAFRYWNYRFLTRIYEEASRAL 
ESEMLNHLLVHATPVGLCIVRRATLEIVVANPIARTMLGLRLSDRHLPQELLSAFESSLA 
EQDTQSDDARIFQFPFTLSRAGHAAVHI EI TYAPAMLNAREVFFCAITDMTAHHQAEILL 
REAKLTSDAAAKAKVAFFASMS~EIRTPLSSLVGNIELIARGPLAPEQQARVKAMETSAR 
GLMQIVNDVLDFSKIDVGELSLMEEWSNIAELLDRLALSHAPLATQQGLKFYMVFDRSLP 
ARLYFDPIRVSQIVNNLLS~ALKFTPSGKIVLRAGWRAGALEISVTDSGIGIPDDLKHRL 
!LPFTQGDSNRLRQARGTGLGLSICARLCELMKGRIDLESTVGVGTRIAVTLPLGVSEAD 
SSDAYWTLPYRRVAVLGRAQENLEWLANLFDPGVTAVTAFSRPAEPIDAHAHDFLMVTDE 
FSPAEVLPWWRRPDSIVWVGQAGPLVPRRRDDGGVEISMYSLAGLKSATHMLAAGRTALA 
EAGHEPPGAEAGMTVLIAEDNLLNRSLLLDQLTTLGVRVIEAKNGEEALALLLKEPVDVV 
MTDIDMPMMDGFQLLAEMRRLGMTMPVYAVSASARPEDVAEGRARGFTDYLAKPVSLERL 
ETVVRACCSAPAGARADEDAQDELPGLPDVPPAYASAFVAQAGSEIAEFDAILRERACRN 
CGGGCTAYRAASRSSGLPHCMSNARSFEPTRANPANGIAKSNCRRWPFGTRWSEWSRR* 
Fig 4.18: The deduced amino acid sequence of ORFb (MrgS protein). Two potential 
membrane-spanning hydrophobic stretches located at theN-terminal region of the protein 
are in red colour. Conserved residues in HPKs including, the H residue corresponding to 
putative autophosphorylation site, N, G 1 (DTGVG), F, and G2 (GTGLG) boxes are 
highlighted and underlined. 
Table 4.7: Amino acid residue composition ofMrgS (%) 
A: 11.6 C: l.3 D: 5.1 E: 6.4 F: 3.6 
G: 6.9 H:l.9 1:4.0 K: 2.1 L: 12.3 
M:3.0 N: 2.6 P: 5.2 Q: 3.1 R: 8.3 
S: 7.0 T: 4.8 V: 7.5 W: 1.3 Y: 2.0 
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Fig 4.19: The predicted secondary structure of MrgS. H represents helix, while E 1s 
extended sheet. 
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Pred str 
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Pred str 
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Pr ed str 
a a 
Pred str 
a a 
Pred str 
a a 
Pred str 
a a 
Pred str 
.... , . ... 1 .. . . , .... 2 .... , .. . . 3 .... , ... . 4 .... , . ... 5 .... , .... 6 
MQGLLQELDGSPLRKFYSLESNLKRERRVFTIVIVLLVCAALSIAAMTVTGLFQTAFRQE 
HHHHHH E HHHHHHHHH EEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHH 
.. .. , .... 7 .... , .... 8 .... , .... 9 . ... , . ... 10 ... , .... 11 .. . , . . .. 12 
EQSARIHEKEVVDVFLQRRMMLTTASLVLQLRMNGAPSALNVPAPNACTPMAHNVRDDAI 
HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH HHHH 
.... , .... 13 ... , .. . . 14 ... , . . .. 15 ... , .... 16 . .. , .... 17 .. . , .... 18 
LRESCDYTVQLLANSGQTPSVEMVTADGSVGYGYLFPTGDLSALRSSTPSELVSAVLERY 
HHHHHHHHHHHHHH EEEEEEE EEEEE HHHHHHHHHHH 
. . .. , .. . . 19 . .. , .... 20 . .. , ... . 21 ... , ... . 22 . . . , .... 23 . .. , .... 24 
GKRGLDPLEAARKKRILWFAVGRGGRGEELHMIGASVVFKDERLYALVLTSVDLHSLVSP 
HH HHHHHHHHHHHHHHH EEEE EEEEE EEEE EEE E 
.... , .... 25 . . . , . .. . 26 ... , ... . 27 ... , . .. . 28 ... , . ... 29 ... , .... 30 
IERAGRVQQPVVVDSEGVPLVNADDAETVRKVDGRLAGQQDGLYHWIPGFGWALRRPAPF 
EEEEE EE HHHHHHHHHHHHH EE 
.... , .... 31 ... , .... 32 ... , . ... 33 ... , .... 34 .. . , .... 35 ... , .... 36 
SGFGHMTYLLPLDLQLRSMRYELSLVGGATLVLIVLLFVAFRYWNYRFLTRIYEEASRAL 
HHHHE HHHHEEEE HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH 
.... , .... 37 . . . , .... 38 ... , .... 39 . . . , .... 40 ... , .... 41 .. . , .. .. 42 
ESEMLNHLLVHATPVGLCIVRRATLEIVVANPIARTMLGLRLSDRHLPQELLSAFESSLA 
HHHHH HHHEEHHHHHHHHHHHHHHHHH HHHHH HHHHHHHHHHHHH 
.. .. , .... 43 ... , .... 44 ... , .... 45 . .. , .... 46 ... , . ... 47 ... , .... 48 
EQDTQSDDARIFQFPFTLSRAGHAAVHIEITYAPAMLNAREVFFCAITDMTAHHQAEILL 
H EEEEEEEEEEEEE E EHHHH HHHHHHHHHHHHHHHHHHHHHHHHHH 
.... , .... 49 . .. , .... 50 ... , .... 51 ... , . . .. 52 ... , .... 53 . .. , .... 54 
REAKLTSDAAAKAKVAFFASMSHEIRTPLSSLVGNIELIARGPLAPEQQARVKAMETSAR 
HHHHHHHHHHHHHHHHHHHHHHHH HHHHHHHHHHH HHHHHHHHHHHHHHH 
. . . . , .... 55 ... , .... 56 ... , .... 57 ... , .... 58 ... , .... 59 . .. , . . .. 60 
GLMQIVNDVLDFSKIDVGELSLMEEWSNIAELLDRLALSHAPLATQQGLKFYMVFDRSLP 
HHHHHHHHHHHHHH EEE HHHHHHHHHHHHHHHHHHH EEEE 
.... , .... 61 ... , .... 62 ... , .... 63 . . . , .... 64 ... , . ... 65 . .. , . . .. 66 
ARLYFDPIRVSQIVNNLLSNALKFTPSGKIVLRAGWRAGALEISVTDSGIGIPDDLKHRL 
HHHHHHHHHHHHHHH EEEEEE EEEEEE HHHHHHH 
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Fig 4 .19 continued 
a a 
Pred str 
a a 
Pred str 
a a 
Pred str 
a a 
Pred str 
a a 
Pred str 
a a 
Pred str 
a a 
Pred str 
• • • • 1 • • • • 67 • • • f • • • • 68 • • • f • • • • 69 • • • f • • • • 70 • • • 1 • • • • 71 . • • 1 • • • • 72 
FLPFTQGDSNRLRQARGTGLGLSICARLCELMKGRIDLESTVGVGTRIAVTLPLGVSEAD 
HHHH HHHHHHHHHHHH EEEE EEEEEEE 
• • • • 1 • • • • 73 . • • 1 • • • • 74 • • • 1 • • • • 75 . . • 1. • • • 76. • • 1 . • • • 77 • • • 1. • • • 78 
SSDAYWTLPYRRVAVLGRAQENLEWLANLFDPGVTAVTAFSRPAEPIDAHAHDFLMVTDE 
HHHHHHHHHHHHHHHHHHHH EEEEEE EEEEE 
• • • • f • • • • 79 • • • 1 • • • • 80 • • • 1 • • • • 81 . • • 1 • • • • 82 • • • f • • • • 83 • • • f • • • • 84 
FSPAEVLPWWRRPDSIVWVGQAGPLVPRRRDDGGVEISMYSLAGLKSATHMLAAGRTALA 
EEEEE EEEEE HHHHHHHHHHHHHHH 
• • • • 1 • • •• 8 5 • • • 1 • • • • 8 6 • • • 1 • • • • 8 7 • • • 1 • • • • 8 8 • • • f • • • • 8 9 • • • 1 • • • • 90 
EAGHEPPGAEAGMTVLIAEDNLLNRSLLLDQLTTLGVRVIEAKNGEEALALLLKEPVDVV 
H EEEEEE HHHHHHHHHHHHH EEEE HHHHHHHHHH EE 
. . .. , . . .. 91 ... , .. . . 92 .. ·I · • • • 93 ... , . .. . 94 . .. , .... 95 . .. , . . .. 96 
MTDIDMPMMDGFQLLAEMRRLGMTMPVYAVSASARPEDVAEGRARGFTDYLAKPVSLERL 
EEE HHHHHHHHHH EEEEE HHHHHHHHHH E HHHH 
· ··· I · ·· .97. ··I · · .. 98 .. . 1 • • • • 99 .. . 1 . . . . 100 . . 1 · ·· . 101 .. , .. .. 102 
ETVVRACCSAPAGARADEDAQDELPGLPDVPPAYASAFVAQAGSEIAEFDAILRERACRN 
HHHHHHHHHHH EEE HHHHHHHHHH 
• • • • f • • • . 103 • • 1 • • • . 104 • • 1 • • • . 105 • • 1 • • • . 106 • • 1 • • • . 107 • • 1 • • • . 108 
CGGGCTAYRAASRSSGLPHCMSNARSFEPTRANPANGIAKSNCRRWPFGTRWSEWSRR 
EEEEEEE HHHHHH 
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Comparison of the protein sequence with other proteins in the database showed that it 
shares homology with a variety of two-component histidine kinase environmental sensors. The 
similarity of the protein to other sensor regulators is summarised in Table 4.8. Sequence 
alignments (Fig 2, Appendix 2) showed that the protein, distributed over its entire length, 
exhibits the highest score, over 57% similarity with 22% identity, to RcsC of E. coli. RcsC is 
known to be the sensor regulator of capsule synthesis in a number of bacterial species including 
Erwinia amylovora, Proteus mirabilis and S. typhi. It may perform its function by sensing 
environmental stimuli, hence the protein was designated MrgS (for melioidosis agent !egulatory 
gene ~ensor). 
Examination of the hydropathy profile of theN-terminal putative sensory domain of MrgS 
protein (Fig 4.20, Table 4.9) revealed two stretches of hydrophobic amino acids of sufficient 
length to span the cell membrane, 25 and 27 amino acid residues, at positions 29-53 and 286-
312 respectively. These putative transmembrane sequences are characteristic of theN-terminal 
region of sensor proteins. Furthermore, the C-terminal portion of MrgS protein contains the five 
blocks of conserved functional subdomains (Stock et al., 1995) characteristic of the histidine 
protein kinase family. A conserved histidine that is the putative site of phosphorylation at 
position 502, and theN, G1 (DTGVG), F, and G2 (GTGLG) boxes at positions 619, 646-650, 
660 and 676-680 respectively. These conserved motifs presumably form a nucleotide-binding 
surface within the active site. Additionally, one or more of the several conserved aspartic acid 
residues (D) that are present in many sensor proteins including, MrgS, at sites 859, 897, 902, 
909 and 948 may correspond to the extra response regulator domain that is a characteristic of 
hybrid histidine kinases. 
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Table 4.8: Homology of MrgS with the sensor regulatory proteins from other bacteria 
Bacteria Protein Function 
Escherichia coli RcsC Capsule synthesis 
Vibrio harveyi LuxQ Sensor kinase 
Salmonella typhi SpiR Virulence regulator 
Escherichia coli TorR Sensor kinase 
Vibrio cholerae VieS Sensor kinase 
Rhodobacter spheroides DmsO/TmaO Sensor kinase 
Klebsiella pneumoniae KvgS Virulence sensor kinase 
Pseudomonas syringae GacS Sensor kinase 
Pseudomonas syringae LemA Sensor kinase 
!Pseudomonas tolassi RtpA Extracellular protease 
IErwinia carotovora RpfA Sensor kinase 
Bon:Jetella bronchiseptica BvgS Virulence sensor kinase 
Escherichia coli ArcB Aerobic respiration control 
Pseudomonas f/uorescens ApdA Antifungal antibiotic 
Pseudomonas tolassi - Multiple function regulator 
Escherichia coli EvgS Virulence sensor kinase 
Pseudomonas aeruginosa LemA Sensor kinase 
Escherichia coli Bar A Sensor kinase 
Escherichia coli Ph oR Alkaline phosphate sensor 
Proteus mirabilis RcsC Capsule synthesis 
Streptomyces coelicolor - Sensor kinase 
Similarity % Identity% 
56.7 22.3 
52.3 16 
49.4 20 
49.2 18.8 
48.3 18 
46.5 18.3 
46 15.7 
45.8 13.5 
45 13 
44.6 12.5 
44.3 14 
44.2 15.7 
44.2 16.3 
44 13.3 
44 12 
43.9 18.2 
43.7 12.3 
43.3 12 
37.6 15.5 
34.3 15.2 
32.5 13 
Table 4.9: The predicted cellular location of MrgS domains 
Amino acid residues Predicted area 
1-28 Inside reg1on 
29-53 Membrane helix 
54-287 Outside region 
286-312 Membrane helix 
313-1078 Inside region 
w~----------------------------------------~ 
tv 
0 50 100 150 200 250 300 35 0 40 
Amino acid 
Fig 4.20: A hydropathy prediction showing proposed transmembrane regions in 
MrgS. Values above the horizontal dashed axis indicate hydrophobic character and 
those below the axis indicate hydrophilic character. 
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4.5 DISCUSSION 
This chapter describes the cloning and characterisation of novel two-component regulatory 
genes from B. pseudomallei strain 204, which necessitated the construction and screening of 
three gene libraries using A.GEM-11, A.ZAP and A.GT-11. The A.GEM-11 library had been used 
to successfully screen for the B. pseudomallei phoP gene, encoding a response regulator 
involved in two-component signal transduction (Sangiambut et al., 2000). 
B. pseudomallei is widely distributed in the tropical environment and is an opportunistic 
pathogen of humans and animals. It demonstrates a remarkable ability to survive under a wide 
range of environmental conditions both in vivo and in vitro, although little is known about the 
genetic determinants that control the expression of the genes that provide an adaptive response 
to environmental changes. The capacity to adapt to changing environmental conditions 
increases a cell's chances of survival. In bacteria, the sensory devices gathering the 
environmental information often involve two-component regulatory system. Furthermore, many 
factors that enhance the capability to interact with host cells and to cause disease are under the 
control of two-component regulatory systems. 
Various strategies have been employed by other researchers attempting to identify the 
genes encoding bacterial two-component systems, mostly based on the conserved amino acid 
motifs that are found among the family members. These include DNA hybridisation with 
degenerate oligonucleotide probes corresponding to the conserved amino acid sequence of the 
histidine protein kinase (HPK) G2 box (Osbourn et al., 1990), PCR with degenerate primers 
derived from the conserved N and G2 boxes (Bayles, 1993; Parkinson, 1995; Stock et al., 
1995), and complementation of HPK-deficient E. coli mutants (Aiba et al., 1993; Utusumi et 
al., 1994). In the present study, PCR primers were designed on the basis of nucleotide sequence 
184 
homology with the response regulatory genes of other bacteria and consequently a putative two-
component regulatory system from B. pseudomallei was identified and characterised. HPK and 
response regulator (RR) genes are frequently organised as an operon, and this is also true for the 
nucleotide sequences characterised in this work. 
A PCR product of 234 bp was used as a hybridisation probe to screen genomic libraries, 
and a 4.3 kb DNA fragment was cloned and sequenced from EcoRI genomic digests. Computer-
aided analysis of the nucleotide sequence identified one complete ORF, ORFa, and immediately 
downstream, another partial OFR reading in the same direction, ORFb, that extended beyond 
the sequence of the 4.3 kb region. PCR amplification from DNA extracted from A.GEM-11 
clones using specific primers complementary to the nucleotide sequences of partial ORFb and 
A.GEM-11 arms, permitted the downstream sequencing of a further 268 bp of ORFb but not the 
entire coding region. However, screening a A.ZAP Express library resulted in the identification 
of an 8.4 kb DNA fragment that was subsequently found to possess the full length of ORFb, 
including the termination codon. 
The putative genes encoded by ORFa and ORFb were designated mrgR and mrgS for 
melioidosis agent ~egulatory gene regulator and sensor, respectively. The mol% G + C of mrgR 
(64%) and mrgS (66.5%) are similar to the overall content of the B. pseudomallei chromosome 
(65.7%) (Songsivilai & Dharakul, 2000). In E. coli, the promoter sequences for many genes 
have been compiled and analysed (Harley & Reynolds, 1987). Some of the highly conserved 
bases that have been identified are 5'-TTGACA-3' around the -35 region and 5'-TATAAT-3' 
around the -10 region, with a usual spacing ranging from 15 to 21 nucleotides between the two 
conserved regions (Hawley & McClure, 1983). However, the spacing between the -10 region 
and the transcriptional start site can vary from 7 to 41 nucleotides (Shiuan et al., 1994). Through 
185 
sequence companson, two putative promoter regions are located upstream from the SO 
sequence associated with ORFa. It is not known which of these promoters is required for 
transcription of mrgR, however, the process may be enhanced by the presence of more than one 
promoter region. Nevertheless, further experimentation is required in order to decisively 
determine the promoter for these genes. The initiation codon of ORFb is preceded by a putative 
SO sequence that is located within the final 14 bases of ORFa. However, there was no evidence 
of a well-defined promoter region for ORFb or a transcriptional termination sequence for ORFa. 
Moreover, the stop codon of the ORFa overlaps with the start codon of ORFb by a single 
nucleotide, TGATG. It may be possible that both genes are transcribed as a polycistronic unit 
under the control of the promoter upstream of ORFa. In bacteria, genes with related functions 
are often located together in a group known as an operon. This group of genes has a single 
promoter site, and is transcribed into a single polycistronic mRNA molecule. It has been 
suggested that if the termination of translation of a gene is very close to or even overlaps the 
translation-initiation site of the next gene, then expression of these genes can be coupled at the 
translational level (Das & Yanofsky, 1984). DNA sequencing of E. coli operons has identified 
several overlaps for trp (Oppenheim & Yanofsky, 1980), his (Bames & Tuley, 1983), gal 
(McKenney et al., 1981 ), and ompR/envZ (Forst & Inouye, 1988) and this also occurs in the irl 
operon of B. pseudomallei (Jones et al., 1997). The single base overlap between ORFa and 
ORFb suggests that translational termination of mrgR could immediately initiate translation of 
mrgS. Because bacterial genes with related functions often are grouped together in operons, it 
can be speculated that both mrgR and mrgS are involved in the regulation of a specific function. 
Furthermore, on the basis of strong homology with the sequences of genes from other bacteria, 
it is most likely that the function is that of a two-component regulatory system. 
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The translated sequences of ORFa and ORFb encode proteins with M, of 23,860 and 
118,267, respectively. Searches for similarity among protein sequences can identify well-
conserved motifs as well as families of related proteins in which homology extends over one or 
several domains of proteins that possess similar functions (Pabo & Sauer, 1984; 1992). The 
deduced amino acid sequence of ORFa was substantially similar to numerous response 
regulator proteins. The sequence was most similar to RcsB, the regulator of capsular synthesis 
of gram-negative bacteria such as Erwinia amylovora, E. coli, Proteus mirabilis, and S. typhi. 
On the other hand, the protein translated from ORFb was most similar to bacterial sensor 
regulators especially RcsC of E. coli. In all known res systems, the rcsB gene is located adjacent 
to the rcsC gene and is transcribed in the opposite direction. Furthermore, an intergenic region 
exists between rcsB and rcsC in E. coli ( 196 bp) (Stout & Gottesman, 1990) and also in S. typhi 
(102 bp) (Virlogeux et al., 1996). In contrast, mrgR and mrgS seem to be physically linked and 
are transcribed in the same direction. 
Response regulators are often transcription factors whose affinity for DNA is modulated 
by phosphorylation. X-ray crystallography studies of the S. typhimurium (Stock et al., 1989) 
and E. coli (Volz & Matsumura, 1991) Che Y and NarL (Baikalov et al., 1996) proteins 
confirmed the structural conservation in the N-terminal domain. They revealed a barrel-like 
arrangement of five sets of alternating ~ strands and a helices, in the sequence starting with ~ 1 
and ending with aE. The ~ strands align to form a hydrophobic inner core with the helical 
segment wrapped around the outside of the molecule. There is a correlation between structure 
and function, in that the residues that have an important role in phosphorylation are located in 
an acidic pocket at one end of the barrel. These include a pair of aspartates near theN-terminus 
(Bourret et al., 1990; Brissette et al., 1991 ), a lysine near the C-terminus (Lukat et al., 1991; 
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Stewart, 1993), and a centrally located aspartate that is the site of phosphorylation, positioned in 
the loop between p3 and ac. (Stock et al., 1989; Volz & Matsumura 1991 ). These and other 
characteristic sequences are present in over 90 known receiver-containing proteins, suggesting 
that all receiver modules could be alp barrels like CheY (Stock et al., 1989; Parkinson, 1993). 
The site of phosphorylation in many of regulatory proteins is an aspartic acid residue 
residing 60-80 amino acids from the N-terminus (Volz, 1993). The corresponding aspartates in 
NRI, PhoB (Makino et al., 1994), and VirG (Jin et al., 1990) have also been shown to be 
phosphorylated. In CheY, the critical role of the three conserved aspartates was shown 
experimentally. Substitution of Asp-12, Asp-13, or Asp-57 with asparagine, glutamate, or lysine 
suggests that residue 12 must be an acidic amino acid and residues 13 and 57 must both be 
aspartates in order to maintain CheY function in vivo (Bourret et al., 1990). MrgR possesses 
several candidate aspartate residues that could possibly be involved in phosphorylation at 
positions 61, 68, 69 and 71. However, phosphorylation at a specific residue requires the 
presence of an acidic pocket in the secondary structure of the protein next to the 
phosphorylation site. The acidic pocket is formed by a P-sheet with two further aspartate 
residues at its C-terminus end. This structure is located at the N-terminus of the protein in 
question. Such a putative P-sheet, VVV ADD, is found within the first 20 amino acid residues of 
MrgR. Multiple alignment of MrgR with CheY (Fig 4.21), the protein involved in flagellar 
control in E. coli, and that is known to be phosphorylated at aspartate 57, confirmed the 
presence of this phosphorylation motif. 
Response regulators have been classified into five families according to sequence 
homologies in their DNA-binding domains (Volz, 1993; Stock et al., 1995). On the basis of 
sequence similarity, the MrgR protein should be assigned to the FixJ or LuxR family, which 
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includes NarL of E. coli. Proteins from this family are cytoplasmically located and are thought 
to bind to specific promoter sequences located upstream of the regulated genes. Consistent with 
this, MrgR is predicted to be a cytoplasmic protein, based on hydrophobicity profiles. 
Furthermore, sequence analysis of MrgR predicts that the C-terminus of this protein possesses a 
helix-turn-helix (H-T -H) DNA binding domain, which further supports a role for MrgR in 
transcriptional regulation. Proteins that bind to DNA usually have an important role in the 
regulation of gene expression and the control of DNA replication. The H-T-H domain projects 
away from the rest of the protein thereby allowing one of the helices, the recognition helix, to 
bind in the major groove of the DNA, while the other helix acts to stabilise the binding 
structure. On the basis of what is known of response regulator proteins, MrgR is likely to 
regulate a variety of genes that remain to be identified. 
According to sequence similarity, MrgS seems to belong to a large family of sensor 
histidine protein kinases (HPKs). Sensor kinases are generally integral membrane proteins that 
respond to specific environmental signals. Most sensor proteins are located in the cytoplasmic 
membrane with the transmitter portion of the molecule projecting into the cytoplasm. More than 
one hundred HPKs have now been sequenced from many species of bacteria and the 
organisation of sequence motifs has been well established, with only a few specific residues 
being conserved in almost all members of the family. The N-terminal portion of the HPK 
functions as an input domain, detecting environmental stimuli directly or interacting with an 
upstream receptor, while at the C-terminal end of the protein is the transmitter module. In a 
typical sensor kinase, this catalytic domain is generally 240 amino acids long and contains 
several blocks of residues that are conserved among HPKs. Amino acid replacements at various 
sites within these conserved regions curtail or eliminate autokinase activity (Oosawa et al., 
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1988; Liu, 1990; Yang & Inouye, 1991). Structural predictions for the N-terrninal half of the 
MrgS protein suggest the presence of two hydrophobic domains separated by a 234-amino-acid 
loop that probably extends into the periplasm, perhaps to sense a specific signal. The C-terminal 
half of MrgS appears to be cytoplasmic and contains the conserved motifs that are generally 
considered to be specific to most HPKs. These include the autophosphorylation site (H box) at 
which a conserved histidine (H502) is phosphorylated following signal activation. In addition, 
four blocks of conserved amino acids are also present, constituting the N619 (asparagine), G 1646-
650, F660 (phenylalanine) and 02676-680 boxes. The G 1 and G2 boxes are glycine-rich sequences 
(DXGXG and GXGXG) that bear a resemblance to the nucleotide binding motifs of other 
proteins and are thought to be the site of nucleotide binding, kinase and phosphatase activities. 
Hence, the putative topology (Fig 4.22), together with the conserved motifs strongly suggests 
that MrgS is involved in a signal transduction pathway. Comparisons of the amino acid 
sequences adjacent to the invariant histidine residue permit the separation of HPKs into four 
distinct subfamilies (Forst & Roberts, 1994). MrgS was found to belong to the group I 
subfamily that is characterised by the consensus sequence HEIRTPL (Table 4.10). 
Several aspartic acid residues, which are highly conserved in most of the aligned HPKs, 
were identified close to the C-terrninal end of the MrgS protein. The presence of one of these 
residues may suggest that MrgS belongs to a separate group of more sophisticated signal 
transduction proteins, the hybrid kinases, that contain domains resembling both the histidine 
kinases and the response regulators in one primary sequence. The response regulator domain of 
these proteins is thought to function as a pseudosubstrate inhibitor of the kinase domain. 
Following an appropriate stimulus, the kinase domain undergoes autophosphorylation, and then 
transfers this phosphate to the regulator domain, thus relieving inhibition. Phosphorylation of 
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CooH 
Fig 4.22: Schematic representation of the predicted topology of the MrgS protein. TM 
indicates a transmembrane region and numbers represent the length of each protein 
fragment. 
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Subfamily Representative member Sequence 
1 2 3 4 5 6 7 
Group I EnvZ H-8-0-ffi-•-P-L 
Group 11 Vir A H-8-0-N-•-P-L 
Group III CheA H-.6-0-ffi-•-•-• 
Group IV DegS H-8- •- •- •-•-• 
Table 4.10: Consensus sequence comparison of region I of the histidine kinase sensor 
molecules. Capital letters indicate invariant positions: H, His; P, Pro; L, Leu; N, Asn. 
Symbols indicate positions that contain conserved residues as follows: 8 represents Asp or 
Glu; 0 represents lie, Leu, Phe, or Met; E9 represents Lys or Arg; • represents positions 
that are variable. The individual members of the subfamilies were derived from Stock et 
al., 1989; Parkinson, 1993. Group I subfamily: EnvZ, KdpD, RcsC, CpxA, ArcB, BarA, 
PhoR, PleC, LemA, KinA, BvgS, VanS, NtrB, CreC. Group 11 subfamily: VirA, FixL, 
PgtB, and DctB. Group Ill subfamily: CheA and FrzE. Group IV subfamily: UhpB, DegS, 
and NarX. MrgS belongs to the group I histidine kinase sensors. 
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the true substrate can then take place. These ideas are largely based on work on ArcB, which 
controls the anaerobic repression of several operons in E. coli by modulating its downstream 
response regulator, AreA (Alex & Simon, 1994). 
The similarities between MrgR-MrgS and the RcsB-RcsC signal transduction system in 
other bacterial species suggests that the B. pseudomallei proteins may perform a similar 
function. The res genes that are involved in the regulation of colanic acid capsule synthesis have 
been well studied in E. coli. Two pathways that regulate the synthesis of colanic acid capsular 
polysaccharide have been recognised. Lon and RcsA compose one regulatory pathway, where 
Lon is an A TP-dependent protease that degrades several proteins, including RcsA, which is a 
positive regulator of capsule synthesis (Torres-Cabassa & Gottesman, 1987). RcsA is, therefore, 
limiting for capsule expression. The RcsB-RcsC two-component regulatory proteins provide the 
second pathway. RcsC is a membrane kinase that receives a stimulatory signal, such as 
temperature shock (Alien et al., 1987), desiccation (Ophir & Gutnick, 1994), osmotic shock 
(Siedjeski & Gottesman, 1996), or perturbations in the structure of the outer cell membrane 
(Clavel et al., 1996), and is converted to an active protein kinase (Gottesman & Stout, 1991 ). 
The activated RcsC protein may activate and deactivate RcsB through cycles of phosphorylation 
and dephosphorylation. The phosphorylated and activated RcsB protein may, in turn, stimulate 
transcription of the target cps genes (Stout & Gottesman, 1990; Gottesman & Stout, 1991, 
Stout, 1994). However, phosphorylated RcsB activates the transcription of cps genes to a 
maximum level only when RcsA is present (Stout et al., 1991). Therefore, both pathways 
require RcsB for the high-level expression of cps genes in E. coli (Gottesman, 1985; Gupte et 
al., 1997; Ebel & Trempy, 1999). 
In addition, it has been proposed that the RcsB and RcsC proteins of E. coli perform 
194 
functions other than regulating capsular synthesis. Experiments by Gervais and Drapeau (1992) 
and Gervais et al. (1992) implied that RcsB has a role in the regulation offtsZ, a gene encoding 
a septum protein that is considered to be essential for cell division, and proposed that RcsB 
increased the transcription offtsZ thus accounting for the restoration of colony formation inftsZ 
mutant cells. Consequently, Gervais et al. (1992) raised the possibility that rcsB is a global 
regulon involved in a variety of cellular functions, which would explain its occurrence in 
organisms that do not synthesise colanic acid. On the other hand, RcsC was believed to play a 
role in the maintenance of cell envelope integrity in E. coli. Homologs of Res proteins have 
been identified in Erwinia spp (Bernhard et al., 1990; Poetter & Coplin, 1991 ), K. pneumoniae 
(Alien et al., 1987; McCallum & Whitfield, 1991 ), and S. typhi (Houng et al., 1992). Because 
these bacteria are normally found in very different environments, they probably do not respond 
to the same environmental signals; however, they do use the same molecular pathway(s) to 
stimulate expression of their respective capsule biosynthesis genes (Stout, 1996). In S. typhi, 
production of Vi antigen, the capsular polysaccharide that correlates with virulence, is partially 
controlled by the two-component regulatory system RcsB-RcsC and by the positive regulator 
TviA, which interacts with RcsB to promote the optimal transcription of the genes involved in 
Vi antigen synthesis (Virlogeux et al., 1996). 
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CHAPTERS 
MOLECULAR CHARACTERISATION OF THE mrgRS LOCUS AND 
FLANKING REGIONS IN DIFFERENT ISOLATES OF 
B. PSEUDOMALLEI AND OTHER BURKHOLDERIA SPECIES 
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5.1 INTRODUCTION 
B. pseudomallei has a wide geographical distribution and host range (sections 2.2.3, 
2.2.9) and it is therefore of interest to examine the mrgRS locus for the presence of variation 
among isolates from different sources. Studies of genetic variations at specific loci may 
yield valuable information about the pathogenicity and epidemiology of bacterial pathogens 
(Watt & Dean, 2000). For example, an examination of the genome sequences of 
Mycobacterium tuberculosis and Mycobacterium bovis has revealed that although only very 
small differences exist in the gene structure of these pathogens this variation is sufficient to 
determine host specificity (Behr et al., 1999). These small differences in genetic 
composition must be reflected in functional differences in gene expression either at the level 
of transcription, translation or post-translation. 
The purpose of this chapter was to compare the mrgRS locus and flanking regions of 
19 isolates of B. pseudomallei from a wide range of sources, including Asia (Thailand, 
Vietnam, Singapore, Malaysia, China), Africa (Burkina Faso, Madagascar), Europe 
(France), and Australia. A selection of clinical and environmental isolates was included. 1n 
addition, in attempting to understand the function of the mrgRS locus, DNA sequence 
analysis of the flanking regions was performed and the presence of open reading frames and 
potential genes was determined. 
5.2 MATERIALS AND METHODS 
The materials and methods for the work performed in this study have been previously 
described in the following sections: genomic DNA isolation (section 3.4.1), restriction 
enzyme digestion (section 3.4.5), agarose gel electrophoresis (section 3.4.6.1 ), nucleotide 
and protein sequence analysis (section 3.9), Southern blotting (section 3.1 0), labelling DNA 
probes (sections 3.1 0.1, 3.1 0.2), DNA sequencing (section 3.8), and PCR (section 3.13). 
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5.3RESULTS 
5.3.1 Nucleotide sequencing of the regions flanking the mrgRS locus 
Sequence information for the mrgRS flanking regions was obtained from pMRG2 
(section 4.3 .I 0) and pMRG4 (section 4.3.15). One plasmid, pMRG2, contains the entire 
mrgR gene and ~2.3 kb of the mrgS gene in addition to the sequence of approximately 1.3 
kb upstream from the mrgR initiation codon. The other plasmid, pMRG4 contains the 
remaining 0.9 kb distal portion of mrgS as well as ~ 4.3 kb of sequence downstream from 
the mrgS stop codon. 
5.3.2 Sequence analysis of the mrgRS flanking regions 
The assembled nucleotide sequence of the regions flanking the mrgRS locus was 
analysed according to the general rules for identifying open reading frames (ORFs) and 
prokaryotic promoters described in sections 3.9 and 4.4.1.2. The analysis included the 
identification of restriction endonuclease cleavage sites, ORFs, initiation codons, -35, -10 
and + 1 regions, Shine-Dalgamo sequences, transcriptional termination loops and stop 
codons. Consequently, a single ORF was found upstream of the mrgRS locus while 6 ORFs 
were present downstream of the mrgRS locus. A schematic presentation of the ORFs and the 
direction of transcription is shown in Fig 5.1, and the characteristics of the ORFs are 
summarised in Table 5.1. The amino acid sequences deduced for each ORF are shown in 
Fig 5.2, and summarised in Table 5.2, while a comparison between amino acid composition 
of each putative protein is summarised in Table 5.3. Deduced amino acids were evaluated, 
and only those of major interest will be discussed. 
The single ORF upstream of mrgRS, ORFc, ends 297 nucleotides upstream from the 
initiation codon of mrgR. Thirty-two nucleotides downstream of the proposed TAG stop 
codon in the non-coding region, an inverted repeat capable of forming a stem-loop structure 
transcriptional termination, is found, with a stem of 7 bases. A free energy (fiG) of -9 kcal, 
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ORFi ORFh ORFg 
I kb 
Fig 5.1: Schematic presentation of the flanking regions ofthe mrgRS locus of B. pseudomallei. Arrows represent 
open reading frames (ORF) and direction of transcription. 
TcFl 
MREISSHADSRSIRRADTFSLWIGSVLGNDVARLSRRSDGGLILMEHTTSIGWAARSHARSE 
HACDRISQWILVLMPIVFVAFCVLLISLWYIDILTGWLIAAFALLIEAMLIGIGFFVFVMVR 
ISHRRRREREAKTALCRANQPDDADVPFPVGFDGVKTVHCMFGSGQVGGFRVSCYNTNCPLM 
RGATETERLPGQAERA 
TcF2 
MEAGITRRRGAFFAREHEHGLSLDEADLERAFEAGEFVMDYQPIVSIRSGAVTGAEATIRWD 
HPEWGALPQRVVHAAADRLGAASRIAGHAFGEACRQLARWKQQGAGVSALSMRLSGAQLGAE 
SVFERLALSIEAFDISSSQFTLEVPEMSAPEESLSLLDRLKRLRQKGYGIVLGDFGAHHTAM 
STLMVLPVTGVKFGESFTERLPGSPTAEAILSSVSRLAHDLGFTLTVSGVENGRQFELLRRF 
RDIELQGAFLFEPMRAEVWHERVNPRALSQLNLREPPF 
TcF3 
VSRVRAAEWARWRDNRRAVDRGARHVSLLHASRGRRFQAPPCAAMCRPPCASARRDARGMGA 
RTRYLAFPHETLSRRCGASSMRRRLDFLSKRSDMAQTFIAVKTILPGDLFFPADAASALCRD 
RAREAPAGSGGLTDREPTVLRHSAGIRAGRFFIGSA 
TcF4 
VSTSSASPWTTYSLPTAGTADERSGPNITIPPVARPGRASGASRCGFAAKIASNSNCGAAAA 
YRSRPESMRPRVRLKKPAIIRSVCRLAAARRAEQATRYGEMKRPARRKHVMPGGWRYFPQPP 
AWPARGLVSGRATSQGSYGTLRANARCRGSSEGAKARLPRLALVQIIGCQGKRRQISERVLP 
AGFIREHLESGMICPFQFELLGVIQRSGLGVIDMLVGEVIDDFSYLADEVLRWEKIGFVNIL 
DSVHRG 
TcFS 
MATELDPPDSFDPFDSIDSYDLFDSLDERQTNFTLSCAMDWGQNIKNPTTDILGKLIIGYLG 
KSTKTKNNRFSIVWGPAVYVDPLSGYAANVTAIFKNTSNDKDYRLAFSGTNPNSQFADIVIE 
DNDVKNLTPFSKYVSDCPPDALIANGTAKALDVTLQTLPSNSSASLTDFLKNLPKESTLTVT 
GHSLGGVLASTFALYFSQSSGYPFKNVFCHSFAAATAGNVAFAAYSDGSLTGKMKRLWHRYD 
VIPSSWNLSTMNRIKYIYEPNLFPTEDFIRKIRKIVYYFSNKHIYYAQPGSLDHSQQFELEG 
AYHSGFKVFTDEAGWQHTFGYLAPLSLTADDLNEGQPWQPSLGTLA 
TcF6 
MTCFLRAGLFISPYRVACSARRAAARRQTLRMIAGFFNLTRGRIDSGRLLYAAAAPQFELLA 
IFAANPHRLAPDARPGRATGGIVIFGPDLSSAVPAVGREYVVQGEAELVDTRAYLGEDGFLG 
RPALVGQTGLEFDFEFLESLICNHFVTLSNF 
TcF7 
MREREIARASAHAARIAPSRRARRAAHGGTRRGLKPPPARRMQKRHMPRSAIHGAPIVAPPR 
PLRRPHPGHARRPFTRRPRMRLRMRSNAHGRACATRRRPARRAIATNRESARRGLPRSLEFD 
CTDRGCATESKFLEMSAQPARRARSTMQARARTTRGRVSNNCDFRAKTSEAMSGRGFAMSRP 
VGPRRAISAGERPRAGRDRVCRRRPHRAARATSNAPCRRACAHGHASASDARSAGHRIAQDW 
RAKA 
Fig 5.2: Amino acid sequences (TcFl-TcF7) derived from the translated nucleotide sequences of 
ORFc-ORFi, respectively. Properties of each putative protein are indicated in text. 
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Table 5.1: Computer predictions of open reading frames and associated characteristics. For 
promoters, capital letters denote nucleotides that are identical to E. coli consensus sequences 
Promoter Promoter mol% 
ORF Size Start Stop RBS probability score G+C 
-35 -10 
c 609 ATG TGA GAAAGG Not obvious 59% 
D 861 ATG TGA GGGAGAG Not obvious 65% 
E 483 GTG TGA GAAAGG TTGAtt TacAgT 0.97 71% 
F 765 GTG TAA GAGA TT GAgA aA T gAT 0.89 & 0.83 59% 
G 1071 ATG TGA AAGGAA TTGAtc TAT AtT 0.9 51% 
H 351 ATG TGA GGAAAA Not obvious 61% 
I 759 ATG TGA GAAAG TTGctg cAT AcT 0.92 72% 
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Table 5.2: Properties of proteins deduced from ORFc-ORFi in the mrgRS flanking regions. 
ORF Protein Molwt pi Major similarity to other Other features designation (Da) proteins 
c TcFI 22,556 8.90 PssL R. leguminosarum Transmembrane domain 
D TcF2 31,527 5.89 BvgR B. pertussis Two conserved domains 
E TcF3 17,700 11.70 FimZ S. typhi Lacks HTH motif 
F TcF4 27,665 10.93 AlgP P. aeruginosa Similar to eukaryotic histones 
G TcF5 39,493 5.23 Serine lipases G-X-S-X-G lipase motif 
H TcF6 16,856 8.60 PscD P. aeruginosa Similar to type III export 
protein 
I TcF7 28,25 I 12.28 -
Signal peptide sequences and 
high arginine content 
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Table 5.3: A comparison of the amino acid compositions of the deduced proteins TcF1-
TcF7 
Residue 
Composition(%) 
TCF1 TCF2 TCF3 TCF4 TCF5 TCF6 TCF7 
A Ala 9.41 11.89 16.88 11.81 7.87 14.19 18.25 
C Cys 2.79 0.35 3.12 2.36 0.84 1.94 2.78 
DAsp 4.95 3.50 5.62 2.36 7.58 3.87 2.38 
E Glu 4.46 9.44 2.50 4.72 2.81 5.16 3.17 
F Phe 5.45 5.94 5.00 2.76 6.46 8.39 1.98 
G Gly 7.92 8.74 7.50 9.84 6.18 9.68 6.35 
H His 2.97 3.15 2.50 1.18 1.97 1.29 4.37 
I Tie 7.92 3.50 2.50 5.91 4.78 4.52 2.78 
K Lys 0.99 1.40 1.25 3.15 5.92 0.00 1.98 
L Leu 8.91 11.19 6.88 6.69 9.27 11.61 2.38 
M Met 3.47 2.45 2.50 1.97 1.12 1.29 3.57 
N Asn 1.98 1.05 0.62 1.97 6.18 2.58 1.98 
PPro 2.97 4.20 5.62 7.09 5.62 5.16 8.33 
Q Gin 1.98 3.85 1.25 3.15 3.09 2.58 1.59 
RArg 10.40 9.44 18.75 12.06 2.25 10.32 24.60 
S Ser 7.92 8.04 8.12 9.06 9.83 4.52 7.14 
TThr 4.46 3.85 3.75 3.54 7.58 4.52 4.37 
V Val 7.43 5.94 3.75 5.91 4.21 5.81 1.59 
WTrp 2.48 1.40 1.25 1.57 1.69 0.00 0.40 
YTyr 0.99 0.70 0.62 2.36 5.06 2.58 0.00 
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was estimated for the stem-loop structure (Fig 5.3). The deduced translation of ORFc codes 
for a protein of 202 amino acid residues, with a calculated molecular weight of 22,556 and 
pi 8.9. The predicted protein was designated TcFl. Amino acid sequence analysis showed 
that TcFI has some similarity to a polysaccharide export protein, PssL, from Rhizobium 
leguminosarum. Protein multiple alignment revealed 50 % similarity with 16% identity over 
a span of ~180 amino acids (Fig 5.4). Analysis of the amino acid sequence ofTcFl by DAS 
transmembrane prediction (section 3.9) suggests that it is a membrane protein. A strong 
hydrophobic domain of 55 residues (70-124) may contain a transmembrane domain allowing 
the C-terminal portion of the molecule to project into the cytoplasm (Fig 5.5). 
To elucidate the possible function of TcFl , sequence information from the B. 
pseudomallei genome sequencing project database at the Sanger Centre, was utilised. The 
Sanger Centre is funded to sequence the genome of the B. pseudomallei clinical isolate, 
K96243 . The nucleotide sequence of ORFc was used as a template to search this database 
and extract nucleotide sequences upstream of the ORFc sequence. An assembled fragment 
of 149,217 bp in length, contig 98, was found to contain an identical sequence to ORFc 
(99% identity) and an additional 24.2 kb of sequence information from the region upstream 
of ORFc. Immediately upstream of ORFc, within the additional 24.2 kb sequence, an ORF 
was identified, ORFx, that is preceded by a Shine-Dalgarno binding site (GAGGAGG) and a 
strong promoter sequence with a predicted probability of 0.97. ORFx ends 389 nucleotides 
upstream of the initiation codon of ORFc. The deduced amino acid sequence of ORFx was 
found to encode a protein, TcFx, of 1057 amino acids with molecular weight 97,905 and pi 
3.68. Hydropathy analysis revealed that TcFx has two strongly hydrophobic regions that are 
capable of spanning the cell membrane (Fig 1, Appendix V). Blast searches indicated that 
TcFx is similar to outer membrane proteins from a number of bacterial species including S. 
typhi, E. coli and Y enterocolitica (Table 1, Appendix V). Protein multiple alignment 
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Fig 5.3: Predicted secondary structure of transcription termination formed by the 
inverted repeat sequence at the 3' end of ORFc; stem-loop structure. Numbers 
indicate distance from the proposed stop codon. 
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SLWI GSVLGNDVARLSRRSDGGLILMEHTTSIGWAARSHARSEHACDRISQWILVLMPIV 
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130 140 150 160 170 180 
I I I I I I 
TALCRANQPDDADVPFPVGFDGVKTVHCMFGSGQVGGFRVSCYNTNCPLMRGATETERLP 
WGLSHVLNMPTDKLGLALHLAILVITGGILYVGSSFVLWLAMKKPNGPETEVQRIFVKFL 
* . 
186 
I 
GQAERA 
SKAKRM 
. . 
. . . ... * . * * 
Fig 5.4: Alignment ofTcFl with PssL protein over a span of 186 amino acids. Stars 
indicate identical residues. 
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Fig 5.5: A hydropathy prediction showing possible transmembrane regions ofTcFl. 
Values above the horizontal dashed axis indicate hydrophobic character. 
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showed that TcFx shares 60% and 63% similarity and 23.6% and 21% identity with surface 
proteins of the plant pathogen Xylella fastidiosa and S. typhi, respectively. This increases to 
91 % similarity and 60% identity over a span of 80 amino acids toward the C-terminal end of 
the proteins (Fig 2, Appendix V). Using the Prosite program a protein kinase C 
phosphorylation site, SER, was identified within this region. In vivo, protein kinase C 
exhibits a preference for the phosphorylation of serine or threonine residues found close to a 
C-terrninal basic residue (Woodget et al. , 1986). 
Two hundred and twenty bases downstream from the mrgRS locus, on the same DNA 
strand, an open reading frame, ORFd, was identified and its sequence was predicted to be 
transcribed in the same direction as mrgRS. ORFd encodes a protein of 286 amino acids, 
designated TcF2, with a predicted molecular weight of 31 ,527 and pi 5.89. A search of the 
GenBank database with the BLAST program showed that TcF2 displays homology to at 
least 50 proteins found in a variety of bacteria (Table 2, Appendix V). Although the precise 
functions of many of these proteins are unknown, their open reading frames are within or are 
tightly linked to operons with well-defmed functions. For example, bvgR is required for 
regulation of all known bvg-repressed genes in Bordetella pertussis, the causative agent of 
whooping cough, and is located immediately downstream from the bvgAS locus encoding a 
two-component regulatory system that upregulates virulence gene expression in B. pertussis. 
Additionally, FixL of E. coli is a sensor regulator that is involved in the control of nitrogen 
fixation and is a member of the family of two-component regulatory proteins. Using the 
Boxshade computer program, sequence alignment of TcF2 with a number of these similar 
proteins (Fig 5.6), showed that TcF2 possesses most of the conserved residues that are 
present in two major domains. Domain I consists of 55 amino acid residues with 23 highly 
conserved residues and domain 11 consists of approximately 90 amino acid residues with 39 
highly conserved residues. Several members of this family of proteins have either domain I 
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Fig 5.6: Sequence alignment using the Boxshade program for TcF2, encoded by ORFd, and 
homologous proteins. Black boxes indicate positions conserved in at least 65% of the 
aligned sequences. 
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or II but none appear to have all the conserved residues. Within this family, it was observed 
that in addition to the high degree of sequence conservation within the two domains, the 
spacing between the two domains, 90 amino acid residues, and the spacing between domain 
11 and the carboxy-terminaJ ends of the proteins, 25 amino acid residues, are also conserved. 
The second ORF downstream from mrgRS locus ORFe, is predicted to start with a rare 
GTG translation initiation codon. The translation of ORFe reveals a protein of 160 amino 
acids with a molecular weight of 17,700 and pi 11.7. The protein was designated TcF3. 
Amino acid sequence analysis revealed that TcF3 has substantial similarity in some areas to 
FirnZ protein, a transcriptional activator necessary for type 1 frmbrial expression in S. typhi 
and E. coil (Table 3, Appendix V). Multiple sequence alignment showed that the protein 
shares 43.3% similarity and 15.7% identity with FimZ from S. typhi. This increases to 73% 
similarity over a span of 60 amino acids towards the C-terminal end of the proteins (Fig 
5.7). However, TcF3 lacks the helix-turn-helix DNA binding motif, which is characteristic 
of the FirnZ regulatory protein. Moreover scanning TcF3 using the Prosite program for 
conserved motifs revealed the presence of several possible conserved kinase 
phosphorylation sites SRR, SMR, SKR and TOR at positions 75-77, 82-84, 91-93 and 137-
139, respectively. 
There are two potential promoter sequences for ORFf with predicted probabilities of 
0.89 and 0.83. Both of these promoters overlap in a region covering 31 nucleotides upstream 
from the rare translational start codon, GTG. ORFf codes for a basic protein, designated 
TcF4, which consists of254 amino acids with a predicted molecular weight of27,665 and pi 
10.93. Sequence analysis of the deduced amino acid sequence revealed some homology to a 
range of hypothetical proteins, eukaryotic DNA binding proteins and to AlgP regulatory 
protein of P. aeruginosa (Table 4, Appendix V). AlgP is a histone like protein that is 
involved in regulating the synthesis of alginate, the viscous mucoid exopolysaccharide in 
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Fig 5.7: Clustal W multiple alignment ofthe TcF3 and E. coli FimZ over a span of60 amino 
acids. Stars indicate identical residues. 
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Pseudomonads. AlgP has an unusual C-terminal region that resembles the tail of eukaryotic 
HI histone and contains multiple repeats of Ala-Ala-Lys-Pro residues. TcF4 does not 
possess multiple repeats of this motif although it does have more alanine (11.81 %), lysine 
(3.15 %) and proline (7.09 %) than are present in most ofthe other translated ORFs (Table 
5.3), and over a span of 48 amino acid residues in the middle of the protein these 3 residues 
represent 40% of the amino acid composition. 
On the reverse direction of the complementary strand three open reading frames have 
been identified, ORFg, ORFh, and ORFi. Unlike each of the other predicted open reading 
frames, ORFg has a relatively low mol% O+C (51%; Table 5.1). The protein encoded by 
ORFg, designated TcF5, consists of 356 amino acid residues and has a predicted molecular 
weight of 39,493 and pi 5.23. The deduced amino acid sequence of TcF5 contains the 
pentapeptide consensus sequence, G-H-S-L-0 (position 187-191), with the active serine 
residue and invariant glycines in positions 3, 1 and 5, respectively. This G-X-S-X-0 
sequence (where X is any amino acid) is the consensus sequence for the active sites of 
esterases, lipases, and serine proteases (Brenner, 1988). Proteins that lack the active site 
serine are devoid of catalytic function. Many of these enzymes are preproenzymes that 
possess a signal peptide at the N-terminus; the mature enzyme is produced following 
cleavage of theN-terminal peptide. However, overall the TcF5 protein is most similar to the 
extracellular phospholipases A 1 (P A 1) from Serratia liquefaciens (50% similarity and 15% 
identity) and Yersinia enterocolitica (43.4% similarity and 12% identity) and also the ABC 
transporter A TP-binding proteins from a number of bacterial species (Table 5, Appendix 
V). Hydropathy predictions suggest that TcF5 does not contain a typical signal peptide that 
is often observed in exported prokaryotic proteins. Moreover, TcF5 was found to contain a 
number of other amino acid signatures for phosphorylation, which although shorter in size 
than the region of similarity described above, may provide some clues about the possible 
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function of the protein. These include protein kinase C phosphorylation sites, STK, TAK, 
TGK and SNK at positions 64, 151, 23 7, and 288, respectively, in addition to casein kinase 
phosphorylation sites, TELD, SLDE, TSND, SLTD and TADD at positions 3, 25, 99, 169 
and 338, respectively. 
ORFh commences one hundred and twenty three nucleotides downstream from ORFg. 
ORFh encodes a protein, TcF6, predicted to be 16,856 molecular weight and pi 8.6. Amino 
acid sequence analysis ofTcF6 showed that it has some similarity to type Ill export proteins 
from a number of bacterial species, including PscD of P. aeruginosa (Table 6, Appendix 
V). Protein sequence alignment with PscD revealed 45.2% similarity with 19.2% identity 
over the 155 amino acid length ofTcF6. 
The predicted molecular weight of TcF7, encoded by ORFi, is 28,251. The first 22 
amino acids of theN-terminus bear all the features of a prokaryotic signal peptide (Fig 5.2). 
The amino terminus contained two positively charged arginine residues following Met-1 and 
a hydrophobic core of 12 residues followed by a helix-breaking residue (proline) within five 
residues preceding the proposed cleavage site, which is located between Ala-22 and Arg-23. 
Following the signal sequence another well-defined peptidase cleavage site was found 
between Ala-72 and Arg-73 (Fig 5.2). Analysis of the amino acid composition of TcF7 
revealed a striking and unusually high content of the positively charged hydrophilic amino 
acid arginine (25%) as well as the hydrophobic nonpolar amino acids, alanine (18%) and 
proline (8%). This was reflected in the high pi value (12.28). Searches of the protein and 
nucleotide sequence databases under stringent parameters failed to reveal any similarity to 
other known proteins. Less stringent searches (expectation value, 1 000) showed only that 
the protein has a limited homology to a range of hypothetical proteins. However, Using the 
Prosite program several candidates for protein kinase C phosphorylation sites were 
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identified, SRR, TRR, TRR, TRR, SAR, TDR, TTR and SGR at positions, 19, 30, 77, 97, 
112, 126, 157, and 177. 
5.3.3 SOUTHERN BLOT ANALYSIS 
5.3.3.1 Development and preparation of oligonucleotide probes 
Oligonucleotide probes covering the mrgRS locus and flanking regions were developed 
for PCR amplification by primers designed on the basis of the nucleotide sequence data. In 
addition to a probe specific for the 4.3 kb EcoRI fragment, RS7 (section 4.3 .2.2), three pairs 
of PCR primers (Table 5.4), were designed (section 3.13.1) and used in PCR reactions to 
amplify and label oligonucleotide probes that span the 3' downstream sequence. The probes 
were labelled with DIG-dUTP (section 3.1 0.2.2) and purified (section 3.1 0.2.3). The probes 
were designed as follows: FR1 (flanking region), spanning 1276 bp over an EcoRI site and 
across the mrgS stop, FR2 spanning 113 7 bp, and FR3 spanning 1781 bp of the 3' region of 
mrgRS (Fig 3, Appendix V). High stringency conditions, 68°C, were used for DNA 
hybridisation and washing steps. 
Table 5.4: PCR primer sequences for DNA probes FR1, FR2 and FR3. 
Forward primer (FRlF) ATGATGGACGGTTTCCAGTTGCTC 
Reverse primer (FR1 R) AACGTTAAATCAAGTCGCGGGTGG 
Forward primer (FR2F) AGAGCGCTGTCGCAACTGAATCTG 
Reverse primer (FR2R) TCGCTTCGCTTGCTGAGAAA 
Forward primer (FR3F) GGTCCGGGCCAAATATTACGATCC 
Reverse primer (FR3R) AGCGGAACCAATCCGAACTCACAG 
5.3.3.2 Detection of the mrgRS locus in different B. pseudo mallei strains 
To confirm the presence of mrgR and mrgS in different B. pseudomallei strains, 
approximately 0.5 ~g of genomic DNA isolated from a number of different B. pseudomallei 
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strains (section 3 .4.1.2) from a wide geographical distribution, as well as other closely 
related Burkholderia species; B. thailandensis, B. cepacia, B. vietnamiensis, B. plantarii, B. 
cocovenenans, B. vandii, Pseudomonas species; P. aeruginosa, P. fluorescens and E. coli 
DH5a (Table 5.5) were completely digested with EcoRl restriction endonucleases (section 
3.4.5.1). The resulting DNA fragments were separated by agarose gel electrophoresis 
(section 3.4.6.1) and transferred onto positively charged nylon membrane prior to DNA 
hybridisation as explained in section 3.10. EcoRl digested DNA from pMRG2 or pMRG4 
(sections 4.3.7 and 4.3.15, respectively) was included in the membrane as a positive control. 
The blot was probed with RS7 (- 10 ng mr1), the 4.3 kb EcoRl fragment labelled with DIG-
11-dUTP, under high stringency conditions for hybridisation and washing (section 3.1 0.3). 
The DNA-DNA hybridisation was detected with anti-digoxigenin phosphatase conjugated 
antiserum and visualised by enzyme-substrate colour reaction (section 3.1 0.4). The 
molecular size of DNA bands were calculated with reference to bacteriophage A. DNA 
digested with Hindlll and labelled with DIG-dUTP. Genomic DNA from all of the 19 
environmental and clinical isolates of B. pseudomallei, originating from different areas of 
the world, possessed a single 4.3 kb EcoRl fragment. On the other hand, the probe did not 
hybridise with the DNA of any of the other closely related bacteria, including B. 
thailandensis (Fig 5.8). 
5.3.3.3 Southern blot hybridisation analysis of the mrgRS flanking regions 
Three oligonucleotide probes (FRl , FR2 and FR3) covering approximately 3 kb of the 
B. pseudomallei genome downstream from mrgRS were used to investigate EcoRl digests of 
genomic DNA from different B. pseudomallei strains as well as B. thailandensis (Table 5.6, 
Fig 4, Appendix V). 
The FRl probe spans an EcoRl site, and on the basis of the sequencing data obtained in 
section 4.3.15, was expected to hybridise two EcoRl fragments of genomic DNA of 684 and 
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Table 5.5: Isolates of B. pseudomallei and other bacterial species that were used in Southern 
hybridisation with probe RS7. NE, Northeast; C, Central. 
Strain Source Sample Geographical origin Date 
B. pseudomallei 
204 Human Blood Thailand -
E8 Environment Soil NE Thailand 1990 
25 Environment Soil Madagascar 1977 
E25 Environment Soil Thailand -
19 Environment Soil Singapore 1991 
33 Environment Manure France 1976 
46 Human Blood NE Thailand 1988 
53 Human Urine NE Thailand 1987 
97 Environment Soil Australia -
98 Environment Soil Australia -
102 Environment Soil Australia -
11 2 Human Multiple NE Thailand 1992 
21 2 Environment Soil NE Thailand 1990 
216 Environment Soil NE Thailand 1990 
217 Environment Soil (wet) NE Thailand 1990 
392 Human Pus NE Thailand 1989 
426 Environment Soil Vietnam -
448 Environment Soil Vietnam -
576 Human Blood Thailand -
B. thailandensis 
E27 Environment Soil Thailand -
E82 Environment Soil NE Thailand 1990 
E255 Environment Soil NE Thailand -
E256 Environment Soil Thailand -
E260 Environment Soil C Thailand 1993 
E38 Environment Soil Thailand -
Closely related species 
B. cocovenenans LMG 11626 
B. plantarii LMG 1 0908 
B. vietnamiensis LMG 6998 
B. cepacia 
B. vandii 
P. aeruginosa 
P. jluorescens 
E. coli DH5 
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Fig 5.8: RS7 hybridisation analysis of the EcoRl-digested genonnc DNA from different B. pseudomallei, B. 
thailandensis (in bold) and closely related bacteria. The RS7 DIG-labelled probe contains the 4.3 kb EcoRl fragment, i.e. 
the flanking region upstream from the mrgRS locus, mrgR and 2342 bp of the total length of mrgS. M: DNA molecular 
markers. The full description of each isolate can be found in Table 5.5. 
Table 5.6: Isolates of B. pseudomallei and B. thailandensis that were used in Southern 
hybridisation analysis with probes FRl , FR2 and FR3. NE, Northeast. 
Strain Source Sample Geographical origin 
B. pseudomallei 
204 Human Blood Thailand 
E8 Environment Soil NE Thailand 
19 Environment Soil Singapore 
22 Environment Soil Burkina Faso 
97 Environment Soil Australia 
98 Environment Soil Australia 
112 Human Multiple NE Thailand 
216 Environment Soil NE Thailand 
392 Human Pus NE Thailand 
426 Environment Soil Vietnam 
448 Environment Soil Vietnam 
576 Human Blood Thailand 
H55 Human Blood China 
H706 Human Parotitis abcesses China 
HI Human Fossa abcesses China 
H2D Human Lymph node China 
abcesses 
B. thailandensis E82 Environment Soil NE Thailand 
B. thailandensis £ 255 Environment Soil NE Thailand 
B. thailandensis £ 256 Environment Soil Thailand 
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Date 
-
1990 
1991 
1973 
-
-
1992 
1990 
1989 
-
-
-
1996 
1996 
1996 
1996 
1990 
-
593 bases in length. The results demonstrated the presence of two bands of the expected 
sizes in most of the isolates of B. pseudomallei. However, two B. pseudomallei isolates, 392 
and H55, lacked the 684 bp fragment and H55 possessed an additional unique band of 
approximately 4.5 kb. No signal was obtained from B. pseudomallei 576 or any of the tested 
B. thailandensis isolates (Fig 5.9). 
The FR2 probe of 1137 bp without any internal EcoRI restriction sites demonstrated 
the presence of single bands in all of the B. pseudomallei isolates, except 576. The bands 
were about 1137 bp in size but in isolate H2D the band was smaller, 1000 bp. All B. 
thailandensis isolates were negative (Fig 5.10). 
On the other hand, the FR3 probe of 1781 bp that lacked an internal EcoRI site 
revealed two banding patterns. One pattern indicated the presence of single bands of 1 . 7 kb 
in seven isolates, as expected from the available sequence information, while the other 
pattern demonstrated two bands of 1421 and 360 bp in nine isolates (Fig 5.11 , Table 5.7). 
This suggests that some isolates of B. pseudomallei must possess an additional EcoRI site in 
the region of the genome spanned by FR3. To investigate this possibility two sets of PCR 
primers (Table 5.8) were used to amplify fragments of 611 bp and 1781 bp from one of the 
isolates thought to possess an additional EcoRI site in this region, B. pseudomallei 112, as 
well as isolate 204 from which the original sequence data had been obtained. The PCR 
products were purified (section 3.1 0.2.3) and the DNA was sequenced (section 3.8). 
Table 5.8: PCR primers for the amplification of a polymorphic region within the B. 
pseudomallei genome. 
Forward primer (FR3 F) GGTCCGGGCCAAATATTACGATCC 
Reverse primer (FR3R) AGCGGAACCAATCCGAACTCACAG 
Forward primer (FR4F) TGAATGCCAGGCGATAGTCCTTGT 
Reverse primer (FR4R) GCATCACTGCCATCATTCGAGCAA 
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Fig 5.9: FRl hybridisation analysis of the genomic DNA from different B. pseudomallei 
(in black) and B. thailandensis (in red) isolates. The FRl DIG-labelled probe spans the 
distal end of mrgS and 285 bp further downstream from the mrgS stop codon. M: DNA 
molecular marker. The full description of each isolate can be found in Table 5.6. 
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Fig 5.10: FR2 hybridisation analysis of EcoRI-digested genomic DNA from different B. 
pseudomallei (in black) and B. thailandensis (in red) isolates. The FR2 DIG-labelled probe 
spans 113 7 bp downstream from the mrgRS locus with no internal EcoRI restriction sites. 
M: DNA molecular size markers. The full description of each isolate can be found in Table 
5.6. 
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Fig 5.11: FR3 hybridisation analysis of the EcoRI-digested genomic DNA from different B. 
pseudomallei (in black) and B. thailandensis (in red) isolates. The FR3 DIG-labelled probe spans 
1781 bp downstream from the mrgRS locus. Probe hybridisation divided the examined B. 
pseudomallei isolates into two groups. M: DNA molecular size markers. The full description of 
each isolate can be found in Table 5.6. 
Table 5.7: FR3 hybridisation patterns of B. pseudomallei isolates with FR3 
Pattern I Source Site Geographical origin Date 
204 Human Blood Thailand -
E8 Environment Soil Thailand 1990 
22 Environment Soil Burkina Faso 1973 
426 Environment Soil Vietnam -
448 Environment Soil Vietnam -
H55 Human Abcesses China 1996 
H20 Human Abcesses China 1996 
Pattern ll 
19 Environment Soil Singapore 1991 
97 Environment Soil Australia -
98 Environment Soil Australia -
112 Human Multiple NE Thailand 1992 
216 Environment Soil NE Thailand 1990 
392 Human Pus NE Thailand 1989 
576 Human Blood Thailand -
H706 Human Abcesses China 1996 
Hl Human Abcesses China 1996 
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Nucleotide sequence alignment of the two sequences from B. pseudomallei isolate 204 
and isolate 112 revealed that the DNA was almost identical (98% identity). Base 
substitutions were detected in 19 positions over a span of 1472 nucleotides (Fig 5, Appendix 
V). One of these substitutions was found to cause a change in the nucleotide sequence from 
GAACTC to GAA IfC, the recognition sequence for the restriction enzyme EcoRI. ORFg 
includes 16 substitutions within its' full length of 1071 bp. At the amino acid level, 10 
substitutions were synonymous, indicating that the peptide sequences were invariable, while 
the other 6 substitutions resulted in changes to 6 amino acids in TcF5, which did not 
apparently alter the overall nature of the encoded protein (Table 5.9). 
5.4 DISCUSSION 
The sequence of the DNA region flanking the B. pseudomallei mrgRS locus was 
analysed and seven putative open reading frames were identified. The 1.319 kb DNA 
sequence upstream from the mrgRS locus contains a single open reading frame, while the 
4.753 kb DNA sequence downstream from the mrgRS transcriptional termination harboured 
six putative genes, three in each orientation. Apart from ORFg, all the identified ORFs 
possessed mol% G+C (59-72%) that are within the overall G+C content of B. pseudomallei 
genome, which ranges between 55.6 and 74.0% with an average of 65.7% (Songsivilai & 
Dharakul, 2000). ORFg has a remarkably low G+C content of 51%. The putative proteins 
encoded by ORFc to ORFi were designated TcFI -7 for two-component flanking proteins, 
- - -
respectively. 
The absence of a well-defined promoter region upstream from ORFc, suggests that it 
may be possible that ORFc may be transcribed as a polycistronic unit under the control of an 
upstream promoter. Consistent with this possibility, a strong promoter sequence with a 
predicted probability of 0.97 was identified in the 5' untranslated sequence of the upstream 
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Table 5.9: Nucleotide substitutions and amino acid changes in ORFg that encodes TcF5. Only the 
characters of amino acids that differ are shown. 
Nucleotides Amino acids Molwt Hydropathy Charge Chemical 
From To From To From To From To From To From To 
G A E E 
A G N s 132 105 Phi Phi 0 0 Amide Hydrox 
A T G G 
c T y y 
c T G G 
c T N N 
T c I I 
G A V I 117 131 Pho Pho 0 0 Aliph Aliph 
A G E G 143 75 Phi Phi - 0 Acidic Aliph 
c T F F 
c T A V 89 117 Pho Pho 0 0 Aliph Aliph 
c T I I 
c T A A 
G A D N 133 132 Phi Phi - 0 Acidic Amide 
c G Q E 146 147 Phi Phi 0 - Amide Acidic 
A G Q Q 
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ORF (ORFx). The presence of a stem-loop transcriptional termination sequence downstream 
from ORFc strongly suggests that transcription does not extend further downstream, into the 
mrgRS locus. Sequence comparison revealed that TcFl has some similarity to PssL, a 
polysaccharide export protein from R. leguminosarum. R. leguminosarum synthesises 
exopolysaccharide during the early stages of nodule invasion, to facilitate the process of root 
infection. 
To further elucidate a possible function for TcFl, sequence information from the B. 
pseudomallei isolate K96243 genome sequencing project database at the Sanger Centre, was 
used. The - 1.3 kb region upstream of the mrgRS locus in isolate 204, containing ORFc, was 
found to be present in the genome sequence of isolate K96243 and to share 99% nucleotide 
sequence identity with that sequence. This region of the B. pseudomallei genome is therefore 
present and nearly identical in isolates K96243 and 204. Furthermore, the nucleotide 
sequence upstream of OFRc in K96243 contained an open reading frame, ORFx, the 
deduced translation of which was found to be substantially similar to outer membrane 
proteins from a number of bacterial species. This was supported by the presence of two 
hydrophobic stretches that are strongly reminiscent of transmembrane regions. In bacteria, 
genes with related functions are often located together in an operon transcribed from a single 
promoter in a single polycistronic mRNA molecule. Hence TcF 1, a possible polysaccharide 
export protein, and TcFx, a potential outer membrane protein, may be cotranscribed under 
certain conditions and may perhaps share some functional relationship. 
The strong termination sequence following the mrgS gene suggests that the 
downstream sequences are transcribed separately. Computer-generated sequence alignments 
placed TcF2 as a member of a family of proteins that are encoded by genes that either lie 
within or are very closely linked to functional operons. Most of the members of this family 
are characterised by two highly conserved domains that are located in the C-terminal portion 
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of the proteins and which are separated by approximately 130 residues. The predicted TcF2 
protein contains two domains that are strongly conserved among a large number of predicted 
proteins from a variety of bacterial species. In addition, the spacing between the two 
domains and the distance between domain 11 and the carboxy-terminal ends of the predicted 
proteins are also conserved. This conservation may reflect the convergent evolution of 
successful structure-function motifs rather than the usual primary sequence similarity. The 
activity of one member of this family, BvgR, has been assigned recently. The bvgR gene, 
which encodes a 32-kDa repressor protein, resides immediately downstream from the well-
characterised bvg locus. The bvg locus encodes a two-component regulatory system 
consisting of a sensor protein, BvgS, and a transcriptional activator, BvgA. This locus is 
known to regulate the Bordetella virulence regulon (Scarlato et al., 1993). Inactivation of 
bvgAS results in the loss of virulence gene expression (Cotter & DiRita, 2000). It is known 
that BvgR binds to a conserved nucleotide sequence element found within the coding 
sequences of the bvg-repressed genes. The expression of bvgR is activated at the level of 
transcription by the products of bvgAS genes. This activation was proposed to result from 
the binding of phosphorylated BvgA to the bvgR promoter. Merkel et al. (1998) have shown 
that in Bordetella pertussis, the gene encoding BvgR resides on a separate regulatory unit 
from the unit containing the bvgA and bvgS two-component regulatory genes. The latter 
genes are transcribed as an operon that is under the control of a positively acting regulator. 
The close correlation between the genomic organisation in bvgAS-bvgR and mrgRS-ORFd 
together with the fact that both BvgAS and MrgRS are members of the two-component 
family allows the speculation that TcF2 may perform a similar function to that of BvgR, 
although absolute proof requires further experimentation. 
The second ORF downstream of mrgRS locus, ORFd, codes for a protein designated 
TcF3. Amino acid sequence analysis of TcF3 suggests that this protein may be related to 
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prokaryotic transcriptional regulators. The most closely related proteins include the positive 
regulator, FimZ from S. typhi (Boyd & Hartl, 1999) and E. coli with which TcF3 shares 
considerable similarity (73%) over a region spanning 60-amino acids in the C-terminal 
portion of the protein. The type 1 pili encoded by fim genes are present in both E. coli and 
Salmonella species (Boyd & Hart!, 1999). The jimZ gene is an essential component of the 
regulatory cascade involved in fimbria! production, and its expression varies according to 
environmental conditions. The ability of FimZ to bind to the promoter region of the S. 
typhimurium fimA gene has been demonstrated and a fimZ mutant was found to be 
nonfimbriate (Yeh et al., 1995). The C-terminal region of FimZ regulators contains 
sequence reminiscent of a helix-turn-helix DNA binding motif; in contrast, TcF3 exhibits 
only weak similarity to this structural motif. However, closer examination of the C-terminal 
region of TcF3 revealed the presence of several possible serine/threonine kinase 
phosphorylation sites (SRR, SMR, SKR, TDR), suggesting that the action of this protein 
could depend on phosphorylation. The apparent lack of a DNA binding motif that is a 
characteristic of transcriptional activators and the small size of the protein and lack of 
apparent transmembrane domains that characterise many phosphorylating sensors suggests a 
different role for TcF3. The TcF3 protein may interact with another protein in order to 
achieve DNA regulation or alternatively, it may act within a unique phosphorelay system. 
ORFe codes for a putative protein, designated TcF4. Protein sequence analysis showed 
that it belongs to a long list of hypothetical proteins, eukaryotic DNA binding proteins and 
AlgP regulatory protein of P. aeruginosa. Eubacteria maintain their DNA in a negatively 
supercoiled form by DNA topoisomerase and by architectural elements called histone-like 
proteins, e.g. HU, HNS, and IHF (Pettijohn, 1988; Owen-Hughes et al., 1992). These 
chromatin-associated proteins organise the bacterial chromosome and also exert regulatory 
influence on transcription, recombination, and DNA replication (Schmid, 1990). AlgP is a 
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histone-like protein that is involved in the regulation of alginate synthesis in Pseudomonads. 
Strains of P. aeruginosa isolated from the lung of cystic fibrosis patients frequently have a 
mucoid phenotype due to the synthesis of a slimy exopolysaccharide called alginate, the 
production of which is partially under the control of AlgP. Prokaryotic chromatin-associated 
proteins with homology to histone H 1 have so far only been identified in pathogenic 
bacteria, including P. aeruginosa and B. pertussis (Goyard, 1996). The AlgP protein 
contains multiple repeats of Ala-Ala-Lys-Pro, as do several other proteins that resemble 
histones. Studies utilising synthetic oligopeptides have shown that these repeats bind to 
DNA in vitro (Medvedkin et al. , 1995). Although none of these repeats are present in TcF4, 
the relatively high content of these residues in the protein may be the reason for this 
homology. 
ORFg codes for a member of the lipase family protein that possesses the lipase serine 
active site, GXSXG, which is conserved in all known lipases (Derewenda & Cambillau, 
1991 ). Many different bacterial species produce and secrete lipases into the extracellular 
medium, which hydrolyse esters of glycerol with preferably long-chain fatty acids. They act 
at the interface generated by a hydrophobic lipid substrate in a hydrophilic aqueous medium. 
The secretion pathway is known for Pseudomonad lipases, P. aeruginosa lipase uses a two-
step mechanism while P. jluorescens lipase uses a one-step mechanism. Additionally, some 
Pseudomonad lipases need specific chaperone-like proteins assisting their correct folding in 
the periplasm. The catalytic site of lipases is buried inside the protein and contains a serine-
protease-like catalytic triad consisting of the amino acids serine, histidine, and aspartate (or 
glutamate). The serine residue is located in a strictly conserved beta-epsilon serine-alpha 
motif. The active site is covered by a lid-like alpha-helical structure, which moves away 
upon contact of the lipase with its substrate, thereby exposing hydrophobic residues at the 
protein's surface and mediating the contact between protein and substrate (Jaeger et al. , 
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1994 ). Lipases of pathogenic bacteria are known to contribute to their pathogenicity, for 
example, the lipases of P. aeruginosa (Wohlfarth et al., 1992) and S. aureus are produced 
during infection and impair the function of different cell types involved in the human 
immune response, such as macrophages or platelets. The similarity of the TcF5 protein to 
phospholipase AI in both Serratia liquefaciens and Neisseria enterococci may be attributed 
to the lipase serine active site. The phospholipase A 1 of both of these species is known to be 
excreted to the outer environment, mainly by means of theN-terminal signal peptide, which 
upon membrane transfer, is cleaved by a specific signal peptidase, resulting in the liberation 
of the mature protein on the exterior of the membrane (Givskov et al. , 1988, Heijne & 
Abrahamsen, 1989). Inspection of the N-terminal sequence of TcF5 protein showed that it 
lacks the features usually associated with a signal peptide. However, the pathways for the 
secretion of extracellular enzymes in Gram-negative bacteria include at least two routes of 
transport for proteins. One depends on the induction of specific helper proteins to assist in 
the secretion of the enzyme, while the other is based on lysis through the enzymatic activity 
of the protein. For example, secretion of S. liquefaciens phospholipase AI in E. coli was 
partially dependent on the induction of a helper protein, PhlB . Furthermore, the secretion of 
metalloprotease from Serratia marcescens and Erwinia chrysanthemi has been demonstrated 
to be totally dependent on the presence of three other genes encoding protease secretion 
functions (Letoffe et al., 1991 ). Another example is the a-haemolysin found in haemolytic 
E. coli strains, for which secretion appears to be independent of the general protein secretion 
pathway. The secretion apparatus for this group of proteins consists of two inner-membrane 
proteins and one outer-membrane protein, which act in concert to direct the protein across 
both cell membranes, without accumulation in the periplasm (Lory 1992, Pugsley, 1993). 
Furthermore, exoenzyme S, an ADP-ribosyltransferase of P. aeruginosa, which also lacks 
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anN-terminal signal peptide is secreted without processing, by a type Ill secretion system 
(Y ahr et al. , 1996). 
The neighbouring open reading frame to ORFg, ORFh, lacks an obvious promoter and 
may be transcribed using the promoter located in the 5' untranslated region of ORFg. The 
A TG translational start is followed immediately by the base A (A TGA). It has been shown 
that this arrangement of bases causes the most efficient binding of tRNA, which would lead 
to enhanced initiation of translation (Taniguchi et al., 1978). In addition, shifting of the 
ribosome by one base at this codon would lead to the reading of TGA stop codon. This may 
be a mechanism by which the organism shuts off translation at the earliest possible 
opportunity should such a shift occur. 
ORFh codes for a protein, TcF6, with low homology to a type Ill export protein from 
P. aeruginosa, PscD. The low degree of homology between related proteins from different 
species is a common feature among components of type Ill secretion systems (Lee, 1997). 
Type Ill secretion systems consists of a secretion apparatus, made up of - 25 proteins, and an 
array of proteins may be released by this apparatus. Some of these released proteins are 
"effectors" which are delivered into the cytosol of the target cell, while others are 
"translocators" which help the effectors to cross the membrane of the eukaryotic cell 
(Bogdanove et al., 1996; Comelis & Gijsegem, 2000). All effectors that are delivered by 
type Ill secretion systems lack the classical N-terminal signal peptide sequence (Michiels et 
al., 1990). In pathogenic bacteria, type Ill secretion systems allow bacteria adhering to the 
external surface of a host cell to inject specialised proteins across the plasma membrane. 
Many Gram-negative pathogens use a type Ill secretion system to translocate protein toxins 
across the bacterial cell envelope, including P. aeruginosa, Bordetella bronchiseptica and B. 
pseudomallei (Hueck, 1998; Winstanley et al., 2000). The PscD protein is located in the 
inner membrane, where it mediates the transport of virulence factors through the bacterial 
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membrane of P. aeruginosa. The pscD gene is located in the psc locus of P. aeruginosa, 
which is homologous to the psc type Ill secretion system of Y ersiniae that, in turn, is 
responsible for controlling the secretion of Yop virulence determinants in vitro (Michiels & 
Comelis, 1991; Salmond & Reeves, 1993). 
Taken together, the presence of a gene encoding a possible type Ill secretion protein, 
TcF6, downstream from a gene encoding a secretory phospholipase A 1 homolog that lacks a 
classical N-terminal signal peptide, perhaps transcribed from the same promoter, may 
suggest a strategy for the secretion ofTcF5. 
The 23 amino acids constituting theN-terminal sequence of TcF7 strongly resemble a 
typical Gram-negative bacterial signal peptide sequence. The signal sequence, which 
distinguishes between exported and cytoplasmic proteins, is presumably required for 
secretion. The general feature of a signal peptide includes from one to three charged residues 
within the five amino acids and a core of at least nine hydrophobic residues that are believed 
to be sufficient to span a membrane, followed at the end by a helix-breaking residue 
(proline) within four to eight residues preceding the cleaving site, which very frequently is 
an alanine (Watson, 1984). The proposed signal sequence of TcF7 possesses all of these 
features. Interestingly, another peptidase cleavage site was identified 50 amino acids toward 
the C-terrninus after the first signal peptide cleavage site. N-terminal signal sequences are 
usually found in precursors of proteins destined for extracellular localisation, as well as in 
membrane and periplasmic proteins. The release of such proteins from Gram-negative 
bacteria proceeds via a two-stage process. First, the N-terminal signal sequence directs the 
protein into the major secretion pathway before the signal peptide is cleaved by the leader 
peptidase. In the second stage of the export process, the protein is released from the cell 
(Lory, 1992). A wide range of bacterial enzymes can be exported with the help of a signal 
peptide including proteases, lipases and toxins. The presence of the second cleavage site 
231 
suggests that the 50 amino acid peptide following the first cleavage site may represent a 
propeptide. Propeptides are essential for proper folding of the enzymes to which they are 
attached and thus are defmed as intramolecular chaperones (IMC) (Inouye, 1991; Shinde 
and Inouye, 1993). Propeptides are well represented in a growing family of proteases. 
Members of this family are generally synthesised as pre-proenzymes with an amino-terminal 
signal (pre) sequence, followed by a relatively long propeptide domain located between the 
signal and the mature enzyme sequence (Inouye, 1991 ). Pro teases assigned to this family 
include proteinases that are mechanistically unrelated (e.g. serine and aspartate proteases), 
and show no striking homology which suggests a convergent evolution of this folding 
mechanism (Mclver et al. , 1995). A well-established member of this family is the elastase of 
P. aeruginosa, which synthesised as a pre-proenzyme containing a classical signal sequence 
and an amino-terminal propeptide. The signal sequence is removed upon passage through 
the inner membrane into the periplasm, where the propeptide is then rapidly cleaved off by 
autoproteolysis (Mclver et al., 1993). The cleaved propeptide remains non-covalently 
associated with periplasmic elastase and appears to specifically inhibit its activity while cell 
bound, while the secretion of mature elastase requires a complex extracellular protein export 
apparatus (Bally et al., 1992). Similarly, the pre-proenzyme structure that exists in TcF7 
suggests that it may belongs to the IMC (protease) family. On the other hand, computerised 
searches of the GenBank and EMBL database using stringent matching criteria failed to 
identify other protein sequences with significant homology to the TcF7 protein. However, 
under less stringent conditions the protein has a limited similarity to a range of hypothetical 
proteins in both prokaryotes and eukaryotes. 
One striking observation is that the amino acid composition of TcF7 contains an 
unusually high content of arginine (25%), alanine (18%), and proline (8%). Eukaryotic 
proteins that have a high arginine content, such as protamine, are known to be capable of 
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folding DNA. Protamine and DNA can form a compact structure, protecting DNA from 
digestion by intracellular enzymes (Yh et al., 1999). Alternatively, the high proportion of 
arginine residues may be a result of the high frequency of the nucleotide G in the coding 
region of the gene, because all six arginine codons contain at least one G. 
Nineteen B. pseudomallei isolates from various sources and recovered over 30 years, in 
addition to other closely related species, were analysed for the presence of the mrgRS locus 
by Southern blot analysis. In selecting the isolates, an attempt was made to represent the 
wide geographical distribution of B. pseudomallei and covered human and environmental 
sources from five different countries. Southern hybridisation using the RS7 DNA probe 
showed that a single copy of the 4.3 kb EcoRl fragment was present in the genome of all of 
these isolates. The 4.3 kb EcoRl fragment contains the flanking sequence upstream from the 
mrgRS locus (1.3 kb), mrgR and 2,342 bp of the total length of mrgS (3 ,237 bp). Moreover, 
the hybridization results demonstrated the high specificity of the cloned 4.3 kb insert in 
pMRG2 as a probe. It did not cross-hybridise with genomic DNA from closely related 
bacteria, such as B. thailandensis and B. cepacia nor did it hybridise with the DNA from the 
other Gram-negative bacteria that were tested, including P. aeruginosa and E. coli . 
Hybridisation analysis of the region downstream from the mrgRS locus was performed 
using the FRl DNA probe. This probe spans the distal end of mrgS and 285 nucleotides 
further downstream from the mrgS stop codon. The results of hybridisation analysis revealed 
that most of the B. pseudomallei isolates that were examined were the same in this region 
although two isolates, 392 and H55, lacked the 684 bp band (the fragment encoding 228 
amino acids of the C-terminal end of mrgS), while one isolate, 576, lacks both bands. In 
addition, H55 has a 4.5 kb band. The result suggests that in these strains this region is 
subject to some variability and may be wholly or partly absent. Furthermore, hybridisation 
analysis using the FR3 DNA probe also indicated that the flanking region downstream from 
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the mrgRS locus is a region of genetic variation. Many studies have demonstrated 
considerable variation in the genetic structure of bacterial species although the reasons for 
this variation are sometimes unclear. This is also true for B. pseudomallei where many 
studies have demonstrated that substantial variation exists across the genome using a wide 
variety of methods (reviewed in section 2.2.14). However, few studies have been carried out 
to assess the extent of variation at specific loci in B. pseudomallei. Haase et al. (1995) 
speculated that the large number of organisms in tropical countries in which melioidosis is 
endemic and the frequent interactions that may be possible in that environment and within 
the human host creates opportunities for genetic change. However, a mutation that confers a 
selective advantage in one environment is unlikely to be a benefit in all environments 
(Cohan, 1994 ). Winstanley et al. (1998) assessed the extent of variation in the flag ell in 
genes of B. pseudomallei by comparing the sequences that were obtained from 
environmental and clinical isolates of the pathogen. The sequences showed either 100% 
identity or differed by a single nucleotide demonstrating a remarkably conservative nature in 
these genes. In this study, a comparison of the sequences that were obtained from two 
isolates, one clinical and one environmental, in a small region of the B. pseudomallei 
genome downstream from the mrgRS locus revealed the presence of no less than 19 
nucleotide substitutions. One of these substitutions resulted in a change in the sequence 
GAA~TC to GAA!TC, the recognition sequence for the restriction enzyme EcoRI. The 
consequent restriction fragment length polymorphism (RFLP) was shown to separate the B. 
pseudomallei isolates into two distinct groups of almost equal proportions (44% and 56%). 
Each group contains isolates from clinical and environmental sources and from different 
geographic origins. There was no apparent association between the source of the isolates, the 
date and place of isolation, and the RFLP pattern. Nevertheless, the substitutions represent a 
stable genetic modification since they have been retained over time. While it is possible that 
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these sequence differences were due to point mutations randomly arising in a bacterial 
population the almost equal distribution of the polymorphism among the isolates suggests 
that it is much more likely that some process of selection may have occurred. For example, 
differences in primary or secondary host factors may play a role in the selection for a 
mutation arising within a bacterial population. 
Alignment of the sequences encoding TcF5, which were obtained from isolates 204 and 
112 and contained 16 variable nucleotides, predicted the occurrence of 6 amino acid 
substitutions. These changes surround the lipase active site ofTcF5. Interestingly, there was 
neither a change in the hydropathic character of the substituted residues nor a remarkable 
difference in the overall molecular weight of the protein. Substitutions occurring outside the 
active site of a protein have been suggested as a means by which adaptive changes arise in 
protein structure. Among five proteins studied in bacteria, polymorphic amino acids tended 
to occur on the exposed surfaces of a protein, their side chain accessible to solvents 
(Bustamante et al., 2000). In E. coli IDH, switching cosubstrate from NAD+ to NADP+ 
involves changing five amino acids around the cosubstrate binding site. In mammalian 
examples, the major pancreatic enzymes; trypsin, chemotrypsin, and elastase, are kinetically 
very similar, catalysing the hydrolysis of peptides and synthetic ester substrates. The 
polypeptide backbones of all three are essentially the same. The difference in their 
specificities lies mainly in a pocket that binds the amino acid side chain (Perona & Craik, 
1997). In trypsin, the residue at the bottom of the pocket is an aspartate instead of the serine 
of chymotrypsin, while in elastase, the two glycines at the mouth of the pocket in 
chemotrypsin are replaced by a bulky valine and threonine. Although the amino acid 
substitutions were not in the active site (GXSXG) of TcF5, it may nevertheless have some 
effect on its functional specificity. Studies utilising anti-catalytic antibodies have shown that 
amino acids replacements that are distant from the active sites of enzymes can dramatically 
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alter the activity of a molecule (Wedemayer et al., 1997). Furthermore, substitutions outside 
the active site may alter the flexibility of the active site by increasing the conformational 
entropy of the enzyme. B. pseudomallei is able to adapt to and survive in two broadly 
distinct habitats, the internal environment of the host and the environment external to the 
host. In addition, it is possible that B. pseudomallei can survive in soil and water by 
parasitising other organisms including amoebae, fungi or plant (Inglis et al., 2000; Pitt et al., 
2000). The observed genetic variation in ORFg among the B. pseudomallei isolates that 
were used in this study may represent an adaptation of the bacterium to two different 
survival strategies, such as secondary hosts. 
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CHAPTER6 
THE CONSTRUCTION AND EXPRESSION OF MrgR AND MrgS 
FUSION PROTEINS AND THEIR RECOGNITION BY POLYCLONAL 
ANTIBODIES 
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6.1 INTRODUCTION 
Following the cloning and characterisation of the mrgRS locus and its flanking regions, 
it was desirable to verify gene expression, in vitro. Gene expression can be studied by a 
number of methods, either at the m.RNA level or at the protein level. Investigation at the 
protein level can provide useful information about protein structure and function. Therefore, 
as a step toward understanding and verifying the expression of the MrgR and MrgS proteins 
in B. pseudomallei, polyclonal antibodies were raised against each of the two proteins. 
Specific antibodies are frequently the key to the characterisation of protein structure, 
function and distribution. They provide tools for the identification of the protein in ELlS A, 
irnrnunoblots and immunohistology, permit efficient purification by affinity chromatography 
and allow functional characterisation by blocking binding or active sites in the molecule. 
The production of specific antibodies usually requires the purification of the native protein 
from cells, tissues or fluids. This strategy is not possible for all proteins for reasons that 
include the scarcity of starting material, lack of a functional assay and the low yields of the 
pure protein obtained (Spiller et al., 1999). With the advent of molecular biology, it became 
possible to obtain a large amount of information about a protein without ever having 
purified it. Antibodies may be generated against peptides derived from the predicted 
sequence and although this approach may be problematic, short peptides are expected to 
yield linear epitopes, the antibodies can be useful for the detection of denatured protein by 
irnrnunoblotting (Atassi, 1986; Getzoff et al. , 1988). On the other hand, purification of a 
recombinant protein requires the efficient expression of the foreign gene in E. coli and is 
dependent on the presence of the appropriate signals that can be recognised by the 
bacterium, which provide instructions for the transcriptional and translational apparatus of 
the cell. These signals include a promoter, a terminator and a ribosome-binding site. 
The objective of this study was to produce polyclonal antibodies that would be useful 
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for the further characterisation of the MrgR and MrgS two-component regulatory proteins, 
and to evaluate the use of these antibodies for the detection of the expressed proteins. 
6.2 MATERIALS AND METHODS 
6.2.1 Construction and expression of recombinant fusion proteins in E. coli K-12 
6.2.1.1 pMAL-C2 expression vector 
The pMAL-C2 plasmid vector (Fig 6.1) provides a means for expressing and purifying a 
protein produced from a cloned gene or open reading frame using E. coli as host. The cloned 
gene is inserted downstream from the malE gene of E. coli K-12, which encodes maltose-
binding protein (MBP) resulting in the expression of an MBP fusion protein (Guan et al., 
1987). The method uses the strong "tac" promoter to sustain a high rate of transcription, and 
hence expression of the cloned sequence. The vector expresses the malE gene fused to the 
lacZa gene. Insertion of a foreign gene into the multiple cloning site inactivates the P-
galactosidase a-fragment activity and allows for blue/white screening (section 3.5.5). In 
addition, the vector carries the lacl gene, which codes for the Lac repressor. This keeps 
expression from P1ac low in the absence of IPTG induction. Furthermore, the multiple 
cloning site allows the insertion of a cloned gene in the correct orientation by using 
directional cloning thereby ensuring the expression of the gene. 
6.2.1.2 Construction of mrgR and mrgS gene fusions 
The procedure was performed according to the instructions provided by the 
manufacturer of the pMAL-C2 fusion vector (New England Biolabs), and to the general 
methods for restriction enzyme digestion (section 3.4.5), cloning into plasmid vectors 
(sections 3.5 & 3.6), restriction mapping (section 3.7), DNA purification (section 3.4.4) and 
DNA sequencing (section 3.8). 
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Fig 6.1: Schematic presentation of the pMAL-C2 cloning vector (New England Biolabs). 
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6.2.1.3 Expression and identification of recombinant fusion proteins 
Following the isolation of E. coli DH5a clones in pure culture, 10 ml LB broths 
(Appendix Ill) supplemented with ampicillin (100 J.lg/ml) and 0.2% glucose were inoculated 
and incubated at 37°C with shaking (275 rpm) to A600 ~ 0.5, usually for 3-4 h. A 1 ml 
sample of the uninduced culture was removed, centrifuged (1 0,000 x g, 2 min, RT) and the 
cell pellet was resuspended in 50 J.ll of SDS-PAGE sample buffer (Appendix Ill). To induce 
the expression of fusion proteins produced by the clones, IPTG, 0.3 mM final concentration, 
was added to the remaining cultures and incubation was continued for a further 2 h. For each 
culture, a 0.5 ml volume was removed, centrifuged (10,000 x g, 2 min, RT) and the cell 
pellet was resuspended in 100 J.ll of SDS-PAGE sample buffer. The samples were then 
analysed by SDS-PAGE (sections 3.14.5 & 6.2.1.5). 
To determine the behaviour of each MBP fusion protein, a small-scale pilot experiment 
was performed. Cultures were grown overnight at 37°C (200 strokes/min) in 10 ml of LB 
broth supplemented with ampicillin ( 100 J.lg/ml) and 0.2% glucose. To 80 ml of pre-warmed 
LB broth containing ampicillin (1 00 J.lg/ml) and 0.2% glucose, a 0.8 rnl volume of the 
overnight culture was added, and incubation was continued at 37°C until an OD of A6oo -
0.5 was reached. A 1 ml sample of the uninduced culture was removed, centrifuged (10,000 
x g, 2 min, RT) and the cell pellet was resuspended in 50 J.ll of SDS-PAGE sample buffer, 
and placed on ice. To the remaining culture, IPTG was added to a fmal concentration of 0.3 
mM and the incubation was continued for 2 h. A 0.5 ml sample was removed, centrifuged 
(10,000 x g, 2 min, RT) and the cell pellet was resuspended in 100 J.ll ofSDS-PAGE sample 
buffer and placed on ice. Following the induction period, 40 ml of the culture was harvested 
by centrifugation (2,500 x g, 10 min, RT), and the cell pellet was resuspended in 5 ml of 
column buffer (Appendix Ill). Samples were frozen overnight at -20°C, thawed in an ice-
water bath and sonicated on ice in short pulses of 3 s for 3 min (W-385 Ultrasonic 
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Processor, Heat Systems Ultrasonics). The samples were centrifuged (9,000 x g, 20 min, 
4°C) and the supernatant (crude extract) was removed and retained on ice, while the pellet 
was resuspended in 5 ml of column buffer (insoluble matter). A 50 J.!l volume of amylose 
resin was washed twice with 1.5 ml volumes of column buffer and then mixed with 50 J.!l of 
the crude extract. The mixture was incubated on ice for 15 min, then centrifuged (9,000 x g, 
1 min, RT) and the cell pellet was washed with 1 mJ of column buffer. After centrifugation 
(9 ,000 x g, 1 min, RT), the pellet was resuspended in 50 J.!l of SDS-P AGE buffer. All of the 
samples were analysed by SDS-PAGE (sections 3.14.5 & 6.2.1.5). 
6.2.1.4 SDS-P AGE analysis 
SDS-PAGE gel electrophoresis was performed as stated in section 3.14.5. The 
resolving gel consisted of I0-12% T (Total acrylamide concentration) and a stacking gel of 
5% T. The samples of uninduced cells, induced cells, crude extracts, insoluble material and 
resin purified protein, which had been mixed with SOS-PAGE sample buffer, were boiled 
for 5 min. Samples were separated on SDS-PAGE gels that included protein molecular 
weight standards and purified maltose-binding protein (New England Biolabs). Following 
electrophoresis, the gels were either stained for protein with Coomassie brilliant blue 
(section 3.14.4) or electro-blotted onto nitrocellulose and probed with the appropriate 
antiserum (section 3.14.5 & 6.3.4). 
6.2.2 Development of polyclonal antibodies 
6.2.2.1 Designing synthetic peptides 
A number of factors should be considered when designing synthetic peptide antigens 
for the development of an antibody in order to improve the chances of a favourable 
outcome. Ideally, a synthetic peptide should be approximately 6 to 20 amino acid residues in 
length, with a high hydrophilicity value, and minimal homology with any other known 
protein sequences. Another useful consideration when selecting peptide sequences is the 
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presence of the candidate peptide in the C- or N-terminal end of the protein, to increase the 
probability of surface orientation (Hopp & Woods, 1986; Doolittle, 1986). To determine the 
degree of homology of the selected peptides to known protein sequences, the BLAST server 
at NCBI and Blitz was used to search the nr database (All non-redundant GenBank CDS 
translations + PDB + SwissProt + PIR + PRF). Several different methods for performing the 
search were used. Both the old (Ungapped) BLAST program and the BLAST2 (Gapped 
BLAST) program were used and the Expect parameter (E) was increased from the default of 
10 to a value of at least 1000. This allows a wider search for less conserved sequence 
homology with low statistical significance. Following this selection process, the peptides 
were synthesised by Bethyl Laboratories Inc. (Montgomery, USA) and the purity of the 
peptides (>90%) was determined by HPLC and verified by mass spectroscopy. 
6.2.2.2 Production of polyclonal antibodies 
Following synthesis and purification of the peptides rabbit polyclonal antibodies were 
raised using the synthetic peptides as immunogens, at Bethyl Laboratories Inc. 
(Montgomery, USA). Typically, 2-3 mg of each peptide was conjugated to keyhole limpet 
hemacyanin (KLH), using maleimide chemistry, linking sulfhydryl-containing residues of 
the peptide to the carrier. The conjugated peptide was mixed with Freund' s complete 
adjuvant (FCA) and injected subcutaneously at multiple sites into 2 New Zealand white 
rabbits. A "two-week" immunisation protocol was followed, with bleeds performed in 
alternate weeks (Table 6.1). 
Following immunisation, the hyperimmune serum was harvested from rabbits 
immunised with peptide-KLH and the peptide-specific antibodies were purified by affinity-
chromatography using a peptide-Sepharose coupled matrix. Finally the affinity-purified 
antibodies were filter sterilised and supplied at a concentration of about 1 mg/ml. 
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Table 6.1: Immunisation protocol for raising anti-peptide antibodies in rabbits 
DayO Pre-bleed, Antigen injection 
Day 14 Antigen injection 
Day 28 Antigen injection 
Day 35 Bleed 
Day42 Antigen injection 
Day49 Bleed 
Day 56 Antigen injection 
Day 63 Bleed 
6.2.2.3 Western blot analysis 
Samples separated by SDS-PAGE were transferred electrophoretically to nitrocellulose 
membrane by using the Bio-Rad Trans-Blot apparatus as described previously (section 
3 .14.5). Blots were washed (3 x 5 min in PBS), then placed in 1% casein blocking solution 
(Appendix Ill) at RT for 2 h. Primary and secondary antibodies were diluted in the blocking 
solutions to reduce non-specific binding. The blots were incubated overnight at 4°C in 
primary antibody, washed (3 x 5 min in 1% casein), and then incubated in secondary 
antibody conjugated to horseradish peroxidase (Dako NS, Glostrup, Denmark) for 2 h at 
RT. A list of the primary and secondary antibodies and the concentrations that were used is 
illustrated in Table 6.2. Following antibody incubation, the blots were washed 3 x 10 min in 
PBS, and antibody binding was visualised (section 3.14.5). 
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Table 6.2: Different primary and secondary antibodies and the working dilutions that were 
used in this study. 
Primary Antibody Dilution Secondary Antibody Dilution 
Anti-MrgR 1:500 Swine Anti-rabbit IgG 1:2000 
peroxidase 
Anti-MrgS 1:300 Swine Anti-rabbit IgG 1:1000 
peroxidase 
Anti-MBP I :1000 Swine Anti-rabbit lgG 1:2000 
peroxidase 
Convalescent melioidosis 1:300 Rabbit Anti-human lgG 1:1000 
patient serum peroxidase 
6.2.3 Specificity of antibodies 
For testing the specificity of the antibodies and to determine non-specific binding, 
rabbit polyclonal anti-peptide antisera were preabsorbed either with the specific peptide 
immunogen or with an irrelevant peptide. Peptides, supplied as lyophilised powder, were 
reconstituted with distilled water, in the case of MrgR, or 1% NH3, for MrgS to a stock 
concentration of 2 mg/ml. The preabsorption was performed by incubating I ml (I mg/ml) 
rabbit serum with 50 J.tl of the peptide immunogen (2 mg/ml) for 60 min at 37°C, and then 
overnight at 4°C with agitation. The preabsorbed antibody was then centrifuged (10,000 x g, 
10 rnin, RT) and stored at -20°C until use. Blots performed with preabsorbed antibody were 
developed as explained above (6.2.2.3). 
6.2.4 Detection of MrgR and MrgS proteins in celllysates and extracellular products of 
B. pseudomallei 
Western blotting of cellular and extracellular components from B. pseudomallei 
cultures was used to identify MrgR and MrgS. The whole cell proteins from 24 isolates of B. 
pseudomallei were prepared from broth cultures and separated by SDS-PAGE (Fig 1, 
Appendix VI). Whole cell lysates from 6 isolates of B. pseudomallei, representing both 
clinical (112, 204, 576) and environmental sources (E8, 98, 216) (Table 3.1), were chosen 
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for further analysis, subjected to electrophoresis (section 3.14.3) and transferred to 
nitrocellulose membrane (section 3.14.5). In order to obtain celllysates, cultures were grown 
statically within a Containment Level 3 Laboratory (section 3.2.2) in LB media (Appendix 
Ill) for 48-72 h, centrifuged ( 4,000 X g, I5 min, 4 °C), and washed in PBS. The cell pellet 
was lysed in a solution containing I 0% SDS, 0.5 M Tris-HCl (pH 6.8), mercaptoethanol and 
glycerol (Appendix Ill), which is typical of SDS sample buffer but lacking bromophenol 
blue. To confirm sterility, viability tests were performed before samples were released from 
the CL3 (section 3.2.3). Approximately 5 j.lg of crude lysate, measured by the microassay 
procedure (section 3.14.2), was boiled for 5 min, separated by SDS-PAGE on IO or I2% 
gels (section 3.14.3) and processed for Western blot analysis as explained earlier (sections 
3.14.5 & 6.2.2.3). For the recovery of extracellular products (ECPs) from culture 
supematants, I 0 rnl volumes of B. pseudomallei broth cultures were grown as above and 
centrifuged (5,000 x g, 20 rnin, 4°C). The resulting supematant was aliquoted into sterile 1.5 
m! microfuge tubes and centrifuged again (15,000 x g, 10 min, 4°C). Following this step, the 
supematant was carefully removed and concentrated by a factor of 250 using Amicon 
Minicon Mini plus units, 10,000 nominal mw cutoff (Millipore Ltd, Watford, UK). The 
protein concentration of the ECPs was determined by the microassay procedure (section 
3.14.2). A 2 j.lg protein sample of the ECPs from 6 isolates of B. pseudomallei were boiled 
for 5 min, separated by SDS-PAGE and transferred to nitrocellulose membrane as described 
(sections 3.14.3, 3.14.5 & 6.2.2.3). 
6.3 RESULTS 
6.3.1 Construction of gene fusions 
6.3.1.1 Construction of malE-mrgR fusion 
From the restriction map available for pMRG2 (section 4.3.1 0), suitable restriction 
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sites for the construction of an in-frame gene fusion were identified. A translational fusion 
of malE and mrgR was constructed in the pMAL-C2 expression vector (Fig 6.2). Plasmid 
pMRG2 was digested with Pstl and Nsil (section 3.4.5.2), releasing a DNA fragment length 
of 701 bp, consisting of 472 bp of mrgR gene and 229 bp from the 3' downstream region. 
The fragment was separated and purified by agarose gel electrophoresis (sections 3.4.6.1 & 
3.4.6.2), and ligated (section 3.5.3) to pMAL-C2, which had been previously digested with 
Pstl, dephosphorylated and purified. The stop codon for this construction is provided by the 
mrgR stop codon. E. coli XLI-Blue was used as the host for transformation with the 
recombinant plasmid DNA (section 3.5.4). Clones were selected on LB agar containing 
ampicillin (1 00 ~g/ml) and small-scale plasmid DNA preparations were made (section 
3.4.2.3), and cleaved with EcoRI and Mlul, in single digests, and EcoRI-Pstl, in double 
digest, to confirm the correct orientation of the inserted DNA (Fig 6.3). The fidelity of each 
gene fusion was confmned by DNA sequencing (section 3.8). One clone, designated 
pMFUl , was selected for further analysis. A complete restriction map of pMFU1 is shown 
in Fig 6.4. 
6.3.1.2 Construction of ma/E-mrgS fusion 
For cloning purposes, the N-terminal region of mrgS was amplified by PCR, using 
pMRG2 as a template. A translational fusion of malE with this mrgS fragment was 
constructed in the pMAL-C2 expression vector (Fig 6.5). Two oligonucleotide primers 
(Table 6.3) were designed (section 3.13 .1) to amplify a 749 bp fragment that consists of 48 
nucleotides upstream from the mrgS start cod on and a further 70 1 nucleotides downstream 
from the mrgS start codon. The 5' end of the forward primer included a 9 nucleotide 
addition containing an EcoRI endonuclease cleavage site plus 4 extra bases to allow efficient 
cleavage of the amplified product. This exogenous sequence was incorporated into the PCR 
product and facilitated subsequent cloning steps. The reverse primer contained a sequence 
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(a) The pMAL-C2 was digested with Pstl restriction enzyme. 
Pstl ~ 
AGO A IT TCA GAA TIC GGA TCC TCT AGA GTC GAC CTG CAG GCA AGC ITG 
5' malE - - /acZa. 
TCC T AA AGT CIT AAG CCT AGG AGA TCT CAG CTG GAC GTC CGT TCG AAC 
RI SE F G SS RV DtQ AS L 
(b) The mrgR gene was digested with Nsil that cuts 192 bp downstream from the mrgR start 
codon and Pstl that cuts 228 bp downstream from the mrgR stop codon. 
Nsil ~ Pstl~ 
TIC ACG ATG CAT CAG GCG AAC----TGA---- ACG TGT TCC TGC AGC GCC GCA 
5' 
AAG TGC TAC GTA GTC CGC ITG-----ACT---- TGC ACA AGG ACG TCG CGG CGT 
F T t H Q A N --- STOP T C S t C S A A 
(c) On ligation, a translational fusion is produced 
AGA GTC GAC CTG CAT CAG GCG AAC---TGA---ACG TGT TCC TGC AGG CAA GCT 
5' 
TCT CAG CTG GAC GAT GTC CGC ITG ---ACT---TGC ACA AGG ACG TCC GIT CGA 
R V D L H Q A N --- STOP 
Fig 6.2 : Cloning strategy for the translational fusion of mrgR and malE in pMAL-C2 
expression vector. 
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Fig 6.3: Agarose gel electrophoresis of restriction enzyme digests of pMFU1. The sizes of 
fragments were estimated by comparison with 1 kb (Lane 1 & 5) and 100 bp (Lane 6) DNA 
ladders. 
No. of No of cleavage Approx. size ofDNA Total 
Track Enzyme (s) DNA sites on fragments (kb) size (kb) 
fragments vector insert 
2 EcoRI 1 1 0 7.347 7.347 
3 EcoRI &Pstl 2 1 1 0.729, 6618 7.347 
4 Mlul 2 1 1 2.574, 4.773 7.347 
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2264 
282 
Mlul 
701 
pMFUl 419 
4354 
7,347 bp 
Pstl 
ampR 
Fig 6.4: Physical map of pMFUl deduced from restriction enzyme digests. The 
pMAL-C2 vector DNA is represented by the yellow area, while the mrgR insert is in 
blue. The ampR gene encodes ampicillin resistance, while numbers represent the 
number of base pairs between adjacent restriction sites. 
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5' 
(a) The pMAL-C2 expression vector was digested with EcoRI and Bamlll 
+ EcoRI 
AGG ATT TCA GAA TTC GGA TCC TCT AGA GTC GAC CTG CAG GCA AGC TTG 
5' malE - - /acZo. 
TCC TAA AGT CTT AAG CCT AGG AGA TCT CAG CTG GAC GTC CGT TCG AAC 
R I S E Ft G S R V D L Q A S L 
BamHI 
(b) The proximal portion of the mrgS gene was amplified by PCR using a forward primer 
containing an EcoRI site and a reverse primer containing a BstYI site. The amplicon was 
digested with both enzymes. 
+ BstYI 
TCG GAA TTC CAC CAA----ATG----TTG ACG AGC GTG GAT CTT CAC AGC 
5' 3' 
AGC CTT AAG GTG GTT----TAC----AAC TGC TCG CAC CTA GAA GTG TCG 
E F t H Q ---- M --- L T S V D t H S 
(c) On ligation, a translational fusion is produced 
AGG ATT TCA GAA TTC CAC CAA----ATG----TTG ACG AGC GTG GAT CCT CTA TGA 
TCC TAA AGT CTT AAG GTG GTT----TAC----AAC TGC TCG CAC CTA GGA GAT ACT 
E F H Q ---- M --- L T S V D P L Stop 
Fig 6.5: Cloning strategy for the translational fusion of the proximal part of mrgS and malE 
in pMAL-C2 expression vector. 
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3' 
that can be cleaved with the restriction enzyme BstYI, thereby producing a cohesive end 
(R/GA TCY) that is compatible with BamHI cleaved DNA (G/GATCC). The amplified DNA 
fragment was purified (section 3.4.4.3), digested with EcoRI and BstYl (section 3.4.5.2), re-
purified (section 3.4.4.3) and then ligated (section 3.5.3) into EcoRI/BamHI-digested and 
dephosphorylated pMAL-C2. The stop codon for this construct is provided by the vector, 30 
nucleotides downstream from the mrgS insert. After transformation (section 3.5.4.1) into E. 
coli XLI-Blue, white colonies (recombinant clones) were recovered on LB agar plates 
(Appendix Ill) containing 100 j.!g/ml ampicillin. Plasmid DNA was extracted from selected 
colonies (section 3.4.2.3) and the presence of the correct insert was verified by restriction 
analysis with EcoRI, Pstl and EcoRV in single digests and EcoRI-Hindiii in double digests 
(section 3.4.5.2) (Fig 6.6) and by DNA sequencing (section 3.8). One clone, containing 
plasmid DNA designated pMFU2, which contains the correctly oriented DNA insert, was 
selected for further analysis. A complete restriction map of pMFU2 is shown in Fig 6. 7. 
Table 6.3: PCR primers used for the amplification of a fragment encoding theN-terminus of 
mrgS. 
Forward primer (FusF) CTCGGAATTCCACCAACGTCGATCTCATCAACTG 
Reverse primer (FusR) GTGAAGATCCACGCTCGTCAAGACGAGCGCGTAG 
6.3.2 Expression of fusion proteins 
6.3.2.1 Expression of MBP-MrgR fusion protein 
Following the construction of pMFU1 , containing the translational fusion of mrgR to 
malE, the fusion protein was expressed in E. coli XL 1-Blue. The Pstl-Nsii truncated mrgR 
gene would encode a product consisting of 165 amino acids and 16,817 molecular weight. 
When fused to the C-terminal end of maltose-binding protein, which has a molecular mass 
of 42,700 daltons, a product of molecular weight 59,517 was expected. The expression of 
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Fig 6.6: Agarose gel electrophoresis of restriction enzyme digests of pMFU2. The sizes of 
fragments were estimated by comparison with 1 kb (Lane 1 & 6) and 100 bp (Lane 7) DNA 
ladders. 
No. of No of cleavage Approx. size of Total 
Track Enzyme (s) DNA Sites on DNA fragments size (kb) 
fragments vector insert (kb) 
2 EcoRI 1 1 0 7.395 7.395 
3 EcoRI & Hindiii 2 1 1 6620, 775 7.395 
4 Psti 2 1 1 6908, 487 7.395 
5 EcoRV 2 1 1 5067, 2328 7.395 
253 
4806 
1814 
pMFU2 
7,395 bp 
EcoRI 
284 
Pstl 
EcoRV 
BamHI 
Pstl 
Hindiii 
4 
230 
235 
22 
Fig 6.7: Physical map of pMFU2 deduced from restriction enzyme digests. The 
pMAL-C2 vector DNA is represented by the yellow area, while the mrgS insert is in 
blue. The ampR gene encodes ampicillin resistance, while numbers represent the 
number of base pairs between adjacent restriction sites. 
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MBP-MrgR was identified as a major protein band (molecular mass - 60 kDa) when cell 
extracts of bacteria containing pMFU I that had been induced with IPTG, were separated on 
SDS-PAGE gels and stained with Coomassie brilliant blue (Fig 6.8). Hence, the size of the 
inducible band corresponds to the predicted size of the fusion. The small-scale pilot 
experiment revealed that the MBP-MrgR fusion protein was expressed at a high level, 
mainly in the soluble form. 
6.3.2.2 Expression of MBP-MrgS fusion protein 
The translational fusion of mrgS with malE was constructed in pMFU2 and expressed 
in E. coli XL !-Blue. The 749 bp EcoRI-BstYl amplicon encoding the N-terminus of MrgS 
would yield a protein consisting of 249 amino acids of molecular weight 25,378. An 
additional 30 bp of vector DNA, encoding I 0 amino acids of molecular weight I, II 0, is 
included before the translational stop. When fused to the C-terminal end of maltose binding 
protein (molecular mass of 42,700 daltons) a product of molecular weight 69,188 was 
expected. The expression of MBP-MrgS was identified as a faint but discernible protein 
band (molecular mass - 70 kDa) when bacteria containing pMFU2, which had been induced 
with IPTG, were loaded onto SDS-P AGE gels and stained with Coomassie brilliant blue 
(Fig 6.9). Hence, the size of the inducible band corresponds to the predicted size of the 
fusion. The small-scale pilot experiment revealed that the MBP-MrgS fusion protein was 
expressed mainly in an insoluble form. 
6.3.3 Development of polyclonal antibodies 
6.3.3.1 Design and production of an anti-peptide antibody for the detection of MrgR 
A synthetic peptide consisting of 9 amino acid residues, DTNVDLINC, corresponding 
to amino acids 206 to 2I4 located toward the C-terminus of MrgR was designed, synthesised 
and used as an immunogen for the production of polyclonal antibodies in rabbits. A glycine 
residue was incorporated into the carboxy terminus of the peptide to facilitate coupling to 
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Fig 6.8: Expression of MBP-MrgR fusion protein in whole cell extracts of E. coli 
XL1-Blue shown on a 12% SDS-PAGE gel stained with Coomassie brilliant blue. 
Lanes 1 & 6: purified MBP; Lanes 2 & 10: protein molecular weight standards (kDa); 
Lanes 3 & 7: uninduced cells; Lanes 4 & 8: 1 h induction; Lanes 5 & 9: 2 h induction. 
The arrows indicate the location of the fusion bands. 
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Fig 6.9: Expression of MBP-MrgS fusion protein in whole cell extracts of E. coli XL 1-
Blue shown on a 12% SDS-PAGE gel stained with Coomassie brilliant blue. Lanes 1 & 
5: uninduced cells; Lanes 2 & 6: 1 h induction; Lanes 3 & 7: 3 h induction; Lane 4: 
protein molecular weight standards (kDa), and Lane 8: purified MBP. The arrows 
indicate the location of the fusion bands. 
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the KLH earner protein. The peptide was designed to include a high percentage of 
hydrophilic residues, over 65%, to improve the chances of success. A predominantly 
hydrophilic peptide may be more likely to be soluble, easier to conjugate and exposed on the 
surface of the native protein. Rigorous computer-based sequence analysis and comparison 
with protein sequence databases demonstrated that the peptide sequence chosen for antibody 
productions was unique. It shared no exact identity when compared with the protein 
sequences contained in the GenBank, EMBL and Protein Identification Resources (PIR) 
databases. However, the peptide does possess up to 60% amino acid homology with a 
number of sequences in the databases (Table 1, Appendix VI). The peptide-KLH conjugate 
was purified prior to immunisation. Rabbit antisera were tested by enzyme-linked 
immunosorbent assay (ELISA) for their ability to specifically recognise the peptide and the 
titre of the antibody preparation was found to be 1/43,970. Approximately 20 mg of 
antibody was obtained from 20 ml of the antiserum. 
6.3.3.2 Design and production of an anti-peptide antibody for the detection of MrgS 
A synthetic peptide consisting of 9 amino acid residues, RKFYSLESN, corresponding 
to amino acids 14 to 22 located in the N-terminus of MrgS was designed and synthesised for 
immunisation. The peptide shared no exact sequence identity with the proteins contained in 
the GenBank, EMBL and PIR (Table 2, Appendix VI). A cysteine residue was attached to 
the N-terminus of the peptide to facilitate conjugation to the immunogenic carrier KLH 
through the sulfhydryl group of the cysteine. The peptide was designed so as to contain 
more than 75% of hydrophilic amino acids. The purified peptide-KLH conjugate was used 
to immunise rabbits and the resulting antisera possessed a specific titre of 1/203,240 when 
tested by ELISA. Approximately 20 mg of the antibody was obtained from 19 ml of the 
antiserum. 
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6.3.4 Immunological identification of MBP-MrgR and MBP-MrgS fusion proteins and 
antibody specificity 
The identity of the 60-kDa MBP-MrgR fusion protein was confirmed by 
immunological assays. Polyclonal antibodies raised against either an MrgR peptide sequence 
(section 6.3.3.1) or MBP (New England Biolabs) were used separately to probe Western 
blots of cell lysates of recombinant E. coli XLI Blue expressing MBP-MrgR. Both 
antibodies recognised bands of- 60 kDa, and although some other smaller bands were also 
evident, it is likely that these represent degradation products of the fusion protein (Fig 6.1 0). 
It can be seen that the expression of the 60 kDa protein band appears to be stronger in the 
IPTG-induced lanes, but there is also a 60 kDa band present in the uninduced cells. The 
latter was consistently observed in Western blots that were probed with the antibodies 
despite considerable care taken to ensure repression of the tac promoter prior to IPTG 
induction. This experiment was repeated a number of times with the same results. Similarly, 
and in contrast to the faintly discernible protein band which was present in Coomassie 
brilliant blue stained SOS-PAGE gels (section 6.3.2.2), both MBP antibody and the anti-
peptide antibody produced for the detection of MrgS reacted specifically with MBP-MrgS 
fusion protein produced in XLI-Biue, and recognised a major immunoreactive band of -70 
kDa (Fig 6.11 and Fig 6.12). However, the reaction with MBP antibody was much stronger 
than that observed with the MrgS antibody. 
The specificity of antibody recognition was determined by blocking experiments in 
which each of the specific antibodies were preincubated with each of the peptide 
immunogens. Only antibodies that had been preincubated with the specific peptide that was 
used for immunisation were blocked from binding to the corresponding fusion protein (Fig 
2, Appendix VI). Furthermore, no protein bands were detected when the primary antibody 
was omitted from the experiment. 
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Fig 6.10: Western blot detection ofMBP-MrgR fusion protein by anti-MrgR antibody. 
Lanes 1& 6: insoluble matter; 2&7: crude extract; 3&8 resin purified extract; 4&9: 3 h 
induced cells; Lane 10: uninduced cells and Lane 5: molecular weight markers (kDa). 
Arrows indicate the position of the fusion proteins. 
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Fig 6.11: Western blot detection ofMBP-MrgS fusion protein by anti-MrgS antibody. 
Lanes 1& 7: insoluble matter; 2 & 5: crude cell extract; 3 & 8: resin purified cell 
extract; 4 & 9: 3 h induced cells; and Lane 5: molecular weight markers (kDa). The 
arrow indicates the expected size of fusion protein. 
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Fig 6.12: Irnmunoblotting of MBP-MrgS fusion protein with anti-MBP 
antibody. Lanes 1&6: insoluble matter; Lane 2 & 7: crude extract; Lanes 3 & 8: 
resin purified extract; Lanes 4 & 9: 3 h induced cells; Lane 10: uninduced cells; 
Lane 5: molecular weight markers (kDa). Arrows indicate the position of the 
fusion protein. 
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6.3.5 Recognition of MBP-MrgR fusion protein by convalescent patient serum 
When cell lysates of E. coli harbouring the plasmid pMFU I were electrophoresed 
(section 3.4.6.1), electroblotted (section 3.14.5) and incubated with serum from a patient 
with melioidosis it was found that a band of -60-kDa that corresponds to the MBP-MrgR 
fusion protein was recognised in soluble, insoluble, and amylose resin purified extracts of 
bacteria that had been induced with IPTG. As with the blots probed with anti-MrgR 
antibody, a low level of recognition was evident in the uninduced cell extracts. The serum 
did not recognise the purified MBP, MBP-MrgS or any other E. coli components (Fig 6.13). 
A variety of components that were present on Western blots of B. pseudornallei whole cell 
extracts were very strongly stained when probed with the same patient serum (Fig 6.14). 
6.3.6 Detection of MrgR and MrgS in B. pseudomallei whole celllysates 
The anti-MrgR peptide antibody detected a band of approximately 24 kDa on Western 
blots of the cell lysates of 6 isolates of B. pseudornallei cultured under standard growth 
conditions (Fig 6.15). This corresponds to the calculated molecular weight of MrgR, 23.860 
kDa, which is based on the deduced translation of the nucleotide sequence of the rnrgR gene 
(section 4.4.2). Unexpectedly, the MrgR antibody labels at least four other bands of varying 
intensities at -150, -90, -80 and -30 kDa. The most intensely stained band was located at 
-80 kDa. 
The anti-MrgS peptide antibody recognised a band of -115 kDa in each of the isolates 
of B. pseudornallei, which corresponds with the calculated molecular weight, 118.227 kDa, 
of the deduced translation of the nucleotide sequence of the rnrgS gene (section 4.4.2). 
However, in some samples this band was stained with greater intensity than in others. The 
antibody also recognised other bands that varied in both staining intensity and molecular 
mass (Fig 6.16). One band of -30 kDa appears to be present in all of the isolates, while a 
band at -90 kDa is present in all but isolate 576 and a band at 80 kDa is present only in 
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Fig 6.13: Western blot analysis showing the recognition of MBP-MrgR fusion 
protein by melioidosis patient serum. Lane 1: protein molecular weight markers 
(kDa); Lane 2: Uninduced cells; Lane 3: 3 h induced cells; Lane 4: resin purified 
cell extract; Lane 5: crude cell extract; and Lane 6: insoluble matter. 
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Fig 6.14: Western blot analysis of B. pseudomallei whole cell proteins with melioidosis 
patient serum. Isolate number is indicated above each lane and protein molecular weight 
markers are on the left (kDa). 
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Fig 6.15: Western blot analysis of MrgR from B. pseudomallei whole cell lysates 
using anti-MrgR antibody. Protein molecular masses (M) are given in kilodaltons. 
The arrows ( ___.) indicate the expected location of MrgR bands, ~ indicates 
possible phosphorylated form of MrgR, while ~ denotes the putative isoforms of 
the protein, as explained in section 6.4. 
266 
M E8 98 112 216 204 576 M 
Fig 6.16: Western blot analysis of MrgS from B. pseudomallei whole celllysates 
using anti-MrgS antibody. Protein molecular masses (M) are given in kilodaltons. 
The arrows (_.)indicate the expected full size location of MrgS bands, while.,... 
and ~denote the putative processed forms of the protein. 
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isolate 216. It was noted that the intensity of the ~ 115 kDa band was stronger in those 
samples with weaker recognition of the ~30 kDa band and the inverse was also true. 
The specific recognition shown by each of the anti-peptide antibodies was totally 
abolished by preincubation with specific peptide against which each antibody was raised. In 
contrast, preincubation with an irrelevant peptide had no effect on the staining intensity. To 
investigate the basis for this specific recognition of a number of proteins in B. pseudomallei 
whole cell lysates, the sequence of the synthetic peptides were compared with sequence 
information from the B. pseudomallei genome sequencing project database at the Sanger 
Centre. The search retrieved 6.2 Mb of overlapping contig sequences in the genome. 
Although no exact match with either peptide sequence was found a number of possible 
sequence matches were identified that could conceivably account for the recognition of more 
than a single band on Western blots (Table 3, Appendix VI). 
In order to investigate the basis for the recognition of MBP-MrgR by serum from a 
convalescent melioidosis patient, Western blots of the ECPs derived from six isolates of B. 
pseudomallei, including the isolate from which the mrgR gene was cloned, were probed with 
anti-MrgR and anti-MrgS peptide antibodies. In this experiment, none of these ECPs 
produced an immunoreactive signal. 
6.4 DISCUSSION 
In order to gain a better understanding of the MrgR-MrgS two-component regulatory 
proteins and to further assess and visualise their expression in B. pseudomallei cells, specific 
antibodies were developed against synthetic peptide analogues to sequences derived from 
the C- and N-termini of MrgR and MrgS, respectively. The production of specific antibodies 
is a desirable prerequisite to the full characterisation of a newly cloned protein. However, 
this requires the expression and purification of the protein in sufficient quantity for the 
immunisation of animals. Even with the development of highly efficient protocols based 
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upon the incorporation of specific peptide tags, this can be a tedious and time-consuming 
process (Spiller et al., 1999). Simple, efficient and rapid methods for the generation and 
characterisation of such antibodies would be of broad utility. A common approach is to use 
peptides derived from the predicted protein sequence (Geysen et al., 1985). Synthetic 
peptides, when coupled to a carrier protein (e.g. KLH or BSA), normally elicit a strong 
humoral response. However, anti-peptide antibodies are often poorly reactive with the native 
protein, limiting their use to the detection of denatured protein by immunoblotting (Spiller et 
al., 1999). Nevertheless, the use of synthetic peptides as immunogens for the production of 
polyclonal antibodies has been widely accepted and relies on the careful selection of a 
peptide sequence and the use of a carrier protein in order to elicit a good immune response. 
This method has been successfully used to generate antibodies for the detection of many 
proteins including exotoxin A from P. aeruginosa (Elzaim et al., 1998) and protease from B. 
pseudomallei (Lee & Liu, 2000). 
To determine whether the anti-peptide antibodies could recognise the MrgR and MrgS 
proteins, chimaeric fusion proteins were constructed and expressed in E. coli XLI-Blue. The 
stability of the pMFUl and pMFU2 recombinant plasmids in the E. coli host was 
demonstrated by the culture of a number of different clones and also by nucleotide 
sequencing. The MBP-MrgR fusion appeared to be expressed at high levels as a soluble 
molecule reflecting the predicted cytoplasmic nature of the protein. However, attempts to 
overexpress the MrgS fragment in pMAL-C2 demonstrated that MBP-MrgS was mainly in 
an insoluble form, an observation that was previously reported for other overexpressed two-
component regulatory and sensory proteins (Schroder et al., 1994). Furthermore, this 
provides some support for the computer-generated structural predictions for this region of 
MrgS, which suggest that it is a predominantly hydrophobic region, and may represent a 
transmembrane domain within the full length of the MrgS protein. The MrgR and MrgS 
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polyclonal antibodies bound to their cognate fusion proteins and the specificity of the 
antibodies for the peptide used for immunisation was demonstrated by the lack of 
recognition of MBP-MrgR and MBP-MrgS fusion proteins when the antibodies were 
blocked by preincubation with the immunising peptide. Furthermore, this specific 
recognition was not blocked by preincubation with an irrelevant peptide. The same result 
was recorded when B. pseudomallei celllysates were probed with the antibodies. 
An important consideration in the choice of the peptides that were used to raise 
antibodies to MrgR and MrgS was that exhaustive searches of protein databases revealed no 
exact match with either of the peptide sequences. Nevertheless, a number of bands were 
recognised by each of the polyclonal antibodies on Western blots of B. pseudomallei cellular 
extracts. The apparently unique nature of the primary amino acid sequences of the peptide 
immunogens together with the observation that immunoreactivity can be blocked by 
preincubation of the serum with the immunising peptide antigen further suggests that this 
recognition is specific. The lack of detectable quantities of either MrgR or MrgS in the ECPs 
of B. pseudomallei strongly suggests that under the conditions employed in this study 
neither of these proteins is secreted. This supports the structural predictions for these 
proteins that were made in Chapter 4 (section 4.4.2). 
There are a number of possible explanations for the occurrence of multiple bands on 
Western blots of B. pseudomallei cells that have been probed with specific antibodies 
against MrgR and MrgS. These include the presence of multiple isoforms of proteins with 
identical epitopes, proteolytic degradation, dimerisation or complexing, and some level of 
antibody cross-reactivity with proteins with very similar epitopes. Some of these 
possibilities provide a more likely explanation for the observed banding patterns. It is 
important to appreciate that the inability to detect similar sequences in protein databases is 
no guarantee that antibodies raised against a peptide will not cross-react with other cellular 
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proteins (Reubi et al., 1999). The lack of sequence identity between the peptides and B. 
pseudomallei sequence should not be taken as definitive evidence that the observed 
reactivity is not directed toward the product of another gene in the B. pseudomallei genome. 
The observed reactivity is presumably directed against a primary sequence feature, as it was 
detected using Western blotting, but the scoring matrixes used in the computer analyses 
have been optimised for detecting evolutionary relationships rather than features important 
for antibody recognition and thus could well have missed the relevant sequence. On the 
other hand, the nature and relationship between an antibody and its antigen is never 
exclusive; therefore, in addition to recognising the epitope against which it was elicited, an 
antibody has the potential to bind to a variety of related moieties, or antigenic sites, which 
share some structural features with the immunogen (V an Regenmortel, 1998). Anti genic 
sites of proteins were thought to consist of short stretches of about six amino acids that may 
be arranged in the primary structure either continuously or discontinuously (Atassi & 
Young, 1985). However, recent structural analyses suggest that antigenic epitopes in native 
proteins are mostly of the discontinuous type, that is they are composed of several short 
stretches, mainly loops exposed on the surface (Laver et al., 1990). In accordance with that, 
the recognition of multiple bands by MrgR and MrgS antibodies may be due to this 
occurrence. 
An alternative and perhaps stronger possibility is that inducing a specific signal(s) may 
promote autophosphorylation of MrgS. This would result in the phosphorylation of MrgR, 
which could then function in concert or sequentially with other components to activate or 
repress the transcription of other genes. Under some conditions, MrgS may not be activated, 
or phosphorylated MrgS may be unstable, and in these circumstances MrgR would not be 
phosphorylated. This proposal resembles what is known about the standard two-component 
paradigm in which phosphorylation-dephosphorylation activities follow stimulation (section 
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2.5). Each of the phosphorylated and non-phosphorylated proteins would migrate 
differentially resulting in two closely located bands, such as those present at 24 and 30 kDa 
on blots probed with anti-MrgR antibody. It has been established that although 
phosphorylation does not alter the overall folding of a protein or result in substantial 
changes in protein secondary structure, it can dramatically affect the molecular surface, 
hence altering both topological and electrostatic features of the protein (Stock et al., 2000). 
There is also a strong possibility that MrgR may dimerise or form a complex with 
another protein. Phosphorylation can promote dimerisation (McCieary, 1996), higher-order 
oligomerisation (Wyman et al., 1997), or interactions with other proteins (Blat & Eisenbach, 
1994) or DNA (Aiba et al., 1989). Some proteins use a combination of these mechanisms 
(Anand et al., 1998). The process of dimerisation is required for the control of transcription 
by all regulators whose three-dimensional structure is known, e.g. lambda repressor (Pabo & 
Lewis, 1982) and BvgA (Scarlato et al., 1990). BvgA, a 23-kDa response regulatory protein 
that regulates virulence genes in B. pertussis, has been shown to dimerise and a cross-
reacting band of 46 kDa was stained on Western blots probed with antibodies specific for 
BvgA (Scarlato et al., 1993). Furthermore, the formation of heterodimers of MrgR and 
another unidentified response regulatory protein is also possible. For example, in E. coli, 
under appropriate conditions RcsF and RcsC were hypothesised to facilitate the 
phosphorylation of the response regulator RcsB. Phosphorylated RcsB then interacts with 
RcsA to form a more stable complex or heterodimer in order to stimulate the expression of 
the capsule genes (Arricau et al., 1998). In P. syringae, heterodimer formation has been 
suggested to occur between HrpR and HrpS, two response regulators that are required for 
transcriptional activation of hrpL (Xiao et al., 1994) and also between CorP and CorR, two 
response regulators that are involved in the temperature-dependent biosynthesis of the P. 
syringae phytotoxin coronatine (UIIrich et al., 1995). In addition, transcriptional regulators 
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that function as homodimers include NtrC (nitrogen regulatory protein) and DtxR 
(diphtheria toxin repressor) in Corynebacterium diphtheriae (Schmitt & Holmes, 1994) and 
LsR-like proteins CarR and AmpR in Citrobacter freundii (Bishop & Weiner, 1993). This 
may offer some explanation for the presence of high molecular weight bands such as those 
at ~80, ~90 and ~150 kDa on blots probed with anti-MrgR antibody. On the other hand, any 
of these higher molecular weight bands may represent either the failure to solubilize MrgR 
fully or aggregation of MrgR with other cellular proteins during electrophoresis at room 
temperature. 
DNA sequencing of the P. aeruginosa genome has led to the identification of 64 and 
63 genes encoding response regulators and histidine kinases, respectively. Given the highly 
conserved nature of two-component regulatory proteins and the adaptable nature of B. 
pseudomallei it may be that it is similar to P. aeruginosa in this respect. Hence it seems 
possible that B. pseudomallei possesses other regulatory proteins that may share substantial 
amino acid sequence identity with MrgR or MrgS and could cross-react with the peptide-
specific antibodies. 
The presence of bands of lower molecular weight than the predicted full size MrgS 
protein on Western blots of B. pseudomallei cell lysates, could arise as a consequence of 
proteolytic processing or degradation of the immunoreactive protein before or during sample 
preparations or during the bacterial growth cycle. This proposal is supported by the 
observation that the staining intensity of the ~30 kDa band seems to vary inversely with the 
staining intensity of the ~ 115 kDa band i.e. when more of one is present, less of the other is 
evident (Fig 6.16). 
Probing Western blots of bacterial preparations with convalescent patient serum is a 
widely used technique for identifying components that may be expressed by pathogens 
during the course of an infection (Watson et al., 1998). Serum from a melioidosis patient 
273 
strongly stained Western blots of MBP-MrgR and B. pseudomallei whole cell lysates, but 
not purified MBP, MBP-MrgS or other E. coli components. Although this is not definitive 
proof that infected hosts specifically recognise the MrgR protein and that MrgR may be 
expressed by B. pseudomallei during melioidosis infection, it does provide some evidence 
for this possibility. Why MrgR should be recognised by patient antibodies remains unclear, 
particularly when an investigation of the ECPs produced by six isolates of B. pseudo mallei 
revealed that MrgR is not present in detectable quantities in B. pseudomallei culture 
supernatant. This supports the suggestion that MrgR, as a member of the response regulator 
family, is probably not secreted and may well act as a cytoplasmically located protein. 
However, because two-component regulatory proteins are involved in mediating cellular 
responses to environmental changes, the possibility that MrgR might be more directly 
involved in the pathogenesis of B. pseudomallei in humans cannot be excluded. 
In conclusion, the anti-peptide antibodies that have been generated in this project 
allowed the detection of the MrgR and MrgS proteins in B. pseudomallei. These antibodies 
will permit further studies of these proteins both in vitro and perhaps in vivo. Such work 
may help to resolve the reasons for the immune recognition of MrgR by an infected host. 
The antibodies may be useful in understanding how the interaction of the bacterium with the 
host modifies the expression of MrgR and MrgS. Understanding where and when during the 
course of infection these proteins are active may provide valuable clues about their function 
and how it may be disrupted. 
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CHAPTER 7 
GROWTH OF B. PSEUDOMALLEJ AND THE EXPRESSION OF MrgR 
AND MrgS PROTEINS UNDER DIFFERENT CONDITIONS OF 
TEMPERATURE, pH AND SALINITY 
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7.1 INTRODUCTION 
The development of anti-peptide antibodies for detecting MrgR and MrgS proteins in 
B. pseudomallei permits further studies of the possible role of these proteins in the adaptive 
responses of the pathogen to environmental stimuli. In this chapter, the effects of variation 
in three environmental parameters on the expression of MrgR and MrgS in a number of 
different isolates of B. pseudomallei were investigated. 
Most, if not all, bacteria are exposed to alterations in environmental conditions during 
their life cycle (Slauch et al., 1996). Accordingly, bacteria regulate gene expression in order 
to ensure that only those genes whose protein products are required at a particular time are 
switched on, while those that are not needed are turned off. Understanding how 
environmental conditions regulate the expression of specific genes is one step towards 
understanding gene function. This is especially important for opportunist pathogens, such as 
Burkholderia pseudomallei, that are capable of survival in a wide range of environmental 
conditions. Environmental conditions can be established in a laboratory setting in order to 
mimic the microenvironment encountered outside or within a host organism (Heithoff et al., 
2000). Although mimicking these environments in the laboratory is problematic since the 
microenvironments within the host tissues are both complex and dynamic, any environment 
encountered by a bacterium during its' life cycle may be defined in terms of parameters such 
as temperature, osmotic pressure, oxygen status, pH and nutrient availability. Many in vitro 
experiments have been conducted for the purposes of detecting bacterial genes whose 
expression is modulated by changes in these parameters, and this work has yielded much 
information on environmentally controlled genes, some of which contribute to virulence 
(Dorman & Bhriain, 1992). 
Temperature is one of a few environmental parameters that have been demonstrated, 
both in vivo and in vitro, as being an important regulator of bacterial genes (Smith, 1990). It 
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is one of the factors that are known to change as a consequence of an induced inflammatory 
response (Wang et al., 1998). Moreover, the role of temperature in the expression of 
virulence genes in human and animal pathogens is well established (Mekalanos, 1992). 
Transcription of these genes is activated when microbes enter their warm-blooded hosts and 
elevated temperature might be an early signal heralding the entry of a pathogen into the host 
from an environmental source. 
Regulation of gene expression by pH has been described in several pathogenic bacteria. 
If a bacterium follows the ingestion route of infection, it must survive the acidic conditions 
of the stomach and the alkaline environment of the small intestine. Likewise, when a 
microbe is engulfed by a macrophage, the phagocytic vesicle reaches pH 6 within minutes; 
after fusion to lysosomes, it reaches a pH of 4.5 (Alpuche-Aranda et al., 1992). Hence, low 
pH has been shown to provide a signal for regulating the expression of bacterial genes that 
are presumed to function within the macrophage. 
Osmolarity has been shown to provide an environmental signal controlling the 
expression of virulence genes in several bacterial species (Mekalanos, 1992). For example, 
in V cholerae the expression of cholera toxin and other virulence determinants is optimal at 
osmolarities that fall within the physiological range of host tissues (Miller & Mekalanos, 
1988). Furthermore, the expression of the virulence-associated alginate capsule of P. 
aeruginosa is affected by osmolarities that reflect the altered environment inside the 'salty' 
cystic fibrosis lung. Usually the influence of osmolarity on gene expression is studied in 
vitro by varying the concentration of either sucrose or NaCl in culture media. 
The aim of this work was to examine the effects of variation in three environmental 
parameters, temperature, pH and salinity, on the expression of MrgR and MrgS proteins in 
different isolates of B. pseudomallei cultured in vitro, by using polyclonal antibodies 
directed against MrgR and MrgS that were reported in Chapter 6. In addition, the effects on 
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bacterial growth were monitored by measuring the total cellular protein concentration in the 
cultures. Temperatures of 25, 37 and 42°C were chosen to reflect the survival and growth of 
B. pseudomallei at ambient tropical temperatures as well as within mammalian and avian 
hosts. Similarly, a range of pH 5, 6.8 and 8, and salinities, 0.15, 0.5 and 2.2% NaCI, were 
chosen to reflect the possible range of conditions that exist within marine and freshwater 
environments and also within the cells, tissues, and organs of an infected mammalian host. 
7.2 MATERIALS AND METHODS 
7.2.1 Culture of B. pseudomallei under different conditions of temperature, pH and 
NaCI 
Three clinical (112, 204, 576) and three environmental (E8, 98, 216) isolates of B. 
pseudomallei (Table 5.5) were inoculated into 10 m! volumes ofLB broth (Appendix I) and 
incubated for 24 hat 37°C within a Containment Level 3 Laboratory (section 3.2.2). Sets of 
10 ml volumes of LB broth with different NaCI contents (0.15, 0.5, 2.2%) were adjusted to 
pH 5, 6.8 and 8 with HCI and then autoclaved. The broth was inoculated with I 00 J.!l of the 
overnight culture then grown statically for 48 hat 25, 37 or 42°C, as detailed in Table 7.1. 
Table 7.1: Different parameters that were used for the culture of B. pseudomallei growth 
Temperature 25 or 37°C 42°C 
pH 5 6.8 8 5 6.8 8 
Salinity% 0.15 0.15 0.15 0.15 0.15 0.15 
pH 5 6.8 8 6.8 6.8 
Salinity% 0.5 0.5 0.5 0.5 2.2 
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7.2.2 Protein estimation, SDS-PAGE and Western blotting analysis 
A I m! volume of bacterial culture was removed, centrifuged {4,000 x g, 10 min, 4°C), 
and washed once in PBS. The pellet was resuspended and lysed in 50 J.!l of modified SDS-
p AGE sample buffer (Appendix I). Determination of total protein concentration in bacterial 
cell lysates was performed by a microassay procedure based on the method of Bradford 
using the Bio-Rad Protein Assay Kit (Bio-Rad, UK) (section 3.14.2). Approximately 5 J.lg of 
whole cell lysate was boiled for 5 min and the protein samples were separated on SDS-
PAGE gels with protein molecular weight standards (section 3.14.3). Following 
electrophoresis, the proteins were electroblotted onto nitrocellulose and probed with either 
the MrgR or MrgS anti-peptide antiserum (sections 3.14.5 & 6.2.2.3). 
7.3 RESULTS 
7.3.1 Growth of B. pseudomallei under different conditions of temperature, pH and 
NaCl 
Although all of the isolates of B. pseudomallei grew under each of the conditions of 
temperature, pH and salinity that were tested, some conditions were more favourable for 
growth (Table 7.2 & Fig 7.1). Optimal growth was assessed by the amount of protein 
produced and this was highest at 42°C, pH 6.8 and 0.5% NaCI. Interestingly, increasing the 
NaCI content to 2.2% under these conditions drastically reduced the amount of protein 
produced by 43-71% depending on the isolate. Generally, growth was better at pH 5 and 
lower at pH 8 and increasing the NaCI content to 0.5% led to reduced growth, although this 
is clearer at 37°C than at 25°C. Isolates 204 and 216, both from NE Thailand, show very 
similar patterns of protein production in contrast to the variation that is present in the other 
isolates (Fig 7.1). 
Generally, isolates grew better at each pH under low NaCJ conditions (0.15%, 20 mM). 
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Table 7.2: Growth of B. pseudomallei isolates under different conditions of temperature, pH and NaCI and the amount of total cellular protein 
produced (mg/ml) 
Growth conditions 
Strain 37°C & 0.15% NaCI 37°C & 0.5% NaCI 25°C & 0.15% NaCI 25°C & 0.5% NaCI 42°C & 0.15% NaCI 42°C & 0.5% 42°C& 2.2% 
5 6.8 8 5 6.8 8 5 6.8 8 5 6.8 8 5 6.8 8 6.8 6.8 
E8 3.55 3.05 !.50 2.35 2.20 2.10 2.15 0.65 1.25 2.00 2.00 0.75 3.60 3.90 2.80 5.10 2.90 
98 5.20 4.10 2.35 3.75 3.65 2.65 1.90 0.75 1.20 4.10 1.60 1.05 4.20 6.10 1.90 6.60 3.00 
112 3.50 2.65 1.30 3.15 2.00 1.30 1.05 2.05 1.05 2.20 2.05 1.05 3.70 2.10 3.00 3.90 1.80 
216 2.85 2.40 0.85 2.50 1.20 0.55 1.00 2.10 1.05 1.05 1.10 0.50 2.80 3.00 1.60 5.60 1.90 
204 7.65 6.15 5.65 5.20 3.30 2.60 1.45 1.30 0.85 1.90 1.70 1.00 8.80 5.00 5.70 6.90 2.90 
576 4.15 3.60 3.45 3.05 2.95 2.50 3.60 2.00 1.90 3.70 1.65 0.85 6.10 4.40 6.00 8.90 2.60 
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Fig 7.1: Growth, as indicated by the production of total cellular proteins (mg/ml), for 6 isolates 
of B. pseudomallei grown under different combinations of temperature and NaCl, including 37°C 
& 0.15% NaCl, 37°C & 0.5% NaCl, 25°C & 0.15% NaCl, and 25°C & 0.5% NaCl. All were 
grown under three different pH values 5, 6.8 and 8. 
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When the isolates were cultured in the presence of 0.5% NaCl (68 mM) the maximum 
protein production occurred at pH 5 and the lowest at pH 8, regardless of whether cultures 
were grown at 25 or 37°C. When the bacteria were cultured using 0.15% NaCl a similar 
pattern was observed but only at 37°C, while growth at 42°C or 25°C resulted in different 
patterns. At 25°C, maximum protein production occurred at pH 5 for four strains; E8, 98, 
204 and 576 and at pH 6.8 for strains 112 and 216. On the other hand, at 42°C, the 3 clinical 
isolates ( 112, 204, 576) all showed a similar pattern of protein production with a peak at pH 
5 and a trough at pH 6.8. The 3 environmental isolates (E8, 98, 216) were typified by 
another pattern of protein production that peaked at pH 6.8 (Fig 7.2). 
7.3.2 Western blot analysis and the effect of different culture conditions on the 
expression of MrgR and MrgS proteins 
MrgR and MrgS antibodies each recognised more than one band on Western blots of 
whole cell lysates of B. pseudomallei grown under each of the culture conditions, which is 
consistent with previous observations (section 6.3.6). In addition to the 24 kDa band, the 
MrgR antibody highlighted 4 other components, two major bands at 80 and 30 kDa that 
were present in all samples, and two faint bands in some samples at 150 and 90 kDa. The 
MrgS antibody mainly recognised the -115 kDa band in addition to two other major bands, 
one at 30 kDa and the other at 90 kDa. The latter band is present in all but isolate 576. 
Figures 7.3-7.8 and 7.9-7.14 show the expression of MrgR and MrgS, respectively, 
under each condition of pH, salt and temperature. Generally, the growth of B. pseudo mallei 
at higher temperature ( 42°C) resulted in a progressive increase in immunoreactive 
components, suggesting that increasing temperature may coordinately up-regulate these 
antigenically-related molecules. This was strikingly obvious on blots that were probed with 
MrgS antibodies where the 90 kDa band is intensely stained in isolates 98, 112, 204 and 216 
grown at 42°C in the presence of 2.2% NaCI. This band is also very obvious in isolate 216 
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Fig 7.2: Growth, as indicated by the production of total cellular proteins (mg/ml), for six 
B. pseudoma/lei isolates grown at 42°C and under different pH and NaCl contents reveals 
two distinct patterns, 'V' for clinical isolates and ' A' for environmental isolates. 
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pH 
pH 
Fig 7.3: Expression of MrgR for 6 isolates of B. pseudomallei grown under different 
combinations of temperature, pH and NaCI. Western blots of whole cell lysates were probed 
with anti-MrgR antibody. The identities of the symbols(___.,..,., ~)are as described in 
Fig 6.15 and as discussed in section 6.4, while the identity of each lane is indicated above 
each figure. M: indicates protein molecular weight markers (kDa). 
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Fig 7.3 continued 
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Fig 7.4: Expression of MrgS for 6 isolates of B. pseudomallei grown under different 
combinations of temperature, pH and NaCI. Western blots of whole cell lysates were probed 
with anti-MrgS antibody. The identities ofthe symbols(--+, ~, .... ) are as described in Fig 
6.16 and as discussed in section 6.4, while the identity of each lane is indicated above each 
figure. M indicates protein molecular weight markers (kDa) 
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Fig 7.4 continued 
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grown in medium containing 0.5% NaCl and in 204 at pH 6.8 and 0.15% NaCI. In contrast, 
at the lower growth temperatures the 90 kDa band is either absent or extremely weak. In 
addition, the 90 kDa band is absent in isolates E8 and 576 under any of the growth 
conditions. On the other hand, some bands that were recognised by anti-MrgS were less 
intensely stained following growth at 42°C. Compared with growth at 25 or 37°C, 
expression of the 30 kDa band was markedly reduced in cultures grown at 42°C, and absent 
when using 2.2% NaCI. Although the 115 kDa band stained with varying intensity in all 
isolates under different growth conditions, it was slightly stronger when the environmental 
isolates (E8, 98, 216) were cultured at 25°C in comparison with culture at 3 7°C, regardless 
of pH or salt content. 
For blots probed with anti-MrgR antibodies the 150 kDa band was very distinct in 
isolate 216 grown at 42°C but was weak or absent at 25 and 37°C. This band was not 
obviously present in any of the other isolates. In all of the isolates, the anti-MrgR antibody 
showed a decrease in the staining intensity of the 24 kDa band and also the 30 kDa band 
when cultures were grown at 25°C and pH 8. While in comparison, the quantity of the 80 
kDa band appeared to be unaffected by these conditions. However, at 42°C, the 80 kDa band 
is much more abundant, particularly at 0.15% NaCl, while the 30 kDa band is also more 
abundant but this is more noticeable at 0.5% NaCI. Similarly, the 90 kDa band was 
somewhat more distinct at 42°C, especially at 0.5% NaCl and to lesser extent at 2.2% NaCl 
while the same band was either absent or extremely weak in each of the other conditions that 
were tested. 
7.4 DISCUSSION 
Many bacteria are commonly exposed to dramatic changes in their environment and 
must respond appropriately in order to survive. This is also true for B. pseudomallei, an 
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opportunist that can survive intracellularly and adapts well to a variety of growth conditions 
(Dejsirilert et al., 1991 ). In an attempt to improve our understanding of this adaptation, B. 
pseudomallei was grown under varying conditions of pH, salinity and temperature that 
reflected the different environments to which the bacterium may be exposed. Both the 
growth of the bacteria and the expression of mrgR and mrgS were studied using B. 
pseudomallei that had been isolated from either clinical or environmental samples as a 
means of determining whether isolates from these sources differ in their response to the 
variables studied. This study has confirmed earlier work showing that B. pseudomallei can 
grow over a wide range of temperatures (Yabuuchi et al., 1993), from 25-42°C, and will 
tolerate extremes of pH and wide variation in NaCl content. 
The interaction between B. pseudomallei and its' environment have been studied by a 
number of authors. In the work presented here, it has been demonstrated that B. 
pseudomallei grows well at pH 5 and under some conditions this growth is at an optimum 
e.g. 37°C and 0.15% NaCI, conditions that reflect those encountered within the mammalian 
host. It is known that B. pseudomallei can survive and grow under low pH conditions both in 
vitro and in vivo (Mitsuchi et al., 1986; Kanai & Kondo, 1994). To some extent this reflects 
the acid soil conditions in endemic areas such as north-east Thailand ranging from pH 4.38-
7.7. However, acid conditions (pH 4.7-5.5; Sprich, 1956) also exist inside the 
phagolysosomes of mononuclear cells, the effects of which B. pseudomallei can withstand 
(Wongwanich et al., 1996). 
According to the results of the protein determination assay, B. pseudomallei can grow 
under conditions covering a wide range of pH, NaCl concentration and temperature. 
However, maximal protein synthesis occurred at 42°C, pH 6.8 and 0.5% NaCI. A dramatic 
decrease in cellular protein under these conditions, up to 71%, occurred in response to an 
elevation in NaCl content to 2.2%. The increased synthesis of protein at 42°C may reflect a 
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survival response by the bacterium to heat-shock or stressful conditions, and a consequent 
reduction or loss of control of its' ability to osmoregulate. On the other hand, lowering the 
temperature to 25°C was most effective in restricting the growth of B. pseudomallei, 
particularly at pH 8. There is some evidence that alkaline pH may present substantial 
difficulties for some isolates of B. pseudomallei and that this may also be related to the 
control of osmoregulation. The combination of growth at 25°C, pH 8 and 0.5% NaCI 
resulted in the lowest levels of protein synthesis in all of the isolates of B. pseudomallei that 
were examined. Once again, this is consistent with the known distribution of the organism 
and its' persistence in the environment and may represent an intolerance to less optimal 
environmental conditions at low temperatures. 
A striking observation was that at 42°C, the 6 isolates of B. pseudomallei that were 
examined showed two consistent patterns of response that apparently reflected the source of 
isolation. The first pattern, which was displayed by the 3 clinical isolates, is 'V' shaped with 
peaks of protein production at pH 5 and pH 8 and a trough at pH 6.8. The other pattern, 
which was shared by the 3 environmental isolates, is 'A' shaped with a single peak of 
protein produced at pH 6.8. It is tempting to speculate that this finding may reflect the 
response of clinical isolates to stressful conditions similar to those that might occur during 
inflammation and the acute phases of infection i.e. higher than normal mammalian body 
temperatures and active phagocytic mechanisms. It may be that the sequential passage of 
clinical isolates through the host has acted to positively select for an increase capacity to 
grow under these conditions. 
This study has demonstrated that MrgR and MrgS are expressed by different isolates of 
B. pseudomallei under different growth conditions. The proteins are therefore required to 
meet the needs of cellular metabolism under most circumstances. Environmental conditions 
are known to modulate the expression of two-component regulatory proteins, although the 
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response may differ from one species to another. For example, the expression of OmpR, a 
response regulatory protein in E. coli, is induced in media of high osmolarity and repressed 
under low osmolarity, as part of the adaptive response to conditions within the mammalian 
gut. However, osmolarity changes do not affect the expression of OmpR in S. typhi (Puente 
et al., 1991). On the other hand, osmotic upshift is one of the environmental signals shown 
to induce the transcription of capsule genes in E. coli through the RcsB-RcsC pathway 
(Sledjeski & Gottesman, 1996). 
Temperature controls virulence gene expression m Bordetella species VIa the 
BvgA/BvgS two-component signal transduction system and in V cholerae by another two-
component system, the ToxR system (Miller et al., 1989). In Listeria monocytogenes, the 
expression of many of the genes that are crucial to the infection process, including the genes 
encoding invasin and listeriolysin as well as many other heat-shock or stress proteins, are 
controlled by temperature via the transcriptional regulator prfA (Leimeisterwachter et al., 
1992; Lingnau et al., 1995). 
Many bacteria are known to respond to pH changes. Most investigators have focused 
on adaptive responses to a decrease in pH. Acidification induces expression of specific 
genes in several bacterial pathogens, such as S. typhimurium (Miller et al., 1991) and V 
cholera (DiRita & Mekalanos, 1989). At least 18 proteins are altered in expression as a 
result of acid shift inS. typhimurium. The bacteria possess an acid tolerance response, which 
is triggered at pH 5.5-6, which protects the cell against even lower pH values. The two-
component regulatory system PhoP-PhoQ negatively regulates the expression of S. 
typhimurium invasion genes and positively regulates the expression of genes required for the 
intracellular survival of the bacteria within acidified macrophages (Miller et al., 1989; 
Pegues et al., 1995). In E. coli, CadC, the membrane-attached DNA-binding protein, 
undergoes a conformational change in response to external pH changes that results in 
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modulation of its transcriptional activation capacity (Watson et al., 1992). 
In many cases, the combined effects of more than one environmental signal may 
activate two-component regulatory systems. For example, BvgAS, which controls the 
expression of virulence factors in Bordetella species, is modulated by the presence of 
MgS04 or nicotinic acid and growth at temperatures below 26°C (Coote, 1991 ). When 
Bordetella is grown at 37°C in the relative absence of MgS04 and nicotinic acid, BvgAS is 
active (Bvg+ phase), hence a large set of genes encoding protein virulence factors are 
expressed. The Bvg- phase is expressed when Bordetella is grown at room temperature or in 
the presence of> I 0 mM nicotinic acid or >40 MgS04. Similarly, Yersinia has a collection of 
genes that are temperature regulated but require another signal to initiate their full range of 
regulatory activities (Straley & Perry, 1995). Many of the genes that are induced by high 
temperature also require the presence of low calcium levels for high level induction m 
culture medium, with cell contact probably providing the equivalent cue in vivo. 
The differences seen in the expression of MrgR and MrgS might reflect differences in 
the growth phase of the B. pseudomallei cultures, since the bacteria were grown statically 
under various combinations of temperature, pH and NaCI concentration. However, in the 
discussion to Chapter 6 it was proposed that the observed pattern of bands on Western blots 
of B. pseudomallei that had been probed with anti-MrgR antibody, may represent the 
formation of complexes between the 24 kDa MrgR and other components. This complex 
pattern of expression of the protein under the variable conditions of pH, salt and temperature 
necessitates the prediction that MrgR may be integrated into more than one regulatory signal 
transduction pathway and a simple two-state model does not adequately explain the 
observed patterns of expression. Bacterial signalling systems are rarely being as simple as a 
system composed of two proteins (Corbell & Loper, 1995). Many regulators are classed as 
'global' because they have the potential to affect the expression of large subsets of genes in 
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the cell (Donnan, 1994). The RcsB response regulator of E. coli and other species, which 
·shares substantial sequence homology with MrgR, is reported to be a global regulon 
involved in a variety of functions including extracellular polysaccharide synthesis and the 
growth of the bacterial cell under certain conditions (Gervais et al., 1992). It is likely that 
the activation of MrgR, by phosphorylation, and the interactions with other cellular 
components, would enhance its binding to other proteins with varying degrees according to 
the stimulus or combined stimuli encountered. Such a process could provide a means to 
optimise the activity of MrgR at critical points of the life cycle. When B. pseudomallei are 
grown under various conditions of osmolarity, pH and temperature, a basal level of 
expression of the 24 kDa MrgR band, and its assumed phosphorylated form the 30 kDa 
band, was observed, although there is evidence for a lower level of expression at pH 8. 
Similarly, the 80 kDa band that was observed to be expressed under different conditions was 
highly expressed at 42°C. In contrast, the 90 kDa band seems to be weakly expressed under 
all growth conditions, apart from growth at 42°C, particularly at higher NaCl content (0.5 
and 2.2%). These results suggest that B. pseudomal/ei has at least two kinds of temperature-
related mechanisms involved in MrgR expression, one working at 25 or 37°C and the other 
at 42°C, which may represent a stress response. On the other hand, the 150 kDa band was 
only expressed in isolate 216 grown at 42°C, especially at 0.5 and 2.2% NaCI. In E. coli, 
although NaCl was shown to enhance the ability of RcsB to activate its own synthesis, high 
NaCI concentration was found to affect the expression of rcsB. Very little or no activation of 
rcsB expression was observed when NaCI concentration increased to 0.3 M (Gervais et al., 
1992). 
The expression of the 115 kDa band, which closely approximates the deduced size of 
the full-length of MrgS, was variable between isolates and growth conditions. Nevertheless, 
the expression of this molecule was more apparent at 25°C in the environmental isolates of 
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B. pseudomallei regardless of pH and salt conditions and this may represent a lower level of 
proteolytic processing or turnover of cell wall components. Similarly, the apparent lack of 
the 90 kDa band in isolates E8 and 576 may arise as a consequence of the proteolysis of the 
full length 115 kDa band. The possibility exists that recycling or degradation of the MrgS 
molecule occurs by a specific proteolytic mechanism and in these isolates that mechanism 
may be absent or the cleavage site(s) within MrgS may be altered. A more striking change 
was observed with the increased expression of the 90 kDa band and the reduction in 
expression of the 30 kDa band at 42°C and its' absence in cultures grown with 2.2% NaCI. 
This change accompanies the increased level of cellular protein synthesis at 42°C and also 
the dramatic decrease in cellular protein production that occurs at this temperature when 
NaCl content is increased to 2.2%. This reduced expression is not apparent at other growth 
temperatures. The conclusion is, therefore, that expression of the 30 kDa band is sensitive to 
higher temperatures but is largely independent of NaCl content. It is possible to speculate 
that the 30 kDa band may arise as a specifically cleaved fragment of the 90 kDa band and 
that this process may be much less efficient at 42°C. 
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CHAPTERS 
GENERAL DISCUSSION 
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The subject of the research presented in this thesis, the saprophyte B. pseudomallei, is 
nutritionally diverse and is capable of resisting a variety of environmental extremes. In 
addition, the bacterium causes melioidosis, an emerging infection that affects the lives of 
many millions of people, particularly in the tropical regions of south-east Asia. This 
pathogen has the potential to adapt to and colonise other areas of the world. A thorough 
review of the scientific literature (Chapter 2) indicates that although there have been 
extensive studies of the biology of B. pseudomallei, very few of these have investigated the 
influence of environmental factors on gene expression and the adaptive responses of the 
bacterium. Recent studies have emphasised the importance of two-component regulatory 
systems in controlling the adaptive responses of many other bacterial species to 
environmental stimuli. This study set out to identify and characterise the genes encoding a 
two-component regulatory system in B. pseudomallei and to examine some of the possible 
environmental conditions that may modify the expression of these genes and control the 
adaptive responses of this pathogen. 
The first step in fulfilling these objectives was the development of an appropriate 
cloning strategy. Genomic libraries were constructed in A.GEM-11 and A.ZAP phage vectors. 
Both libraries, as well as a previously constructed A.GT-11 library, were screened with 
separate DNA probes that were complementary to known two-component gene sequences. 
A number of recombinants were identified, and the fragments of cloned B. pseudomallei 
genomic DNA were sequenced. The initial analysis of these clones was described in Chapter 
4. Nucleotide sequencing of about 4 kb of cloned genomic DNA revealed two open reading 
frames that were designated mrgR and mrgS. Because the deduced amino acid sequences of 
mrgR and mrgS are most similar to the sequences of genes encoding known response 
regulators and sensors, it has been inferred that these two loci constitute a two-component 
signal transduction system. All of the invariant amino acids that are found in RR and HPK 
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proteins are also found in the predicted protein sequences of MrgR and MrgS. The 
molecules are most similar to the RcsB and RcsC proteins that are involved in the regulation 
of capsular polysaccharide synthesis in E. coli and other bacterial species. In accordance 
with the gene organisation of the majority of the known bacterial two-component systems, 
mrgR and mrgS are physically linked on the chromosome. Furthermore, they are likely to be 
transcribed from the same promoter. MrgS, like BvgS of Bordetella pertussis, is a member 
of a family of complex sensor proteins, hybrid kinases, which contain multiple cytoplasmic 
domains that are believed to participate in a phosphorylation cascade in signal transduction. 
Sequence analysis, hydrophilicity profiles and protein expression studies highlighted the 
transmembrane association of MrgS, with a 232 amino acid domain protruding into the 
periplasm, possibly as a means of monitoring environmental parameter(s). The probable 
membrane location of MrgS is expected for a sensor regulatory protein that lends itself to 
signal transduction. On the other hand, the location of MrgR was predicted to be 
cytoplasmic which is consistent with the nature of a DNA-binding protein. 
The copy number for mrgRS was determined by Southern blot analysis. The 
hybridisation pattern indicated that mrgRS is a single copy locus in B. pseudomallei, and it is 
widely distributed among different isolates that have a broad geographical derivation. The 4 
kb mrgRS gene locus has the potential for usage as a B. pseudomal/ei-specific DNA probe, 
and hence as a tool for diagnosis. The probe was highly specific for B. pseudomal/ei DNA 
although the sensitivity of the probe has yet to be determined, particularly when extracting 
DNA from a wide variety of clinical and environmental samples. 
The regions of the genome flanking the mrgRS locus of B. pseudomallei were 
characterised by DNA sequencing and Southern hybridisation analysis. The results of DNA 
sequencing revealed the presence of a single ORF upstream and six ORFs downstream of 
mrgRS. The first gene downstream of the 3' end of mrgS, ORFd, was of special interest 
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because of its' predicted regulatory function and similarity to BvgR which is similarly 
located downstream of the regulatory bvgAS locus of B. pertussis. The deduced amino acid 
sequences of MrgR and MrgS place them in the families of FixJ response regulators and 
hybrid kinases, respectively, and this is also true of BvgA and BvgS of B. pertussis. In this 
way, the mrgRS locus seems to mirror the bvgAS locus. It seems possible that a strategy 
similar to that used by the bvg signal transduction system of B. pertussis could be used by 
the mrgRS locus of B. pseudomallei. If this were the case, then mrgRS and ORFd would 
perform antagonistic regulatory functions. 
Also downstream of mrgRS but reading m the opposite direction lies a sequence 
containing three potential genes, two of which are possibly transcribed from a single 
promoter (Chapter 5). One of these, ORFg, may encode a member of the lipase family, 
possibly phospholipase A I. Although the deduced protein apparently lacks a signal peptide 
for secretion, the downstream ORF, ORFh, is similar to a type III export protein and this 
may provide a possible strategy for the secretion of the putative phospholipase. Intriguingly, 
the third ORF in the series, ORFi, codes for a novel protein that possesses all of the general 
features of a signal peptide but lacks any significant homology to protein sequences in any 
of the public data bases. Southern blot analysis revealed restriction fragment polymorphisms 
in the mrgRS downstream flanking region, one of these was located within ORFg and 
separated isolates of B. pseudomallei into two almost equally sized groups. The biological 
significance of this genetic variation remains to be established experimentally. 
In an attempt to elucidate the effects of environmental variation on the expression of 
mrgR and mrgS, a study was made of the growth of B. pseudomallei under differing 
conditions of temperature, initial pH and NaCl concentration. Although the bacterium grows 
over a wide range of variation in these parameters, the highest quantities of protein were 
produced, as an indication of optimal growth, at 42°C, pH 6.8 and 0.5% NaCI. At either 37 
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or 42°C, and pH 5 and 0.15% NaCI, substantial growth was recorded, whilst at pH 8 all the 
cultures grew poorly. The present finding agrees with earlier studies showing that B. 
pseudomallei is highly adaptable to acidic environments (Yabuuchi et al., 1970; Dejsirilert 
et al., 1991) and its optimum growth temperature in vitro is between 37-42°C (Dance, 
2000abc). While the in vitro situation can only attempt to mimic that of the natural 
environment, these results draw attention to the finding that B. pseudomallei grows 
exceptionally well at 42°C under some conditions. The possible association of B. 
pseudomallei with an intermediate host has been previously suggested. Such associations 
can provide many benefits for the bacterium, such as nutrient supply and freedom from 
competition, especially if the bacterium can enter a privileged niche like the internal 
compartments of host cells. Associations with protozoa (Inglis et al., 2000) or plants (Pitt et 
al., 2000) have been postulated to explain the prevalence and the uneven occurrence of 
bacterial infections especially in endemic areas (Dance, 2000). Birds are considered to be 
relatively resistant to B. pseudomallei infection (Lajudie & Brygoo, 1953) and the preferable 
growth at 42°C of all of the isolates of B. pseudomallei raises the possibility that birds may 
also be candidates for consideration as intermediate hosts. This is consistent with the studies 
of Vesselinova et al. ( 1996) who postulated that hens might act as a reservoir of B. 
pseudomallei and pose a risk for the transmission of active melioidosis to other species. 
Although many bacterial two-component regulatory systems have been identified the 
sensory stimuli to which the systems respond are largely unknown. In an attempt to identify 
the nature of the environmental signal that is transduced by the MrgR!MrgS system, the 
expression of MrgR and MrgS was tested under a range of environmental conditions that 
were considered to mimic those that may be encountered in the host. Western blot analysis 
using anti-MrgR and anti-MrgS antibodies was carried out to examine the expression of 
MrgR and MrgS proteins. The results suggest that this system is under multifactorial control, 
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being expressed under different combinations of temperature, pH and salinity but especially 
at low pH. One possibility is that the MrgR!MrgS system transmits information about low 
pH, perhaps reflecting phagolysosomal pH. 
In this study, the growth of B. pseudomallei under different conditions of pH, salt 
concentration and temperature was not apparently correlated with their ability to express 
MrgR-MrgS two-component regulatory proteins. Although B. pseudomallei responds to 
certain combinations of the tested parameters by reducing protein synthesis, the expression 
of MrgR and MrgS is not greatly affected suggesting that these genes may indeed have 
multiple biological functions. There are a number of possible explanations for the 
requirement for constitutive expression of MrgR and MrgS proteins but the most likely 
seems to be related to the ability of B. pseudomallei to survive in widely varied 
circumstances, from rice paddy fields to mammalian host tissues. Under such rapidly 
changing conditions the bacterium needs to respond quickly in a coordinate manner. MrgR 
and MrgS constitute a two-component regulatory system, where each of the two proteins 
may be coupled to more than one regulatory circuit. Cross-talk, which refers to the non-
specific interactions between non-partner sensor and regulator proteins that collectively 
influence several regulatory responses (Gervais & Drapeau, 1992) (section 2.5.3.6), is 
common between members of the two-component family. This would provide a useful way 
to optimise expression of different sets of genes at any particular time, for example those 
that are needed to survive in the intracellular rather than extracellular situation or vice versa. 
Furthermore, it provides opportunities for signal integration and/or amplification, thereby 
fine-tuning adaptive responses. The EnvZ/OmpR system in E. coli and S. typhimurium is an 
example of a regulon that is networked to several other regulons and plays a role in both 
commensal and pathogenic processes. InS. typhimurium different sets of genes are regulated 
by the PhoPQ two-component regulatory system, in order to effect differential expression 
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during infection (Finlay & Falkow, 1997). Alternatively, such apparently constitutive 
expression may point to the existence of other regulatory factors, whether host-derived or 
endogenous, that come into play in vivo but which are not observed in vitro. On the other 
hand, it may be that other as yet untested parameters will effect substantial changes in the 
expression of MrgR and MrgS in vitro. e.g. iron, nutrients, oxygen, metabolites. 
Fusion proteins, MBP-MrgR and MBP-MrgS, were constructed and expressed in E. 
coli and serum from a convalescent melioidosis patient reacted with MBP-MrgR by 
immunoblotting (section 6.3.5). Although this does not provide definitive proof for the 
specific recognition of MrgR by infected hosts it does raise the possibility that MrgR may be 
expressed by B. pseudomallei during melioidosis infection. It is not yet obvious why a 
cytoplasmic regulatory protein should be exposed to the host immune system and highlights 
the need for further investigation of the mrgRS regulatory locus. 
There are a variety of studies that should be undertaken in order to fully investigate the 
ways in which MrgR and MrgS interact with each other, with other regulatory systems and 
with the transcriptional elements that regulate the expression of other genes. In particular, 
the antibodies that were developed in this study could be used to examine the in vivo 
expression of MrgR and MrgS. Evidence for the direct interaction between MrgR and MrgS 
has yet to be established. The isolation and purification of the MrgR and MrgS proteins will 
allow studies of the predicted biochemical properties of the proteins and their interactions. 
Studies of the phosphorylation of MrgS and the transfer of the phosphate moiety to MrgR 
would support the classification of these proteins as partner molecules of a two-component 
regulatory system. 
In order to facilitate studies into the possible regulatory functions of the mrgRS locus, 
an attempt was made to construct a mrgR null mutant by gene disruption. The loss of 
function as a result of specific mutagenesis, and the restoration of the function by gene 
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complementation, has become the classic way of demonstrating the role of a cloned gene. 
The strategy required the insertion of an antibiotic cassette into the reading frame of mrgR, 
and the cloning of this construct into a non-replicative delivery system or suicide vector 
(Appendix VII). The mutant is generated by the replacement of the wild type allele with the 
disrupted mrgR suicide vector construct. Collaborators are still attempting to achieve this 
goal. The availability of such a mutant will allow further characterisation of the gene locus. 
For instance, differences in the biochemical and protein profiles of B. pseudomallei wild 
type and mrgR mutant strains could then be examined, e.g. by two-dimensional gel 
electrophoresis patterns, to evaluate the genes that are affected by mrgR, particularly under 
different growth conditions. Additionally, the effect on virulence could be assessed in 
experimental models of infection. Bacterial pathogenicity is multifactorial and pathogens 
require a number of mechanisms that may act individually or in concert to produce infection 
and disease. Nevertheless the elimination of a single component may yield valuable data 
about the contribution of the gene to these processes. 
A total of four potential two-component regulatory systems have to date been identified 
m B. pseudomallei. i.e. ir/Riir/S (Jones et al., 1997), pho (Sangiambut et al., 2000), 
mrgR!mrgS and ntrB (this study, Appendix 4). The nature of B. pseudomallei suggests that 
many more of these genes will be identified in this species particularly because the analysis 
of the complete bacterial genome sequences that are currently available indicates that the 
number of two-component systems is related to genome complexity (Msadek, 1999). The 
annotation of the recently completed B. pseudomallei genome sequence will facilitate the 
identification of the genes encoding two-component regulatory systems. Given the important 
regulatory functions of two-component signalling systems, an improved understanding of 
their function in B. pseudomallei could lead to the design of new classes of antibiotics, 
vaccines, or broad-spectrum antimicrobials that can block these signalling pathways. 
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APPENDIX I 
ABBREVIATIONS, MOLECULAR WEIGHTS AND CLASSIFICATIONS OF 
AMINO ACIDS 
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Amino acid Abbreviation MoiWt Cod on Functional Hyd rophobicity Charge Chemical 
Alanine Ala (A) 89 GCA HNP Pho 0 Aliphalic 
GCC 
GCG 
GCU 
Arginine Arg (R) 174 AGA + Phi + Basic 
AGG 
CGA 
CGC 
CGG 
CGU 
Asparagine Asn (N) 132 AAC POU Phi 0 Amide 
AAU 
Aspartic acid Asp (D) 133 GAC - Phi - Acidic 
GAU 
Cysteine Cys (C) 121 UGC POU Phi 0 Sui fur 
UGU 
Glutamic acid Glu (E) 147 GAA POU Phi - Acidic 
GAG 
Glutamine Gin (Q) 146 CAA POU Phi 0 Amide 
CAG 
Glycine Gly (G) 75 GGA POU Phi 0 Aliphatic 
GGC 
GGG 
GGU 
Histidine His (H) 155 CAC + Phi + Basic 
CAU 
Isoleucine lie {I) 131 AUA HNP Pho 0 Aliphatic 
AUC 
AUU 
Leucine Leu (L) 131 CUA HNP Pho 0 Aliphatic 
cue 
CUG 
cuu 
UUA 
UUG 
Lysine Lys (K) 146 AAA + Phi + Basic 
AAG 
Methionine Met (M) 149 AUG HNP Pho 0 Sui fur 
Phenylalanine Phe (F) 165 vue HNP Pho 0 Aromatic 
uuu 
Proline Pro (P) 115 ccu HNP Pho 0 Imino 
ccc 
CCA 
CCG 
Serine Ser (S) 105 AGC POU Phi 0 Hydroxyl 
AGU 
UCA 
ucc 
UCG 
ucu 
Threonine Thr (T) 119 ACA POU Phi 0 Hydroxyl 
ACC 
ACG 
ACU 
Tryptophan Trp (W) 204 UGG HPH Pho 0 Aromatic 
Tyrosine Tyr (Y) 181 VAC POU Pho 0 Aromatic 
UAU 
Valine Val (V) 117 GUA HPN Pho 0 Aliphatic 
GUC 
GUG 
GUU 
Tennination End UAA 
UAG 
UGA 
HNP = Hydrophobic nonpolar. POU = Polar uncharged. Pho =Hydrophobic, Phi= Hydrophilic 
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Fig 1: The structure of the cell wall of a typical Gram-negative bacterium. Adapted from 
Madigan et al. (1999). 
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Fig 2: Sequence features and phosphorylation activities of the communication modules of 
two component regulatory proteins. Abbreviations: T, transmitter; R, receiver; H, histidine; 
D, aspartate; Pi, inorganic phosphate. (Adapted from Parkinson, 1993) 
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Table 1: Examples of two-component regulatory systems from various bacterial species and 
the adaptive responses they regulate. 
System Histidine protein kinase Response regulator(s) Adaptive response Organism 
Che CheA CheB/CheY Chemotaxis Ec/St 
NR = Ntr NRII=NtrB NRI=NtrC Nitrogen regulation Ec/Kp/St 
Nar NarX/NarQ Narl Nitrate regulation Ec 
Pho Ph oR Ph oB Phosphate regulation Ec/Bs 
Omp EnvZ OmpR Porin gene regulation Ec/St 
Spa KinNKinB SpoONSpoOF Sporulation Bs 
Dct DctB DctD Dicarboxylate transport RI 
Hyd HydH HydG Hydrogenase Ec 
Pgt PgtB PgtA Phosphoglycerate transport St 
Arc CpxA AreA Respiratory control Ec 
Cre CreC CreB Catabolite repression Ec 
Vir Vir A VirA/VirG Agrobacterium virulence At 
Pho PhoQ PhoP Salmonella virulence St 
Uhp UhpB UhpA Hexose phosphate uptake Ec 
Fix Fixl FixJ Nitrogen fixation Rm 
Nar NarX Narl Nitrate reductase Ec 
Deg DegS DegU Secretion of enzymes Bs 
Frz FrzE FrzE Motility/development Mx 
Vir= Bvg VirS = BvgS VirR = BvgR Bordetella virulence Bp 
Res RcsC RcsB Capsule synthesis Ec/KpNc 
Alg AlgR2 AlgR1 Capsule synthesis Pae 
Kdp KdpD KdpD Potassium transport Ec 
lrl IriS lriR Heavy metal resistance Bp m 
Abbreviations: Ec, Escherichia coli; St, Salmonella typhi; Kp, Klebsiella pneumoniae; Bs, 
Bacillus subtilis; RI, Rhizobium leguminosarum; At, Agrobacterium tumefaciens; Rm, 
Rhizobium meliloti; Mx, Myxococcus xanthus; Bp, Bordetella pertussis; Vc, Vibrio cholerae; 
Pae, Pseudomonas aeruginosa; Bpm, B. pseudomallei. 
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Table 2: A list of the ORFs that are considered to be involved in phosphotransfer signalling 
in E. coli. Adapted from Mizuno (\998). 
Sensor/regulator Relative adaptive systems, [putative] 
OmpR-family 
PhoR/PhoB Phosphate regulation 
f480/f227 [Cops/R, Pseudomonas, copper response] 
KdpD/KdpE Potassium transport 
TorS/TorR Trimethylamine metabolism 
PhoQ/PhoP Stress situations 
RstB/RstA ? 
f452/f239 [CzcS/C, Alcaligenes, heavy metal homeostasis) 
BaeS/BaeR [AFQ2/1, Streptomyces, secondary metabolism) 
o449/o219 [YgiH/X, Haemophilus, unknown) 
ArcB/ArcA Respiratory control 
EnvZ/OmpR Osmotic regulation 
CpxNCpxR Multiple systems 
BasS/BasR Virulence 
CreC/CreB Catabolite repression 
NarL-family 
NarX/NarL Nitrate regulation 
RcsB/RcsC Capsule synthesis 
EvgS/EvgA [Bvgs/A, Bordetella, virulence) 
NarQ/NarP Nitrate regulation 
UhpB/UhpA Hexose phosphate uptake 
-/FimZ [-/FimZ, Salmonella, fimbria! expression) 
-/UvrY ? 
NtrC-family 
NtrB/NtrC Nitrogen regulation 
AtoS/AtoC Acetoacetate metabolism 
HydH/HydG Labile hydrogenase activity 
f496/f444 ? 
Che Y-family 
CheNCheB/CheY Chemotaxis 
Others 
o552/o226 [-/CriR, Shigella, ipa genes expression) 
YjdH/YjdG [CitNB, Klebsiella, citrate metabolism) 
YehU/YehT [Lyts/T, Bacillus, autolysin response] 
o565/o244 [-/MrkE, Klebsiella, fimbria! expression) 
-/RssB Sigma-S degradation 
YojN ? 
BarN- Pilus adherence 
The annotations in parentheses are putative, based on similarities to the members 
of other species, as indicated. 
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Fig 3: Chromosomal map of E. coli showing the positions of ORFs that are predicted to 
encode one or both of the signal transducer proteins. Adapted from Mizuno ( 1997). 
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APPENDIX Ill 
FORMULATION AND PREPARATION OF MEDIA, BUFFERS AND SOLUTIONS 
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Unless otherwise stated all buffers and media were autoclaved at 121 oc (IS-pounds/square 
inch) for 15 min. The recipes contained the following per litre of distilled and deionised 
water. 
MEDIA FOR BACTERIAL CULTURING 
· Luria-Bertani (LB) broth (pH 7.2) 
Bacto-tryptone 10 g 
Bacto-yeast extract 5 g 
NaCI 5 g 
LB agar 
The same as LB broth plus 1.5% (w/v) agar. 
LB soft agar overlay 
The same as LB broth plus 0.75% (w/v) agar. 
Table 1: ANTIBIOTIC STOCK SOLUTIONS (Filter sterilised, 4°C) 
Antibiotic Stock concentration 
Ampicillin 50 mg/ml 
Chloramphenicol 25 mg/ml 
Kanamycin 25 mg/ml 
Tetracycline 15 mg/ml 
PHAGE MEDIA AND BUFFERS 
NZCYM broth (pH 7.0) 
NZ amine (casein hydrolysate) I 0 g 
Bacto-yeast extract 5 g 
NaCl 5 g 
Casamino acids I g 
MgS04. 7H20 2 g 
NZCYM agar 
The same as NZCYM broth plus 1.5% (w/v) agar 
NZCYM agarose overlay (soft) 
Solvent 
ddHzO 
100% ethanol 
ddH20 
50% v/v ddH20/ethanol 
The same as NZCYM broth plus 0.75% (w/v) agarose 
320 
Working cone. 
50-100 !J.g/ml 
25 !J.glml 
25 !J.g/ml 
15 !J.glml 
BaCteriophage propagation medium 
Consists of the following separately autoclaved solutions: 
Casamino acid 10 g 
M9 salts ( 1 OX) 
20% Maltose 
5 M MgC}z 
I M CaCiz 
M9 salts (lOX) 
Na2HP04 
KH2P04 
NaCl 
N~Cl 
SM buffer 
NaCl 
MgS04.?H20 
I M Tris (pH 7.5) 
2% Gelatine 
100 ml 
20ml 
5ml 
0.1 ml 
60 g 
30 g 
5g 
10 g 
5.8 g 
2g 
50ml 
5 ml 
EXTRACTION AND PURIFICATION OF DNA 
B. PSEUDOMALLEI GENOMIC EXTRACTION SOLUTIONS 
STE solution (pH 8.0) 
NaCl 
Tris-HCl 
EDTA 
Solution A 
Sucrose 
Tris-HCl (pH 8.0) 
Solution B 
Lysozyme 
Tris-HCl (pH 8.0) 
Solution C 
Na2EDT A (pH 8.0) 
0.1 M 
lOmM 
lmM 
25% (w/v) 
0.15 M 
15 mg/ml 
0.05 M 
0.5 M 
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Solution D 
Triton X100 
Na2EDTA 
8% (w/v) 
0.25 M 
PLASMID DNA EXTRACTION SOLUTIONS 
Birnboim and Doly (B & D) (1979) plasmid extraction 
B & D Solution I (Resuspension solution) (pH 8.0) 
Tris-HCI 2S mM 
EDTA IOmM 
Glucose SO mM 
B & D Solution 11 (Lysis solution) 
NaOH 0.2 M 
SDS 1% 
B & D Solution Ill (Neutralisation solution) 
Na acetate SM 
The pH was adjusted to 4.8 with glacial acetic acid 
B & D Solution IV 
Tris-HCI 
Na acetate 
RNase solution 
50 mM (pH 8.0) 
100 mM (pH -'1.6) 
Pancreatic RNase 1 mg/ml in SO mM Tris-HCI (pH 8.0), heated at 95°C for 10 min, then 
stored at 20°C. 
Lysozyme solution 
10 mg/ml in 10 mM Tris-HCI (pH 8.0) 
Tris-EDTA (TE) buffer (pH 8.0) 
Tris-HCI I 0 mM (pH 8.0) 
EDTA !mM 
Phenol: chloroform: IAA mixture (25:24:1) 
Chloroform: iso amyl alcohol (IAA) 24:1, water saturated 
Liquefied phenol equilibrated with Tris buffer (pH 7.4): chloroform IAA I: I 
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AGAROSE GEL ELECTROPHORESIS OF DNA 
Tris-borate-EDTA (TBE) buffer (10 X) 
Tris base 108 g 
Boric acid 
EDT A 0.5 M (pH 8.0) 
55 g 
40ml 
This stock solution was diluted to prepare a 1 X TBE solution. 
Gel loading buffer (6X) 
Per 10 ml ddH20 
Bromophenol blue 
Xylene cyanol FF 
Ficoll400 
Ethidium bromide solution 
0.25 g 
0.025 g 
1.5 g 
Ethidium bromide l 0 mg/ml in ddH20, stored in dark bottles. 
Table 2: Range of DNA separation using different agarose concentrations 
Amount of agarose in gel Efficient range of separation of 
(o/ow/v) linear DNA molecules (kb) 
0.3 5-60 
0.6 I - 20 
0.7 0.8- 10 
0.9 0.5-7 
1.2 0.4-6 
1.5 0.2-3 
2.0 0.1 - 2 
LIGATION CONDENSING AGENT 
Hexaminecobalt chloride (HEX CO) made up as 10 mM stock solution in water and stored at 
-20°C. 
TRANSFORMATION OF RECOMBINANT DNA INTO E. coli K-12 
RF1 medium 
12 g 
9.9 g 
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Potassium acetate (!M, pH 7.5) 30 m! 
CaCh.2 H20 1.5 g 
Glycerol 15 m! 
The pH was adjusted to 5.8 with 0.2 M acetic acid and filter sterilised. 
RF2 medium 
RbCl 
MOPS (0.5 M, pH 6.8) 
CaCh.2 H20 
Glycerol 
1.2 g 
20 ml 
11 g 
150 ml 
The pH was adjusted to 6.8 with NaOH and filter sterilised. 
BLUE/WHITE SCREENING 
IPTG solution 
Isopropyl-p, D-thiogalactopyranoside (IPTG) made up as 24 mg/ml stock solution in dH20. 
Filter sterilised and stored at 4°C. 
X-gal solution 
5-bromo-4-chloro-3-indolyl-P-D-galactoside (X-gal) made up as 20 mg/ml stock solution in 
dimethylforrnamide (DMF). Filter sterilised and stored at 4°C. 
HYBRIDISATION SOLUTIONS 
SSC (20 X) (pH 7.0) 
Na3C6Hs01 
NaCl 
Prehybridisation buffer 
Per litre of SSC (5 X) solution 
88.24 g 
175.32 g 
Blocking reagent (salmon sperm DNA) 0.5% (w/v), 
SDS 0.02% (w/v) 
N-lauroylsarcosine, Na-salt 0.1% (w/v) 
The buffer was made fresh, dissolved and kept at 65oC. 
Hybridisation buffer 
Prehybridisation solution 
Digoxygenin-11-dUTP labelled DNA probe 
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Wash buffer 1 
SSC (20X) 100 ml 
SDS (10%) !Oml 
ddH20 890 ml 
Wash buffer 2 
SSC (20X) 5ml 
SDS (10%) 10 m! 
ddH20 985 m! 
Detection buffer 1 (pH 7.5) 
Tris-HCI lOO mM 
NaCI !50 mM 
Detection buffer 2 
Buffer I 
Blocking reagent 0.5% 
The buffer was made fresh, dissolved and kept at 65°C. 
Detection buffer 3 (pH 9.5) 
Tris-HCI I 00 mM 
NaCI 
MgCh 
lOO mM 
50 mM 
Detection buffer 4 (pH 8.0) 
Tris-HCI 10 mM 
EDTA !mM 
Depurination solution 
HCI 0.2M 
Denaturation solutions 
NaCI 1.5M 
NaOH 0.5 M 
Neutralisation solution 
NaCI 1.5 M 
Tris-HCI (pH 8.0) !M 
Colour development solution 
Per 1 00 ml of Detection buffer 3 
NBT 0.033 g 
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X-phosphate 
Transfer buffer 
SSC (20X) 
ddH20 
0.0165 g 
500 ml 
500 ml 
PROTEIN ANALYSIS SOLUTIONS 
SDS-P AGE preparations 
Buffer A 
Tris-HCl (pH 8.8) 
SDS 
Buffer B 
Tris-HCl (pH 6.8) 
SDS 
Ammonium persulfate (APS) 
0.75 M 
0.2% (w/v) 
0.25 M 
0.2% (w/v) 
Made up as I 0 mg/ml stock solution in dH20 
Resolving gel (12.5%) 
Buffer A 5.2 ml 
dH20 1.4 ml 
Acrylamide (30% w/v) 4.4ml 
APS (1 0 mg/ml) 0.380 ml 
TEMED 30 Ill 
Stacking gel (5%) 
Buffer B 2ml 
dH20 1.3 m! 
Acrylamide (30% w/v) 0.7 m! 
APS (10 mg/ml) 0.1 ml 
TEMED 15 111 
SDS-P AGE loading buffer (2X) 
Per 10 m! 
0.5 M Tris-HCI (pH 6.8) 2.5 ml 
SDS 10% (w/v) 0.2 m! 
P-mercaptoethanol 0.5 m! 
bromophenol blue (0.1 %) 0.5 ml 
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Glycerol 
ddH20 
2.0 ml 
4.3 ml 
SDS-P AGE modified loading buffer 
The same as SOS-PAGE loading buffer minus bromophenol blue 
Electrophoresis buffer (pH 8.3) 
Tris-HCI 
Glycine 
SDS 
3 g 
14.4 g 
I g 
STAINING OF POLYACRYLAMIDE GELS 
Coomassie brilliant blue stain 
Coomassie blue R250 
Methanol 
Acetic acid 
Destaining solution 
Methanol 
Acetic acid 
WESTERN BLOTTING 
Transfer buffer (pH 8.3) 
Tris-HCI 
Glycine 
Methanol 
Phosphate-buffered saline (PBS) 
0.25% 
30% 
10% 
30% 
10% 
3.03 g 
14.4 g 
lOOm! 
One PBS tablet (Oxoid, Basingstoke) dissolved in 100 ml ofddH20. 
Blocking solution 
Casein I% (w/v) in PBS buffer. 
DAB Development solution 
Per I 00 ml PBS buffer 
NaCI 
Tris-Hcl 
DAB 
NiCh 
H202 
1.17 g 
0.6 g 
0.06 g 
0.03 g 
I 00 !!I 
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Fusion protein column buffer (pH 7.4) 
Tris-HCI 20 mM 
NaCI 
EDTA 
PCR 
200mM 
!mM 
Table 3: PCR reaction mixture (50 Jll) 
Components Amount 
Buffer 5 Jll 
dNTP mix (200 f.!M) 0.4 fll 
Sense primer 20 pmollfll 3 fll 
Anti-sense primer 20 pmol/fll 3 fll 
Taq polymerase 5U/fll 0.2 Jll 
Template DNA 20 ng/1 1-3 Jll 
HPLC H20 up to 50 Jll 
PCR buffer (IX) for Taq polymerase (Promega) 
Trsi-HCI pH 9 at 20°C 
KC! 
Triton-X-1 00 
11.2 mM 
56 mM 
0.112% 
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APPENDIX IV 
DATA RELEVANT TO CHAPTER 4 
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Table 1: Complete restriction map of the 4.3 kb EcoRI fragment 
Enzyme 
Aatii 
Acc16I 
AccBli 
AccB7I 
AccBSI 
Ace! 
Ace III 
Acsi 
Acyl 
Afei 
Afliii 
Age! 
Ahdi 
Alw21I 
Alw44I 
AlwNI 
Arna87I 
Aor51HI 
Apai 
ApaLI 
Apoi 
Asci 
AspEI 
As pHI 
Asp! 
At si 
Avai 
Aviii 
Ball 
Ban! 
Ban I! 
Baniii 
Bbei 
Bbiii 
BbrPI 
Bbsi 
Cuts No. Positions of sites Recognition sequence 
137 505 561 3596 
1920 4290 
gacgt/c 
tgc/gca 
g/gyrcc 
4 
2 
5 
1 
9 
139 1173 2293 3198 4013 
3088 
448 462 2065 2653 2764 2920 
3733 4126 
ccannnn/ntgg 
3556 gagcgg 
4 154 1896 2199 2799 
2 123 2790 
3 1 421 4322 
13 134 140 502 558 1174 1431 1714 
1803 2294 2396 3101 3593 4242 
2 1908 2519 
4 601 1795 2202 2301 
1 3021 
1 3256 
7 601 1684 2007 2309 2514 3633 
4191 
1 2305 
1 2377 
10 999 1683 1884 2039 2386 2513 
3062 3560 4211 4237 
2 1908 2519 
1 2863 
1 2305 
3 1 421 4322 
2 114 2268 
1 3256 
7 601 1684 2007 2309 2514 3633 
4191 
1 1892 
1 1892 
10 999 1683 1884 2039 2386 2513 
3062 3560 4211 4237 
2 1920 4290 
2 2381 4223 
5 139 1173 2293 3198 4013 
4 1654 1684 2007 2863 
3 3482 4071 4284 
3 143 1177 2297 
13 134 140 502 558 1174 1431 1714 
1803 2294 2396 3101 3593 4242 
1931 1 
5 653 773 823 895 2074 
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gt/rnkac 
t/ccgga 
r/aatty 
gr/cgyc 
age/get 
a/crygt 
a/ccggt 
gacnnn/nngtc 
gwgcw/c 
g/tgcac 
cagnnn/ctg 
c/ycgrg 
age/get 
gggcc/c 
g/tgcac 
r/aatty 
gg/cgcgcc 
gacnnn/nngtc 
gwgcw/c 
gacn/nngtc 
gacn/nngtc 
c/ycgrg 
tgc/gca 
tgg/cca 
g/gyrcc 
grgcy/c 
at/cgat 
ggcgc/c 
gr/cgyc 
cac/gtg 
qaaqac 
Table 1 continued 
Bbui 4 
Bbv12I 7 
316 588 1027 3314 
601 1684 2007 2309 2514 3633 
4191 
gcatg/c 
gwgcw/c 
Bbv16II 5 
Bcgi 7 
Bell 1 
Bcoi 10 
653 773 823 895 2074 
327 507 1173 1383 2981 3179 
1618 
999 1683 1884 2039 2386 2513 
3062 3560 4211 4237 
gaagac 
4025cgannnnnntgc 
t/gatca 
c/ycgrg 
Bgli 4 
gccnnnn/nggc 
Blpi 3 
Bpii 5 
Bpmi 3 
Bpull02I 3 
Bpu14I 3 
BpuAI 5 
Bsa29I 3 
BsaAI 2 
BsaBI 4 
BsaHI 13 
1639 2961 3787 4256 
3218 3662 3836 
653 773 823 895 2074 
1820 2484 3142 
3218 3662 3836 
239 1096 3228 
653 773 823 895 2074 
3482 4071 4284 
1931 3336 
642 753 2081 3614 
134 140 502 558 1174 1431 1714 
1803 2294 2396 3101 3593 4242 
Bsai 
BsaMI 
BsaOI 
1 3816 
4 97 311 1187 1793 
26 58 169 218 254 296 379 611 646 
1113 1135 1375 2079 2421 2433 
2508 2706 2719 2736 3108 3162 
3706 3772 4195 4251 4271 4284 
gc/tnagc 
gaagac 
ctggag 
gc/tnagc 
tt/cgaa 
gaagac 
at/cgat 
yac/gtr 
gatnn/nnatc 
gr/cgyc 
ggtctc 
gaatgc 
cgry/cg 
BsaWI 
Bsci 
Bse118I 
7 123 702 869 2790 2885 3006 3021 w/ccggw 
3 3482 4071 4284 at/cgat 
18 298 793 1101 1112 1747 2132 2290 r/ccggy 
Bse8I 
BseAI 
BseCI 
BsePI 
BseRI 
Bsgi 
Bsh1285I 
Bsh1365I 
BshNI 
BsiEI 
2714 2731 3021 3103 3195 3705 
3884 3896 3993 4016 4270 
4 642 753 2081 3614 gatnn/nnatc 
2 123 2790 t/ccgga 
3 3482 4071 4284 at/cgat 
19 114 302 1707 1863 2174 2268 2469 g/cgcgc 
2555 2710 3055 3164 3269 3301 
3542 3572 3599 3880 3900 4038 
4 1670 2167 2611 3679 
3 1931 2374 2728 
26 58 169 218 254 296 379 611 646 
1113 1135 1375 2079 2421 2433 
2508 2706 2719 2736 3108 3162 
3706 3772 4195 4251 4271 4284 
4 642 753 2081 3614 
5 139 1173 2293 3198 4013 
26 58 169 218 254 296 379 611 646 
1113 1135 1375 2079 2421 2433 
331 
gaggag 
gtgcag 
cgry/cg 
gatnn/nnatc 
g/gyrcc 
cgry/cg 
Table I continued 
BsiHKAI 
Bsii 
BsiMI 
BsiWI 
BsmBI 
Bsmi 
BsoBI 
Bsp106I 
Bsp119I 
Bsp120I 
Bsp13I 
Bsp143II 
Bsp1720I 
Bsp68I 
BspCI 
BspDI 
BspEI 
BspMI 
BspXI 
BsrBI 
BsrBRI 
BsrDI 
BsrFI 
BssAI 
BssHII 
BssSI 
BssTli 
BstBI 
BstD102I 
BstDSI 
BstEII 
BstH2I 
7 
9 
2 
2 
1 
4 
10 
3 
3 
1 
2 
9 
3 
1 
10 
3 
2 
2 
3 
9 
4 
3 
18 
2508 2706 2719 2736 3108 3162 
3706 3772 4195 4251 4271 4284 
601 1684 2007 2309 2514 3633 
4191 
gwgcw/c 
289 343 1093 1168 2248 2503 2767 ctcgtg 
2980 3523 
123 2790 
1567 3336 
3595 
97 311 1187 1793 
999 1683 1884 2039 2386 2513 
3062 3560 4211 4237 
3482 4071 4284 
239 1096 3228 
2859 
123 2790 
143 347 1177 1296 1910 2218 2282 
2297 2521 
3218 3662 3836 
3734 
169 218 611 646 1375 2079 2706 
3162 3772 4284 
3482 4071 4284 
123 2790 
925 3206 
3482 4071 4284 
448 462 2065 2653 2764 2920 3556 
3733 4126 
642 753 2081 3614 
501 905 1081 
298 793 1101 1112 1747 2132 2290 
2714 2731 3021 3103 3195 3705 
3884 3896 3993 4016 4270 
t/ccgga 
c/gtacg 
cgtctc 
gaatgc 
c/ycgrg 
at/cgat 
tt/cgaa 
g/ggccc 
t/ccgga 
rgcgc/y 
gc/tnagc 
tcg/cga 
cgat/cg 
at/cgat 
t/ccgga 
acctgc 
at/cgat 
gagcgg 
gatnn/nnatc 
gcaatg 
r/ccggy 
18 298 793 1101 1112 1747 2132 2290 r/ccggy 
19 
9 
1 
3 
9 
2 
1 
9 
2714 2731 3021 3103 3195 3705 
3884 3896 3993 4016 4270 
114 302 1707 1863 2174 2268 2469 
2555 2710 3055 3164 3269 3301 
3542 3572 3599 3880 3900 4038 
289 343 1093 1168 2248 2503 2767 
2980 3523 
3456 
239 1096 3228 
448 462 2065 2653 2764 2920 3556 
3733 4126 
230 2590 
4312 
143 347 1177 1296 1910 2218 2282 
2297 2521 
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g/cgcgc 
ctcgtg 
c/cwwgg 
tt/cgaa 
gag egg 
c/crygg 
g/gtnacc 
rgcgc/y 
Table I continued 
BstMCI 26 58 169 218 254 296 379 611 646 egry/eg 
1113 1135 1375 2079 2421 2433 
2508 2706 2719 2736 3108 3162 
3706 3772 4195 4251 4271 4284 
BstPI 1 4312 g/gtnaee 
BstSFI 2 2210 2924 e/tryag 
BstX2I 2 2680 3414 r/gatey 
BstYI 2 2680 3414 r/gatey 
BstZI 11 55 251 293 376 1110 1132 2418 e/ggeeg 
2505 2716 4248 4268 
Bsu15I 3 3482 4071 4284 at/egat 
CeiNI 1 293 ge/ggeege 
Celii 3 3218 3662 3836 ge/tnage 
Cfr10I 18 298 793 1101 1112 1747 2132 2290 r/eeggy 
2714 2731 3021 3103 3195 3705 
3884 3896 3993 4016 4270 
Cfr42I 2 233 2593 eege/gg 
Cfr9I 2 999 4237 e/eeggg 
Cfri 19 55 251 293 376 1110 1132 1357 y/ggeer 
1912 2118 2379 2418 2505 2716 
3240 3453 4182 4221 4248 4268 
Cl a! 3 3482 4071 4284 at/egat 
Cpoi 2 2788 3193 eg/gweeg 
Csp45I 3 239 1096 3228 tt/egaa 
Cspi 2 2788 3193 eg/gweeg 
Ora!! 1 2860 rg/gneey 
Draiii 2 1427 2326 eaennn/gtg 
Drdi 3 1941 2429 4241 
gaennnn/nngte 
Dsai 2 230 2590 e/erygg 
Ea er 19 55 251 293 376 1110 1132 1357 y/ggeer 
1912 2118 2379 2418 2505 2716 
3240 3453 4182 4221 4248 4268 
Eagi 11 55 251 293 376 1110 1132 2418 e/ggeeg 
2505 2716 4248 4268 
Eam1104 I 1 3967 etette 
Eam1105I 1 3256 
gaennn/nngte 
Earl 1 3967 etette 
Eell36II 2 1682 2005 gag/ete 
EelHKI 1 3256 
gaennn/nngte 
Eel XI 11 55 251 293 376 1110 1132 2418 e/ggeeg 
2505 2716 4248 4268 
Eeo130I 1 3456 e/ewwgg 
Eeo24I 4 1654 1684 2007 2863 grgey/e 
Eeo31I 1 3816 ggtete 
Eeo32I 3 52 787 2444 gat/ate 
Eeo47III 2 1908 2519 age/get 
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Table 1 continued 
Eco52I 11 55 251 293 376 1110 1132 2418 c/ggccg 
2505 2716 4248 4268 
Eco57I 3 2056 3853 3955 ctgaag 
Eco64I 5 139 1173 2293 3198 4013 g/gyrcc 
Eco72I 1 1931 cac/gtg 
Eco88I 10 999 1683 1884 2039 2386 2513 c/ycgrg 
3062 3560 4211 4237 
Eco91I 1 4312 g/gtnacc 
EcoiCRI 2 1682 2005 gag/ctc 
EcoNI 2 3206 3671 cctnn/nnnagg 
Eco0109I 1 2860 rg/gnccy 
Eco065I 1 4312 g/gtnacc 
EcoRI 2 1 4322 g/aattc 
EcoRV 3 52 787 2444 gat/ate 
EcoT14I 1 3456 c/cwwgg 
EcoT22I 1 1513 atgca/t 
Ehei 3 141 1175 2295 ggc/gcc 
Er hi 1 3456 c/cwwgg 
Esp1396I 1 3088 ccannnn/ntgg 
Esp3I 1 3595 cgtctc 
FauNDI 2 1210 2616 ca/tatg 
Fbai 1 1618 t/gatca 
FriOI 4 1654 1684 2007 2863 grgcy/c 
Fsei 1 4274 ggccgg/cc 
Fspi 2 1920 4290 tgc/gca 
Gsui 3 1820 2484 3142 ctggag 
Haeii 9 143 347 1177 1296 1910 2218 2282 rgcgc/y 
2297 2521 
Hinli 13 134 140 502 558 1174 1431 1714 gr/cgyc 
1803 2294 2396 3101 3593 4242 
Hincii 7 155 1801 1897 2200 2229 2800 gty/rac 
3622 
Hindii 7 155 1801 1897 2200 2229 2800 gty/rac 
3622 
Hsp92I 13 134 140 502 558 1174 1431 1714 gr/cgyc 
1803 2294 2396 3101 3593 4242 
Kasi 3 139 1173 2293 g/gcgcc 
!Kpn2I 2 123 2790 t/ccgga 
Ksp22I 1 1618 t/gatca 
Ksp632I 1 3967 ctcttc 
Kspi 2 233 2593 ccgc/gg 
Lspi 3 239 1096 3228 tt/cgaa 
M ami 4 642 753 2081 3614 gatnn/nnatc 
Mfli 2 2680 3414 r/gatcy 
Mlui 3 601 1795 2301 a/cgcgt 
MluNI 2 2381 4223 tgg/cca 
Mph1103I 1 1513 atgca/t 
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Table 1 continued 
Mroi 
MroNI 
Msci 
Msli 
Msp17I 
MspAli 
Mva1269I 
Naei 
Nari 
Ndei 
NgoAIV 
NgoMI 
Noti 
Nrui 
Nsii 
NspBII 
Nspi 
NspV 
Paei 
PaeR7I 
Pfl23II 
PflMI 
PinAI 
Ple19I 
PmaCI 
Pmli 
Ppu10I 
PshAI 
Psp124BI 
Psp1406I 
PspAI 
PspALI 
PspEI 
PspLI 
PspOMI 
Psti 
Pvui 
Pvuii 
Rsrii 
Sac I 
Sac II 
Sali 
Sfci 
Sfr274I 
Sfr303I 
2 
6 
2 
7 
13 
6 
4 . 
6 
3 
2 
6 
6 
1 
1 
1 
6 
7 
3 
4 
4 
2 
1 
1 
10 
123 2790 
298 2290 2714 3884 3896 4270 
2381 4223 
44 311 1259 1641 2312 3389 4250 
134 140 502 558 1174 1431 1714 
1803 2294 2396 3101 3593 4242 
232 1628 2020 2545 2592 3508 
97 311 1187 1793 
300 2292 2716 3886 3898 4272 
140 1174 2294 
1210 2616 
298 2290 2714 3884 3896 4270 
298 2290 2714 3884 3896 4270 
293 
3734 
1513 
232 1628 2020 2545 2592 3508 
316 416 588 908 1027 1847 3314 
239 1096 3228 
316 588 1027 3314 
2039 2513 3062 4211 
1567 3336 
3088 
3021 
169 218 611 646 1375 2079 2706 
3162 3772 4284 
1 1931 
1 1931 
1 1509 
1 3104 
2 1684 2007 
1 1327 
2 999 4237 
2 1001 4239 
1 4312 
2 1567 3336 
1 2859 
2 2214 2928 
10 169 218 611 646 1375 2079 2706 
3162 3772 4284 
1 1628 
2 2788 3193 
2 1684 2007 
2 233 2593 
4 153 1895 2198 2798 
2 2210 2924 
4 2039 2513 3062 4211 
2 233 2593 
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t/ccgga 
g/ccggc 
tgg/cca 
caynn/nnrtg 
gr/cgyc 
cmg/ckg 
gaatgc 
gcc/ggc 
gg/cgcc 
ca/tatg 
g/ccggc 
g/ccggc 
gc/ggccgc 
tcg/cga 
atgca/t 
cmg/ckg 
rcatg/y 
tt/cgaa 
gcatg/c 
c/tcgag 
c/gtacg 
ccannnn/ntgg 
a/ccggt 
cgat/cg 
cac/gtg 
cac/gtg 
a/tgcat 
gacnn/nngtc 
gagct/c 
aa/cgtt 
c/ccggg 
ccc/ggg 
g/gtnacc 
c/gtacg 
g/ggccc 
ctgca/g 
cgat/cg 
cag/ctg 
cg/gwccg 
gagct/c 
ccgc/gg 
g/tcgac 
c/tryag 
c/tcgag 
ccgc/gg 
Table 1 continued 
Sfui 3 239 1096 3228 tt/cgaa 
SgrAI 2 298 793 cr/ccggyg 
Smai 2 1001 4239 ccc/ggg 
Sphi 4 316 588 1027 3314 gcatg/c 
Spli 2 1567 3336 c/gtacg 
Srfi 1 1001 gccc/gggc 
Ssti 2 1684 2007 gagct/c 
Sstii 2 233 2593 ccgc/gg 
Sty I 1 3456 c/cwwgg 
Sun I 2 1567 3336 c/gtacg 
Tth111I 1 1892 gacn/nngtc 
Van91I 1 3088 ccannnn/ntgg 
Vnei 1 2305 g/tgcac 
Xcmi 1 3463 ccannnnn/nnnntgg 
Xhoi 4 2039 2513 3062 4211 c/tcgag 
Xhoii 2 2680 3414 r/gatcy 
Xmai 2 999 4237 c/ccggg 
Xmaiii 11 55 251 293 376 1110 1132 2418 c/ggccg 
2505 2716 4248 4268 
Zsp2I 1 1513 atgca/t 
The following endonucleases don't cut the sequence: 
Aati, Accll3I, Acc65I, AclNI, Aflii, Aoci, Asei, Asni, Asp700I, Asp718I, 
Avrii, BamHI, Bfri, Bglii, Blni, Bse21I, Bspl407I, Bspl9I, BspHI, BspLUlli, 
BspTI, BsrGI, Bstll07I, Bst98I, Bsti, BstSNI, BstXI, Bsu36I, Cvni, Drai, 
EcolOSI, Ecol47I, Eco255I, Eco81I, Hindiii, Hpai, Kpni, Mfei, MspCI, Muni, 
Ncoi, Nhei, Paci, Pme55I, Pmei, PpuMI, PshBI, PspSII, PstNHI, Real, Sapi, 
Sbfi, Seal, SexAI, Sfii, Sgfi, Smii, SnaBI, Spei, Sse8387I, SseBI, SspBI, 
Sspi, Stul, Swai, Vha464I, Vspi, Xbai, Xmni. 
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Table 2: Codon usage deduced from ORFa (mrgR) 
Cod on Count 0/o Cod on Count % Cod on Count 0/o Cod on Count % 
TIT-Phe 2 0.09 TCT-Ser 0 0.00 TAT-Tyr 0 0.00 TGT-Cys 0 0.00 
TTC-Phe ... .) 1.35 TCC-Ser 2 0.90 TAC-Tyr 2 0.90 TGC-Cys 3 1.35 
TTA-Leu 0 0.00 TCA-Ser 0 0.00 TAA-*** 0 0.00 TGA-*** I 0.45 
TTG-Leu 5 2.25 TCG-Ser 11 4.95 TAG-*** 0 0.00 TGG-Trp 0 0.00 
CTT-Leu I 0.45 CCT-Pro 0 0.00 CAT-His 3 1.33 CGT-Arg I 0.45 
CTC-Leu 7 3. 15 CCC-Pro I 0.45 CAC-His 4 1.80 CGC-Arg 10 4.50 
CTA-Leu 0 0 .00 CCA-Pro 0 0.00 CAA-Gin 2 0.09 CGA-Arg 0 0.00 
CTG-Leu 12 5.40 CCG-Pro 5 2.25 CAG-Gin 4 1.80 CGG-Arg 3 1.35 
ATT-Ile 0 0.00 ACT-Thr 0 0.00 AAT-Asn 4 1.80 AGT-Ser 0 0.00 
ATC-Ile 9 4.05 ACC-Thr 4 1.80 AAC-Asn 5 2.25 AGC-Ser 5 2.25 
ATA-Ile 0 0.00 ACA-Thr I 0.45 AAA-Lys I 0.45 AGA-Arg I 0.45 
ATG-Met 9 4.05 ACG-Thr 9 4.05 AAG-Lys 5 2.25 AGG-Arg 2 0.90 
GTT-Val 2 0.90 GCT-Aia I 0.45 GAT-Asp 4 1.80 GGT-Gly I 0.45 
GTC-Val 12 5.40 GCC-Aia 7 3. 15 GAC-Asp 7 3. 15 GGC-Giy 10 4.50 
GTA-Val I 0.45 GCA-Aia I 0.45 GAA-Giu I 0.45 GGA-Giy I 0.45 
GTG-Val 12 5.40 GCG-Aia 11 4.95 GAG-Giu 10 4.50 GGG-Giy 4 1.80 
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Table 3: Codon usage deduced from ORFb (mrgS) 
Cod on Count 0/o Cod on Count 0/o Cod on Count 0/o Cod on Count % 
TIT-Phe 4 0.37 TCT-Ser 0 0.00 TAT-Tyr 10 0.92 TGT-Cys I 0.09 
TTC-Phe 35 3.24 TCC-Ser 10 0.92 TAC-Tyr 12 1.11 TGC-Cys 13 1.20 
TTA- Leu 0 0.00 TCA-Ser I 0.09 TAA-•u 0 0.00 TGA-*** I 0.09 
TTG- Leu 17 1.57 TCG-Ser 33 3.05 TAG-*** 0 0.00 TGG-Trp 14 1.29 
CTT-Leu 5 0.46 CCT-Pro 2 0.18 CAT-His 6 0.55 CGT-Arg 3 0.27 
CTC-Leu 46 4.26 CCC-Pro 9 0.83 CAC-His 15 1.39 CGC-Arg 46 4.26 
CTA-Leu 3 0.27 CCA-Pro I 0.93 CAA-Gln 5 0.09 CGA-Arg I 0.09 
CTG-Leu 62 5.74 CCG-Pro 44 4.07 CAG-Gln 28 2.95 CGG-Arg 33 3.05 
ATT-Jle 3 0.27 ACT-Thr I 0.09 AAT-Asn 9 0.83 AGT-Ser I 0.09 
ATC-lle 40 3.70 ACC-Thr 10 0.92 AAC-Asn 19 1.76 AGC-Ser 30 2.78 
ATA-lle 0 0.00 ACA-Thr 2 0.18 AAA-Lys 3 0.27 AGA-Arg I 0.09 
ATG-Met 32 2 .. 96 ACG-Thr 39 3.61 AAG-Lys 20 1.85 AGG-Arg 5 0.46 
GTT-Val 3 0 .27 GCT-Ala 2 0.18 GAT-Asp 19 1.76 GGT-Gly 6 0.55 
GTC-Val 28 2.59 GCC-Ala 34 3.15 GAC-Asp 36 3.33 GGC-Gly 45 4.17 
GTA-Val I 0.09 GCA-Aia 6 0.55 GAA-Giu 26 2.40 GGA-Gly 11 1.01 
GTG-Val 49 4.54 GCG-Aia 83 7.69 GAG-Giu 43 3.98 GGG-Giy 12 1.1 I 
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Fig 1: Multiple sequence alignment of proteins with >59% homology with the response 
regulator MrgR. Highly conserved amino acids are in bold and underlined. 
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I I I I I I 
-------------MIKVLVVDDHDLVRTGITRMLADIDGLQVVGQADSGEESLKKARELK 
-------------MIRVLVVDDHDLVRTGITRMLADIDGLQVVGQAESGEESLLKARELK 
-------------MISVFLVDDHELVRTGIRRIIEDVRGMKVAGEADSGEEAVKWCRTNH 
-------------MIRVLIADDHEIVRAGLRQFLSEERDIEVAGEAASGEEVMEQLRTEA 
-------------MITVALIDDHLIVRSGFAQLLGLEPDLQVVAEFGSGREALAGLPGRG 
--------MNEGTTTRILLVDDHPMMRRGLRDLLDLEDDLEMVGEAGNGEDAIRLALQIE 
--------MPEATPFQVMIVDDHPLMRRGVRQLLELDPGSEVVAEAGDGASAIDLANRLD 
--------MSARPPIRVLLADDHTLVRRGVRLILDGEPDLTVVAEAGDGAEAVAAARATE 
-----------MNNLNVIIADDHPIVLFGIRKSLEQIEWVNVVGEFEDSTALINSLSKLD 
-----------MNNMNIIIADDHPIVLFGIRKSLEQIEWVNVVGEFEDSTALINNLPKLD 
-----------MNNLNIIIADDHPIVLFGIRKSLEQIEWVNVVGEFEDSTSLINNLSKLN 
-----------MNNLNIIIADDHPIVLFGIRKSLEQIEWVNVVGEFEDSTSLINNLSKLN 
------MSNVALHTRKVVVADDHPIVLRAVTDYVNSLPGFHVVASVSSGDALLSAMREQE 
------------MYNKVLIIDDHPVLRFAVRVLMEKE-GFEVIGETDNGIDGLKIAREKI 
MQAALKLQSDDARPLQILIVDDHPVVAEGWGRIIRTKTACEIASAP-SASEGWRAWRQAR 
: *** 
70 80 90 100 110 120 
I I I I I I 
PDVVLMQVKMP----GIG~LEATRKMLRSHPDIKVVAVTVCEEDPFPTRLLQAGAA~YMT 
PYVVLMQVKMP----GIG~LEATRKLLRSHPDIKVVAVTVCEEDPFPTRLLQAGAA~YLT 
ADVILMQMNMP----GIG~LEATKKLLRVNPDIKIIVLTVHTENPFPTKVMQAGAA~YLT 
FDVVV~ISMP----DRN~IDTLKLVRQRHPDLPVLILSTFPEDQYAINLIRAGAS~YLT 
VQVCICQISMP----DIS~LELLSQLPKG---MATIVLSVHDSPALVEQALNAGAR~FLS 
PDLILMQLNMP----GID~LETTRRMRDADIDARIIMFTVSDEQSHVLEALRNGAD~YLL 
IDVILLQLNMK----GMS~LDTLNALRRDGVTAQIIILTVSDASSDVFALIDAGAD~YLL 
IDLAVLQVAMP----RMT~LQAARELSRRLPELRILILTMYDNEQYFFEALKAGAC~YVL 
ANVLVTDLSMPGEKYG-DGITLIKYIKRHYPDLSIIVLTMNNNPAILSAVLDLDIEGIVL 
- - -AHVLITDLSMPGDKYG-DGITLIKYIKRHFPSLSIIVLTMNNNPAILSAVLDLDIEGIVL 
ADALITDLSMPGDKYG-DGITLIKYIKRHYPNLSIIVLTMNNNPAILSAVLDLEIGGIVL 
- -ADALITDLSMPGDKYG-DGITLIKYIKRHYPNLSIIVLTMNNNPAILSAVLDLEIGGIVL 
- -VNLVVTQFTMHQANDDKD~LRLISHLMRAYERTPIIVFTMLTNSGVISQLCRMGVA~LVG 
PNLVVLQIGIP----KLD~LEVIARLQSLGLPLRVLVLTGQPPSLFARRCLNSGAA~FVC 
PDLMVVQLSIG--RNKIA~IRLIERLRRVDPDLPILVFTMHRSPVLARRALMFGAN~IIN 
*. . * : * : 
130 140 150 160 170 180 
I I I I I I 
~GAGLAEMVQAIRLVFAGQ-RYISPQIAQQLALKSFQPQVNN--SPFDLLSE~IQIALM 
~GAGLNEMVQAIRLVFAGQ-RYISPQIAQQLVFKSFQPSSD---SPFDALSE~IQIALM 
~GAAPDEMVNAIRIVHSGQ-RYISPEIAQQMALSQFSPASE---NPFADLSE~LQIMLM 
~ESAPDELVKAIRTVSQGR-RYVSPTVAELLIGGLEKPTDQ---PLHQTLSK~FQIFCK 
~RCSPDELIAAVHTVATGG-CYLTPDIAVKLAAGRQDPLTK-----------~RQVAEK 
~DMDAEQLIEQIRIAATGR-MALSPELTQVLAEAIRVRPKPSGQVQFSHLTK~KEVLRL 
~DSDPEVLLEAIRAGAKGS-KVFSERVNQYLREREMFGAEED---PFSVLTE~LDVLHE 
~SVADRDLVEACRAAVRDE-PFIYPGAERALVRSYLDRVQGGGGLPERPITE~EEILKL 
KQGAPTDLPKALAALQKGK--KYTPESVAKLLEK--ISAGG---YGDKRLSPKESEVLRL 
~QGAPTDLPKALAALQKGK--KFTPESVSRLLEK--ISAGG---YGDKRLSP~SEVLRL 
KQGAPADLPKALAALQKGK--KFMPESVAKLLEK--VNANG---YGDKRLSPKE SEVLRL 
~QGAPADLPKALAALQKGK--KFMPESVAKLLEK--VNANG---YGDKRLSP~SEVLRL 
KEEEIAELGRVCVSVARGVSQSLSPGMAHRLAAVGSIRPGE---AAFNALTPKELEVVRL 
EHENLHEVINAAKAVMAGY-TYFPSTTLSEMRMGDNAKSDS---TLISVLSNRELTVLQL 
KDSPPAEICAAFTEVARGG- NYVDSRLAMQIALLNVSRPGT----SAPRLTGREEEILGM 
* =* 
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Fig 1 continued 
Psy GacA 
Pfl GacA 
Vc VarA 
Ra s VsrA 
St UhpA 
Pst NarL 
Ec NarP 
Se Sc4H 
Era RcsB 
St RcsB 
Prm RcsB 
Ec RcsB 
Bpm MrgR 
Bpe BvgA 
Pde Mo xX 
190 200 210 220 230 
I I I I I 
IVGCQKVQT~SDKLCLSPK!VNTYRYRIFE~SISSDVELALLAVRHGMVDASA-- ­
IVGCQKVQI~SDKLCLSPK!VNTYRYRIFE~LSISSDVELTLLAVRHGMVDASL--­
ITKGQKVTD~SEQLSLSPN!VNSYRYRLF~LNING DVELTHLAIRHGILDTEKL- ­
LARGQSVSI~AEELFLSVK!VSTYRTRILE~GMKSNADLTYYAIKNGLVE- --- - ­
LAQGMAVKE~AAELGLSPK!VHVHRANLLE~GVSNDVELAHRMFDGW--------­
IAKGQSNKM!ARKLGITEG!VKVHVKNLLH~GLRSRVEAAVWVLENEAKG----- ­
LAQGLSNKQ~ASVLNISEQ!VKVHIRNLLR~NVRSRVAATILFLQQRGAQ-----­
VAEGHTSKE!GELLFISAK!VERHRANLLQ~GVRDRLELTRYAIRAGLIEP---- ­
FAEGFLVTE~AKKLNRSIK!ISSQKKSAMM~GVDNDIALLNYLSSVSMTPVDK--­
FAEGFLVTE~AKKLNRSIK!ISSQKKSAMM~LGVENDIALLNYLSSVTLSPTDKE-­
FAEGFLVTE~AKKLNRSIK!ISSQKKSAMM~GVDNDIALLNYLSSVTIDKEINGES 
FAEGFLVTE~AKKLNRSIK!ISSQKKSAMM~GVDNDIALLNYLSSVTIDKEINGES 
FTGGMSLTD~ARTLNRSLG!VSTQKRS~HVDTNVDLINCAREQGLL------­
LAQGMSNKD~ADSMFLSNK!VSTYKTRLLQ~NATSLVELIDLAKRNNLA------­
ITEGMSYRDI ADRACISYKTVSNVSLVLKDKLGAANLADLVVKGIRYFEGD------
- -
* * : * : 
Abbreviations: Psy, Pseudomonas syringae; Pfl, Pseudomonas jluorescens; Ye, Vibrio 
cholerae; Ras, Ralstonia solanacearum, St, Salmonella typhi; Ec, Escherichia coli; Se, 
Streptococcus coelicolor; Era, Erwinia amylovora; Prrn, Proteus mirabilis; Bpm, 
Burkholderia pseudomallei; Bpe Bordetella p ertussis; Pde, Paracoccus denitrificans. 
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Fig 2: Multiple sequence alignment of the C-terminal of proteins with > 34% homology with 
the MrgS sensor regulator. Highly conserved amino acids are in bold and underlined. 
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I I I I I I 
--TFISTISHELRTPLNGIVGLSRILLDTELTAEQEKY-LKTIHVSAVTLGNIFNDIIDM 
--DFLAKMSHE I RTPINGILGVAQLLKDSVDTQEQKNQ-IDVLCHS GEHLLAVLNDILDF 
KSEFLANMSHEIRTPLNGIL~FTHLLQKSELTPRQLDY-LGTIEK~ADS~LGIINEI~F 
KSEFLANMSHE I RTPLNGILGFTHLLQKSELTPRQLDY- LGTIEKSADSLLGIINEILDF 
KSEFLANMSHE I RTPLNGILGFTHLLQKSELSPRQLDY-LGTIEKSADNLLGIINEILDF 
KSEFLANMSHE IRTPLNGIL~FTHLLQKSELTPRQFDY-LGTIEK~ADN~LSIINEIL~F 
- ---LANMSHE IRTPLNGIL~FTHLLQKSELTPRQFDY-LGTIEK~ADN~LSIINEI~F 
KSEFLANMSHE IRTPLNGIL~FTNLLQKSELSPRQQDY-LTTIQK~AES~LGIINEILQF 
KSEFLANMSHE IRTPLNGII~FTNLLQKCELTPRQHDY-LNTIQK~ADS~LDIINEILQF 
KSEFLANMSHELRTPLNGLI~FTRQTLKTPLNTTQTDY-LLTIER~ANN~LNIINDVLQF 
KSEFLANMSHELRTPLNGVI~FTRLTLKTELTPTQRDH-LNTIER~ANN~LAIINDVLQF 
--MFLATVSHELRTPLYGII~NLDLLQTKELPKGVDRL-VTAMNN~SSL~LKIISDILQF 
---FLATVSHELRTPLYGII~NLELLQSLTQNEETARL-LKTMDN~SSL~LKIISDI~F 
-VAFFASMSHEIRTPLSSLV§NIELIARGPLAPEQQAR-VKAMET~ARG~QIVNDVLQF 
-TTFLATMSHEIRTPMNAII~MLELALLRPADQEPDRQSIQVAYD~ARS~LELIGDILQI 
:: . :***:***: . : :* * * : . . ::: * : 
70 80 90 lOO 110 120 
I I I I I I 
D~ERRKVQLDNQPVDFTSFLADLENLSALQAQQKGLRFNLEPTLPLPHQVITQGT~LRg 
S~IEQGKFNIQKHPFSFTDTMRTLENIYRPICTNKGVELVIENELDPNVEIFTQQ~LNg 
S~IEAGKLVLDSIPFNLRDLLQDTLTILAPAAHAKQLELVSLVYRDTPLSLVGQPL~Kg 
S~IEAGKLVLDSIPFNLRDLLQDTLTILAPAAHAKQLELVSLVYRDTPLSLVGQPL~LKg 
S~IEAGKLVLDSVPFNLRDLLQDTLTILAPAAHAKQLELVSLVYRDTPLALVGQPL~LKg 
S~IEAGKLVLDNIPFNLRDLLQDTLTILAPAAHAKQLELVSLVYRDTPLALSGQPL~Rg 
S~IEAGKLVLDNIPFNLRDLLQDTLTILAPAAHAKQLELVSLVYRDTPLALSGQPL~LRg 
S~IEAGKLVLENLPFNLRDLIQDALTMLAPAAHEKQLELVSLVYRDTPIQLQGQPQ~LKg 
S~IEAGKLVLEHTPFNLRELIQDTLTILAPAAHA.KHLELVSLIYRDTPLALNGQPQ~LRg 
S~LEAGKLVLEDIPFSLHNTLDDVVMLLAHTAHEKGLELTLSIQNDVPEQFVGQPL~IQg 
S~LEAGKLILESIPFPLRSTLDEVVTLLAHSSHDKGLELTLNIKSDVPDNVIGQPL~LQg 
S~IESEQLKIEPREFSPREVMNHITANYLPLVVRKQLGLYCFIEPDVPVALNGQPM~LQg 
S~IESKQLKIDVKPFNCRQVVSFVISNYLPLIAKKDLAIYCFIEPDVPKIVNNQPV~VQg 
S~IDVGELSLMEEWSNIAELLDRLALSHAPLATQQGLKFYMVFDRSLPARLYFQPI~Vsg 
~IEAGKFDLAPVRTALRALPEGAIRVFDGLARQKGIELVLKTDIVGVDDVLIQPL~Kg 
*: : . . . . . * * : * 
130 140 150 160 170 180 
I I I I I I 
ILWNLIS~AVKFTQQ~QVTVRVRYD---- -EGDMLHFEVEQS~I~IPQDELDKI~AMYYg 
ILFNLVSNAVKFTPIGSIRLHAELEQFYGAENSVLVVELTDTGI GIESDKLDQMFEPFVQ 
ILTNLVSNAIKFTREGTIVARAMLEE-EHEDSVQLRISIQDTGI GLSNQDVRALFQAFSQ 
ILTNLVSNAIKFTREGTIVARAMLEE-EHEDSVQLRISIQDTGI GLSNQDVRALFQAFSQ 
ILTNLISNAIKFTREGTIVARAMVED-EEEDSVQLRISVQDTGI GLSNQDVRALFQAFSQ 
ILTNLVSNAIKFTREGTIVARAMLED- ETEEHAQLRISVQDTGI GLSSQDVRALFQAFSQ 
ILTNLVSNAIKFTREGTIVARAMLED-ETEEHAQLRISVQDTGI GLSSQDVRALFQAFSQ 
ILTNLVGNAIKFTQGGTVAVRAMLED-ESDDRAQLRISVQDTGI GLSEEDQQALF KAFSQ 
VLTNLISNAIKFTNEGTIAVRAMVED-IGEEFAQLRISVHDTGI GLSQEDLNALFQAFSQ 
IITNLLGNAIKFTEQGNIDIRVEKRR-QELHQVLLEVQIRDTGIGIAELQQSQLFQAFRQ 
IITNLVGNAI KFTENGNIDILVEKRA-LSNTKVQIEVQIRDTGI GIPERDQSRLFQAFRQ 
VISNLLS~AIKFTDT~CIVLHVRADG------DYLSIRV~T~V~IPAKEVVRLFDPFFQ 
VISNLL~SIKFTTT~CITLHLYRDE------YYLYFDIHQT~R~INEKMLHQL~EPFFQ 
IVNNLLS~ALKFTPS~KIVLRAGWR------AGALEISVTDSGIGIPDDLKHRLFLPFTQ 
VLSNLVG~AIKFTTE~QVVLTVTARP--DGEAAHVQFSVS~T~C~ISEADQRQL~KPFSQ 
**: .* : : *** * . . . * : * *: : * * 
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Fig 2 continued 
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190 200 210 220 230 240 
I I I I I I 
VKOSHGGKPATGTGI GLAVSRRLAKNMGGOITVTSEQGKGSTFTLTIHAPS---------
E-ESTTTREYGGSGLGLTIVKNLVOMLEGOVQVRS SKGGGTTFVITLPVKOR-- - ---- -
A-ONSLSRQPGGTGLGLVISKRLIEQMGGEIGVOSTPGEGSEFWISLNLPKTROOAE--0 
A-ONSLSRQPGGTGLGLVISKRL IEQMGGEIGVOSTPGEGSEFWISLRLPKTROOAE--0 
A- ONSLSRQPGGTGLGLVISKRLIEQMGGEIGVOS TPGEGSEFWISLNLPKTROOV0--0 
A-ONSLSRQPGGTGLGLVISKRLIEQMGGEIGVOS TPGEGSEFWISLKLPKAREOKE--E 
A-ONSLSRQPGGTGLGLVISKRL IEQMGGEIGVOS TPGEGSEFWISLKLPKAREOKE--E 
A- ONSLSRQAGGTGLGLVISKRL IEQMGGEIGVOS TPGEGAEFWISLSLPKSROONE--E 
A-ONSLTRQAGGTGLGLVISKRL IEQMGGEIGVNSVPGEGSEFWIRLSLPLOOHSEO- -E 
A-OTSISRRHG~T~LGLVITQR~VKEMG~OISFQ~ELSK~STFWFHITLPLNPHAIP--T 
A-OASISRRHGQTQLGLVITQK~VNEMGQOISFH~QPNRQSTFWFHINLOLNPNIII --E 
V-GTGVQRNFQGTGLGLAICEKLISMMOGOISVDSEPGMGSQFTVRIPLYGAQYPQ----
V-SQNTESASE~T~LGLAICEK~INLMO~OISVV~QENV~SRFTVRIPLYGALNSSOGQT 
G-DSNRLRQARQTQLGLSI~CELMKQRIDLE~TVGVQTRIAVTLPLGVSEADSS--­
VGGSAEAGPAPGTGLGLSISRRLVELMGGTLVMRSAPGVGTTVSVDLRLTMVEKS---- -
250 
I 
--- - - - -
* : * ; ** * . . * . . * * : . . . 
260 
I 
270 
I 
280 
I 
290 
I 
300 
I 
LP-GPPLLGRRVAVLENHELARQALQHQLEOCGLEVTPFNTLEALTNGITGVHQSEQAIO 
LP-APPLLGRRVAVLENHELARQALQHQLEOCGLEVTPFNTLEALTNGVTGVHQTEQAIO 
LP-SAPLLGRRVAVLENHELARQALQHQLEDCGLEVTPFNTLESLTNGITSTHQTEQAID 
SL-NIPLGGLRAAVLEHHOLARQALEHQLEDCGLQTIVFNNLENLLNGVTAAHETPAAID 
SL- NIPLGGLRAAVLEHHDLARQALEHQLEDCGLQTIVFNNLENLLNGVTAAHETPAAID 
PG-ASWAAGQRVALLEPQELTRRSLHHQLTOFGLEVSEFADLDSLQESLRNPPPGQLPIS 
P--PTALHGHRVALLEQHELARQSIQHQLEOCGLEVQPFAELDSLLAGVAAARQEERPVG 
EPAYTMLQGKHLAYVEYHPIAAQATLOILSQTPLIVSYSPTFEQLPEGEFDILLLGIPVQ 
GPSTQCLAGKRLAYVEPNSAAAQCTLOILSETPLEVVYSPTFSALPPAHYOMMLLGIAVT 
KKGVEGLSGKRCWLAVRNASLCQFLETSLQRSGIVVTTYEGQEPTPEDVLITOEVVSKKW 
KYNLYKESTIRCFISIKNLYLESFVERYLSYVGLHCQLFTEVTQVSENOFIITDHOECLO 
-DAYWTLPYRRVAVLGRAQENLEWLANLFDPGVTAVTAFSRPAEPIDAHAHDFLMVTDEF 
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--------------------------------VAEEVDDAFOEDDMPLP---- -------
---------------------------- ERVLRPLEVSQRIKPEALFOE--- - - -- - - --
LAVLGITTNDMSPERLSQHIWDLEHLGCKVLVLCPTTEQTLFHLSVPNPHSQLQAKPACT 
LAVLGITTNOMPPERLNQHIWDLEHLGCKVLVLCPTTEQTLFHLSVPNPHSQLQAKPACT 
LAVLGVTANOIPPERLNQHLWDLEHLGCKVLVLCPTTEQMLFNQSVPNPNSQLQAKPACT 
LAVLGVTALEISPERLRQHIWOLENLNCKVMVLCPTTEHALFQLAVHOVYTQLQAKPACT 
LAVLGVTALEISPERLRQHIWDLENLNCKVMVLCPTTEHALFQLAVHOVYTQLQAKPACT 
LAVLGVSAAIHPPEELSQSFWEFERLGCKTLVLCPTTEQAQYHATLPDE--QVEAKPACT 
LAVLGVTSRDTSAEELAQRIADLERLGCKCLVLCPTTEQMFYQEVLPEAQIQLQSKPAHR 
YRNTLLDYTPRLRDICRRSPCVILALPSLAQMOAEQLKTFGVHACLSKPLAASRLLPLLQ 
FREPLTMQHERLAKAVSMTDFLMLALPCHAQVNAEKLKQOGIGACLLKPLTPTRLLPALT 
QGRAVVTFCRRHIGIPLEKAPGEWVHSVAAPHELPALLARIYLIEMESDDPANALPSTOK 
NSCQFIRIYEHYFEPAKKISENNWLCSTYKLNELIKIILQLPQTKLESODSENNALMTO-
SPAEVLPWWRRPDSIVWVGQAGPLVPRRRDDGGVEISMYSLAGLKSATHMLAAGRTALAE 
- - -- - ----------- - ------------AQATPPAAAAQATPSKPQVS-----------
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Fig 2 continued 
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EFCHHKQNTLLP--------VTDESK-LAMTVMAVDQNP~LKLIGALLEDMVQHVELCD 
----------AV------ ------SDNDDMMILVVDQHPI~RRLLADQLGSLGYQCKTAN 
--- ------ --- - ---- -------HDLQLLTVLIVDQHPI~RLLLTDQLKKIGFNTATAE 
AG--------HE---------PP-GAEAGMTVLIAEQ~SLLLDQLTTLGVRVIEAK 
---- ---- ------- - --- --- -------LRVLVVDQHKP~LMLLRQQLDYLGQRVVAAD 
. : * * 
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T~KAALEMFKPGEYQLVLLQIQL~DMT~LDISRELTKRYPRED----LPPLVALT~VLK 
D~LDAMELLSDTTYQLILMQNQL~HLG~IETTHEIRQNLRLG------TPIYACT~DTAK 
N~YAALNAIQTEPFQLVMMQVQM~GMD~RKSTEAIRQWESER-H-GTPLPIVALT~HAMA 
S~YAAVKAVQNES FQLVMMQVQM~GMD~RQSTEAIRQWESER-N-CTPLPVIALT~HAMA 
S~YAAIDAVKQETFQLVLMQVQM~GMD~RQSTEAIRQWESER-H-GTPLPVVALT~AMA 
G~YAAVNAVQQEAFQLVLMQVQM~GMD~RQATEAIRAWEAER-N-QSSLPIVALT~ 
G~YAAVNAVQQEAFQLVLMQVQM~GMD~RQATEAIRAWEAER-N-QSSLPIVALT~AMA 
S~YAALEVVQRERFQLVFMQVQM~GMD~RQATEAIRRWEAER-E-VSPVPVIALT~ALS 
S~HAAVEAAQRERFQLIFMQVQM~GMD~RQATRAIRQWEAGQPE-QRHTPIIALT~ALA 
S~QDAIAQAELNQCQIILMQIQM~GMD~ICASELIRQIPHHA--- --TTPIIAVT~QTMT 
S~HQAVERAKQMPFQLILMQIQM~DMD~IRACELIHQLPHQQ-----QTPVIAVT~AMA 
D~VDALNVLSKNHIQIVLSQVNM~NMD~YRLTQRIRQLGLTL------ P-VIGVT~ALA 
D~CDALAFMQENHVQIILTQVNM~NMN~YQLATTVRELSSTI ---- -- P-I IGVT~NAIA 
N~EEALALLLKGPVQVVMTQID~MMD~FQLLAEMRRLGMTM------P-VYAVS~SARP 
S~EASLALWHEHAFQVVITQCNM~GIN~YELARRIRAAEAAPGYGRTRCILFGFT~SAQM 
* * ::: * ::* * . . :* 
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DK-QEYLNA~MDDVLSKPLSVPALTAMIKKFWDTQDDEESTVTTEENSKSEALLD---IP 
ETSDAFMAA~ANYVMLKPIKENALHEAFVDFKQRFLVERT-- - - - --------- --- - - ­
NEKRALLQS~MDDYLTKPISERQLAQVVLKWTGLALRNQGPERASERPELGLELQ-VLDQ 
NEKRALLQS~MDDYLTKPISERQLAQVVLKWTGLALRNQGPERTGEPSGNGLELQ-VLDH 
NEKRALLQS~MDDYLTKPISERQLAQVVLKWTGLALRNQGPERGNDNLGHGVQLL-VLDH 
NEKRSLLQS~MDDYLTKPISERQLAQVVLKWTGLALRNPAPERQNEALEVHVGPL-VLDH 
NEKRSLLQS~MDDYLTKPISERQLAQVVLKWTGLALRNPAPERQNEALEVHVGPL-VLDH 
NEKRALLQA~MDDYLTKPIDEQQLAQVVLKWTGLSL---GQSLASMSRAPQLGQLSVLDP 
NERRALLQS~MDDYMTKPINERQLAQVVHKWTRLHLRSPGAQQVHEVQPASIGHLSVLDS 
GEREHLLRS~MDDYLAKPIDEQMLKSVLTRHARQDPLKRNRGEMTGLLNEHDDSQLSLDW 
GQKEKLLGA~MSDYLAKPIEEERLHNLLLRYKPGSGIS-SRVVTPEVNEIVVNPNATLDW 
EEKQRCLES~MDSCLSKPVTLDVIKQTLTLYAERVRKSRDS-- - ---------------­
EEKQRCIDA~MNDCVSKPVSLTVLKDV---- - - --------------------------­
EDVAEGRAR~FTDYLAKPVSLERLETVVRACCSAPAG-------------------ARAD 
DEAHACRAA~MDDCLFKPIGVDALRQRLNEAAARAALPTPPSPQAAAPATHDATPAAFSA 
* **: 
343 
Fig 2 continued 
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RHLQQLGQQIQSPDLP-A- WEDNVGEWIEEMKEEWRHDVEVLKAWVAKATKK------
PQLRAACQRSETLLKQ---EDAKAFAALDELDHAIGRLAAEARTNA------------
PQLRAACQRSETLLKQ- --EDIKAFAALDELERAINRLATEARINA- - --------- -
PQLRAACQRAETLLKQ--- DDAKAMAALDELDMAIARLASEARVNA----------- -
PQLRSACQRAETLLKQ- - -NAPHTEEALNDLDKAIIRLEAEARVMA---------- --
PQLRSACQRAETLLKQ---NAPHTEEALNDLDKAIIRLEAEARVMA---------- --
PQLRAACQTSETLLKQ---NDPAAAAALDELDKAIEALADTASATTHLSSTSLDSSEL 
PQLRAACQHSETLLKQ- - - HAPAADTALDELDAAILRLAGEAKFGA---- --------
P- LQPICRYLEQQLRKGV- HASDLEPEWLELLDEIDNVNRAAQPHINPRLP-------
PRMKNLCQLIEQQLRSGT- KEEDLEPELLELLDEMDNVAREASKILG---- -------
PHCMSNARSFEPTRAN---PANGIAKSNCRRWPFGTRWSEWSRR--------------
KAMIDTALALEKKAQGQAGPSPEIDGMVRTLAAQSAALETQLRAWLEQRPHQGQP---
Abbreviations: Ec, Escherichia coli; Vha, Vibrio harveyi, Pfl, Pseudomonas jluorescens; St, 
Salmonella typhi; Pto, Pseudomonas tolassi, Psy, Pseudomonas syringae; Pae, Pseudomonas 
aeruginosa, Ye, Vibrio cholerae; Ere, Erwinia carotovora; Prm, Proteus mirabilis; Bpm, 
Burkholderia pseudomallei; Bbr, Bordetella bronchiseptica. 
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Fig 3: The complete nucleotide sequence of pMRG 1 containing the partial sequences of 
two ORFs, ORFI (in red) and ORFII (in blue). The deduced translation of ORFI encodes 
a protein with high homology (up to 92%) with glutamine synthetase, GlnA, while ORFII 
encodes a protein with high homology (up to 63%) to sensor histidine kinase, NtrB. The 
putative stop and start codons are underlined. 
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Table 4: Examples of the NCBI BLAST matches for ORFI identified on a 1.8 kb B. 
pseudomallei DNA fragment (pMRGI) 
Accession number Match sequence title 
AF082873 Histidine kinase- Herbaspirillum seropedicae 
D83006 Two-component sensor NtrB- Pseudomonas aeruginosa 
AF072440 Two-component sensor NtrB- Enterobacter gergoriae 
L08499 Two-component sensor NtrB- Vibrio alginolyticus 
A24114 Two-component sensor NtrB- Klebsiella pneumoniae 
P41788 Two-component sensor NtrB- Salmonella typhimurium 
S23900 Two-component sensor NtrB- Proteus vulgaris 
C82038 Two-component sensor NtrB- Vibrio cholerae 
P06712 Two-component sensor NtrB- Escherichia coli 
AB038389 Two-component sensor NtrB- Shewanella violacea 
AAC41398.1 Two-component sensor NtrB- Acidithiobacillus ferrooxidans 
P45670 Two-component sensor NtrB- Azospirillum brasilense 
Q52977 Two-component sensor NtrB- Rhizobium meliloti 
P09431 Two-component sensor NtrB- Rhodobacter capsulatus 
P14377 Sensor protein HydH- Escherichia coli 
P08401 Sensor protein CreC- Escherichia coli 
AF3059141 Sensor protein HydH- Klebsiella pneumoniae 
AAB07807.1 Probable sensor protein MtrB- Mycobacterium tuberculosis 
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Table 5: Examples of the NCBI BLAST matches for ORFII identified on a 1.8 kb B. 
pseudomallei DNA fragment (pMRG 1) 
Accession number Match sequence title 
AF082873 Glutamine synthetase GlnA- Herbaspirillum seropedica 
AAF40802.1 Glutamine synthetase- Neisseria meningitidis 
AAB61772.1 Glutamine synthetase - Neisseria gonorrhoeae 
AAF95885.1 Glutamine synthetase- Vibrio cholerae 
BAB11930.1 Glutamine synthetase- Shewanella benthica 
BAB11926.1 Glutamine synthetase- Shewanella violacea 
AB03004.1 Glutamine synthetase- Escherichia coli 
P06201 Glutamine synthetase- Salmonella typhi 
P28786 Glutamine synthetase- Proteus vulgaris 
Q59747 Glutamine synthetase- Rhizobium meliloti 
Pl0583 Glutamine synthetase- Azospirillum brasilense 
P43794 Glutamine synthetase- Haemophilus influenzae 
QI0377 Glutamine synthetase- Mycobacterium tuberculosis 
347 
%homology 
92 
85 
85 
83 
82 
83 
82 
82 
80 
79 
79 
77 
72 
APPENDIX V 
DATA RELEVANT TO CHAPTER 5 
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Fig 1: A computer hydropathy prediction showing possible transmembrane regions 
in the TcFx protein. Values above the horizontal dashed axis indicate regions of 
hydrophobic character and those below the axis indicate hydrophilic character. 
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Table 1: Examples of the NCBI BLAST matches for TcFx encoded by ORFx 
Accession number Match sequence title 
A82615 Surface protein XF 1981- Xylella fastidiosa 
D82671 Surface protein XF 1529- Xylella fastidiosa 
AE005587 Putative adhesin- Escherichia coli 
CAC14217 Autotransporter protein SapB- Salmonella typhi 
AAC43721 Adhesin Hia- Haemophilus injluenzae 
C82672 Surface-exposed outer membrane protein- Xylella fastidiosa 
NP052433 Adhesin YadA- Yersinia enterocolitica 
AF181072 Outer membrane protein- Moraxella catarrhalis 
AAC44560 Hsf protein- Haemophilus inj/uenzae 
P31489 Invasin precursor YadA- Yersinia enterocolitica 
P10858 Invasin precursor YadA- Yersinia pseudotuberculosis 
G81133 Adhesin protein- Neisseria meningitidis 
AF226366 Outer membrane protein GNA992- Neisseria meningitidis 
A81888 Surface fibril protein NMA 1200- Neisseria meningitidis 
S04911 Outer membrane protein YopA- Yersinia pseudotuberculosis 
AJ277636 Putative autotransporter protein MapB- Pasteurella multocida 
U86135 Outer membrane protein- Moraxella catarrhalis 
AF187008 Serum resistance membrane protein- Haemophilus ducreyi 
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Fig 2: Clustal W multiple alignment ofTcfx withXylellafastidiosa surface protein over a 
span of 80 amino acids located toward the C-terminal end of the proteins 
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Table 2: Examples of the NCBI BLAST matches for TcF2 encoded by ORFd 
Accession Number Match sequence title 
AAC23902 BvgR protein- Bordetel/a pertussis 
D64902 Hypothetical protein- Escherichia coli 
BAA15144 Sensor protein FixL- Escherichia coli 
P76129 Hypothetical protein Y ddU- Escherichia coli 
P76129 Hypothetical protein Pseudomonas tolassi 
S74609 Hypothetical protein Slr1102- Synechocystis sp. 
CAB69812 Hypothetical protein Yko W protein- Bacillus cereus 
CAA77326 Hypothetical protein Orf-2- Pseudomonas aeruginosa 
AAC38223 Hypothetical protein Urf2- Pseudomonas stutzeri 
P55552 Hypothetical 91.8 kDa protein Y 411- Rhizobium sp 
B70302 Sensory box/ GGDFE family protein- Deinococcus radiodurans 
Q11024 Hypothetical 67.7 kDa protein Y d54- Mycobacterium tuberculosis 
P77334 Hypothetical 74.7 kDa protein YciR- Escherichia coli 
T09113 Probable response regulator VieA- Vibrio cholerae 
P32701 Hypothetical 60.8 kDa protein Yjcc- Escherichia coli 
Q11027 Hypothetical 33 .9 kDa protein Yd57- Mycobacterium tuberculosis 
P74101 Hypothetical 79.7 kDa protein Yi95- Synechocystis sp 
E64862 Probable membrane protein B 1168- Escherichia coli 
P37649 Hypothetical 73 .1 kDa protein YhjK- Escherichia coli 
Q04855 Hypothetical 80.5 kDa protein YntC- Azorhizobium caulinodans 
P77473 Hypothetical 58.9 kDa protein YlaB- Escherichia coli 
P21514 Hypothetica140.7 kDa protein YahA- Escherichia coli 
AF071413 Hypothetical protein YfeA- Escherichia coli 
P76446 Rtn protein- Escherichia coli 
AAA50754 Rtn protein- Proteus vulgaris 
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Table 3: Examples of the NCBI BLAST matches for TcF3 encoded by ORFe 
Accession number Match sequence title 
P26319 Expression regulatory protein FimZ- Salmonella typhimurium 
P21502 Expression regulatory protein FimZ- Escherichia coli 
AE0044432 Probable response regulator- Pseudomonas aeruginosa 
AAF82336.1 Putative response regulator Y srR- Yersinia enterolitica 
CAA35973 Putative two-component protein- Streptomyces coelicolor 
882043 Transcription regulator LuxR family- Vibrio cholerae 
NB106300 Response regulator- Mesorhizobium loti 
BABOI271.1 DNA binding protein- Arabidopsis thaliana 
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Table 4: Examples of the NCBI BLAST matches for TcF4 encoded by ORFf 
Accession number Match sequence title 
AAF12376.1 Adenine deaminase-related protein- Deinococcus radiodurans 
Q9SMV7 DNA repair- DNA binding protein- Arabidopsis thaliana 
CAB69856.1 Hypothetical protein- Arabidopsis thaliana 
P24563 Hypothetical 57.4 kDa protein- Pseudomonas aeruginosa 
AAF35965.1 Hypothetical protein- Caenorhabditis e/egans 
B75276 DNA binding response regulator- Deinococcus radiodurans 
Q62755 Transcriptional regulator-DNA binding protein- Rattus norvegicus 
BAA83713.1 RNA binding protein- Homo sapiens 
NP057417.1 RNA binding protein- Homo sapiens 
A36128 Regulatory protein AlgP- Pseudomonas aeruginosa 
BAB01996.1 DNA repair protein MutS- Arabidopsis thaliana 
354 
Table 5: Examples of the NCBI BLAST matches for TcF5 encoded by ORFg 
Accession number Match sequence title 
Pl8952 Extracellular phospholipase A 1- Serratia liquefaciens 
AAC31479.1 Extracellular phospholipase A 1- Yersinia enterocolitica 
AAB09557.1 Putative ABC transporter ATPase BldkD- Streptomyces coelicolor 
Pl8765 Oligopeptide transport A TP-binding protein- Streptococcus pneumoniae 
CAB38590.1 Putative lipase- Streptomyces coelicolor 
AAC26305.1 Hypothetical lipase- Caenorhabditis elegans 
CAA35216.1 AimE transport protein- Streptococcus pneumoniae 
Q07954 Low density lipoprotein- Homo sapiens 
AAG51101.1 Putative lipase- Arabidopsis thaliana 
AAC26305.1 Putative lipase- Caenorhabditis elegans 
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Table 6: Examples of the NCBI BLAST matches for TcF6 encoded by ORFh 
Accession number Match sequence title 
AAC44775.1 Type Ill export protein PscD- Pseudomonas aeruginosa 
AAC12650.1 Glycosidase OleR- Streptomyces antibioticus 
F70 111 V -type A TPase, subunit A homologous- Borrelia burgdorferi 
AAG03817.l Probable A TP-dependent RNA helicase- Pseudomonas aeruginosa 
CAB84378.1 Putative isocitrate dehydrogenase- Neisseria meningitidis 
E70839 Probable PE protein- Mycobacterium tuberculosis 
075477 Probable general secretion pathway protein- Deinococcus radiodurans 
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Fig 3: The complete nucleotide sequence of the cloned 10 kb fragment showing the 
location of DNA probes, FRl , FR2 and FR3 used in Southern hybridisation analysis. 
Sequence in blue indicates mrgRS flanking regions, while the PCR primer sequences 
that were used to generate each probe are in red bold. 
GAATTCTAACTTCTTTGATGTTCGTCCGATGCGGGTTCGCATATAAATGGATATCGGCCGCAGTCAGG 
CCGCCGCGCGAACGCCGGGCGACGCATTCGAGCAAGAAAATAGCGGCGCGCCCGTCCGGATGCGGACG 
TCGGCGCCAACAGGATGTCGACGGTGGCGCGATCGTTCGGCGGCGGATGCGCTTTCGCCGCACGCGCG 
TTCGGACAGTCGATCGGGAATCGTCCCGCGGCTTTCGAACGAGAGGCGGCCGTCGAGCGCGATCCCGC 
AGGCGCGTTTTCTCGTGGGGCGGCCGCCGGCGCGCATTCGCATGCAAGCGTTTCGTCGATTTTCGCTC 
GTGGCGCTTTTCGCAACGCTATGATTTTCGCCGCCCGGCCGCGCATCTATTTTCGTGAAAGGCCGATG 
TGGACATGCGTGAAATTTCGAGTCACGCCGATTCCCGCTCGATTCGGCGAGCGGACACTTTTTCTCTC 
TGGATCGGGAGCGTATTGGGCAATGACGTCGCGCGACTTTCGCGGCGGAGCGATGGGGGATTGATTTT 
GATGGAACACACGACGTCGATTGGATGGGCGGCTCGCTCGCATGCGCGATCCGAGCACGCGTGCGATC 
GGATTTCTCAATGGATTCTTGTTCTGATGCCGATCGTCTTCGTCGCGTTCTGCGTACTCCTGATTTCG 
CTCTGGTACATCGACATCTTGACCGGATGGCTGATCGCGGCTTTTGCGCTGCTCATTGAAGCCATGCT 
GATCGGCATCGGGTTTTTTGTCTTCGTGATGGTGCGGATATCGCACCGGCGGCGGCGCGAGCGCGAGG 
CGAAGACGGCGTTGTGCCGCGCGAATCAGCCCGACGATGCCGATGTGCCGTTTCCGGTGGGATTCGAC 
GGCGTGAAGACGGTTCATTGCATGTTTGGATCGGGGCAGGTCGGTGGGTTTCGGGTAAGCTGTTACAA 
CACGAATTGCCCGTTGATGCGTGGAGCAACGGAAACCGAGCGATTGCCCGGGCAGGCGGAGCGAGCGT 
AGGCATGCGACGCGCCATGACATGAAAAGCGAAAGCATATTGAAACCTTGAATATGCAATGGATGCGC 
TCGTGATTCGAAGCCGGTTCACGGCCGGTTTACAGCCGATTCACGGCCGATTCGCGGCATGGCGAGGC 
GGGGCGCACGAGCGTCGGCGCCGTTGCATTCGAGCGAATCGCGCTCGCAAGGCATATGCAGGAACGCA 
GGCAATCGTTATCGTTTTGCATGGAACGCGCATGAGCGTGCGCCGGACCTCGTTCGTGCGGCACGGAG 
GCGCTTTCCGCTTTTTTCGGAGCCGCCATGTCCAACGTTGCCCTGCATACAAGAAAAGTCGTCGTGGC 
CGACGATCATCCGATCGTCCTGCGTGCGGTGACGGATTACGTCAATTCGCTGCCGGGTTTTCACGTCG 
TGGCGTCGGTTTCGTCGGGGGACGCGCTGTTGTCCGCGATGCGGGAGCAGGAGGTCAATCTCGTCGTG 
ACCGATTTCACGATGCATCAGGCGAACGACGACAAGGACGGCTTGCGCTTGATCTCGCACCTGATGAG 
GGCGTACGAGCGCACGCCGATCATCGTGTTCACGATGCTGACCAATAGCGGCGTGATCAGCCAGCTGT 
GCCGCATGGGCGTGGCGGGGCTCGTCGGCAAGGAGGAGGAGATCGCCGAGCTCGGGCGCGTATGCGTG 
AGCGTGGCGCGCGGCGTCAGCCAATCGTTGTCGCCCGGCATGGCTCACCGGCTTGCCGCCGTCGGCAG 
CATCAGGCCGGGCGAGGCGGCATTCAACGCGTTGACGCCGAAGGAACTGGAGGTCGTGCGGCTGTTTA 
CGGGCGGCATGTCGCTCACGGACATCGCGCGCACGCTGAATCGCTCGCTCGGGACCGTGTCGACGCAG 
AAGCGCTCGGCCATGCGCAAGCTGCACGTGGACACCAACGTCGATCTCATCAACTGCGCCCGCGAGCA 
AGGACTGCTCTGATGCAAGGACTTCTGCAAGAGCTCGACGGATCGCCGCTGAGGAAGTTCTATTCGCT 
CGAGTCGAATCTGAAGCGCGAGCGGCGGGTCTTCACGATCGTCATCGTGCTGCTCGTCTGCGCGGCCC 
TCAGCATCGCGGCCATGACCGTCACCGGCTTGTTCCAGACCGCTTTCCGGCAGGAGGAGCAATCCGCG 
CGCATCCACGAAAAGGAAGTGGTCGACGTGTTCCTGCAGCGCCGCATGATGTTGACGACGGCAAGCCT 
CGTGCTGCAACTGCGGATGAACGGCGCGCCTTCGGCGCTGAACGTGCCGGCGCCGAACGCGTGCACGC 
CGATGGCCCACAATGTGCGCGACGATGCGATCCTGCGCGAGAGCTGCGATTACACGGTGCAGTTGCTG 
GCCAACTCGGGGCAGACGCCGAGCGTCGAAATGGTGACGGCCGACGGTTCGGTCGGCTATGGATATCT 
GTTTCCGACGGGCGACCTGAGCGCGCTACGCTCCAGCACGCCGTCCGAACTCGTGTCGGCCGTGCTCG 
AGCGCTACGGCAAGCGCGGCCTGGACCCGCTGGAAGCCGCGCGCAAGAAGCGGATTCTCTGGTTCGCG 
GTGGGCCGCGGCGGGCGCGGCGAGGAGCTGCATATGATCGGCGCGTCAGTCGTGTTCAAGGACGAGCG 
GCTCTACGCGCTCGTCTTGACGAGCGTGGATCTTCACAGCCTCGTTTCGCCGATCGAGCGCGCCGGCC 
GCGTGCAGCAGCCGGTCGTCGTGGATTCCGAGGGCGTGCCGCTCGTGAACGCGGACGACGCGGAAACG 
GTCCGGAAGGTCGACGGGCGGCTCGCCGGACAACAGGATGGCCTGTATCACTGGATTCCCGGCTTCGG 
GTGGGCCCTACGCCGTCCCGCGCCGTTTTCCGGTTTCGGGCACATGACGTATCTGCTTCCGCTCGATC 
TGCAGTTGCGCTCGATGCGCTACGAGTTGAGCCTCGTCGGCGGCGCGACGCTCGTGCTGATCGTGTTG 
CTGTTCGTCGCGTTCCGGTACTGGAATTACCGGTTCTTGACGCGCATCTACGAGGAAGCGTCGCGCGC 
GCTCGAGAGCGAAATGCTCAACCATCTGCTGGTTCATGCGACGCCGGTCGGGTTGTGCATCGTGCGGC 
GGGCGACACTGGAGATCGTCGTCGCCAACCCGATCGCGCGCACGATGCTCGGCTTGCGGCTGTCGGAC 
CGGCACCTGCCGCAGGAATTGCTGAGCGCGTTCGAATCGTCGCTGGCCGAGCAGGACACCCAGTCCGA 
CGACGCGCGCATTTTCCAGTTCCCGTTCACGCTGTCGCGCGCCGGGCATGCGGCGGTCCATATCGAAA 
TCACGTACGCGCCCGCGATGCTGAACGCGCGGGAGGTGTTCTTTTGCGCGATCACGGACATGACGGCG 
CACCACCAGGCGGAGATCCTGCTGCGCGAGGCGAAGCTGACGAGCGACGCGGCGGCCAAGGCGAAGGT 
GGCGTTCTTCGCATCGATGAGCCATGAAATCCGCACGCCGCTGTCGTCGCTCGTGGGCAACATCGAGC 
TGATCGCGCGCGGGCCGCTCGCGCCCGAGCAGCAGGCGCGCGTGAAGGCGATGGAGACGTCGGCGCGC 
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GGCTTGATGCAGATCGTCAACGATGTGCTCGATTTCTCGAAGATCGACGTGGGCGAGCTGAGCCTCAT 
GGAGGAGTGGTCGAACATCGCCGAGCTGCTCGACCGGCTCGCGCTCTCGCACGCGCCGCTCGCGACGC 
AGCAGGGTTTGAAGTTCTACATGGTGTTCGATCGCAGCCTGCCCGCGCGGCTCTACTTCGATCCGATC 
CGGGTCTCGCAGATCGTGAACAATCTGCTGAGCAACGCGCTGAAGTTCACGCCGTCCGGCAAGATCGT 
GCTGCGCGCCGGCTGGCGTGCCGGCGCGCTCGAAATCAGCGTGACGGATTCCGGCATCGGCATCCCCG 
ATGACCTGAAGCACCGCCTCTTCCTGCCCTTCACGCAGGGCGACAGCAACCGGCTGCGGCAGGCACGC 
GGCACCGGCCTCGGATTGTCGATCTGCGCGCGTCTGTGCGAGCTGATGAAAGGGCGCATCGATCTGGA 
AAGCACCGTCGGCGTGGGAACCCGGATCGCGGTGACACTGCCGCTCGGCGTGTCGGAGGCCGATTCGA 
GCGATGCGTACTGGACGCTTCCGTATCGGCGCGTGGCCGTGCTCGGTCGCGCACAGGAAAATCTCGAG 
TGGCTGGCCAACCTGTTCGACCCGGGCGTCACGGCCGTGACGGCTTTCTCGCGGCCGGCCGAGCCGAT 
CGATGCGCACGCGCACGATTTCCTGATGGTCACCGACGAATTCTCGCCGGCCGAGGTGCTGCCGTGGT 
GGAGGCGGCCGGACTCGATCGTGTGGGTCGGGCAGGCCGGCCCGCTCGTGCCGAGACGGCGCGACGAC 
GGCGGAGTGGAAATCAGCATGTATAGCCTCGCGGGGCTGAAATCCGCGACTCACATGCTCGCGGCCGG 
CCGCACGGCGCTCGCCGAAGCGGGGCACGAGCCGCCGGGAGCCGAGGCGGGAATGACGGTGCTGATCG 
CCGAGGACAATCTGCTCAACCGCAGCCTGCTGCTCGATCAGCTGACGACGCTGGGCGTGCGGGTCATC 
GAGGCGAAGAACGGCGAGGAGGCGCTCGCGTTGCTGTTGAAGGAGCCGGTGGACGTCGTGATGACCGA 
CATCGACATGCCGATGATGGACGGTTTCCAGTTGCTCGCCGAGATGAGGCGGCTCGGCATGACGATGC--
CGGTGTACGCGGTGAGTGCGAGCGCGCGGCCGGAAGATGTGGCGGAAGGCCGGGCGCGCGGCTTTACC 
GACTATCTCGCGAAGCCGGTTTCGCTCGAGCGGCTCGAGACGGTGGTACGCGCATGTTGCAGCGCGCC 
GGCGGGCGCGCGCGCCGACGAAGACGCGCAGGACGAACTGCCGGGCCTACCCGACGTGCCGCCCGCCT 
ATGCGAGCGCGTTCGTCGCGCAGGCCGGCAGCGAAATCGCGGAATTCGACGCGATCCTGCGCGAACGC 
GCCTGCCGAAACTGCGGCGGTGGCTGCACGGCGTATCGGGCGGCATCGCGGTCCTCGGGCCTTCCGCA 
CTGCATGAGCAATGCCAGGAGCTTCGAGCCTACGCGCGCGAATCCGGCGAATGGAATCGCGAAATCGA 
ACTGCAGGCGCTGGCCATTCGGAACGCGCTGGAGCGAATGGTCGCGGCGCTGACGAGCGCGTGATCGG 
CGCGGGCGCGGCCCTGCCGGAGCGGGCCCGCGCCCGCCATGGACGGCGCGGCGCGGGGGTGTGCGCGG 
CGTCGCACGTTCCGGCGCGGATTCGAAGATTTGTGATTCTCCCCACCCGCGACTTGATTTAACGTTTC 
CTGACGATTCGCGGGGCGATCGGGCCGGCGGGCGTCGGCGTCGTGTGACGAGGCCGTCCTGCGGCGAT 
CGCCAAGCCGCGACGAGCGATGCTGCGACGGCGGCGTCTTTGGGAGAGCGATATGGAAGCGGGCATCA 
CGCGTCGTAGGGGTGCATTCTTTGCCCGGGAACACGAACACGGACTGTCGTTGGACGAGGCCGATCTC 
GAGCGGGCATTCGAGGCCGGAGAATTCGTCATGGATTATCAGCCGATCGTCTCGATCCGCTCCGGGGC 
CGTGACGGGCGCCGAAGCGACGATACGATGGGATCATCCGGAATGGGGCGCGCTGCCTCAGCGTGTGG 
TCCACGCCGCCGCGGACCGATTGGGCGCGGCGTCCCGGATCGCCGGCCACGCGTTCGGCGAGGCGTGC 
AGGCAGCTCGCGCGCTGGAAGCAGCAGGGCGCCGGCGTGTCGGCGCTGTCGATGCGGCTTTCGGGCGC 
CCAGTTGGGCGCCGAAAGCGTATTCGAGCGACTCGCGCTGTCGATCGAGGCGTTCGATATCTCGAGCA 
GCCAGTTCACGCTCGAAGTGCCGGAAATGTCGGCGCCGGAGGAATCGCTGAGTCTTCTCGATCGCCTG 
AAGCGGCTGAGGCAGAAGGGTTACGGCATCGTGCTCGGCGATTTCGGAGCGCATCACACGGCGATGTC 
GACGTTGATGGTGCTGCCCGTCACGGGCGTCAAATTCGGCGAATCGTTCACGGAGCGATTGCCCGGTT 
CGCCGACTGCGGAGGCGATCCTGTCGAGCGTCTCGCGTCTCGCGCACGATCTGGGTTTCACGTTGACG 
GTGTCCGGCGTCGAAAACGGCCGGCAGTTCGAATTGCTGCGTCGCTTTCGCGATATCGAGCTGCAGGG 
CGCCTTTCTGTTCGAGCCGATGCGCGCCGAGGTGTGGCACGAGCGCGTGAATCCGAGAGCGCTGTCGC 
AACTGAATCTGCGTGAGCCGCCGTTCTGACGCGGCGAGCCTGGCCGTTCGCGTTTCATCCCGAGGTGC 
GCGGTCGGCCCGCCCGCATGGCGAGCCGGGTTGCGCAGCCGCCGCGCGTGCGCCGACGCGAGGACGGC 
CGCGAGTCGCGGCCGGTGAGATCCGCGCCGCGCTCGCGCGCGCCGATGTCTGGCGCGGGCGTCGCGGA 
TGGCGTTTATGCCGCTCATGCTTTCGCTCGCCAGTCTTGGGCGATCCGGTGGCCCGCCGAGCGCGCAT 
CCGATGCGCTCGCGTGTCCGTGCGCGCATGCGCGGCGGCACGGCGCGTTCGACGTGGCCCGAGCGGCG 
CGATGCGGCCGACGACGGCATACGCGATCGCGCCCGGCGCGGGGCCGTTCGCCTGCCGATATCGCGCG 
CCGCGGCCCGACGGGCCGGCTCATTGCGAACCCACGTCCAGACATTGCCTCGCTTGTCTTCGCCCGGA 
AATCACAATTGTTAGAGACGCGGCCTCGTGTCGTTCTTGCACGCGCTTGCATCGTCGAGCGCGCGCGT 
CGCGCCGGCTGCGCGGACATTTCTAAGAACTTTGATTCAGTCGCGCACCCGCGATCTGTACAGTCGAA 
TCCCAACGAGCGAGGCAGGCCGCGCCGCGCGCTTTCACGATTCGTCGCGATGGCGCGCCGGGCGGGGC 
GCCTCCGCGTCGCGCATGCCCGGCCGTGCGCATTCGAGCGCATTCGAAGGCGCATGCGCGGACGCCGC 
GTGAAAGGTCGGCGAGCGTGTCCCGGGTGCGGGCGGCGGAGTGGGCGCGGTGGCGCGACAATCGGCGC 
GCCGTGGATCGCGGAGCGCGGCATGTGTCGCTTCTGCATGCGTCGCGCGGGCGGCGGTTTCAAGCCCC 
GCCGTGTGCCGCCATGTGCCGCCCGCCGTGCGCGTCGGCTCGGCGCGATGCGCGCGGCATGGGCGCTC 
GCACGCGCTATCTCGCGTTCCCGCATGAAACGCTTTCGCGCCGGTGCGGCGCTTCGAGTATGCGGCGC 
CGGCTCGATTTTCTCAGCAAGCGAAGCGACATGGCACAGACCTTCATCGCGGTGAAGACCATCCTGCC 
CGGCGATCTGTTTTTTCCGGCCGACGCCGCATCGGCGCTTTGCCGCGATCGCGCGCGGGAAGCCCCTG 
CCGGAAGCGGCGGGCTGACGGACCGCGAGCCGACGGTGCTGCGCCACAGCGCCGGAATTCGAGCGGGG 
CGTTTTTTTATCGGGTCCGCGTGAGCAAGCTTTTTGACGGCGATGCAAGACTGCGCGAGCGACGAATT 
TCAAGCGAATGGCAAAAAATGTGAGATCAGAAATTTGAGAGTGTGACGAAATGATTGCATATCAGCGA 
TTCAAGGAACTCAAAATCGAACTCGAGGCCCGTTTGGCCGACGAGCGCAGGGCGGCCAAGGAAGCCGT 
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Fig 3 continued 
CCTCACCGAGATACGCGCGTGTGTCGACGAGTTCGGCTTCTCCCTGGACGACGTATTCCCTCCCGACG 
GCGGGCACGGCAGACGAAAGGTCCGGGCCAAATATTACGATCCCGCCAGTGGCGCGACCTGGTCGGGC 
GTCGGGCGCGAGCCGGTGTGGATTCGCGGCAAAGATCGCGAGCAATTCGAATTGCGGTGCAGCGGCGG 
CGTACAGGAGTCGTCCTGAATCGATGCGCCCGCGCGTGAGGTTGAAGAAGCCGGCGATCATCCGCAGC 
GTCTGCCGTCTTGCCGCAGCCCGACGGGCCGAGCAAGCGACACGATACGGCGAAATGAAAAGGCCCGC 
GCGAAGAAAACACGTCATGCCGGGAGGTTGGCGATATTTTCCGCAACCGCCCGCATGGCCCGCGCGTG 
GCCTCGTTTCGGGGCGCGCAACTTCGCAAGGCTCGTACGGAACCTTGCGTGCCAACGCCCGCTGTCGT 
GGGTCAAGCGAGGGTGCCAAGGCTCGGTTGCCACGGCTGGCCCTCGTTCAGATCATCGGCTGTCAAGG 
AAAGCGGCGCCAGATATCCGAACGTGTGTTGCCAGCCGGCTTCATCCGTGAACACCTTGAATCCGGAA 
TGATATGCCCCTTCCAATTCGAATTGCTGGGAGTGATCCAGCGATCCGGGCTGGGCGTAATAGATATG 
CTTGTTGGAGAAGTAATAGACGFATTTTTCTTATCTTGCGGATGAAGTCCTCCGTTGGGAAAAGATTG 
GGTTCGTAAATATACTTGATTCTGTTCATCGTGGATAAATTCCACGAGGATGGAATGACGTCATACCG 
ATGCCAAAGTCGCTTCATTTTTCCTGTCAACGAGCCGTCTGAATATGCGGCGAATGCGACGTTTCCGG 
CGGTGGCGGCTGCAAAAGAGTGGCAGAAAACGTTTTTGAATGGGTAACCCGAGGATTGCGAGAAATAT 
AGCGCGAAGGTGGATGCCAGAACGCCGCCGAGGCTATGCCCCGTCACGGTGAGGGTGGATTCTTTGGG 
TAAATTTTTCAGGAAATCGGTGAGCGATGCCGAGCTATTTGAGGGGAGGGTTTGAAGGGTGACGTCCA 
ATGCCTTGGCTGTCCCGTTTGCTATGAGCGCATCCGGCGGGCAATCGCTGACATATTTCGAGAACGGG 
GTCAGATTTTTGACGTCATTGTCTTCAATGACTATATCGGCAAACTGTGAGTTCGGATTGGTTCCGCT 
GAATGCCAGGCGATAGTCCTTGTCGTTGCTGGTGTTTTTGAAGATCGCGGTTACGTTGGCGGCATATC 
CGGAAAGAGGGTCGACATAGACCGCGGGACCCCAGACAATGGAAAATCTATTGTTTTTCGTCTTCGTT 
GATTTGCCGAGGTAGCCGATAATTAATTTTCCCAGGATGTCCGTGGTGGGATTCTTGATATTCTGGCC 
CCAGTCCATCGCGCACGATAACGTGAAATTCGTTTGTCGCTCGTCGAGAGAGTCGAATAAATCGTATG 
AGTCGATCGAATCGAATGGATCGAATGAATCGGGAGGATCGAGTTCGGTGGCCATGATGGTGTTCCTT 
GAATTCGGCGGGGTGGGGGCATGCAATTCAAGATATTCGCAAGCTCTTCGTGAGTGTGCTTGCCCGAA 
TAAAATATATGGGTATCGCCGCGCGATCAATTACAGGGGATTACGCGCAATATAAATTCCGGATCGCC 
GTCTCCCCGCTGGACGAGCCGTGGCAAAGCGGTTCCGGGAGGGATGCCGACTCGACCGTATCACGATG 
TGCAGTCCGCTCGAGGGGATGACAGTCGCGCAAAAAGTATTCTTGCTCGAATGATGGCAGTGATGCAG 
CTGAACGGGCCGCATCGGCGAATGAGCCGGGCTGGATCACTCGTTTTTCTCGCTCGCGAAGAACATTC 
CGTCTGATGATCTATTCGTCGTCGGATTGCCGGATGGGGAAGAGAAAGAAGGCGCGGGGTCGATGGAG 
TTTGTGACGCTCTGTCTCGAAGACTGGCAAGCAGCGCTGAATCGCGGGCTCGATGTGCTGTCGTTCTC 
GGCCCCGCCGGCGTTCCTGACGGTGTGCCCGAATGTTTTTCAGCCACTTTTCGCACAAGCGGCCGACG 
ATCTGGACGCCGTACACGGGCACGCCGGGTATGCGGTGAATCTGTCACTGCTGCGGCGCGATCCGAAC 
GCGGCGTCGGAGTATTTTCTGGCTCGTCGCTATGGTCCGGGGCTCGATGTAGGTGACCCAGTTCTCGT 
GGTCACTTCCCGAATGACGAGGCCGTGATCA 
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Fig 4: Agarose gel electrophoresis of EcoRI digested genomic DNA from a number 
of isolates of B. pseudomallei and B. thailandensis, as well as pMRG4. 
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Fig 5: Polymorphic sites within mrgRS downstream region of two clinical isolates of B. 
pseudomallei, 204 and 11 2. Atypical nucleotides are in bold and underlined. 
204 : 1 ggtccgggccaaatattacgatcccgccagtggcgcgacctggtcgggcgtcgggcgcga 60 
I I I I I I I I I I I Ill I I I I I I I I I I 11 I I I I 11 I I I I I I I I I I 11 I I I I I I I I I I 11 I I I I 
112 : 1 ggtccgggccaaatattacgatcccgccagtggcgcgacctggtcgggcgtcgggcgcga 60 
204: 61 gccggtgtggattcgcggcaaagatcgcgagcaattcgaattgcggt gcagcggcggcgt 120 
11 I 11 I I I I I I I l l I I I I Ill 1111111 I I I I I I I I I I I I 11 111111 I I I I 111111 I I 
112: 61 gccggtgtggattcgcggcaaagatcgcgagcaattcgaatt gcggtgcagcggcggcgt 120 
204: 121 acaggagtcgtcctgaatcgatgcgcccgcgcgtgaggttga~gaagccggcgatcatcc 180 
I I I I I I I I I I I I ll I I I I I I I I I Ill 1111111 1 11 I I I I I I I I I I I I I I 11 I Ill I 11 
112: 121 acaggagtcgtcctgaatcgatgcgcccgcgcgtgaggttga~gaagccggcgatcatcc 180 
204 : 181 gcagcgtctgccgtcttgccgcagcccgacgggccgagcaagcgacacg~tacggcgaaa 240 
I Ill I I I I I I 11 11 I I 11 I I I I I Ill I Il l Ill I I I I I I I I I I I I I 11 I Ill 1111111 
112: 181 gcagcgtctgccgtcttgccgcagcccgacgggccgagcaagcgacacg~tacggcgaaa 240 
204: 241 tgaaaaggcccgcgcgaagaaaacacgtcatgccgggaggttggcgatattttccgcaac 300 
I I 11111 I I I I I 111111 I I I Ill I 11 I I I I Ill I I I I I I I I I I I I I I I I Ill I I I 11 11 
112: 241 tgaaaaggcccgcgcgaagaaaacacgtcatgccgggaggttggcgatattttccgcaac 300 
204: 301 cgcccgcatggcccgcgcgtggcctcgtttcggggcgcgcaacttcgcaaggctcgtacg 360 
I I I I I I I I I I I I 11 I I I I I I I I I Ill I I I I I Ill I I Ill I 11 I I I I 111111 1 I I I 11 11 
112: 301 cgcccgcatggcccgcgcgtggcctcgtttcggggcgcgcaacttcgcaaggctcgtacg 360 
204: 361 ga~ccttgcgtgccaacgcccgctgtcgtgggtcaagcgagggtgccaaggctcgg~tgc 420 
I I 11 I I I I I I I 11 Ill I I I I 11 I Ill I I I I I I 11 I I I I I I I I I I I I I I 11 Ill I I I 11 
112: 361 ga2ccttgcgtgccaacgcccgctgtcgtgggtcaagcgagggtgccaaggctcgg~tgc 420 
204 : 421 cacggct2gccctcgttcagatcat~ggctgtcaaggaaagcggcgccagatatccgaac 480 
I I I I I I I I I 11 I I I I I I 11 I I Ill I I 111 1111 I I I I I I I I 11 I I I I I I 111 11 11 11 
112: 42 1 cacggct~gccctcgttcagatcat~ggctgtcaaggaaagcggcgccagatatccgaac 480 
204: 481 gtgtgttgccagcc2 gcttcatccgtgaacaccttgaatccggaatgatatgccccttcc 540 
I I I I I I I I Ill I I I I 11 I I I 11 I 111111 Ill Ill I 11 11 11 Ill I l l 11 I 11 I I I I I I 
112: 481 gtgtgttgccagcc~gcttcatccgtgaacaccttgaatccggaatgatatgccccttcc 540 
204 : 541 aattcgaattgctgggagtgatccagcgatccgggctgggcgtaatagatatgcttgttg 600 
I I I I I I I I I I 11 I I I I I I 11 I I 11 I I I I l l I I I I I I I I I I I I I ll I I I I I I I I I 11 11 11 
112: 541 aattcgaattgctgggagtgatccagcgatccgggctgggcgtaatagatatgcttgttg 600 
204: 601 gagaagtaatagacgatttttcttatcttgcg2 atgaagtcctccgttgggaaaagattg 660 
I I I 11 I I I I I I I I I I I I I I I I I I Ill I I 11 I I 11 I I I I I I I I I I I I I I I I 11 I 11 11 11 
112 : 601 gagaagtaatagacgatttttcttatcttgcg~atgaagtcctccgttgggaaaagattg 660 
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204 : 661 ggttcgtaaatatacttgattctgttcatcgtggataaattccacgaggatggaatgacg 720 
I I I 11 I 11 I 11111 11 111111 11111 11 I I 1111111111111 Ill I I I 11111 Ill 11 
112: 661 ggttcgtaaatatacttgattctgttcatcgtggataaattccacgaggatggaatgacg 720 
204 : 720 tcataccgatgccaaagtcgcttcatttttcctgtcaacgagccgtctgaatatgcg~c~ 780 
I I I Ill I 11 11 I ll I I I I I 11 I I I ll 11 11 I 11 Ill I I I l l I I I I I I 11 I I 11 I I 11 I 
112: 721 tcataccgatgccaaagtcgcttcatttttcctgtcaacgagccgtctgaatatgcg~c~ 780 
204 : 780 aatgcgacgtttccggcggtggcggctgcaaaagagtggcagaaaacgtttttgaatggg 840 
Ill I I 11111111111111111 111111111111111111 1111111111 I 111111111 
112 : 781 aatgcgacgtttccggcggtggcggctgcaaaagagtggcagaaaacgtttttgaatggg 840 
204 : 840 taacccgaggattgcgagaaatatagcgcgaaggtggatgcca gaa cgccgccgaggcta 900 
I I Ill I Ill 11 I 111111111111111 I I 11111 I 11111 I I 11111111111 11 11 Ill 
112 : 841 taacccgaggattgcgagaaatatagcgcgaaggtggatg ccagaa cgccgccga ggcta 900 
204: 900 tgccccgtcacggtgagggtggat~ctttgggtaaatttttcaggaaatcggtgagcgat 960 
11 I I I I I I I I I Ill I I I I I Ill 11 Ill I I 1111111111 11 I I I I I I I I I 11 11 Ill 11 
112: 901 tgccccgtcacggtgagggtggat~ctttgggtaaatttttcaggaaatcggtgagcgat 960 
204: 960 gccgagctatttgaggggagggtttgaagggtga~gtccaatgccttggctgtcccgttt 1020 
Ill I I 1111111 11111 11111 I I 1111111111 11 I 11 11111111111 111111111 
112: 961 gccgagctatttgaggggagggtttgaagggtga~gtccaatgccttggctgtcccgttt 1020 
204: 1020 gctatgagcgcatccggcgggcaatcgctgacatatttcgagaacggggtcagatttttg 1080 
11 Ill I I I I 11111 I I I I I 111111111 I I Ill I 111111 11 I I I I 11 I I Ill 11 11 Ill 
112: 1021 gctatgagcgcatccggcgggcaatcgctgacatatttcgaga acggggtcagatttttg 1080 
204: 1080 acgtcattgtcttc~atgactatatcggcaaactgtga~ttcggattggttccgctgaat 1140 
11111111111111 11111111111111111111111 111111111111111111111 
112: 1081 acgtcattgtcttc~atgactatatcggcaaactgtga~ttcggattggttccgctgaat 1140 
204: 1140 gccaggcgatagtccttgtcgttgctggtgtttttgaagatcgcggttacgttggcggca 1200 
I I I I I I I 11 11 11 I I I I I I 11 I I I 11111 I 1111111 I I Ill I I I I Ill I Ill I I I I I 11 
112: 1141 gccaggcgatagtccttgtcgttgctggtgtttttgaagatcgcggttacgttggcggca 1200 
204: 1200 tatccggaaagagggtcgacatagaccgcgggaccccagacaatggaaaatctattgttt 1260 
I I I I I I I I I I I Ill I I I I I 11 I 111111 I I I Ill I 11111 11 I I I I I I I I I I I I I I I 11 I 
112: 1201 tatccggaaagagggtcgacatagaccgcgggaccccagacaatggaaaatctattgttt 1260 
204: 1260 ttcgtcttcgttgattt~ccgag~tagccgataattaattt~cccaggatgtccgtggtg 1320 
11111111111111111 11111 11111111111111111 111111111111111111 
112: 1261 ttcgtcttcgttgattt~ccgag~tagccgataattaattt~cccaggatgtccgtggtg 1320 
204: 1320 gga~tcttgatattctggccccagtccatcgcgcacgataacgtgaaattcgtttgtcg~ 1380 
I I I I I I 11 Ill 11111 11 I I I I I Ill I I I l l I I I I I I I I 11 11111111 I 1111111 I 
112 : 1321 gga~tcttgatattctggccccagtccatcgcgcacgataacgtgaaattcgtttgtcg~ 1380 
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204 : 1380 tcgtcgagagagtcgaataaatcgtatgagtcgatcgaatcgaatggatcgaatgaatcg 1440 
I I I I 11 I I I Ill I I I 11 I Ill I I I Ill I I I I I I I 11 I I I I I I I I I I I I I I 11 I I I I 11 11 
112: 1381 tcgtcgagagagtcgaataaatcgtatgagtcgatcgaatcgaatggatcgaatgaatcg 1440 
204: 1440 ggaggatcgagttcggtggccatgatggtgtt 1472 
I I Ill I 11 I I I I I I I I I I 11 I 11 11 I I I I I I I 
112: 1441 ggaggatcgagttcggtggccatgatggtgtt 1472 
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APPENDIX VI 
DATA RELEVANT TO CHAPTER 6 
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M E8 I 9 22 25 E25 33 22 M M 53 97 98 102 I 12 204 2 12 \1 
M 216 217 392 426 448 576 Zhl M 
M Hal Ha2 Ha4 H55 H93 106 H706 M 
Fig 1: A comparison of the whole cell proteins from different B. pseudomallei 
isolates. M indicates molecular weight markers (kDa). 
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Table 1: Homology ofDTNVDLINC peptide used for the production ofanti-MrgR antibody 
to sequences in database. Identical amino acid residues are in red bold. 
Sequence Description Homologous sites 
SW: FMK.l- E. coli P04740 Fimbrillin precursor DTNVDLINC 
SW: MT21 - S. pneumoniae P04043 Methylase DTNVDLINC 
SW: YHEV- E. coli P56622 Hypothetical protein DTNVDLINC 
SW: PAPA- E. coli Pap fimbria! protein DTNVDLINC 
SW: YRBE- E. coli Hypothetical protein DTNVDLINC 
SW: PERA- E. coli Transcriptional activator DTNVDLINC 
SW: FER- C. butyricum Ferrodoxin DTNVDLINC 
SW: YJEB- V. parahaemolyticus Hypothetical protein DTNVDLINC 
SW: MALD- S. pneumoniae Maltodextrin transport DTNVDLINC 
SW: HSTO- V. cholerae Enterotoxin DTNVDLINC 
SW: HST- V. cholerae Heat shock protein DTNVDLINC 
SW: DMA7- E. coli DNA adenine methylase DTNVDLINC 
SW: DMA- H influenzae DNA adenine methylase DTNVDLINC 
SW: SP4A- B. subtilis sporulation protein DTNVDLINC 
SW: YQJM- B. subtilis NADH dependent flavin DTNVDLINC 
SW: YTFM- H influenzae Hypothetical protein DTNVDLINC 
SW: ALGE- P. aeruginosa Alignate production protein DTNVDLINC 
SW: G3P- P. aeruginosa Glyceraldhyde 3-phosphate DTNVDLINC 
SW: YDGJ- E. coli Hypothetical oxidoreductase DTNVDLINC 
SW: DNIV- E. coli DNA integrase DTNVDLINC 
SW: EUTH- E. coli Ethanolamine utilizing protein DlNVDLINC 
SW: MALD- S. pneumoniae Maltodextrin transport DTNVDLINC 
SW:Y390- M genitalis Hypothetical ATP-binding DTNVDLINC 
SW: YJDB- S. typhimurium Hypothetical protein DTNVDLINC 
SW:MT21- S. pneumoniae Methylase DTNVDLINC 
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Table 2: Homology ofRKFYSLESN peptide used for the production of anti-MrgS antibody 
to sequences in database. Identical amino acid residues are in red bold. 
Sequence Description Homologous sites 
SW: YCBK- H injluenzae Hypothetical protein RKFYSLESN 
SW: RL27- E. coli 50S Ribosomal protein RKFYSLESN 
SW: YWF A- B. subtilis Hypothetical protein RKFYSLESN 
SW: CLPR- H injluenzae Glycerol3-phosphate regulator RK.FYSLESN 
SW: YDGT- E. coli Hypothetical protein RKFYSLESN 
SW: RF AP- E. coli Lipopolysaccharide core RKFYSLESN 
SW: BINR- S. aureus DNA invertase RK.FYSLESN 
SW:DDLB- E. coli D-alanine ligase RKFYSLESN 
SW: YPB3- E. coli Hypothetical protein RKFYSLESN 
SW: Y074- H injluenzae Hypothetical protein RKFYSLESN 
SW: RlBR- B. subtilis RibR regulatory protein RKFYSLESN 
SW: SP5M- B. subtilis Sporulatoin protein RKFYSLESN 
SW: FMFl- E. coli Fimbria! protein RKFYSLESN 
SW: LEP3- V cholerae Prepilin-like protein RKFYSLESN 
SW:YQEL- B. subtilis Hypothetical protein RKFYSLESN 
SW: P ARP- E. coli DNA replication protein RKFYSLESN 
SW:TEHB- H injluenzae Resistance protein RKFYSLESN 
SW: SAPC- E. coli Peptide permease RKFYSLESN 
SW:SAPC- E. coli Peptide transport protein RKFYSLESN 
SW: YBDJ- K pneumoniae Hypothetical protein RKFYSLESN 
SW: Y AAC- B. subtilis Hypothetical protein RKFYSLESN 
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Fig 2: Specificity of anti-MrgR antibody. Failure of recognition of MBP-MrgR 
fusion after blocking with specific peptide. M indicates protein molecular 
weight markers (kDa). 
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Table 3: Examples of the homology of DTNVDLINC and RKFYSLESN peptides to 
potential proteins deduced from the genome sequence of B. pseudomal/ei isolate K96243. 
Identical amino acid residues are in red bold. 
Homologous sites 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLJNC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSL ESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLJNC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLJNC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLJNC RKFYSL ESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLINC RKFYSLESN 
DTNVDLJNC RKFYSLESN 
369 
APPENDIX VD 
CONSTRUCTION OF A GENE MUTANT 
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Creating a mrgR deficient mutant of B. pseudomallei 
Further investigation of the role of MrgR in the adaptive responses of B. pseudomallei 
would be greatly facilitated by the construction of a mutant deficient in the expression of the 
mrgR gene. The strategy used to create such a mutant is illustrated in Fig 1. 
pCVD442 suicide vector 
The pCVD442 plasmid vector (Donnenberg and Kaper, 1991) (Fig 1) is based on R6K, 
which means it will only replicate in permissive E. coli strains in which the 7t protein 
encoded by the pir gene is provided in trans (Kolter et al. , 1978). In most cases this is 
achieved by using E. coli strains that are lysogenic for a ')... pir transducing phage (Simon et 
al., 1983), e.g. E. coli SY327. In addition, pCVD442 contains the mob region of RP4 such 
that strains with the RP4 tra functions inserted on the chromosome are able to mobilise the 
plasmids into the target bacteria (Simon et al., 1983). The suicide vector is used as the basis 
to develop positive selection that permits marker exchange mutagenesis and introduction of 
the reporter gene fusion onto the chromosome. The basis of the positive selection is the 
presence of a cloned Bacillus subtilis sacB gene; this encodes levensucrase, which catalyses 
the hydrolysis of sucrose as well as the synthesis of levans (Gay et al. , 1983). Expression of 
the sacB gene is toxic for Gram-negative bacteria when they are growing in the presence of 
5% sucrose. This greatly facilitates the introduction of defined deletion mutations back into 
the chromosome of the bacteria (Simon et al., 1991 ). Once a single homologous 
recombination event has been achieved, it is possible to directly select for the second 
recombination event by growing the strains in the presence of sucrose. Only those colonies 
that have lost the vector sequences will be able to grow on this medium. The pCVD442 
suicide vector was kindly provided by Or G. Dougan, Imperial college, London, UK. 
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Disruption of mrgR by the insertion of a gene encoding kanamycin resistance 
It was decided that the most suitable antibiotic to use for the mutagenesis of B. 
pseudomallei would be kanamycin. The kanamycin resistance gene (kanR) was cleaved 
from pGD103 (Fig 1) using Pvuii (section 3.4.5.1), which cleaves sites located 5' and 3' to 
the gene. The gene fragment was checked on 0.8% agarose gel (section 3.4.6) and purified 
with the Prep-A-Gene kit (section 3.4.4.3). The resultant blunt-ended DNA fragment was 
ligated (section 3.5.2) into the Pmn restriction site in pMRG2 (section 4.3.7) located at 
nucleotide 612 in the mrgR coding sequence. Recombinants were selected on LB agar 
containing kanamycin (25 f.Lg/ml) and ampicillin (100 f.Lg/ml). One clone, pMMUT1 , was 
selected for further analysis. 
Insertion of the disrupted mrgR gene into pCVD442 
The mrgR::kan: :mrgR fragment was obtained by EcoRV digestion of the pMMUT1, 
which produced a fragment carrying the disrupted mrgR gene plus a flanking region of 532 
bp upstream and 459 bp downstream sequences. This fragment was purified then ligated into 
the unique Smal site of pCVD442 before transforming E. coli SY327 (section 3.5.4.1). 
Recombinants were selected on LB agar containing both ampicillin (100 f.Lg/rnl) and 
kanamycin (25 f.Lg/rnl). The construction, in the correct orientation, was confirmed by 
restriction site mapping of the recombinant plasmid DNA, and a positive clone, referred to 
as pMMUT2, was chosen for further studies. 
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Fig 1: Strategy for the construction of mrgR mutant in pCVD442 suicide vector. 
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